index,PaCMAP 1,PaCMAP 2,PaCMAP 3,PaCMAP 4,PaCMAP 5,Clinical Trial,Sample Type,Patient_ID,ELN AML 2022 Diagnosis,Train Test,Batch,Hematopoietic Lineage,MethylScoreAML_Dx_predictions
0003fe29-7b8f-4ef1-b9bc-40306205f1fd_noid,14.163744,-12.102138,11.901865,15.43214,-16.474106,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANVPB,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
0031efba-f564-4fff-bd7b-2b97f37218c1_noid,-5.85957,-11.12918,6.4362636,7.4309936,10.586304,AAML0531,Bone Marrow Normal,PASDKZ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
0037ec75-bb9e-4dbb-a2d9-de1f9bfd2362_noid,13.5449,-14.129482,-1.1719126,-14.600304,-12.464355,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PASDKZ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
003d9efe-90a1-42cf-84c4-03fbabefe60b_noid,-10.709123,-15.305382,-21.7717,6.981653,-21.686016,TARGET ALL,Bone Marrow Normal,TARGET-00-SJNORM054698,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
004c953f-d999-4d82-898d-c091e692df3c_noid,-14.334599,-13.189907,2.2610595,25.173847,-12.7937565,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PASAUT,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
005fdc28-ef44-4957-bc70-ddd5c19bb4cb_noid,-5.47703,-11.416238,5.9946733,7.061894,10.688519,TCGA AML,Diagnosis,TCGA-AB-2972,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
0066d4af-8019-46a0-ba29-d2962c9537a7_noid,10.688504,-27.276545,-13.80344,4.209973,16.79484,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASYWA,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
00bb876d-e77c-4479-ab39-0c4d56d08077_noid,-0.3670665,-11.666441,9.90654,11.882847,10.278313,AAML03P1,Bone Marrow Normal,PAMYMA,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),MDS-related or secondary myeloid neoplasms
010603fe-b2bf-41ff-9059-9999e7b71613_noid,15.57923,-7.726502,-19.177387,-14.428823,20.503115,TCGA AML,Diagnosis,TCGA-AB-2955,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
0138b648-4c9f-4566-b266-19f314c94b13_noid,16.695835,-7.586953,-19.419437,-14.365843,19.863039,TCGA AML,Diagnosis,TCGA-AB-2979,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
014d5833-4193-4919-b42d-112c3c6f2b11_noid,13.721321,4.220471,19.505833,-6.4609804,17.22256,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016340,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
01a4d800-3999-41ee-bee3-551c5d031939_noid,1.2271719,-13.577886,7.775577,11.729786,9.00794,TCGA AML,Diagnosis,TCGA-AB-2923,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
0282f163-cc24-4638-9ee1-05f3ea386461_noid,-14.626357,-13.178058,2.000435,24.96923,-12.743947,AAML0531,Recurrent Blood Derived Cancer - Peripheral Blood,PARNZW,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
029772ca-d11d-4490-b35f-fd1793db9b29_noid,-11.544268,11.724011,4.5882792,-23.694202,11.350171,TCGA AML,Diagnosis,TCGA-AB-2853,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
02b94d3d-2b6f-4c7a-9554-8e6256ddc791_noid,12.756259,6.9618764,21.689531,-1.0267311,22.311605,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASSLT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
02d84607-0150-48ac-b9dc-f857e5cabf1c_noid,-13.957327,-13.374085,2.3310175,25.99323,-13.191642,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PAPXWI,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
046e9dd9-eed9-4547-98bd-14459d593f14_noid,13.978712,-12.154322,11.736729,15.036803,-14.339343,TCGA AML,Diagnosis,TCGA-AB-3002,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
05d55b6f-b25a-4e2d-8dbe-d8ad05e4662e_noid,14.870596,-12.042522,11.984692,15.767176,-15.105029,TCGA AML,Diagnosis,TCGA-AB-2877,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
066a0e74-f87e-4f06-ab5c-d42972ba8394_noid,-9.846023,-7.0658784,12.128544,11.057442,11.190958,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARFIW,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
06ab4c03-1ac8-4106-9bb9-34038132bdd7_noid,-4.298743,-11.541025,7.2904577,8.717558,10.332228,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAKTCX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
06e6d2a3-e9c4-4d46-b922-89dc0a4ec3d3_noid,1.2327,22.057577,-12.449728,-6.537745,14.739416,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML007112,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
0717a5b5-d437-4d56-bdb6-e79d25486de4_noid,13.561879,4.4238224,20.053083,-4.8071723,16.84179,TARGET ALL,Recurrent Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016343,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),MDS-related or secondary myeloid neoplasms
0756d4f2-8aba-49ab-bd6a-1b240f07274b_noid,-13.833779,-13.467428,2.3005466,26.368996,-13.3869915,AAML0531,Bone Marrow Normal,PARUWX,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
077fefd3-42de-46ae-84db-929a521e4bd2_noid,14.673764,-10.692318,-1.444298,-16.649511,-14.691251,CCG2961,Primary Blood Derived Cancer - Peripheral Blood,PAEFGT,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
07cc5884-1128-459f-9a13-f2c004b60b86_noid,-16.553127,-8.822446,-18.528543,15.954624,18.95384,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARTAL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
07f68bf2-e455-4f68-ba9b-ea1c2135553f_noid,-14.168683,-13.257427,2.3145044,25.488028,-12.942435,AAML0531,Bone Marrow Normal,PATIAK,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
083a4451-7f82-4dfa-bc5d-9cfe4a3e3264_noid,-8.917923,-8.110175,12.69609,11.079443,11.399721,AAML0531,Bone Marrow Normal,PATKBK,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
0916e199-6305-4030-9f62-e10b99f1b43c_noid,13.623211,4.8191195,19.99561,-5.247731,17.662983,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016447,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),MDS-related or secondary myeloid neoplasms
09188087-8ca5-4841-8061-b5010da37283_noid,-11.836122,-5.1789665,13.059579,11.386011,11.534909,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASRLS,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
093ffb56-9f6c-4c7c-a37d-f54b5fca26c1_noid,-11.580548,-11.85987,19.598621,-13.743925,-16.172127,TCGA AML,Diagnosis,TCGA-AB-2911,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
0993929a-de98-4de0-9e5d-b3586b05bc2a_noid,13.553593,-7.8342533,-19.256664,-13.927295,19.815275,TCGA AML,Diagnosis,TCGA-AB-2940,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
09e28366-5553-47ba-81e8-6b04eef348aa_noid,-12.113084,-8.633119,20.493076,-12.316769,-16.74093,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANTWV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
0a2c68c6-f4b6-4691-97e3-0503e8c620f2_noid,-15.645105,-8.524225,-18.5624,15.931132,18.912476,TCGA AML,Diagnosis,TCGA-AB-2954,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
0a3c09c4-4630-4eab-9de5-b13670639b98_noid,12.808905,-12.395382,-1.3197097,-17.218508,-11.529571,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASYEJ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
0a91f18a-9b85-4d76-8440-265228e55a24_noid,-1.064104,-9.5617485,3.4164379,10.472465,9.796454,TCGA AML,Diagnosis,TCGA-AB-2968,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
0aed4334-f8e3-46ae-8dd2-7c54ab4288f2_noid,12.861711,6.414624,21.22613,-1.1436894,21.328028,TCGA AML,Diagnosis,TCGA-AB-2849,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
0b0f1d16-fd0a-42ef-bc78-04033b048d13_noid,14.763331,-11.928887,-1.3969713,-15.789832,-13.294483,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASTUH,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
0b30575c-c5fb-4cff-9d4a-fecd7ba1bbcb_noid,-13.953603,-4.097029,14.288401,11.568868,12.343006,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARNAW,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
0b70eb7a-be03-4a64-978e-bbc2c3050cd8_noid,-11.518694,11.941858,4.2459626,-24.591957,11.565193,TCGA AML,Diagnosis,TCGA-AB-2925,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
0baa12d9-2c32-4a96-a771-65752ad105e6_noid,12.852568,6.6140485,21.378428,-1.3464335,21.640026,AAML0531,Bone Marrow Normal,PASSLT,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
0bd38c1b-4205-4517-9c50-193abbecf2eb_noid,-15.329817,-0.16661991,14.580249,11.971596,12.616569,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PAPBEJ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
0c2c4cbd-df11-44ec-8996-24f816f9771e_noid,-5.948539,-10.014504,10.969447,10.519776,11.1062155,AAML0531,Bone Marrow Normal,PASFHK,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with other rare recurring translocations
0c98657f-3109-409f-bd6b-a56cb212d916_noid,-13.775425,-13.425848,2.4239347,26.267109,-13.308987,CCG2961,Bone Marrow Normal,PAKVGI,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
0d8b1fcb-5e53-4b29-8cee-54367498868e_noid,-5.9798346,-11.353037,6.5435553,7.552636,10.179304,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PADYIR,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
0d9d39b3-f015-4e7c-aa03-30e44239a2ab_noid,13.989789,0.594993,19.284634,-11.254358,15.6079035,TARGET ALL,Primary Blood Derived Cancer - Peripheral Blood,TARGET-10-PASZJW,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
0db24aae-68e1-4cad-a88e-cd24209589eb_noid,-14.191417,-13.4873905,1.9210223,26.23576,-13.396031,AAML0531,Bone Marrow Normal,PARIMT,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
0e2489f4-e1e9-4820-9606-4889f9982656_noid,13.008983,-12.595042,-1.0657032,-16.923153,-10.505853,TCGA AML,Diagnosis,TCGA-AB-2973,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
0e923f1b-1816-498a-a750-03acdc1e63ad_noid,-8.673162,-8.378973,12.8977,11.094829,11.480897,CCG2961,Blood Derived Normal,PAECCE,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
0eecc3b5-9d78-419d-8567-50845a452f57_noid,15.803962,-7.692928,-19.251814,-14.304525,20.143255,TCGA AML,Diagnosis,TCGA-AB-2808,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
0fd2a6ec-08d9-436b-8ab0-7b034406d25e_noid,12.063579,-25.984571,-12.979449,3.5921884,16.664698,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040037,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
0fe894a2-068f-4c76-80eb-ed6383bf5443_noid,12.918268,-13.096697,-1.252275,-16.74836,-10.383637,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASGCE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
10248a38-651a-4f04-95c0-ca45d9f2424b_noid,-11.382051,12.046769,4.266865,-24.62789,11.683244,TCGA AML,Diagnosis,TCGA-AB-2981,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
108a4381-e304-4545-8a58-0961ab4119e0_noid,-1.9797657,-11.324939,5.1734614,8.878389,10.592731,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARUBT,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
10eadc0c-2a3a-479e-b46d-191cf54f67ae_noid,13.471621,-14.337814,0.24930087,-11.896879,-16.178915,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012418,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
120dcc9d-f0eb-4944-b432-bb02975dc512_noid,-16.573523,6.0103707,14.587451,12.668141,13.536287,AAML0531,Bone Marrow Normal,PATDHA,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
122d2b73-14b4-442e-90d5-fdf9c69980be_noid,-13.050036,-13.6219,2.806851,27.331985,-13.757798,AAML03P1,Bone Marrow Normal,PANGTF,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
1332a645-9fab-4c82-b155-6bcc6a34c7c8_noid,-10.610069,6.6526203,-16.04091,-1.0497869,-22.642162,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016343,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
1334d1b0-4fb5-47c5-8e78-02abf70b85df_noid,-16.512642,6.457039,14.398929,12.940611,13.57423,AAML0531,Bone Marrow Normal,PARVAI,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
14b433a9-f327-4954-a805-163ac8d075f1_noid,15.504816,-9.2701435,1.3253516,-14.494634,-16.193598,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARSAN,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
162c2eab-f29a-46cd-9f6d-1e545f317709_noid,13.053222,4.703061,19.869291,-0.371843,18.519997,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARPDS,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
1634c681-7242-4ef9-85ce-e5fe38e01d94_noid,11.794885,-26.206676,-13.128366,3.7175405,16.683725,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL042793,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
167e8d20-2281-4f0b-a65d-f85b02f0daba_noid,1.8330197,23.259935,-13.423692,-6.364644,13.955905,TCGA AML,Diagnosis,TCGA-AB-2858,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
16babfa2-98b2-4e77-80eb-5a01d9eeba9c_noid,-13.376622,-13.454983,2.7618752,26.59034,-13.400773,AAML0531,Bone Marrow Normal,PARWXU,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
16fc046f-cec5-475d-8333-1421c3ff2752_noid,-6.867345,12.177978,-19.116283,-0.1913823,-21.336473,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-SJBALL004182,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
17056b19-d78b-4ded-a54e-d1c70d47e9e3_noid,3.826091,20.023115,-13.830615,-6.809923,14.773738,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARPPY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
1799dbfd-5deb-4ee1-86ee-54c79fc1a711_noid,-11.252669,12.250687,4.2286477,-25.259943,12.080268,TCGA AML,Diagnosis,TCGA-AB-2809,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
183d74b6-7c41-4b54-b048-cc23bb2e518c_noid,-11.971712,-9.608991,20.263214,-12.749023,-16.573072,TCGA AML,Diagnosis,TCGA-AB-2842,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
183e430f-311b-40b2-a804-272b60151139_noid,13.324168,-12.640398,-1.233209,-16.368603,-12.258565,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARNZW,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
193a4af6-9584-4cac-9f08-d126696acd0b_noid,-8.843878,7.024555,-18.115946,-0.73879486,-20.928173,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046471,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
19476c93-8d91-47dd-8fae-f926197b08c9_noid,-2.690045,10.867418,-17.929182,0.91689736,-21.40501,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016448,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
19fea866-30c9-4f49-b912-3ebd84fee370_noid,0.6984916,22.30518,-12.682015,-6.811841,14.2606945,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045740,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
1a66e194-f28e-4602-9992-1f8edb32e05f_noid,3.9754505,14.214638,-12.512101,3.2005808,-25.436214,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-SJBALL021816,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
1a7cbb26-d434-4609-90f8-34ea9421f9b3_noid,16.184158,-7.671083,-19.194843,-14.909278,21.214458,TCGA AML,Diagnosis,TCGA-AB-2876,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
1ac0a1a4-0570-4ec1-878d-294283c70f62_noid,-5.214474,-10.3213415,6.8915052,8.609175,10.783309,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARTAL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
1af905c6-7670-4e2e-9c09-f566cfc1cdb9_noid,-16.748663,-10.608299,-17.082165,15.712364,20.093725,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARUDL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
1f03d9d5-0175-4455-9d4b-42dcc4247d91_noid,10.11726,-28.35098,-14.361479,4.3809605,16.965792,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PABLDZ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
1f9f5369-6c62-419f-b97b-d1d5e1cd6672_noid,4.2152324,14.031064,-12.574695,3.191511,-25.157455,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-SJBALL014146,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200517480142_R01C01,-13.114192,12.880735,20.183672,-4.091216,-19.001862,Japanese AML05,Diagnosis,G_AML_187,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200517480142_R02C01,13.57911,-14.191725,-1.0844625,-14.255609,-12.988032,Japanese AML05,Diagnosis,G_AML_222,AML with other rare recurring translocations,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200517480142_R03C01,-17.039263,-19.044266,0.95429504,-14.333876,-23.002531,Japanese AML05,Diagnosis,G_AML_105,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with mutated NPM1
200517480142_R04C01,14.867269,-7.7798576,-19.162056,-14.122142,20.100664,Japanese AML05,Diagnosis,G_AML_434,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200517480142_R05C01,-17.105244,-19.027784,0.8843496,-14.400213,-23.036903,Japanese AML05,Diagnosis,G_AML_373,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with mutated NPM1
200517480142_R06C01,-12.4086685,10.158814,20.003565,-5.1826925,-18.410217,Japanese AML05,Diagnosis,G_AML_357,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200517480142_R07C01,13.099895,4.663925,19.690228,-0.28431517,18.358433,Japanese AML05,Diagnosis,G_AML_394,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200517480142_R08C01,1.3192388,23.440733,-13.237306,-6.4055862,13.909831,Japanese AML05,Diagnosis,G_AML_070,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200517480143_R01C01,12.849889,-12.459985,-1.4419491,-17.502584,-10.301051,Japanese AML05,Diagnosis,G_AML_432,AML with mutated NPM1,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with mutated NPM1
200517480143_R02C01,13.954405,-12.573541,-0.053608138,-13.672962,-15.935183,Japanese AML05,Diagnosis,G_AML_012,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200517480143_R03C01,-17.25203,-18.997484,0.72011036,-14.546167,-23.115213,Japanese AML05,Diagnosis,G_AML_319,AML with mutated NPM1,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with mutated NPM1
200517480143_R04C01,14.762228,-7.7179894,-19.282362,-15.493475,22.305176,Japanese AML05,Diagnosis,G_AML_440,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200517480143_R05C01,-15.457767,0.16577458,14.623305,11.998328,12.685244,Japanese AML05,Diagnosis,G_AML_038,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200517480143_R06C01,-12.113187,13.41927,19.555883,-4.7557626,-18.70784,Japanese AML05,Diagnosis,G_AML_021,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200517480143_R07C01,3.8281655,20.413008,-13.740793,-7.2226787,14.376444,Japanese AML05,Diagnosis,G_AML_120,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200517480143_R08C01,13.572241,-13.71296,-1.0928586,-14.962296,-12.184055,Japanese AML05,Diagnosis,G_AML_225,AML with other rare recurring translocations,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200517480198_R01C01,16.938736,-7.552591,-19.405687,-15.214391,21.306042,Japanese AML05,Diagnosis,G_AML_040,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200517480198_R02C01,-17.751308,-10.4855,-16.981789,15.235119,18.885983,Japanese AML05,Diagnosis,G_AML_128,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200517480198_R03C01,12.972837,-11.869475,-1.6037431,-18.00028,-10.657677,Japanese AML05,Diagnosis,G_AML_051,AML with mutated NPM1,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with mutated NPM1
200517480198_R04C01,-12.402312,10.599726,20.514503,-2.458951,-18.489632,Japanese AML05,Diagnosis,G_AML_049,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200517480198_R05C01,-11.894002,-11.289555,20.175676,-13.496207,-16.330505,Japanese AML05,Diagnosis,G_AML_014,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200517480198_R06C01,1.1718292,22.740873,-13.221291,-6.985846,13.721817,Japanese AML05,Diagnosis,G_AML_129,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200517480198_R07C01,14.622062,-10.323821,-0.7705616,-16.612871,-14.125101,Japanese AML05,Diagnosis,G_AML_136,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with mutated NPM1
200517480198_R08C01,2.4918475,12.014099,-10.074799,2.5891128,-26.6036,Japanese AML05,Diagnosis,G_AML_109,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210048_R01C01,13.093509,-13.73906,-1.045449,-15.463204,-11.437971,Japanese AML05,Diagnosis,G_AML_188,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210048_R02C01,16.591478,-7.6231947,-19.325535,-14.292374,19.89478,Japanese AML05,Diagnosis,G_AML_048,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200526210048_R03C01,-11.523405,13.220733,19.378044,-5.9096746,-19.694534,Japanese AML05,Diagnosis,G_AML_065,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210048_R04C01,-5.868317,-11.432576,5.8866105,6.7875066,10.642611,Japanese AML05,Diagnosis,G_AML_067,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210048_R05C01,-12.488903,13.715409,19.786308,-4.7379456,-18.993418,Japanese AML05,Diagnosis,G_AML_164,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210048_R06C01,14.240925,-11.487887,-0.720724,-15.351571,-15.402715,Japanese AML05,Diagnosis,G_AML_153,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with mutated NPM1
200526210048_R07C01,-3.125814,-11.153395,9.697471,11.131209,10.099269,Japanese AML05,Diagnosis,G_AML_430,Unknown,Discovery (train) Samples,GSE133986,Unknown,MDS-related or secondary myeloid neoplasms
200526210048_R08C01,1.4747432,22.645782,-12.87116,-6.6338444,14.245829,Japanese AML05,Diagnosis,G_AML_144,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200526210054_R01C01,1.8682338,20.89311,-12.891765,-6.9552364,14.661743,Japanese AML05,Diagnosis,G_AML_175,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200526210054_R02C01,-3.4821544,-10.195537,7.6728215,10.315393,10.6832285,Japanese AML05,Diagnosis,G_AML_176,Unknown,Discovery (train) Samples,GSE133986,Unknown,MDS-related or secondary myeloid neoplasms
200526210054_R03C01,-10.803816,12.448234,20.054585,-4.846976,-18.613832,Japanese AML05,Diagnosis,G_AML_006,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210054_R04C01,-13.185082,13.393647,20.08953,-4.276159,-19.09881,Japanese AML05,Diagnosis,G_AML_356,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210054_R05C01,1.2458842,-13.224601,7.35007,11.883393,8.762327,Japanese AML05,Diagnosis,G_AML_306,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
200526210054_R06C01,-4.9651585,-11.299129,5.7947145,6.9529295,11.2020445,Japanese AML05,Diagnosis,G_AML_086,Unknown,Discovery (train) Samples,GSE133986,Unknown,MDS-related or secondary myeloid neoplasms
200526210054_R07C01,-5.9677114,-10.591007,10.835101,11.205853,9.520773,Japanese AML05,Diagnosis,G_AML_061,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210054_R08C01,13.749803,-11.535861,-0.51548725,-17.002472,-10.611826,Japanese AML05,Diagnosis,G_AML_185,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210082_R01C01,-11.321269,11.027979,20.888504,-3.1322305,-17.664112,Japanese AML05,Diagnosis,G_AML_388,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210082_R02C01,1.4954938,23.066637,-13.187623,-6.753882,13.830906,Japanese AML05,Diagnosis,G_AML_013,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200526210082_R03C01,-3.7670932,-11.35833,9.45885,10.636158,10.013826,Japanese AML05,Diagnosis,G_AML_228,Unknown,Discovery (train) Samples,GSE133986,Unknown,MDS-related or secondary myeloid neoplasms
200526210082_R04C01,13.823268,-13.785319,0.73720545,-11.416253,-17.259222,Japanese AML05,Diagnosis,G_AML_204,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210082_R05C01,-5.4924345,-11.3381195,5.6443415,6.5387397,11.173594,Japanese AML05,Diagnosis,G_AML_329,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210082_R06C01,1.7041129,-13.620284,8.279636,11.564734,9.136132,Japanese AML05,Diagnosis,G_AML_269,Unknown,Discovery (train) Samples,GSE133986,Unknown,MDS-related or secondary myeloid neoplasms
200526210082_R07C01,15.866809,-7.723669,-19.100586,-14.697858,21.04229,Japanese AML05,Diagnosis,G_AML_125,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200526210082_R08C01,-12.6152525,13.927744,19.094608,-6.170458,-19.898193,Japanese AML05,Diagnosis,G_AML_259,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210087_R01C01,13.2496605,4.661135,19.319876,-0.6501779,18.033298,Japanese AML05,Diagnosis,G_AML_398,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210087_R02C01,-11.584914,-11.787773,19.608301,-13.71255,-16.180529,Japanese AML05,Diagnosis,G_AML_068,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210087_R03C01,2.3510733,19.978495,-13.409835,-7.158686,14.606915,Japanese AML05,Diagnosis,G_AML_237,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200526210087_R04C01,13.769496,-10.186496,-1.1086152,-18.300776,-12.077696,Japanese AML05,Diagnosis,G_AML_101,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with mutated NPM1
200526210087_R05C01,15.7445345,-7.682063,-19.326687,-13.969334,19.463411,Japanese AML05,Diagnosis,G_AML_169,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200526210087_R06C01,-11.820617,8.033398,21.81196,-2.0173836,-17.740057,Japanese AML05,Diagnosis,G_AML_347,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210087_R07C01,13.819764,-12.471886,0.10064518,-13.907349,-15.346848,Japanese AML05,Diagnosis,G_AML_381,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200526210087_R08C01,15.476823,-9.258272,1.8367693,-14.281826,-15.484974,Japanese AML05,Diagnosis,G_AML_324,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with mutated NPM1
200526210091_R01C01,-12.149965,-8.303347,20.549585,-12.171012,-16.7949,Japanese AML05,Diagnosis,G_AML_156,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210091_R02C01,13.1185255,4.326709,19.444664,-0.35388803,17.782991,Japanese AML05,Diagnosis,G_AML_424,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210091_R03C01,-11.835508,-10.645444,20.041193,-13.208869,-16.399006,Japanese AML05,Diagnosis,G_AML_108,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200526210091_R04C01,1.9418929,22.761158,-13.0037775,-7.0416675,13.872233,Japanese AML05,Diagnosis,G_AML_276,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200526210091_R05C01,17.384768,-7.546139,-19.358973,-14.937953,20.834814,Japanese AML05,Diagnosis,G_AML_223,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200526210091_R06C01,-15.173849,-3.6818416,15.121382,11.638859,12.985536,Japanese AML05,Diagnosis,G_AML_352,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with other rare recurring translocations
200526210091_R07C01,15.128183,-9.084331,0.0027893777,-16.431393,-15.226352,Japanese AML05,Diagnosis,G_AML_437,AML with mutated NPM1,Discovery (train) Samples,GSE133986,Acute myeloid leukemia (AML),AML with mutated NPM1
200526210091_R08C01,17.536243,-7.524607,-19.397718,-14.955683,20.784399,Japanese AML05,Diagnosis,G_AML_018,Unknown,Discovery (train) Samples,GSE133986,Unknown,AML with in-frame bZIP mutated CEBPA
200720060088_R01C01,-5.6030955,11.289529,-17.759672,0.2691959,-21.087572,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_429,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200720060088_R02C01,-4.1913276,-11.954879,9.120366,10.163049,9.517768,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_451,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200720060088_R03C01,13.873093,3.8994853,18.931526,-9.215377,15.881416,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_460,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200720060088_R04C01,14.154978,5.3542523,19.920954,-6.976426,16.006918,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_468,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200720060088_R05C01,13.930916,4.283872,19.427412,-7.722571,16.290321,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_474,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200720060088_R06C01,13.749146,4.3014574,19.343084,-6.7187696,17.167881,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_477,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200720060088_R07C01,14.240195,5.531556,19.862797,-6.47973,16.141413,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_479,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200720060088_R08C01,-9.896715,-18.146387,10.628166,-21.55108,14.379505,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_482,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200722330095_R01C01,14.171646,5.401903,19.948568,-6.879882,16.007471,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_638,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330095_R02C01,13.995636,3.9752808,18.930876,-8.537457,15.985101,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_646,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330095_R03C01,13.855865,4.409648,19.699007,-7.3597608,16.456633,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_667,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200722330095_R04C01,13.780072,4.0578847,18.804842,-9.633755,15.817215,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_670,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330095_R05C01,-8.612464,7.2468457,-18.250584,-0.6825571,-20.835594,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_672,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200722330095_R06C01,4.529133,13.171012,-12.153629,3.060072,-24.770712,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_673,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330095_R07C01,13.989048,4.5257792,19.196205,-8.077661,16.029837,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_698,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330095_R08C01,5.6489863,13.235053,-11.61833,3.2932572,-24.81358,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_699,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330109_R01C01,-5.600543,-11.168897,7.144889,8.265871,10.22073,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_576,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200722330109_R02C01,-10.443738,-17.958479,10.580069,-21.885624,14.491029,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_584,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200722330109_R03C01,13.865554,4.9194903,19.857988,-6.199943,16.790443,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_599,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330109_R04C01,13.978611,4.738264,19.730192,-7.3933654,16.189959,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_601,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200722330109_R05C01,-5.285941,11.71534,-17.58475,0.38969067,-21.027529,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_621,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330109_R06C01,14.071073,5.1988826,19.898218,-6.6550198,16.275343,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_623,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330109_R07C01,-4.5723515,11.916762,-17.56709,0.54934067,-21.29294,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_627,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200722330109_R08C01,-0.7417559,-8.815747,1.7762121,10.495145,9.564557,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_635,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750002_R01C01,13.480797,5.4568253,20.336521,-4.2399507,18.722645,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_485,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750002_R02C01,-10.295627,-17.81197,10.586123,-21.664932,14.41316,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_486,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750002_R03C01,-9.506393,-17.541458,10.631803,-20.811012,14.120341,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_489,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750002_R04C01,14.035514,4.456871,18.782663,-8.677386,15.748476,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_494,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750002_R05C01,-9.958532,-17.529852,10.599473,-21.192192,14.248128,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_497,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750002_R06C01,13.587041,5.079847,20.042368,-4.896604,18.11012,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_498,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750002_R07C01,13.882169,4.2327394,18.73659,-9.367451,15.744609,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_522,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750002_R08C01,13.493155,5.5496,20.387346,-4.254872,18.792204,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_527,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750014_R01C01,14.034921,5.4767756,19.891256,-5.850202,16.85114,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_701,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750014_R02C01,13.99347,4.4195986,18.72967,-8.731014,15.800544,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_724,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750014_R03C01,-15.217186,9.31531,15.428743,9.714604,13.681531,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_731,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200727750014_R04C01,-0.29528588,-8.42646,0.8718075,9.993605,10.005482,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_732,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750019_R01C01,13.599005,5.3305593,20.191801,-4.7056556,18.238008,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_238,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750019_R02C01,13.431172,3.6042368,18.97947,-10.224999,16.178238,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_242,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750019_R03C01,14.050943,4.5790324,19.171217,-8.335495,15.826675,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_244,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750019_R04C01,14.380042,3.284064,18.365892,-8.382323,15.685699,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_371,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750019_R05C01,13.711088,5.1208234,19.998623,-5.2201343,17.683979,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_375,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750019_R06C01,-10.491337,-17.299448,10.551951,-21.487883,14.345667,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_392,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750019_R07C01,-6.195254,-11.221902,6.76527,7.7310925,10.107033,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_407,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
200727750019_R08C01,-6.1439447,-11.3570385,6.9174933,7.8680882,9.941963,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_419,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
200727750020_R01C01,-9.849792,-17.134079,10.5920315,-20.836517,14.120948,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_439,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750020_R02C01,-10.183655,-18.080732,10.604663,-21.749329,14.446172,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_525,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750020_R03C01,0.7562326,12.071474,-12.347673,2.0981593,-25.13067,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_529,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750020_R04C01,-0.2703694,-8.42075,0.83404535,9.915203,10.070837,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_532,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750020_R05C01,13.580396,3.9587584,19.252087,-6.2845845,17.67621,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_533,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750020_R06C01,13.820281,4.1344533,19.248962,-7.149482,16.87932,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_565,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750020_R08C01,14.184061,5.5292096,19.958424,-6.530557,16.110292,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_231,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750040_R01C01,13.979037,4.4983563,18.992456,-8.696307,15.799885,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_528,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750040_R02C01,-10.359857,-17.363483,10.564013,-21.421078,14.323447,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_534,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750040_R03C01,13.527454,5.4449024,20.304445,-4.422664,18.588293,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_539,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
200727750040_R04C01,13.7213125,3.8305476,18.683287,-9.845016,15.8750105,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_546,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750040_R05C01,13.730585,4.0795245,18.791319,-9.638781,15.87905,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_547,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750040_R06C01,-10.857409,-18.117994,10.55644,-22.34167,14.648678,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_549,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200727750040_R07C01,14.693638,3.3242364,17.76812,-8.159646,15.337185,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_570,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200727750040_R08C01,-10.385555,-17.714077,10.575809,-21.675222,14.415385,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_572,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
200973410077_R01C01,15.836791,-7.695836,-19.203632,-14.6976795,20.892267,AAML0531,Diagnosis,PASZBM,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410077_R02C01,15.33389,-11.945066,12.133153,16.311949,-14.572349,AAML0531,Diagnosis,PASZUT,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410077_R03C01,-12.431046,13.030057,19.772793,-4.4991665,-18.696445,AAML0531,Diagnosis,PASZYU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410077_R04C01,13.800815,-14.249222,-1.0880978,-13.850482,-13.634413,AAML0531,Diagnosis,PATAER,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410077_R05C01,-11.028611,12.337919,20.179354,-4.7917547,-18.566486,AAML0531,Diagnosis,PATAEA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410077_R06C01,15.154486,-8.959097,0.12888597,-16.387827,-15.334102,AAML0531,Diagnosis,PATAKC,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410077_R08C01,-17.53375,-11.53253,-16.924774,15.7774935,19.657173,AAML0531,Diagnosis,PATAVF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410079_R01C01,-0.781564,-11.39886,9.587131,11.683272,10.569926,AAML0531,Diagnosis,PATIHH,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
200973410079_R02C01,-17.013737,-11.041195,-16.518103,14.986579,18.197506,AAML0531,Diagnosis,PATILU,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410079_R03C01,13.111475,-12.078933,-0.558317,-17.048462,-10.472021,AAML0531,Diagnosis,PATISV,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410079_R04C01,-18.302467,-9.58235,-17.86815,15.509462,18.66019,AAML0531,Diagnosis,PATIVW,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410079_R05C01,-12.602018,10.513947,19.93457,-5.385823,-18.672823,AAML0531,Diagnosis,PATJKC,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410079_R06C01,0.7603378,22.542894,-12.326124,-6.9473925,14.277653,AAML0531,Diagnosis,PATJLP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410079_R07C01,-11.679431,13.600762,19.134188,-6.4915137,-19.937977,AAML0531,Diagnosis,PATJNI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410079_R08C01,-16.077492,-10.8885,-16.271475,14.768456,18.019667,AAML0531,Diagnosis,PATJSP,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410080_R01C01,-13.607935,-4.303574,14.050536,11.556397,12.096789,AAML0531,Diagnosis,PAPWFN,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410080_R02C01,-14.53894,-1.7041625,14.262956,11.829204,12.279557,AAML0531,Diagnosis,PASVWK,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410080_R03C01,13.281684,-14.767013,0.10919074,-11.915421,-15.587454,AAML0531,Diagnosis,PATELT,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410080_R04C01,-15.233677,-0.3747299,14.543338,11.951896,12.573722,AAML0531,Diagnosis,PASRSS,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410080_R05C01,-16.44422,-11.190452,-17.192816,16.142565,20.534101,AAML0531,Diagnosis,PATCWP,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410080_R06C01,12.918473,6.114947,20.726904,-0.500116,20.74143,AAML0531,Diagnosis,PATKUG,Unknown,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410080_R07C01,14.97438,-11.412047,-1.6938084,-16.627737,-12.455362,AAML0531,Diagnosis,PATKLS,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410080_R08C01,-15.505777,-0.010069206,14.690373,11.978403,12.711512,AAML0531,Diagnosis,PATKGM,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410081_R01C01,12.840414,6.2186637,21.13976,-0.8694052,21.086681,AAML0531,Diagnosis,PATHIW,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410081_R02C01,-13.722399,12.946975,20.0918,-4.618692,-19.49678,AAML0531,Diagnosis,PATGIG,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410081_R03C01,0.31889102,-12.334704,9.008166,11.59111,10.883291,AAML0531,Diagnosis,PATGGI,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
200973410081_R04C01,-15.443704,-0.07810145,14.647779,11.978916,12.674264,AAML0531,Diagnosis,PATDLH,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410081_R05C01,15.273689,-9.246814,0.43563813,-15.549286,-15.957834,AAML0531,Diagnosis,PATCTM,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410081_R06C01,-1.015341,-11.443343,9.769501,11.738432,10.45231,AAML0531,Diagnosis,PATBXU,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
200973410081_R07C01,12.902392,5.4228473,20.542664,-0.32879668,19.829262,AAML0531,Diagnosis,PATBPW,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410081_R08C01,-10.796333,-6.3239465,12.70801,11.242776,11.3139715,AAML0531,Diagnosis,PATBIR,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410083_R01C01,5.4259524,18.766068,-14.467731,-7.297222,14.685065,AAML0531,Diagnosis,PARTBN,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410083_R02C01,-11.214557,12.56567,19.889107,-4.648868,-18.615396,AAML0531,Diagnosis,PARUBE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410083_R03C01,2.2380054,22.58785,-13.35957,-6.6778846,14.042294,AAML0531,Diagnosis,PARURW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410083_R04C01,-11.401272,10.224246,21.3084,-3.127924,-17.595299,AAML0531,Diagnosis,PARVUC,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410083_R05C01,4.0627546,12.341484,-10.835905,2.8592699,-25.509617,AAML0531,Diagnosis,PARVZU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410083_R06C01,-12.332118,-5.1053004,12.83619,11.579075,10.571536,AAML0531,Diagnosis,PARZHI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410083_R07C01,-5.175283,-10.706108,6.11877,6.9062996,12.005048,AAML0531,Diagnosis,PARZGM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410083_R08C01,-11.917067,-9.876105,20.169222,-12.867669,-16.522171,AAML0531,Diagnosis,PARZPD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410084_R01C01,1.7389501,20.879473,-12.798474,-7.338481,14.420588,AAML0531,Diagnosis,PARENB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410084_R02C01,-16.68954,-10.023593,-16.96547,15.29789,19.64492,AAML0531,Diagnosis,PATJYT,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410084_R03C01,-10.880305,12.518314,4.254946,-25.222885,12.284417,AAML0531,Diagnosis,PATJXZ,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410084_R04C01,1.7696589,23.066813,-13.284814,-6.4555316,14.028494,AAML0531,Diagnosis,PATJUT,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410084_R05C01,3.5109315,20.64024,-13.632859,-6.739975,14.681005,AAML0531,Diagnosis,PATKAH,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410084_R06C01,13.8021555,-13.452322,0.47887886,-11.997902,-17.25034,AAML0531,Diagnosis,PATKMB,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410084_R07C01,15.286809,-8.447677,-0.056365486,-17.54953,-13.485892,AAML0531,Diagnosis,PATKPC,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410084_R08C01,1.8023984,-12.94725,9.207212,11.486586,10.371067,AAML0531,Diagnosis,PATKYT,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410086_R01C01,-5.652062,-11.1306715,6.1675677,7.095378,10.975539,AAML0531,Diagnosis,PASTXM,Unknown,Discovery (train) Samples,GSE124413,Unknown,APL with t(15;17)(q24.1;q21.2)/PML::RARA
200973410086_R02C01,-15.981773,-11.0801325,-16.053251,14.676046,18.006113,AAML0531,Diagnosis,PASUAF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410086_R03C01,17.188616,-7.551611,-19.402855,-14.704248,20.396635,AAML0531,Diagnosis,PASULX,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410086_R04C01,1.5668039,22.232843,-12.972792,-7.5437927,13.667845,AAML0531,Diagnosis,PASUMD,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410086_R05C01,-5.0614095,-10.798474,6.4533668,7.770764,11.148703,AAML0531,Diagnosis,PASURR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410086_R06C01,2.844683,21.542233,-13.6267,-7.2906775,13.879646,AAML0531,Diagnosis,PASUVD,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410086_R07C01,-13.594677,-8.691619,-18.104057,15.906612,19.454884,AAML0531,Diagnosis,PASUUP,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410086_R08C01,-8.569535,-8.335677,12.4935875,11.004913,11.385236,AAML0531,Diagnosis,PASVAN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410087_R01C01,15.239218,-9.1140175,0.40614998,-16.058186,-14.946211,AAML0531,Diagnosis,PASXVC,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410087_R02C01,15.652155,-7.523408,-0.45460802,-18.739233,-12.826979,AAML0531,Diagnosis,PASXWN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410087_R03C01,4.473712,18.178732,-14.242407,-7.690972,14.623162,AAML0531,Diagnosis,PASXYG,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410087_R04C01,-16.124762,-10.317983,-16.777594,15.075294,18.59604,AAML0531,Diagnosis,PASYRR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410087_R05C01,-10.422482,12.528107,19.581854,-6.3206034,-19.161179,AAML0531,Diagnosis,PASYRE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410087_R06C01,1.9886287,23.259357,-13.396523,-6.26426,14.062445,AAML0531,Diagnosis,PASYWV,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410087_R07C01,14.106038,-11.245209,-0.11138817,-14.61297,-16.911135,AAML0531,Diagnosis,PASZAF,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200973410087_R08C01,-15.54236,-10.772832,-17.25046,15.988036,20.03197,AAML0531,Diagnosis,PASZEB,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410088_R02C01,-10.996747,12.964677,19.034277,-6.742192,-19.956656,AAML0531,Diagnosis,PASEYM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410088_R03C01,-12.271205,13.178424,19.445524,-5.187335,-19.275545,AAML0531,Diagnosis,PASFIE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410088_R04C01,-12.76023,13.843337,19.402096,-4.981621,-19.131208,AAML0531,Diagnosis,PASFNP,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410088_R05C01,-12.732005,10.969784,20.054295,-3.743166,-19.064516,AAML0531,Diagnosis,PASFRD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410088_R06C01,14.939683,-9.018744,-0.22140352,-17.260866,-13.877602,AAML0531,Diagnosis,PASHWN,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200973410088_R07C01,-12.0959015,10.9039135,20.542257,-1.8699746,-18.257948,AAML0531,Diagnosis,PASJXN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410088_R08C01,5.3685446,17.440634,-14.601389,-7.7758837,14.724212,AAML0531,Diagnosis,PASLDL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410090_R01C01,-12.331047,-5.198204,12.771068,11.592265,10.418471,AAML0531,Diagnosis,PASAMY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410090_R02C01,3.146163,21.063118,-13.574409,-7.4404283,14.000817,AAML0531,Diagnosis,PASAFH,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410090_R03C01,1.7449596,20.196922,-13.497393,-7.9538608,13.823068,AAML0531,Diagnosis,PASAUN,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410090_R04C01,3.1561625,20.494726,-13.726437,-7.6569138,13.959925,AAML0531,Diagnosis,PASBPW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410090_R05C01,-13.720609,13.921268,19.523462,-5.274992,-19.974329,AAML0531,Diagnosis,PASBAX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410090_R06C01,-15.845814,-11.1727295,-17.166294,15.990858,19.769615,AAML0531,Diagnosis,PARLSW,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410090_R07C01,-11.612733,11.839655,4.0993223,-24.212543,11.194916,AAML0531,Diagnosis,PASDET,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410090_R08C01,-5.2369576,-11.24129,5.678786,6.6507797,11.356429,AAML0531,Diagnosis,PASDIR,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410091_R01C01,16.551643,-7.578088,-19.397133,-15.259382,21.455227,AAML0531,Diagnosis,PATAWB,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410091_R02C01,13.315233,-12.379252,0.7057503,-13.916853,-14.812844,AAML0531,Diagnosis,PATBIP,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410091_R03C01,12.733759,-11.323027,-1.8079664,-18.172422,-13.103349,AAML0531,Diagnosis,PATBNP,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
200973410091_R04C01,14.537044,4.5171094,17.358545,-6.7525697,15.793263,AAML0531,Diagnosis,PATBUR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410091_R05C01,-16.68057,-8.418365,-18.829742,15.91207,18.402435,AAML0531,Diagnosis,PATBVX,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410091_R06C01,14.30701,-11.31302,0.007937694,-14.610427,-15.997938,AAML0531,Diagnosis,PATBVJ,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200973410091_R07C01,-15.998576,-10.675634,-17.331718,16.061605,20.39994,AAML0531,Diagnosis,PATBYV,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410091_R08C01,-16.75558,-11.069982,-17.073694,15.93554,20.338451,AAML0531,Diagnosis,PARYTI,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410095_R01C01,14.67639,-11.739054,-1.064862,-16.208403,-11.591495,AAML0531,Diagnosis,PATMNY,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410095_R02C01,2.8094294,19.494604,-13.559345,-7.829676,14.244097,AAML0531,Diagnosis,PASREH,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410095_R03C01,-10.9722395,12.053125,19.635298,-3.865941,-17.819408,AAML0531,Diagnosis,PASRRL,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410095_R04C01,13.9174185,-10.415794,-0.921627,-17.267971,-13.84854,AAML0531,Diagnosis,PARYHR,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200973410095_R05C01,3.0788035,12.122946,-10.925599,2.6323066,-25.651737,AAML0531,Diagnosis,PATGXE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410095_R06C01,-18.513735,-9.641877,-17.924448,15.5579,18.645018,AAML0531,Diagnosis,PASFJB,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410095_R07C01,1.5545467,20.289997,-13.0459795,-7.4669614,14.381303,AAML0531,Diagnosis,PASRZX,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410095_R08C01,13.577772,-11.3495,-1.0385185,-17.42724,-11.701097,AAML0531,Diagnosis,PAPUSR,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410096_R01C01,13.955969,-13.788146,-0.44894585,-12.804028,-16.077501,AAML0531,Diagnosis,PASLTS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410096_R02C01,-12.438292,-5.014298,12.846689,11.61178,10.489184,AAML0531,Diagnosis,PASLTF,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410096_R03C01,15.039932,-9.838888,0.0438803,-15.768474,-15.139634,AAML0531,Diagnosis,PASLYX,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410096_R04C01,1.6264262,20.928759,-13.649875,-7.7400603,13.62521,AAML0531,Diagnosis,PASMPC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410096_R05C01,1.6250428,23.37576,-13.3875065,-6.5330186,13.787519,AAML0531,Diagnosis,PASNAL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410096_R06C01,-15.366757,-0.093274035,14.596079,11.976695,12.63838,AAML0531,Diagnosis,PASNDA,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410096_R07C01,-10.643364,12.523784,19.351059,-6.470284,-19.459463,AAML0531,Diagnosis,PASNIY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410096_R08C01,3.3629215,20.493612,-13.743069,-6.795584,14.615834,AAML0531,Diagnosis,PASPKE,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410100_R01C01,17.121544,-7.5635347,-19.35753,-14.914195,20.835693,AAML0531,Diagnosis,PASVWW,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410100_R02C01,-14.372984,-13.100145,2.370379,24.854343,-12.610549,AAML0531,Diagnosis,PASUHK,Unknown,Discovery (train) Samples,GSE124413,Unknown,Otherwise-Normal Control
200973410100_R03C01,-15.423035,-0.043039262,14.62314,11.982377,12.651391,AAML0531,Diagnosis,PASTTJ,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410100_R04C01,-14.829442,-3.7384531,14.870697,11.628452,12.779668,AAML0531,Diagnosis,PASFEW,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410100_R05C01,13.019402,4.8394055,19.806746,-0.30900195,18.705633,AAML0531,Diagnosis,PARPBF,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410100_R06C01,-12.907087,13.267803,19.695908,-4.706388,-19.065268,AAML0531,Diagnosis,PASSVI,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410100_R07C01,-11.404568,11.349046,20.991413,-4.098097,-18.006617,AAML0531,Diagnosis,PASPWZ,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410100_R08C01,-10.445836,-6.662586,12.551381,11.18715,11.251949,AAML0531,Diagnosis,PASNLR,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410114_R01C01,-12.423748,13.3758955,19.325989,-4.91456,-18.713263,AAML0531,Diagnosis,PARAEF,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410114_R02C01,15.083383,-7.791523,-19.074411,-14.21805,20.370296,AAML0531,Diagnosis,PASBBE,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410114_R03C01,-12.432898,10.659426,20.593437,-1.9707977,-18.398113,AAML0531,Diagnosis,PARPZP,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410114_R04C01,3.0102441,19.398766,-13.727111,-7.9155445,14.144304,AAML0531,Diagnosis,PAPVKG,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410114_R05C01,2.4550085,21.571651,-13.04353,-6.283345,14.902314,AAML0531,Diagnosis,PARTST,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410114_R06C01,13.877002,-12.934429,0.43007192,-12.309082,-17.866215,AAML0531,Diagnosis,PATKEA,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410114_R07C01,13.061097,-11.993128,-0.44616592,-17.079483,-10.40996,AAML0531,Diagnosis,PASCBW,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410114_R08C01,14.445685,-12.159445,11.817812,15.130047,-15.838458,AAML0531,Diagnosis,PARBLP,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410123_R01C01,-16.197918,-11.137851,-16.474459,15.110029,18.455439,AAML0531,Diagnosis,PARPWL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410123_R02C01,-13.063983,-10.103202,-16.539688,15.177575,19.090849,AAML0531,Diagnosis,PARUTH,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410123_R03C01,-16.77134,-8.7754345,-18.61421,15.938484,18.72794,AAML0531,Diagnosis,PARUSN,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410123_R04C01,3.3693593,12.170024,-10.697781,2.7065766,-25.773758,AAML0531,Diagnosis,PARWXU,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410123_R05C01,-11.968437,-10.218121,20.282738,-13.023617,-16.49214,AAML0531,Diagnosis,PASDGX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410123_R06C01,-11.64464,9.702053,21.531874,-2.1118095,-17.594194,AAML0531,Diagnosis,PASFWI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410123_R07C01,2.1488278,19.836153,-13.436169,-7.9156313,14.057112,AAML0531,Diagnosis,PASHYZ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410123_R08C01,5.3705564,18.610416,-14.455249,-7.422821,14.648279,AAML0531,Diagnosis,PASJEJ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410149_R01C01,12.881469,6.801033,21.372068,-1.2818713,21.837402,AAML0531,Diagnosis,PATDRL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410149_R02C01,-5.4553704,-10.667868,8.168806,8.676409,11.078594,AAML0531,Diagnosis,PATDVM,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410149_R03C01,-17.293068,-11.096542,-17.059664,15.673496,19.372381,AAML0531,Diagnosis,PATEMK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410149_R04C01,6.090829,17.61181,-14.801928,-7.6984706,14.688883,AAML0531,Diagnosis,PATEIA,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410149_R05C01,6.173223,18.187544,-14.75287,-7.498912,14.6659355,AAML0531,Diagnosis,PATEID,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410149_R06C01,1.5138566,21.661709,-12.992699,-7.0589375,14.219182,AAML0531,Diagnosis,PATEMV,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410149_R07C01,14.907236,-9.270572,-0.18817836,-16.613419,-15.100784,AAML0531,Diagnosis,PATELV,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410149_R08C01,-16.76242,-10.824239,-17.333078,16.045862,20.342844,AAML0531,Diagnosis,PATEWX,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410150_R01C01,1.5287035,21.997238,-13.147084,-7.459901,13.715511,AAML0531,Diagnosis,PASWPT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410150_R02C01,-12.15752,-8.217683,20.560719,-12.132923,-16.807453,AAML0531,Diagnosis,PASWTY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410150_R03C01,4.6369534,19.102224,-14.177329,-7.1242957,14.767936,AAML0531,Diagnosis,PASXAH,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410150_R04C01,-15.917633,-9.114414,-18.1687,15.872373,19.161179,AAML0531,Diagnosis,PASXAP,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410150_R05C01,13.667344,-12.260656,0.4171114,-13.930704,-15.273708,AAML0531,Diagnosis,PASXLJ,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with in-frame bZIP mutated CEBPA
200973410150_R06C01,-11.558018,8.626434,21.833544,-2.3917954,-17.567625,AAML0531,Diagnosis,PASXKT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410150_R07C01,13.074119,4.4422145,19.577877,-0.37200797,18.041441,AAML0531,Diagnosis,PASXNR,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410150_R08C01,14.420744,-7.7835603,-19.22787,-14.256392,20.300581,AAML0531,Diagnosis,PASXSF,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410151_R01C01,13.711828,-11.39017,-1.023333,-17.22825,-11.591543,AAML0531,Diagnosis,PATCYY,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410151_R02C01,2.7433865,21.29718,-13.330638,-7.593701,13.893236,AAML0531,Diagnosis,PATCYP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410151_R03C01,6.072533,17.690397,-14.780965,-7.661566,14.697561,AAML0531,Diagnosis,PATDIC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410151_R04C01,15.064604,-9.07012,0.25389808,-16.674532,-13.981491,AAML0531,Diagnosis,PATDLI,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410151_R05C01,5.8262897,17.302553,-14.758227,-7.806867,14.714029,AAML0531,Diagnosis,PATDMY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410151_R06C01,-11.864377,12.412315,18.01169,-7.8103924,-19.372202,AAML0531,Diagnosis,PATDNN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410151_R07C01,-11.25355,11.289081,20.351738,-2.9248018,-17.384094,AAML0531,Diagnosis,PATDLZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410151_R08C01,-17.11574,-11.211712,-17.16725,15.952625,19.97393,AAML0531,Diagnosis,PATENX,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410152_R01C01,-12.1481085,-8.288003,20.544811,-12.164025,-16.794407,AAML0531,Diagnosis,PASGGK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410152_R02C01,4.6451178,17.706356,-14.33135,-7.6286125,14.808737,AAML0531,Diagnosis,PASPTW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410152_R03C01,16.548977,-7.624834,-19.273998,-14.891107,21.008493,AAML0531,Diagnosis,PASAFM,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410152_R04C01,14.757584,-7.7819996,-19.169632,-14.229875,20.2937,AAML0531,Diagnosis,PARTXH,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410152_R06C01,-13.556945,13.804126,19.573011,-5.2422056,-19.89882,AAML03P1,Diagnosis,PANTRL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410152_R08C01,-11.652762,-11.483911,19.71911,-13.57788,-16.239197,AAML0531,Diagnosis,PASWAT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410153_R01C01,-16.245031,-11.211194,-16.949583,15.702094,19.321472,AAML0531,Diagnosis,PASVMU,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410153_R02C01,13.654126,-11.218653,-0.71117276,-15.935132,-15.52443,AAML0531,Diagnosis,PASVTP,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200973410153_R03C01,-12.407299,12.984045,17.676311,-8.055883,-19.518654,AAML0531,Diagnosis,PASVYL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410153_R04C01,-5.3271494,-10.872035,6.6143064,7.987869,10.702497,AAML0531,Diagnosis,PASVVM,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410153_R05C01,14.08037,-12.5276575,-0.6615591,-14.455229,-15.148444,AAML0531,Diagnosis,PASWER,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410153_R06C01,-17.48315,-10.36837,-17.487408,15.67331,19.140726,AAML0531,Diagnosis,PASWGL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410153_R07C01,1.2439271,21.781199,-13.348833,-7.393912,13.701648,AAML0531,Diagnosis,PARXJW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410153_R08C01,-8.7093315,-8.231692,12.557621,11.023844,11.401689,AAML0531,Diagnosis,PASWMP,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410169_R05C01,-13.155786,-8.6676,-18.07928,15.921205,19.487524,AAML0531,Diagnosis,PARBVE,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410169_R06C01,13.258743,-11.009174,-1.3863933,-17.09112,-15.166821,AAML0531,Diagnosis,PARCAU,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
200973410169_R07C01,14.096059,-11.587114,-0.48851213,-15.114715,-15.442113,AAML0531,Diagnosis,PARCEV,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200973410169_R08C01,12.656013,-11.365167,-1.8515584,-18.205362,-13.151236,AAML0531,Diagnosis,PARCIN,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
200973410170_R01C01,1.0035932,21.99101,-13.025209,-7.4156785,13.763819,AAML0531,Diagnosis,PARUUB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410170_R02C01,13.788271,-12.127194,11.813909,15.219654,-15.854433,AAML0531,Diagnosis,PARZWH,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200973410170_R03C01,4.774228,18.373991,-14.26172,-7.2354474,14.914567,AAML0531,Diagnosis,PASBHI,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410170_R04C01,3.2838798,18.5773,-13.82671,-7.862122,14.453203,AAML0531,Diagnosis,PASFIT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200973410170_R05C01,13.98824,-13.241176,-0.3209139,-13.603202,-14.799745,AAML0531,Diagnosis,PASFZN,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200973410170_R06C01,13.100703,4.5333333,19.668339,-0.4141187,18.18716,AAML03P1,Diagnosis,PANXAF,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200973410170_R07C01,-18.546104,-9.580516,-17.988083,15.52384,18.374504,AAML03P1,Diagnosis,PANYNR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410170_R08C01,-12.119101,12.705211,18.15103,-7.377197,-19.254074,AAML03P1,Diagnosis,PANZKA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410178_R01C01,-11.703752,8.962801,21.783161,-1.816242,-17.551065,AAML0531,Diagnosis,PASWWD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410178_R02C01,-17.483545,-9.54176,-18.110493,15.858365,19.138098,AAML0531,Diagnosis,PASXSS,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200973410178_R03C01,15.325348,-9.184894,1.18072,-15.193703,-15.04505,AAML0531,Diagnosis,PASYJL,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200973410178_R05C01,14.760697,-12.311282,-1.1411685,-15.364341,-12.595744,AAML0531,Diagnosis,PASTHA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410178_R06C01,16.068264,-7.674264,-19.296906,-13.840387,19.240152,AAML0531,Diagnosis,PASTSH,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with in-frame bZIP mutated CEBPA
200973410178_R07C01,15.367996,-9.40016,1.4178591,-14.554789,-15.627678,AAML0531,Diagnosis,PASTVM,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200973410178_R08C01,3.9434323,20.628355,-13.868245,-7.219287,14.243677,AAML0531,Diagnosis,PASTWE,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060007_R01C01,1.8192277,22.633202,-13.416632,-7.093801,13.641951,AAML0531,Diagnosis,PASKFN,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060007_R02C01,-12.544235,13.43612,19.389858,-4.710561,-18.707972,AAML0531,Diagnosis,PASKPI,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200989060007_R03C01,2.406455,20.499453,-13.360101,-6.917764,14.633095,AAML0531,Diagnosis,PASLGD,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060007_R04C01,-17.307873,-18.985525,0.6588429,-14.601611,-23.144894,AAML0531,Diagnosis,PASPGA,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060007_R05C01,4.5709133,18.317467,-14.250368,-7.43299,14.772272,AAML0531,Diagnosis,PASSHZ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060007_R06C01,-15.537694,-10.765429,-16.800917,15.369122,18.864246,AAML0531,Diagnosis,PASTEI,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200989060007_R07C01,-15.688066,-11.573197,-16.947048,15.796081,18.939459,AAML0531,Diagnosis,PASUGU,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200989060007_R08C01,-11.844235,-10.305144,20.045107,-13.057335,-16.445389,AAML0531,Diagnosis,PASWAJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200989060017_R01C01,3.3462887,20.956871,-13.97979,-7.4618454,13.82116,AAML0531,Diagnosis,PASPSV,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060017_R02C01,13.9228735,-11.256504,-0.7656787,-15.21258,-17.236837,AAML0531,Diagnosis,PASRTP,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060017_R03C01,14.623069,-11.179339,-1.2942854,-16.302832,-14.140534,AAML0531,Diagnosis,PASRUJ,Unknown,Discovery (train) Samples,GSE124413,Unknown,Otherwise-Normal Control
200989060017_R04C01,-15.764586,-10.18235,-17.122849,15.558041,19.646082,AAML0531,Diagnosis,PASSDX,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200989060017_R05C01,4.459968,17.907063,-14.289952,-7.714168,14.675832,AAML0531,Diagnosis,PASSUW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060017_R06C01,14.005443,-11.10383,-0.63657314,-15.1230755,-17.432459,AAML0531,Diagnosis,PARMME,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060017_R07C01,15.825173,-7.6892624,-19.25686,-14.358112,20.226027,AAML0531,Diagnosis,PARMZC,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200989060017_R08C01,13.182485,-11.7645445,-0.9758647,-15.7079525,-16.200129,AAML0531,Diagnosis,PARPVZ,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
200989060052_R01C01,11.041062,-26.591507,-13.452172,4.1056604,16.6855,AAML0531,Diagnosis,PAPZYS,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200989060052_R02C01,-15.296242,-3.4679062,15.172609,11.660929,13.03032,AAML0531,Diagnosis,PARAIC,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200989060052_R03C01,-17.76865,-11.348289,-17.003736,15.682432,19.349735,AAML0531,Diagnosis,PARAHF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200989060052_R04C01,-13.019805,13.690574,19.322937,-5.5207343,-19.559145,AAML0531,Diagnosis,PARASV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200989060052_R05C01,-2.8560479,-10.284066,5.4437127,9.4753895,10.389273,AAML0531,Diagnosis,PARANT,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
200989060052_R06C01,16.009928,-7.631592,-19.334633,-15.218264,21.561283,AAML0531,Diagnosis,PARBEL,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200989060052_R07C01,14.536581,-12.162892,11.78434,15.076218,-14.849692,AAML0531,Diagnosis,PARBFJ,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060052_R08C01,14.565544,-12.0641165,11.8839,15.556445,-13.750569,AAML0531,Diagnosis,PARBCV,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
200989060073_R01C01,15.134088,-9.283255,0.17114481,-15.760532,-16.22393,AAML0531,Diagnosis,PATLJF,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060073_R02C01,14.702883,-9.097312,-0.89673257,-18.667486,-11.611217,AAML0531,Diagnosis,PATLXB,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060073_R03C01,-17.10192,-10.198824,-17.013763,15.360367,19.598743,AAML0531,Diagnosis,PATMFM,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200989060073_R04C01,-17.890503,-10.655089,-17.190971,15.600048,19.531973,AAML0531,Diagnosis,PATMIK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200989060073_R05C01,-18.097708,-11.271879,-16.902437,15.557191,19.397623,AAML0531,Diagnosis,PARGYS,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200989060073_R06C01,14.328319,-12.383224,0.9372464,-11.934688,-18.307302,AAML0531,Diagnosis,PARIEG,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200989060073_R07C01,-11.330568,11.733451,20.13642,-3.3216953,-17.981705,AAML0531,Diagnosis,PARIYP,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200989060073_R08C01,5.0861135,18.826384,-14.349546,-7.464073,14.567274,AAML0531,Diagnosis,PARMMN,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060100_R01C01,0.5397115,-12.786532,8.164773,11.222472,11.014858,AAML0531,Diagnosis,PASMRU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
200989060100_R02C01,-17.16266,-19.017384,0.81849927,-14.456085,-23.068598,AAML0531,Diagnosis,PASDUD,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060100_R03C01,-12.182547,-7.979186,20.598478,-12.027693,-16.845572,AAML0531,Diagnosis,PATHAE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200989060100_R04C01,13.221929,3.7350748,18.816835,0.10023885,16.64324,AAML0531,Diagnosis,PASJCL,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200989060100_R05C01,-12.183012,-7.9797616,20.601389,-12.029401,-16.851429,AAML0531,Diagnosis,PASJYX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200989060100_R06C01,-11.116362,-6.105359,12.733199,11.296369,11.198508,AAML0531,Diagnosis,PASJZX,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200989060100_R07C01,-8.73805,-8.230455,12.583711,11.040779,11.384783,AAML0531,Diagnosis,PASKDS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200989060100_R08C01,13.233971,3.5295181,18.652134,0.20158191,16.317095,AAML0531,Diagnosis,PASRIN,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200989060146_R01C01,14.943572,-8.989612,-0.2978341,-17.39291,-13.771226,AAML0531,Diagnosis,PARJLW,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200989060146_R02C01,13.540939,-11.311658,-0.7375854,-17.268984,-11.550138,AAML0531,Diagnosis,PARLHW,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200989060146_R03C01,13.133984,4.120671,19.322569,-0.29710534,17.45692,AAML0531,Diagnosis,PARVLP,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200989060146_R04C01,5.8878927,17.777514,-14.718049,-7.657247,14.683859,AAML0531,Diagnosis,PARVXT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060146_R05C01,2.709752,19.868538,-13.507594,-7.2363677,14.572128,AAML0531,Diagnosis,PARXDI,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060146_R06C01,14.09858,-11.373567,-0.39565438,-14.700065,-17.06824,AAML0531,Diagnosis,PARXVI,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200989060146_R07C01,1.8983345,20.382889,-12.897381,-7.254184,14.623464,AAML0531,Diagnosis,PARZHT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200989060146_R08C01,-11.890097,8.049155,21.741373,-1.9947199,-17.792143,AAML0531,Diagnosis,PASAXB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620013_R01C01,-11.586595,11.673419,19.870588,-4.6595473,-18.321564,AAML0531,Diagnosis,PASARM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620013_R02C01,-11.403168,11.803117,20.05746,-3.386834,-17.930824,AAML0531,Diagnosis,PARKCX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620013_R03C01,13.790821,-10.838313,-1.1245588,-17.628338,-12.06401,AAML0531,Diagnosis,PARVAI,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620013_R04C01,-12.095722,12.690298,18.566437,-6.6186733,-18.918776,AAML0531,Diagnosis,PARWDZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620013_R05C01,-6.8153286,-9.070548,9.726181,10.19953,10.950183,AAML0531,Diagnosis,PARXBT,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620013_R06C01,15.893655,-7.7295623,-19.077099,-14.668397,21.020824,AAML0531,Diagnosis,PARXNG,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200991620013_R07C01,13.689561,-12.458438,-0.04908771,-13.896823,-16.10037,AAML0531,Diagnosis,PARYGA,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620013_R08C01,-17.1569,-10.36407,-17.011194,15.476867,19.865892,AAML0531,Diagnosis,PARYFN,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620022_R01C01,-15.945611,-11.49382,-17.008194,15.871824,19.290071,AAML0531,Diagnosis,PARCHW,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620022_R02C01,4.740273,17.527657,-14.402685,-7.8219914,14.699409,AAML0531,Diagnosis,PARDDA,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620022_R04C01,-17.215004,-9.09154,-18.346388,15.822103,18.793344,AAML0531,Diagnosis,PAREFM,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620022_R05C01,-11.908793,12.038541,17.94332,-8.165755,-19.622347,AAML0531,Diagnosis,PARFZP,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620022_R06C01,5.795471,17.433037,-14.730765,-7.768187,14.707878,AAML0531,Diagnosis,PARGTL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620022_R07C01,14.914743,-11.983172,12.083193,16.101065,-15.521738,AAML0531,Diagnosis,PARHBA,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200991620024_R01C01,4.6873403,17.63194,-14.368983,-7.7335186,14.741008,AAML0531,Diagnosis,PARZUU,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620024_R02C01,14.173371,-11.1980915,-0.81856805,-16.73205,-12.089611,AAML0531,Diagnosis,PASGWH,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620024_R03C01,14.175049,-12.330309,-0.35849887,-14.466615,-14.663016,AAML0531,Diagnosis,PARWPW,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200991620024_R04C01,-15.281904,-3.6640797,15.197625,11.642185,13.045334,AAML0531,Diagnosis,PASECW,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620024_R05C01,-11.182355,11.502873,20.252243,-3.2707334,-17.483578,AAML0531,Diagnosis,PATMIY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620024_R06C01,15.2114525,-7.7371426,-19.243872,-14.047727,19.802708,AAML0531,Diagnosis,PASPTM,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200991620024_R07C01,10.971774,-27.155546,-13.69142,4.0583825,16.799702,AAML0531,Diagnosis,PASJDV,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620024_R08C01,-13.985823,-8.679313,-18.040545,15.794537,19.333109,AAML0531,Diagnosis,PASKNV,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620031_R01C01,3.768611,18.625126,-13.930961,-7.2974877,14.852793,AAML0531,Diagnosis,PASLPU,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620031_R02C01,-17.78422,-10.615289,-16.975534,15.384435,19.36807,AAML0531,Diagnosis,PASNRB,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620031_R03C01,14.017182,-12.0216875,-1.1118853,-16.5049,-11.510371,AAML0531,Diagnosis,PASTZU,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620031_R04C01,-13.545275,-8.622749,-18.06877,15.842635,19.388222,AAML0531,Diagnosis,PASUUD,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620031_R05C01,16.35805,-7.7352448,-18.995724,-14.310757,20.460587,AAML0531,Diagnosis,PAPZZE,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200991620031_R06C01,1.2495382,22.728607,-13.306138,-6.931266,13.729637,AAML0531,Diagnosis,PARCVP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620031_R07C01,1.7788706,21.49064,-13.044766,-6.9059277,14.39346,AAML0531,Diagnosis,PARCZL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620031_R08C01,14.142102,-10.008513,-0.8437671,-17.80377,-12.605657,AAML0531,Diagnosis,PAREHK,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200991620045_R03C01,13.00789,-12.09924,-0.83451295,-17.1202,-11.188007,AAML0531,Diagnosis,PARYXV,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200991620045_R04C01,-15.046086,-0.69456255,14.461936,11.923399,12.494264,AAML0531,Diagnosis,PATLFJ,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620045_R05C01,-10.348885,-6.7361846,12.6046505,11.179114,11.318662,AAML0531,Diagnosis,PASWTG,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620045_R06C01,-13.792175,-3.0600069,13.969762,11.689216,12.027736,AAML0531,Diagnosis,PATMDJ,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620045_R07C01,13.18324,4.1254845,19.245054,-0.4467802,17.34445,AAML0531,Diagnosis,PARWCG,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620045_R08C01,10.639349,-27.541788,-13.920969,4.196849,16.847322,AAML0531,Diagnosis,PARMGH,Unknown,Discovery (train) Samples,GSE124413,Unknown,Otherwise-Normal Control
200991620055_R01C01,-11.4346075,-5.8360357,12.85653,11.331306,11.274927,AAML0531,Diagnosis,PATABK,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620055_R02C01,-9.0414715,-8.018371,12.81635,11.108484,11.440745,AAML0531,Diagnosis,PATCHL,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620055_R03C01,-8.134327,-8.494408,11.874819,10.835387,11.275503,AAML0531,Diagnosis,PATASP,Unknown,Discovery (train) Samples,GSE124413,Unknown,Otherwise-Normal Control
200991620055_R04C01,12.852105,6.517927,21.206453,-0.8590993,21.473228,AAML0531,Diagnosis,PATFGK,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620055_R05C01,-5.2118754,12.015573,-17.269737,0.53757185,-20.127317,AAML0531,Diagnosis,PARKJZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620055_R06C01,15.102213,-9.090231,0.07150406,-16.150396,-15.942853,AAML0531,Diagnosis,PARKHV,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200991620055_R07C01,13.211069,4.932608,19.9202,-1.8896124,18.621284,AAML0531,Diagnosis,PARBZJ,Unknown,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),Otherwise-Normal Control
200991620055_R08C01,12.924303,6.039369,20.803514,-0.7188688,20.658669,AAML0531,Diagnosis,PASVUI,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620063_R01C01,13.268285,4.0430045,19.019281,-0.4304893,17.047604,AAML0531,Diagnosis,PATAML,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
200991620063_R02C01,-13.018556,12.4418,20.0746,-4.1258397,-19.006493,AAML0531,Diagnosis,PASNKC,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620063_R03C01,-16.305668,6.6411233,14.407752,12.671834,13.542232,AAML0531,Diagnosis,PASKAS,Unknown,Discovery (train) Samples,GSE124413,Unknown,Otherwise-Normal Control
200991620063_R04C01,-14.778122,-1.1276095,14.337474,11.883837,12.361793,AAML0531,Diagnosis,PATLMH,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200991620063_R05C01,14.9117,-7.786752,-19.121464,-14.268175,20.410036,AAML0531,Diagnosis,PARILH,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
200991620063_R06C01,13.0107565,5.086295,20.327497,-0.5525176,19.221867,AAML0531,Diagnosis,PARIAP,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
200991620063_R07C01,14.13743,3.157944,18.382498,-7.6760793,16.323877,AAML0531,Diagnosis,PARAPD,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620063_R08C01,1.5701953,-12.638805,8.735201,11.063131,9.491912,AAML0531,Diagnosis,PARAEG,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
200991620068_R01C01,-10.418915,-6.6793275,12.637742,11.195764,11.309781,AAML0531,Diagnosis,PARUZS,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
200991620068_R02C01,-11.015884,11.843744,20.168787,-3.9200876,-18.022184,AAML0531,Diagnosis,PASFFS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620068_R03C01,4.309242,18.873718,-14.058696,-6.9974494,14.974763,AAML0531,Diagnosis,PASINA,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620068_R04C01,12.75426,-11.230369,-1.8255054,-18.213095,-13.2398615,AAML0531,Diagnosis,PATGTL,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
200991620068_R05C01,2.9098191,19.176123,-13.778461,-7.9710174,14.144425,AAML0531,Diagnosis,PASXNT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620068_R06C01,13.580334,-14.272797,0.53617746,-11.456615,-16.716711,AAML0531,Diagnosis,PATCBV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620068_R07C01,14.717393,-11.366808,0.928852,-12.702497,-18.215614,AAML0531,Diagnosis,PATCVL,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200991620068_R08C01,-17.573336,-10.184292,-17.221676,15.56013,19.9435,AAML0531,Diagnosis,PATLHB,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620105_R02C01,14.0658045,-13.036333,0.25612763,-12.267623,-17.814125,AAML0531,Diagnosis,PARHVK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620105_R03C01,-3.2613502,-10.707291,9.564036,11.06239,10.467666,AAML0531,Diagnosis,PARJGD,Unknown,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
200991620105_R04C01,3.761247,20.868057,-13.774191,-6.565342,14.678088,AAML0531,Diagnosis,PARJET,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
200991620105_R05C01,-17.059639,-11.094822,-17.152746,15.928339,20.096325,AAML0531,Diagnosis,PARJYP,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620105_R06C01,-13.439465,13.777669,19.520273,-5.210039,-19.830112,AAML0531,Diagnosis,PARKFB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620105_R07C01,-8.783995,-8.243678,12.78589,11.0775,11.451394,AAML0531,Diagnosis,PARKGB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620105_R08C01,-11.232767,11.49429,18.67425,-7.3076587,-19.504774,AAML0531,Diagnosis,PARSXZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620141_R01C01,15.15331,-11.972943,12.099386,16.165222,-15.076272,AAML0531,Diagnosis,PASIZX,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200991620141_R02C01,14.194258,-11.672727,-0.6759572,-15.039698,-15.800937,AAML0531,Diagnosis,PARIHK,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
200991620141_R03C01,15.453642,-11.93339,12.142583,16.367638,-14.125917,AAML0531,Diagnosis,PASCCS,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
200991620141_R04C01,-15.353947,-10.546359,-15.826181,14.3377695,17.96472,AAML0531,Diagnosis,PARZMZ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620141_R05C01,12.886919,5.7599573,20.7403,-0.49258095,20.33459,AAML0531,Diagnosis,PARUNX,Unknown,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620141_R06C01,-12.152596,-8.221901,20.551714,-12.134527,-16.805122,AAML0531,Diagnosis,PARJCR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
200991620141_R07C01,-18.624546,-9.707339,-17.877966,15.532636,18.627636,AAML0531,Diagnosis,PASYJI,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
200991620141_R08C01,-12.588769,10.526591,19.941036,-5.062657,-18.7054,AAML03P1,Diagnosis,PANGTF,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010034_R01C01,12.666254,-11.26914,-1.8465114,-18.334686,-12.971178,AAML03P1,Diagnosis,PANTXR,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010034_R02C01,13.543793,-11.965586,-0.8659401,-15.416046,-15.505274,AAML03P1,Diagnosis,PANUTX,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010034_R03C01,-12.131002,-8.397108,20.517403,-12.211767,-16.773321,AAML03P1,Diagnosis,PANXWX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010034_R04C01,3.0983348,19.626497,-13.561127,-7.9925413,14.104403,AAML03P1,Diagnosis,PANZXI,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010034_R05C01,13.980772,-13.981638,1.5611265,-9.981996,-18.446545,AAML03P1,Diagnosis,PANHWD,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010034_R06C01,13.492426,-11.440844,-0.89198077,-17.342173,-11.490991,AAML03P1,Diagnosis,PANKBX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010034_R07C01,15.197534,-9.098057,0.14372352,-16.246145,-15.2177305,AAML0531,Diagnosis,PAPSCM,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
201005010034_R08C01,-17.910576,-11.266149,-16.882929,15.549254,19.37434,AAML0531,Diagnosis,PARDMG,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010036_R01C01,3.45313,12.407431,-10.664804,2.7835538,-25.959738,AAML0531,Diagnosis,PARFMY,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010036_R02C01,13.4247,-11.652594,-1.1467716,-15.793573,-16.307037,AAML0531,Diagnosis,PARFVC,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010036_R03C01,15.261213,-9.420569,0.6817642,-15.0895605,-16.219896,AAML0531,Diagnosis,PARHUP,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
201005010036_R04C01,3.181989,20.715378,-13.479058,-6.920613,14.568628,AAML0531,Diagnosis,PARKUY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010036_R05C01,-12.060666,-8.883841,20.403406,-12.427288,-16.691978,AAML0531,Diagnosis,PARMST,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010036_R06C01,2.9624655,21.696928,-13.476243,-6.271104,14.678852,AAML0531,Diagnosis,PARNFZ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010036_R07C01,-17.400677,-8.894684,-18.51174,15.831152,18.635952,AAML0531,Diagnosis,PARNIL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010036_R08C01,-11.797918,11.684636,4.1879387,-24.23364,11.129044,AAML0531,Diagnosis,PARUEX,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010039_R01C01,2.5182774,22.544691,-13.419222,-6.131679,14.462521,AAML0531,Diagnosis,PATEUF,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010039_R02C01,-15.407476,0.08951516,14.599482,11.994464,12.666351,AAML0531,Diagnosis,PATESX,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010039_R03C01,-15.454411,-10.554744,-15.948609,14.427544,17.962263,AAML0531,Diagnosis,PATFGL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010039_R04C01,-12.198238,12.162224,17.88087,-7.644402,-19.071684,AAML0531,Diagnosis,PATFMR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010039_R05C01,13.341874,-12.044315,-0.5937973,-14.581762,-17.467785,AAML0531,Diagnosis,PATFNK,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010039_R06C01,-10.471175,12.478708,19.69892,-6.0548296,-18.981907,AAML0531,Diagnosis,PATFRY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010039_R07C01,-15.396069,-3.5070696,15.254466,11.65817,13.0974455,AAML0531,Diagnosis,PATFYN,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010039_R08C01,-14.770668,-3.7192128,14.824704,11.6288,12.74298,AAML0531,Diagnosis,PATGAN,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010074_R01C01,13.574497,-11.48156,-1.2230324,-17.172592,-12.568685,AAML0531,Diagnosis,PATGBX,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010074_R02C01,-12.520642,9.016629,19.66175,-4.740982,-18.969336,AAML0531,Diagnosis,PATGDZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010074_R03C01,1.5470314,20.421928,-13.512612,-7.7705984,13.851094,AAML0531,Diagnosis,PATGGY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010074_R04C01,1.0672145,-14.327985,8.101634,11.944577,9.844474,AAML0531,Diagnosis,PATGIY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
201005010074_R05C01,-18.254385,-10.775183,-17.14703,15.4566,18.968018,AAML0531,Diagnosis,PATGRP,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010074_R06C01,15.942008,-7.6771064,-19.208643,-15.048049,21.46749,AAML0531,Diagnosis,PATGUB,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
201005010074_R07C01,-11.658297,9.145843,21.79268,-1.9892505,-17.492298,AAML0531,Diagnosis,PATGXW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010074_R08C01,13.773967,-12.95992,0.11631564,-12.822287,-17.302414,AAML0531,Diagnosis,PATHMB,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010075_R05C01,-11.708648,8.771044,21.742592,-2.0702403,-17.62722,AAML0531,Diagnosis,PARBXE,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010075_R06C01,13.102256,-10.945439,-1.5699549,-17.99198,-13.3809,AAML0531,Diagnosis,PATIAB,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010075_R07C01,-13.571738,-8.441176,-18.232267,15.88847,19.332092,AAML0531,Diagnosis,PATIDY,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010075_R08C01,16.016457,-7.6999693,-19.142746,-14.7775545,21.09175,AAML0531,Diagnosis,PATIGE,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with in-frame bZIP mutated CEBPA
201005010083_R01C01,1.5640564,22.597015,-13.306382,-7.3288407,13.513879,AAML0531,Diagnosis,PAPUEM,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010083_R02C01,15.3010435,-9.016023,0.41874474,-16.022161,-15.176358,AAML0531,Diagnosis,PAPUNR,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010083_R03C01,-17.929459,-10.813232,-17.159946,15.617173,19.469318,AAML0531,Diagnosis,PAPVCN,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010083_R04C01,3.1413896,19.661621,-13.74952,-7.782395,14.150487,AAML0531,Diagnosis,PAPVGE,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010083_R05C01,-16.907438,-11.381784,-17.0992,15.916089,19.691467,AAML0531,Diagnosis,PAPVZK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010083_R06C01,14.7836485,-7.742504,-19.237474,-14.935727,21.403837,AAML0531,Diagnosis,PAPWIU,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
201005010083_R07C01,3.6478717,19.113796,-13.828626,-6.9687734,14.966442,AAML0531,Diagnosis,PAPWHS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010083_R08C01,-17.731382,-11.219083,-17.021662,15.765096,19.86322,AAML0531,Diagnosis,PAPWYK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010084_R01C01,-12.418287,-5.09934,12.746079,11.640886,10.243067,AAML0531,Diagnosis,PATANY,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010084_R02C01,-10.329504,-6.76109,12.603636,11.181522,11.299673,AAML0531,Diagnosis,PASZJC,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010084_R03C01,-15.136577,-3.604276,15.076494,11.646494,12.9472885,AAML0531,Diagnosis,PASYYW,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010084_R04C01,-10.979394,-6.099593,12.8974285,11.287545,11.432165,AAML0531,Diagnosis,PASYTW,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
201005010084_R05C01,12.988398,5.9458246,20.582045,-0.9271754,20.372309,AAML0531,Diagnosis,PASYTG,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010084_R06C01,-12.563741,-5.1390533,12.70663,11.690517,9.989201,AAML0531,Diagnosis,PASZNB,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010084_R07C01,-5.1727366,-11.047888,5.644206,6.490889,11.797443,AAML0531,Diagnosis,PASWVH,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010084_R08C01,-8.74159,-8.150168,12.3995285,10.99795,11.359761,AAML0531,Diagnosis,PASWGS,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010090_R01C01,-13.247725,-14.460391,23.2568,17.677923,-9.458469,AAML03P1,Diagnosis,PANPKN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010090_R02C01,15.46154,-7.6704264,-19.301895,-15.36694,21.948578,AAML03P1,Diagnosis,PANIGD,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
201005010090_R03C01,-11.082802,12.226798,18.554312,-7.5057635,-19.615349,AAML03P1,Diagnosis,PANFMG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010090_R04C01,14.184301,-11.749149,-0.5922047,-15.071505,-15.219423,AAML03P1,Diagnosis,PANKCE,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
201005010090_R05C01,13.980747,-13.980467,1.512299,-10.040459,-18.413227,AAML03P1,Diagnosis,PANKEF,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010090_R06C01,13.429937,-11.401063,-0.8914626,-17.4851,-11.396092,AAML03P1,Diagnosis,PANRWM,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
201005010090_R07C01,-10.573374,11.915067,19.66727,-6.0463033,-18.61196,AAML03P1,Diagnosis,PANTCT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010090_R08C01,-7.48929,-17.162985,-20.886007,-21.225512,14.56732,AAML03P1,Diagnosis,PANTIV,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE124413,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
201005010092_R01C01,2.5918908,19.29734,-13.598914,-7.8382325,14.264858,AAML0531,Diagnosis,PATKYC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010092_R02C01,15.567699,-9.011129,1.1851898,-14.850981,-16.119053,AAML0531,Diagnosis,PATLDB,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010092_R03C01,2.0486367,20.77549,-13.156026,-6.9422326,14.590557,AAML0531,Diagnosis,PATLBC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010092_R04C01,16.270031,-7.621083,-19.312433,-15.233808,21.581638,AAML0531,Diagnosis,PATLIG,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
201005010092_R05C01,15.066824,-10.330774,0.89357173,-13.734212,-17.504868,AAML0531,Diagnosis,PATLKU,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010092_R06C01,15.143894,-8.760566,-0.059449866,-17.347065,-13.498949,AAML0531,Diagnosis,PATLVC,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010092_R07C01,13.6751585,-11.474182,-0.6136088,-15.098573,-16.968369,AAML0531,Diagnosis,PATLVK,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010092_R08C01,-12.645304,12.21269,19.22723,-5.955136,-19.027617,AAML0531,Diagnosis,PATLZB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010094_R01C01,15.496174,-9.180998,1.5918336,-14.617254,-15.33567,AAML0531,Diagnosis,PATMCW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010094_R02C01,5.148369,17.735487,-14.506913,-7.7067685,14.698173,AAML0531,Diagnosis,PATBIZ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010094_R03C01,13.003677,-12.5037365,-1.2888371,-16.649382,-12.560129,AAML0531,Diagnosis,PATDFZ,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
201005010094_R04C01,-14.135144,-2.328613,14.067591,11.768736,12.092554,AAML0531,Diagnosis,PATFDF,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010094_R05C01,-4.724112,11.8481245,-17.4095,0.5964631,-20.568861,AAML0531,Diagnosis,PATIII,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010094_R06C01,-12.06344,-8.990923,20.413252,-12.475039,-16.678965,AAML0531,Diagnosis,PATIIM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010094_R07C01,12.926171,6.2659626,21.000088,-1.1702367,20.990948,AAML0531,Diagnosis,PARFAL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010094_R08C01,-15.405801,-0.08639607,14.61897,11.979245,12.647887,AAML0531,Diagnosis,PARDDY,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
201005010102_R01C01,-16.40941,5.750128,14.685864,12.311526,13.467131,AAML0531,Diagnosis,PASNDH,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010102_R02C01,-12.72454,11.462579,20.25855,-3.2894697,-18.899557,AAML0531,Diagnosis,PASJRD,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010102_R03C01,-11.1855345,12.163614,3.9474964,-24.132807,11.174906,AAML0531,Diagnosis,PASBSB,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010102_R04C01,-12.56814,13.211725,19.847353,-4.4162517,-18.664742,AAML0531,Diagnosis,PARJWH,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010102_R05C01,12.855302,6.416214,21.145193,-0.81546277,21.32505,AAML0531,Diagnosis,PARERV,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010102_R06C01,-11.708859,13.902337,19.119825,-6.63397,-19.992807,AAML0531,Diagnosis,PARCUK,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010102_R07C01,3.6724792,20.242256,-13.746566,-6.463302,14.984668,AAML0531,Diagnosis,PARAJX,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010102_R08C01,-9.783533,-7.300588,12.754173,11.15963,11.391719,AAML0531,Diagnosis,PAPZJT,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
201005010130_R01C01,-11.547921,11.965076,19.373127,-3.8199341,-17.675892,AAML0531,Diagnosis,PARNTM,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010130_R02C01,13.286799,-11.19969,-1.4190704,-16.852245,-15.3646755,AAML0531,Diagnosis,PARZYF,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010130_R03C01,14.695839,-10.849335,0.7135175,-13.995983,-16.408585,AAML0531,Diagnosis,PASWNZ,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
201005010130_R04C01,-11.767622,10.768958,20.765903,-4.084892,-17.96426,AAML0531,Diagnosis,PASKRJ,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010130_R05C01,-13.204094,-8.586376,-18.14791,15.939466,19.483513,AAML0531,Diagnosis,PASMYS,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010130_R06C01,3.1584074,22.479925,-13.706917,-5.840833,14.609225,AAML0531,Diagnosis,PARIZR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010130_R07C01,-17.083288,-19.034903,0.9070843,-14.376336,-23.026285,AAML0531,Diagnosis,PARTYK,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010130_R08C01,-15.449109,-9.480624,-17.155487,15.228052,19.120512,AAML0531,Diagnosis,PASELF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010131_R01C01,-6.191838,-9.920404,11.565264,10.726483,11.196431,AAML0531,Diagnosis,PAPXVK,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010131_R02C01,-12.732243,13.592495,18.837847,-5.909943,-19.11218,AAML0531,Diagnosis,PAPVET,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010131_R03C01,13.822146,-12.544359,0.068094835,-13.512875,-16.394747,AAML0531,Diagnosis,PARDRM,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010131_R04C01,1.696291,22.907774,-13.171215,-6.6637635,13.984945,AAML03P1,Diagnosis,PAMYAS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010131_R05C01,3.2074277,19.48471,-13.714205,-7.762216,14.255949,AAML0531,Diagnosis,PATCLR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010131_R06C01,15.563845,-11.920734,12.156004,16.43394,-13.813379,AAML0531,Diagnosis,PASWIM,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010131_R07C01,-14.8853445,-9.042175,-17.4181,15.299572,19.029861,AAML0531,Diagnosis,PASANH,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010131_R08C01,15.385343,-7.694179,-19.24125,-15.308665,21.950174,AAML03P1,Diagnosis,PANCSC,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
201005010136_R01C01,-16.434225,-10.775462,-17.159212,15.955345,20.523106,AAML0531,Diagnosis,PASFYF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010136_R02C01,4.214993,20.042831,-13.876247,-6.7943463,14.795921,AAML0531,Diagnosis,PARAUM,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010136_R03C01,-15.942354,-9.839607,-17.04384,15.345246,19.609694,AAML0531,Diagnosis,PARGMH,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010136_R04C01,0.5203421,21.650957,-12.843923,-7.345051,13.989776,AAML0531,Diagnosis,PARHYP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010136_R05C01,-17.805798,-9.911545,-17.35931,15.458079,19.53468,AAML0531,Diagnosis,PARJRG,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010136_R06C01,1.8697717,19.987835,-13.306536,-7.5680523,14.305198,AAML0531,Diagnosis,PARLMY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010136_R07C01,4.8487587,19.745407,-14.141683,-7.180499,14.537585,AAML0531,Diagnosis,PARNJC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010136_R08C01,-17.68888,-10.311119,-16.808891,15.148622,19.392138,AAML0531,Diagnosis,PARNPC,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010140_R01C01,-16.945091,-11.589344,-16.743505,15.576069,19.094788,AAML0531,Diagnosis,PAPXWI,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010140_R02C01,-15.311514,-10.720631,-17.272686,15.92192,19.663063,AAML0531,Diagnosis,PAPYUI,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010140_R03C01,12.816042,6.742684,21.436493,-1.0166773,21.876125,AAML0531,Diagnosis,PAPZCL,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010140_R04C01,17.115135,-7.545241,-19.434471,-14.785356,20.499004,AAML0531,Diagnosis,PAPZFV,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
201005010140_R05C01,-11.932773,-10.176096,20.210573,-13.003237,-16.48769,AAML0531,Diagnosis,PAPZIZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010140_R06C01,-11.588255,-11.7421665,19.614567,-13.691862,-16.187744,AAML0531,Diagnosis,PAPZLT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010140_R07C01,-11.907143,-10.15786,20.15982,-12.993686,-16.483326,AAML0531,Diagnosis,PAPZTC,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010140_R08C01,1.348784,22.398678,-13.064855,-7.244721,13.758172,AAML0531,Diagnosis,PAPZXN,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010141_R01C01,-17.824327,-10.929497,-16.909967,15.356972,18.951902,AAML0531,Diagnosis,PARRFC,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010141_R02C01,-15.095081,-10.463823,-15.835822,14.332793,17.952711,AAML0531,Diagnosis,PARSAA,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010141_R03C01,-13.399042,-9.006158,-17.812881,15.83467,19.56073,AAML0531,Diagnosis,PARTWN,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010141_R04C01,-17.147837,-11.222229,-16.993387,15.845885,20.110426,AAML0531,Diagnosis,PARUAD,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010141_R05C01,2.956233,22.369274,-13.491162,-5.921733,14.688073,AAML0531,Diagnosis,PARWWW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010141_R06C01,-17.576778,-10.455198,-16.936306,15.411272,19.836151,AAML0531,Diagnosis,PARXNP,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010141_R07C01,12.797479,6.6153717,21.384497,-0.77310365,21.731117,AAML0531,Diagnosis,PASLPE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010141_R08C01,-12.474354,11.8629465,20.022934,-4.332629,-18.02492,AAML0531,Diagnosis,PASMGW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010142_R01C01,12.487081,-11.395698,-1.948313,-18.461826,-12.851618,AAML0531,Diagnosis,PASURM,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
201005010142_R02C01,14.867244,-9.561474,-0.26963955,-16.846983,-13.788522,AAML0531,Diagnosis,PARAFA,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010142_R03C01,1.2821046,-12.5691395,8.786619,11.179725,10.810943,AAML0531,Diagnosis,PARFLB,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
201005010142_R04C01,-10.480405,-6.6037173,12.50732,11.1798,11.251553,AAML0531,Diagnosis,PARFKS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010142_R05C01,12.79028,6.7879567,21.472477,-0.769096,21.986689,AAML0531,Diagnosis,PASZZE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010142_R06C01,13.90074,-10.266415,-0.8890104,-17.84523,-12.420478,AAML0531,Diagnosis,PARFWM,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010142_R07C01,13.148573,4.0777116,19.237158,-0.19032428,17.347744,AAML0531,Diagnosis,PARHKY,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010142_R08C01,-15.366094,-10.317709,-16.315716,14.654698,18.068018,AAML0531,Diagnosis,PARIYB,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010157_R01C01,3.682283,20.745413,-13.6832695,-6.389467,14.894805,AAML0531,Diagnosis,PASCRP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010157_R02C01,14.150088,-12.125478,11.852882,15.285163,-16.130365,AAML0531,Diagnosis,PASFVP,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
201005010157_R03C01,14.394073,-12.077005,11.938172,15.573083,-16.12156,AAML0531,Diagnosis,PASGEM,Unknown,Discovery (train) Samples,GSE124413,Unknown,MDS-related or secondary myeloid neoplasms
201005010157_R04C01,-14.992449,-10.007261,-16.350948,14.628382,18.202387,AAML0531,Diagnosis,PASGZV,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010157_R05C01,13.697148,-12.701463,-0.03305254,-13.973225,-15.066434,AAML0531,Diagnosis,PASHZX,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with other rare recurring translocations
201005010157_R06C01,13.160773,-11.597651,-0.76257604,-17.517664,-11.048253,AAML0531,Diagnosis,PATBHG,Unknown,Discovery (train) Samples,GSE124413,Unknown,AML with mutated NPM1
201005010157_R07C01,3.0774648,21.318842,-13.375828,-6.4910617,14.718047,AAML0531,Diagnosis,PATJIC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201005010157_R08C01,10.112838,-28.364168,-14.367188,4.3817153,16.968142,AAML0531,Diagnosis,PATJWN,AML with mutated NPM1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with mutated NPM1
201005010158_R01C01,-11.876491,11.176137,20.497173,-2.0653572,-18.073242,AAML0531,Diagnosis,PARPEK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010158_R02C01,-11.102134,12.963687,19.078632,-6.7310605,-19.777185,AAML0531,Diagnosis,PARIFD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010158_R03C01,13.470616,-7.834164,-19.273031,-13.883068,19.726463,AAML0531,Diagnosis,PARTYV,AML with other rare recurring translocations,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with other rare recurring translocations
201005010158_R04C01,-12.277249,13.352153,19.591084,-4.5161977,-18.639208,AAML0531,Diagnosis,PASPYR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010158_R05C01,-11.575112,13.618789,19.467407,-5.96208,-19.764061,AAML0531,Diagnosis,PASSSI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201005010158_R06C01,-18.2562,-11.311752,-17.038395,15.55638,18.887985,AAML0531,Diagnosis,PARMZF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201005010158_R07C01,17.752346,-7.533232,-19.33795,-14.805093,20.584452,AAML0531,Diagnosis,PASTPU,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
201005010158_R08C01,3.4923391,18.478867,-13.901835,-7.8491416,14.479527,AAML0531,Diagnosis,PAPVDV,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE124413,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
201101a2-5971-43a0-8f77-5feff5cfe27b_noid,15.463437,-8.010948,-0.5311703,-18.35811,-13.176786,TCGA AML,Diagnosis,TCGA-AB-2967,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
201114530010_R06C01,-11.196385,12.018113,18.658249,-7.308792,-19.55023,Beat AML Consortium,Diagnosis,AML1,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201114530028_R08C01,-12.828431,13.297104,19.24986,-5.6174064,-19.341806,Beat AML Consortium,Diagnosis,AML2,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201114530033_R05C01,-10.745402,12.722369,19.656391,-5.980262,-19.339169,Beat AML Consortium,Diagnosis,AML4,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650023_R01C01,-10.617434,-16.209484,-21.912025,7.2769694,-21.78958,French GRAALL 2003–2005,Diagnosis,TCRn_1,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233650023_R02C01,-10.612988,-16.253595,-21.918293,7.291357,-21.794317,French GRAALL 2003–2005,Diagnosis,TCRp_1,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233650023_R05C01,-10.62294,-16.155476,-21.903582,7.259156,-21.78367,French GRAALL 2003–2005,Diagnosis,SPo4_1,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233650023_R06C01,-10.603386,-16.347023,-21.933542,7.321637,-21.804998,French GRAALL 2003–2005,Diagnosis,SPo8_1,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233650024_R01C01,14.097014,5.392315,19.72581,-6.175834,16.576574,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_417,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233650024_R02C01,-15.190521,9.421719,15.445001,9.6606,13.689582,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_437,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233650024_R03C01,-10.189661,-18.17497,10.607879,-21.817095,14.470648,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_550,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233650024_R04C01,-10.092226,-18.120707,10.612615,-21.697681,14.429279,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_567,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233650024_R05C01,14.004617,5.048826,19.653355,-6.273567,16.695871,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_597,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650024_R06C01,13.931796,5.4280043,19.95854,-5.6394753,17.168276,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_469,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233650050_R01C01,14.211891,5.508769,19.834272,-6.5018435,16.214487,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_691,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650050_R02C01,14.345411,6.1267123,20.264746,-6.138859,16.149794,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_702,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650050_R03C01,13.765647,4.110312,18.582804,-9.874319,15.740231,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_723,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650050_R04C01,-5.779406,-10.974892,7.3107777,8.478907,10.129296,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_726,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
201233650050_R05C01,13.897967,4.223309,18.592758,-9.3333435,15.740675,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_727,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650050_R06C01,13.548081,5.5414953,20.342398,-4.445699,18.624825,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_728,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650050_R07C01,-0.27926573,-8.5151615,0.9108994,9.877957,10.07056,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_730,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233650050_R08C01,-9.722125,-17.146816,10.599436,-20.736853,14.087703,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_733,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233650075_R01C01,-15.314276,8.973212,15.392898,9.86625,13.656627,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_GEN_EE,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233650075_R02C01,13.866167,4.4042487,19.504759,-7.071846,16.693817,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_CON_NI,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650075_R03C01,14.428618,4.4888196,17.755493,-7.3569384,15.7263155,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_DUB_GL,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650075_R04C01,-9.905222,-18.209658,10.629961,-21.599735,14.39716,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_MOL_JU,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233650075_R05C01,13.954441,4.125249,18.764538,-8.938693,15.850691,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_POT_EL,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650075_R06C01,13.972147,4.421303,18.877861,-8.925873,15.741431,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_RAD_MI,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233650075_R07C01,-10.609064,-16.291656,-21.924707,7.3036847,-21.798935,French GRAALL 2003–2005,Diagnosis,CD34_1,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233650075_R08C01,-10.609829,-16.284271,-21.923958,7.3013434,-21.798622,French GRAALL 2003–2005,Diagnosis,ISP_1,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233760043_R02C01,14.063477,4.6783104,19.338367,-8.109222,15.847434,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_243,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760043_R03C01,13.767797,4.4068713,19.931622,-6.9919343,16.682014,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_255,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760043_R04C01,13.74257,4.540518,19.581707,-6.014358,17.414415,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_256,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760043_R05C01,-5.67624,-11.19456,8.104381,9.16318,9.696754,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_366,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760043_R07C01,-5.6644306,-11.070995,7.4993896,8.691419,9.982498,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_381,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
201233760043_R08C01,-5.991901,-10.946936,7.7671623,8.870305,9.82829,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_383,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
201233760070_R01C01,14.072636,4.222516,18.062353,-8.942948,15.665009,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_592,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760070_R02C01,14.261215,5.4699416,19.19526,-6.2131224,16.29367,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_593,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760070_R03C01,-6.138734,-11.408411,7.0231924,8.064252,9.737106,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_595,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
201233760070_R04C01,14.143163,4.35463,18.726128,-8.504635,15.684609,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_600,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760070_R05C01,13.550369,5.4081116,20.251055,-4.4790444,18.480804,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_607,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760070_R06C01,-15.268484,9.0079565,15.449375,9.709808,13.649262,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_616,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233760070_R07C01,-10.478433,-17.91514,10.5766,-21.88808,14.4909935,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_617,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760070_R08C01,14.40744,4.5655484,17.732145,-7.766776,15.535194,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_622,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760071_R01C01,-2.2467916,-11.503506,5.332104,8.977517,10.116268,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_569,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760071_R02C01,14.041701,4.368162,18.836529,-8.622777,15.781343,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_571,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760071_R03C01,-6.2369447,-11.056924,7.2561326,8.26414,9.941153,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_573,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
201233760071_R04C01,14.090057,4.277291,18.9047,-8.816278,15.640972,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_583,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760071_R05C01,-10.277529,-17.576096,10.578327,-21.493301,14.350953,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_585,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760071_R06C01,-10.379623,-17.0505,10.549712,-21.22817,14.252907,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_586,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760071_R07C01,-10.149962,-18.075659,10.606982,-21.717318,14.435201,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_587,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760071_R08C01,14.729826,3.1371253,17.905256,-8.35671,15.234506,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_590,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760083_R01C01,14.060352,4.9518566,19.448908,-7.4448056,16.04809,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_624,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760083_R02C01,-9.626141,-18.34319,10.655282,-21.454088,14.349386,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_626,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760083_R03C01,13.934996,4.273619,18.711372,-9.316454,15.681341,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_628,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760083_R04C01,-15.2744,8.537442,15.582246,9.430869,13.583567,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_629,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233760083_R05C01,-10.304226,-17.968092,10.591536,-21.775236,14.453318,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_642,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760083_R06C01,14.054058,4.5008397,19.038582,-8.438742,15.802835,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_649,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760083_R07C01,13.980741,4.4281344,19.017288,-7.3376126,16.438894,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_655,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760083_R08C01,14.044382,4.632549,18.89442,-8.443795,15.79003,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_661,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760104_R01C01,14.469783,4.904261,17.655178,-6.9663515,15.696157,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_666,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760104_R02C01,-15.151682,9.476588,15.496698,9.524487,13.687181,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_674,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233760104_R03C01,13.510965,5.3702617,20.217648,-4.323685,18.58655,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_676,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760104_R04C01,-2.5912528,-11.80113,6.3098054,10.021536,9.421069,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_677,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760104_R05C01,13.769131,3.9325144,18.552727,-9.859427,15.785488,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_679,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760104_R06C01,-10.59494,-17.838509,10.5659275,-21.936403,14.506359,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_680,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760104_R07C01,13.566306,5.4353285,20.279776,-4.5445156,18.447176,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_689,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760104_R08C01,14.165006,5.266812,19.905777,-7.117922,15.935868,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_690,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760122_R01C01,14.156972,4.3280263,18.758764,-7.038581,16.327284,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_515,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760122_R02C01,13.568917,5.4320025,20.256662,-4.534278,18.44414,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_523,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760122_R03C01,-10.612556,-16.257421,-21.916798,7.2929115,-21.793879,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_548,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233760122_R04C01,13.546483,5.4870267,20.309744,-4.4102874,18.54683,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_551,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760122_R05C01,13.913351,4.4568644,19.583681,-7.335675,16.449446,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_552,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760122_R06C01,-15.112844,9.642736,15.495013,9.498727,13.699628,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_554,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
201233760122_R07C01,-10.05943,-17.75492,10.601166,-21.42773,14.331442,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_557,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760122_R08C01,-10.105483,-17.858545,10.601458,-21.534893,14.36998,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_558,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760134_R01C01,13.89379,5.5513883,20.019583,-5.298061,17.42534,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_389,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760134_R02C01,-9.936234,-17.406397,10.596437,-21.092226,14.212019,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_409,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760134_R03C01,14.288026,4.432758,18.115307,-7.9351106,15.703214,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_415,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760134_R04C01,-10.507747,-17.954626,10.576196,-21.938847,14.508883,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_420,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760134_R05C01,-9.866605,-17.110073,10.589411,-20.833662,14.12055,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_421,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760134_R06C01,-10.410295,-17.71732,10.574228,-21.698767,14.423454,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_428,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760134_R07C01,14.188014,5.717662,19.90587,-6.0333614,16.496916,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_464,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760134_R08C01,14.12356,5.153541,19.731035,-7.1726522,16.03793,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_465,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760140_R01C01,-10.320449,-18.135344,10.596827,-21.9005,14.498657,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_466,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760140_R02C01,14.18855,5.4984174,20.005013,-6.5848475,16.111998,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_470,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760140_R03C01,-1.8309866,-10.787367,4.3506403,9.6622505,9.523054,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_480,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
201233760140_R04C01,-10.36371,-18.252003,10.598025,-22.01581,14.539707,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_481,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760140_R05C01,-9.975064,-18.329712,10.629361,-21.73811,14.446138,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_487,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760140_R06C01,-10.456147,-17.614912,10.566822,-21.668829,14.411754,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_491,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with mutated NPM1
201233760140_R07C01,13.9124,4.213163,18.55493,-9.381625,15.702486,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_506,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201233760140_R08C01,13.801298,3.935498,18.755842,-9.476942,15.884835,French GRAALL 2003–2005,Diagnosis,T-ALL_sample_507,Unknown,Discovery (train) Samples,GSE147667,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201394350039_R05C01,-10.998134,12.078923,18.827188,-7.1961823,-19.25022,Beat AML Consortium,Diagnosis,AML3,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201557510013_R02C01,-11.305788,13.425085,19.264236,-6.4512076,-19.834398,Beat AML Consortium,Diagnosis,AML8,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201557510013_R07C01,-12.112031,-8.622511,20.491325,-12.312005,-16.739164,Beat AML Consortium,Diagnosis,AML9,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201557510013_R08C01,-12.139841,-8.399854,20.533463,-12.2137165,-16.775633,Beat AML Consortium,Diagnosis,AML10,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201557510053_R05C01,-11.619794,-11.636535,19.666256,-13.645695,-16.210152,Beat AML Consortium,Diagnosis,AML5,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201557510053_R06C01,-11.974143,-9.950897,20.282074,-12.903376,-16.52928,Beat AML Consortium,Diagnosis,AML6,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201557510053_R07C01,-12.056092,-10.246694,20.453257,-13.03866,-16.51336,Beat AML Consortium,Diagnosis,AML7,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500043_R01C01,-10.71383,12.749244,19.29936,-6.6046896,-19.825897,Beat AML Consortium,Diagnosis,AML11,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500043_R02C01,-12.689014,11.177314,19.93275,-4.269689,-19.283588,Beat AML Consortium,Diagnosis,AML12,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500043_R03C01,-12.121665,10.202987,21.456863,-3.033397,-17.412766,Beat AML Consortium,Diagnosis,AML13,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500043_R04C01,-12.45176,13.612109,18.675297,-6.39795,-19.24522,Beat AML Consortium,Diagnosis,AML14,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500043_R06C01,-11.646929,-11.682493,19.72136,-13.6656475,-16.208925,Beat AML Consortium,Diagnosis,AML15,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500043_R07C01,-12.00036,-9.80634,20.32555,-12.839479,-16.554909,Beat AML Consortium,Diagnosis,AML16,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500043_R08C01,-11.8641815,13.578277,18.810738,-6.821881,-19.764393,Beat AML Consortium,Diagnosis,AML17,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
201858500162_R03C01,14.763441,-12.017448,11.865366,15.699588,-11.135154,Beat AML Consortium,Relapse,AML40R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
201858500162_R04C01,-16.761774,6.928095,14.70003,12.591883,13.689674,Beat AML Consortium,Relapse,AML43R,Unknown,Discovery (train) Samples,GSE159907,Unknown,Otherwise-Normal Control
201858500162_R06C01,-0.2775598,-8.390059,0.8157187,9.965781,10.035542,Beat AML Consortium,Relapse,AML37R,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
201869690119_R01C01,13.173495,4.0309496,19.158026,-0.19289243,17.207457,Beat AML Consortium,Relapse,AML34R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with other rare recurring translocations
202148010005_R01C01,-11.877404,11.530536,4.2094693,-23.651999,10.7625675,Beat AML Consortium,Relapse,AML39R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
202148010005_R03C01,-12.092269,11.269595,4.297122,-23.04744,10.509767,Beat AML Consortium,Relapse,AML36R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
202148010005_R06C01,-5.0829563,-10.766273,6.0401587,6.914159,11.936214,Beat AML Consortium,Relapse,AML41R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010005_R08C01,-5.9676633,-9.39615,8.240455,9.220782,11.419391,Beat AML Consortium,Relapse,AML38R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
202148010027_R01C01,-12.240812,11.420953,19.30375,-5.6894784,-18.503824,Beat AML Consortium,Diagnosis,AML18,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010027_R02C01,-11.813931,11.778846,18.743464,-6.5702114,-18.957087,Beat AML Consortium,Diagnosis,AML19,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010027_R03C01,-11.97438,-10.216198,20.292372,-13.023087,-16.494398,Beat AML Consortium,Diagnosis,AML20,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010027_R04C01,-11.931011,-10.473495,20.218073,-13.135756,-16.448322,Beat AML Consortium,Diagnosis,AML21,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010027_R06C01,-11.612476,-11.687103,19.65637,-13.667966,-16.201546,Beat AML Consortium,Diagnosis,AML22,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010127_R02C01,-11.627925,11.192782,18.75315,-6.9848037,-19.16687,Beat AML Consortium,Diagnosis,AML23,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010127_R03C01,-12.630252,12.948244,17.94636,-7.4269676,-19.293034,Beat AML Consortium,Diagnosis,AML24,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010127_R04C01,13.832472,-13.458478,0.33893988,-12.181564,-17.014214,Beat AML Consortium,Diagnosis,AML25,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010127_R05C01,-11.755043,-10.953809,19.899874,-13.344488,-16.337643,Beat AML Consortium,Diagnosis,AML26,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010127_R06C01,-12.485442,13.230274,18.010073,-7.524368,-19.50116,Beat AML Consortium,Diagnosis,AML27,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202148010127_R07C01,-2.8916402,-11.177298,7.9968557,10.048328,10.729049,Beat AML Consortium,Relapse,AML42R,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202148010127_R08C01,-0.4685367,-8.362188,1.0499703,10.19708,9.890577,Beat AML Consortium,Relapse,AML35R,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202242400068_R01C01,-11.592118,10.998489,20.368303,-4.8823147,-18.21102,Beat AML Consortium,Diagnosis,16-00494,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202242400068_R02C01,16.164583,-7.6448674,-19.31513,-14.59435,20.491491,Beat AML Consortium,Diagnosis,15-00248,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202242400068_R03C01,-7.5981417,-17.038218,-20.826628,-21.308897,14.652097,Beat AML Consortium,Diagnosis,16-00410,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202242400068_R04C01,-14.594064,-8.574577,-18.190422,15.7797785,19.120695,Beat AML Consortium,Diagnosis,12-00301,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202242400068_R07C01,14.14423,-12.149952,11.821716,15.161733,-16.192467,Beat AML Consortium,Diagnosis,12-00127,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202242400068_R08C01,1.0259093,22.28925,-12.659801,-7.6802516,13.661757,Beat AML Consortium,Diagnosis,16-00474,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202250790076_R02C01,14.687241,-12.028454,11.84913,15.638248,-11.251466,Beat AML Consortium,Diagnosis,16-00004,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202250790076_R03C01,-4.651999,-9.075587,6.8080654,10.121629,10.60358,Beat AML Consortium,Diagnosis,16-01005,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202250790076_R04C01,-14.908419,-8.536813,-18.163416,15.686695,18.971678,Beat AML Consortium,Diagnosis,13-00163,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202250790076_R05C01,-2.727432,-11.03398,8.006312,10.374361,10.574723,Beat AML Consortium,Diagnosis,15-00616,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202250790076_R06C01,-11.803863,11.565383,4.248066,-23.54439,10.810096,Beat AML Consortium,Diagnosis,16-01098,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202250790076_R07C01,-7.2712374,-17.413828,-21.004824,-21.060995,14.399646,Beat AML Consortium,Diagnosis,13-00204,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202250790076_R08C01,1.7109243,20.687231,-13.593537,-7.680607,13.795136,Beat AML Consortium,Diagnosis,13-00245,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202250790092_R01C01,-4.578408,-10.285757,6.7810054,8.811575,11.018363,Beat AML Consortium,Diagnosis,13-00544,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202250790092_R02C01,1.2278423,22.761806,-12.801648,-7.39614,13.647045,Beat AML Consortium,Diagnosis,13-00146,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202816900018_R01C01,-0.83896375,-12.053892,6.5972724,9.748396,10.255219,Beat AML Consortium,Diagnosis,15-00693,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202816900018_R02C01,-1.2060817,-9.167347,2.7839882,10.873245,9.320967,Beat AML Consortium,Diagnosis,15-00813,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202816900018_R03C01,13.26306,-14.770159,0.31977707,-11.755196,-15.529264,Beat AML Consortium,Diagnosis,16-00094,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with other rare recurring translocations
202816900018_R04C01,1.5016625,-12.988547,8.342012,11.046056,9.778713,Beat AML Consortium,Diagnosis,16-01223,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202816900018_R05C01,-12.199181,11.315094,3.9692557,-23.618578,10.249107,Beat AML Consortium,Diagnosis,16-00278,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202816900018_R06C01,-5.897028,-9.854905,8.712516,8.815037,11.85294,Beat AML Consortium,Diagnosis,13-00365,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202816900018_R07C01,13.837131,-11.582794,-0.57590276,-14.845941,-17.03599,Beat AML Consortium,Diagnosis,16-00056,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202816900018_R08C01,-7.5187006,-17.144514,-20.854862,-21.263943,14.59258,Beat AML Consortium,Diagnosis,13-00226,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202817030087_R01C01,-16.993654,-10.171892,-16.859076,15.143925,19.182674,Beat AML Consortium,Diagnosis,15-00702,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202817030087_R03C01,-18.026844,-18.829405,-0.13186824,-15.317521,-23.523897,Beat AML Consortium,Diagnosis,16-00220,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030087_R04C01,-0.37384778,-8.534592,1.0620667,9.832945,10.141462,Beat AML Consortium,Diagnosis,14-00021,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030087_R05C01,17.113892,-7.5446696,-19.429203,-14.880637,20.67103,Beat AML Consortium,Diagnosis,16-00351,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202817030087_R06C01,-2.1047246,-10.518164,7.081971,10.993438,10.362426,Beat AML Consortium,Diagnosis,16-00595,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030087_R08C01,-1.3464113,-8.276788,2.23442,10.927929,9.53825,Beat AML Consortium,Diagnosis,14-00670,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030094_R01C01,-11.862511,11.834234,3.8335853,-25.097574,11.344609,Beat AML Consortium,Diagnosis,15-00717,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030094_R02C01,1.0252464,-13.705574,8.00285,10.534384,9.845917,Beat AML Consortium,Diagnosis,12-00069,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202817030094_R03C01,15.235469,-9.491514,-0.99044055,-17.05093,-14.52582,Beat AML Consortium,Diagnosis,14-00658,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030094_R04C01,-5.863018,-11.10288,6.2089806,7.238432,10.693994,Beat AML Consortium,Diagnosis,14-00831,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202817030094_R05C01,-15.306284,-0.120851405,14.547934,11.975933,12.594975,Beat AML Consortium,Diagnosis,16-00392,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with other rare recurring translocations
202817030094_R06C01,0.1533709,-12.852797,8.305686,11.224606,10.060495,Beat AML Consortium,Diagnosis,16-00731,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202817030094_R07C01,-5.117339,-11.1382,6.944815,7.8890786,10.9619875,Beat AML Consortium,Diagnosis,16-00547,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030094_R08C01,14.819019,-12.058456,11.958262,15.676254,-15.086717,Beat AML Consortium,Diagnosis,15-00051,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with mutated NPM1
202817030106_R02C01,15.426124,-7.9270573,-0.701376,-18.706638,-12.866258,Beat AML Consortium,Diagnosis,15-00734,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030106_R03C01,2.398584,-12.764184,8.306611,10.697629,9.20481,Beat AML Consortium,Diagnosis,15-00261,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202817030106_R04C01,2.078416,-12.791988,8.412383,10.959222,9.315969,Beat AML Consortium,Diagnosis,14-00774,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202817030106_R05C01,-3.4594846,-10.733274,9.067691,10.697746,10.46595,Beat AML Consortium,Diagnosis,14-00289,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030106_R06C01,15.516227,-7.7261224,-19.14861,-14.904824,21.376492,Beat AML Consortium,Diagnosis,15-00377,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202817030106_R07C01,0.013450155,-12.749519,8.550455,11.283447,10.51478,Beat AML Consortium,Diagnosis,14-00135,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030106_R08C01,14.274026,-11.253691,-1.325118,-16.626007,-13.84231,Beat AML Consortium,Diagnosis,15-00556,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202817030117_R01C01,16.334663,-7.630651,-19.370834,-14.064125,19.47172,Beat AML Consortium,Diagnosis,14-00034,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202817030117_R02C01,13.233593,4.0235143,19.070734,-0.3961532,17.072828,Beat AML Consortium,Diagnosis,14-00052,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
202817030117_R03C01,-12.104591,11.61502,3.7751575,-24.795746,10.989739,Beat AML Consortium,Diagnosis,14-00559,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030117_R04C01,1.0157143,-13.428516,7.5849886,11.598502,8.879773,Beat AML Consortium,Diagnosis,14-00141,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202817030117_R05C01,14.819473,-12.039597,11.965199,15.751145,-14.546072,Beat AML Consortium,Diagnosis,14-00567,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
202817030117_R06C01,13.638945,-14.3513,0.86373395,-10.883915,-17.187664,Beat AML Consortium,Diagnosis,14-00578,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with other rare recurring translocations
202817030117_R07C01,-18.04906,-18.82553,-0.15401353,-15.33885,-23.534538,Beat AML Consortium,Diagnosis,15-00965,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030117_R08C01,-11.672789,11.002299,19.607208,-3.557161,-16.624462,Beat AML Consortium,Diagnosis,15-00990,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202817030142_R01C01,-7.529161,-17.113804,-20.868246,-21.25216,14.597758,Beat AML Consortium,Diagnosis,15-00338,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202817030142_R02C01,16.84922,-7.6004405,-19.296858,-14.854609,20.864594,Beat AML Consortium,Diagnosis,14-00272,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202817030142_R03C01,14.918309,-12.013285,11.95559,15.838197,-13.049771,Beat AML Consortium,Diagnosis,15-00269,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030142_R04C01,-0.6141812,-11.468355,9.886171,11.816992,10.4352665,Beat AML Consortium,Diagnosis,15-00900,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202817030142_R05C01,-12.964073,10.758089,19.893608,-5.4907494,-18.897625,Beat AML Consortium,Diagnosis,13-00034,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030142_R06C01,14.695411,-12.029009,11.854689,15.644297,-11.379912,Beat AML Consortium,Diagnosis,15-00670,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202817030142_R07C01,-11.630973,11.846269,4.125502,-24.39945,11.258117,Beat AML Consortium,Diagnosis,17-00025,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030142_R08C01,-10.475417,12.878539,19.731817,-5.926939,-19.362144,Beat AML Consortium,Diagnosis,15-00563,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202817030166_R01C01,-1.9496995,-11.553414,5.8354235,9.205737,10.347434,Beat AML Consortium,Diagnosis,15-00417,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030166_R02C01,14.665084,-11.457709,0.9031837,-12.678358,-18.196882,Beat AML Consortium,Diagnosis,14-00543,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030166_R03C01,-12.000405,-9.806054,20.326784,-12.838987,-16.55496,Beat AML Consortium,Diagnosis,14-00464,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202817030166_R04C01,-1.3074409,-11.19682,7.093432,11.093396,10.128595,Beat AML Consortium,Diagnosis,16-00354,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030166_R05C01,-0.93855184,-10.331889,4.3230143,10.362226,9.882462,Beat AML Consortium,Diagnosis,13-00255,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030166_R06C01,14.8220625,-10.3337145,-1.2729369,-17.208921,-12.916574,Beat AML Consortium,Diagnosis,13-00535,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202817030166_R07C01,-0.4649085,-8.423964,1.1195832,10.105984,9.967067,Beat AML Consortium,Diagnosis,16-00007,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202817030166_R08C01,-4.9827156,-10.820798,6.0777497,7.0079494,11.870297,Beat AML Consortium,Diagnosis,13-00393,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860003_R01C01,-1.340544,-11.916769,8.626445,10.868544,10.46717,Beat AML Consortium,Diagnosis,15-00766,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860003_R02C01,-11.895766,11.420835,4.379126,-23.18042,10.729979,Beat AML Consortium,Diagnosis,10-00136,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
202818860003_R03C01,-18.047567,-18.824602,-0.15500991,-15.338466,-23.535116,Beat AML Consortium,Diagnosis,15-00302,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860003_R04C01,-17.30833,-9.011013,-18.265978,15.61706,18.327269,Beat AML Consortium,Diagnosis,15-00045,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202818860003_R05C01,12.992088,-12.133882,-1.0783122,-17.428848,-10.4425125,Beat AML Consortium,Diagnosis,13-00157,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860003_R06C01,-11.692308,11.935456,3.8629787,-24.965118,11.365954,Beat AML Consortium,Diagnosis,16-01022,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860003_R07C01,-7.512146,-17.128418,-20.882505,-21.234032,14.583695,Beat AML Consortium,Diagnosis,16-01262,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202818860003_R08C01,-1.0784135,-9.483895,3.3987215,9.666223,10.589496,Beat AML Consortium,Diagnosis,12-00294,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860060_R01C01,14.42471,-12.111546,11.88335,15.383293,-15.856039,Beat AML Consortium,Diagnosis,16-01151,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860060_R02C01,0.5587261,-13.226986,8.132609,11.261392,10.559807,Beat AML Consortium,Diagnosis,16-01185,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860060_R03C01,0.15655579,-12.813028,8.465781,11.022934,10.297339,Beat AML Consortium,Diagnosis,15-00975,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202818860060_R04C01,-11.889974,11.721983,3.9493275,-24.667633,11.102185,Beat AML Consortium,Diagnosis,16-01254,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860060_R05C01,0.9953288,-12.337442,7.624514,10.9873905,10.380548,Beat AML Consortium,Diagnosis,13-00266,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860060_R06C01,14.365782,-9.411101,-0.82187736,-18.44499,-11.90658,Beat AML Consortium,Diagnosis,14-00023,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860060_R07C01,-12.556959,13.572512,19.33209,-5.544168,-19.539371,Beat AML Consortium,Diagnosis,14-00447,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860060_R08C01,14.415105,-12.076953,11.811419,15.418738,-12.508866,Beat AML Consortium,Diagnosis,14-00581,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202818860067_R01C01,17.24962,-7.5448127,-19.410624,-14.767489,20.48279,Beat AML Consortium,Diagnosis,15-00786,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202818860067_R02C01,13.019639,-12.169303,-1.6340476,-17.796528,-10.241277,Beat AML Consortium,Diagnosis,11-00090,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860067_R03C01,0.42117605,-12.228453,7.330701,10.967896,9.990391,Beat AML Consortium,Diagnosis,16-00115,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202818860067_R04C01,15.545582,-9.017767,1.4463134,-14.724317,-15.80093,Beat AML Consortium,Diagnosis,15-00148,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860067_R05C01,13.804179,-13.99414,-0.2995078,-12.744824,-15.513828,Beat AML Consortium,Diagnosis,13-00186,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860067_R06C01,-4.512763,-8.978288,6.1929297,10.080962,10.429929,Beat AML Consortium,Diagnosis,16-01055,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860067_R07C01,-0.3694,-8.492761,1.0620131,10.007876,10.017696,Beat AML Consortium,Diagnosis,15-00610,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202818860067_R08C01,-11.795783,12.1654415,19.964113,-3.8628237,-18.437351,Beat AML Consortium,Diagnosis,13-00425,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860068_R01C01,-17.953823,-18.845476,-0.050781995,-15.244453,-23.48499,Beat AML Consortium,Diagnosis,15-00858,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860068_R02C01,14.091752,-0.07801569,19.247137,-11.967754,15.348439,Beat AML Consortium,Diagnosis,14-00546,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202818860068_R03C01,-12.036854,10.528575,20.639996,-4.606688,-17.877592,Beat AML Consortium,Diagnosis,15-00633,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860068_R04C01,13.747102,-13.920634,-0.4153934,-13.305211,-14.42463,Beat AML Consortium,Diagnosis,12-00023,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with other rare recurring translocations
202818860068_R05C01,-1.1262612,-8.219406,1.9474014,10.883739,9.5692005,Beat AML Consortium,Diagnosis,14-00448,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860068_R06C01,-18.090685,-18.815475,-0.20126286,-15.38078,-23.557453,Beat AML Consortium,Diagnosis,16-01225,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860068_R07C01,13.232156,-14.17016,-1.0113014,-14.765927,-11.975051,Beat AML Consortium,Diagnosis,15-00615,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202818860068_R08C01,4.334715,18.659586,-14.0522175,-7.192615,14.911768,Beat AML Consortium,Diagnosis,13-00615,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202818860080_R01C01,-11.768317,11.823246,3.9850097,-24.766367,11.279886,Beat AML Consortium,Diagnosis,14-00259,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860080_R02C01,-16.739067,-8.584532,-18.637962,15.838226,18.505085,Beat AML Consortium,Diagnosis,14-00279,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202818860080_R03C01,-16.247543,-8.893311,-18.08669,15.593417,18.693233,Beat AML Consortium,Diagnosis,13-00454,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202818860080_R04C01,-10.344963,12.785266,19.601318,-6.312886,-19.337812,Beat AML Consortium,Diagnosis,14-00434,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860080_R05C01,-12.312293,11.282652,3.7793298,-23.768108,10.119963,Beat AML Consortium,Diagnosis,14-00228,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860080_R06C01,-0.2227772,-11.525631,5.867173,11.035096,9.727103,Beat AML Consortium,Diagnosis,14-00335,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202818860080_R07C01,-11.459854,11.925536,18.404142,-7.5038304,-19.375637,Beat AML Consortium,Diagnosis,14-00504,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860080_R08C01,-0.9384594,-10.2063,4.023717,10.346638,9.821423,Beat AML Consortium,Diagnosis,14-00514,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860098_R01C01,1.7852857,-12.494151,8.3202915,10.781704,9.389743,Beat AML Consortium,Diagnosis,15-00464,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202818860098_R02C01,-18.350956,-9.994142,-17.395487,15.269517,18.599506,Beat AML Consortium,Diagnosis,14-00613,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202818860098_R03C01,-12.05185,10.831145,20.712526,-3.8551095,-17.747585,Beat AML Consortium,Diagnosis,13-00513,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860098_R04C01,-11.85337,11.762582,3.8689578,-24.667444,11.0567665,Beat AML Consortium,Diagnosis,16-00836,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860098_R05C01,-4.888486,-10.983229,5.982991,7.0939207,11.578007,Beat AML Consortium,Diagnosis,15-00767,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202818860098_R06C01,3.227526,20.291397,-13.582746,-7.3285356,14.363174,Beat AML Consortium,Diagnosis,15-00763,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202818860098_R07C01,-0.68013626,-8.947074,1.9966522,9.981819,10.084036,Beat AML Consortium,Diagnosis,17-00094,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202818860098_R08C01,-18.61649,-9.996111,-17.650518,15.404242,18.372704,Beat AML Consortium,Diagnosis,16-00001,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202818860110_R01C01,15.724877,-7.687783,-19.21505,-15.088989,21.560894,Beat AML Consortium,Diagnosis,15-00471,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202818860110_R02C01,-11.766266,11.420197,19.160915,-6.3483267,-18.926058,Beat AML Consortium,Diagnosis,15-00296,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860110_R03C01,-11.875177,11.662522,4.1182127,-24.429543,11.048911,Beat AML Consortium,Diagnosis,14-00092,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860110_R04C01,14.274279,-9.558462,-0.9692247,-18.565067,-11.688875,Beat AML Consortium,Diagnosis,16-00815,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860110_R05C01,-4.9678473,-10.932654,6.201257,7.3378124,11.430109,Beat AML Consortium,Diagnosis,13-00354,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
202818860110_R06C01,0.70866585,20.824677,-13.171535,-8.016198,13.623488,Beat AML Consortium,Diagnosis,15-00807,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202818860110_R07C01,-18.759106,-9.69902,-17.832766,15.413373,18.313396,Beat AML Consortium,Diagnosis,14-00125,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202818860110_R08C01,-7.6444387,-16.997263,-20.788729,-21.356098,14.6887865,Beat AML Consortium,Diagnosis,16-00498,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
202818860111_R01C01,14.244797,-9.93253,-0.7448136,-16.687155,-15.86805,Beat AML Consortium,Diagnosis,15-00680,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860111_R02C01,1.4765575,22.60668,-13.213716,-7.07833,13.738623,Beat AML Consortium,Diagnosis,15-00756,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202818860111_R03C01,15.510904,-11.94728,12.069758,16.225407,-12.534363,Beat AML Consortium,Diagnosis,16-00027,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
202818860111_R04C01,14.1574,-12.176221,11.758977,14.989361,-15.4296255,Beat AML Consortium,Diagnosis,16-00981,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
202818860111_R05C01,-5.431098,-10.28768,11.774928,10.786187,11.429889,Beat AML Consortium,Diagnosis,14-00041,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
202818860111_R06C01,-1.2954371,-10.3625145,4.4550953,10.122024,9.959417,Beat AML Consortium,Diagnosis,15-00870,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860111_R07C01,-11.084108,12.046465,18.80698,-7.136842,-19.485968,Beat AML Consortium,Diagnosis,15-00578,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860111_R08C01,-12.09273,12.933371,19.198906,-5.004886,-18.407188,Beat AML Consortium,Diagnosis,16-01100,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860138_R01C01,-1.0341344,-11.924088,8.749378,10.911912,10.274735,Beat AML Consortium,Diagnosis,15-00688,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860138_R03C01,-12.136141,11.486882,3.8581486,-24.26572,10.643152,Beat AML Consortium,Diagnosis,16-00078,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860138_R04C01,-17.919727,-18.853539,-0.012037662,-15.209697,-23.466892,Beat AML Consortium,Diagnosis,16-01121,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860138_R05C01,15.072316,-11.996829,12.001363,15.955532,-13.387918,Beat AML Consortium,Diagnosis,16-00269,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
202818860138_R06C01,12.889974,6.256537,20.921722,-0.65114355,21.013111,Beat AML Consortium,Diagnosis,13-00028,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202818860138_R07C01,-0.37769598,-12.1005745,9.003866,11.445996,10.337884,Beat AML Consortium,Diagnosis,13-00396,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202818860138_R08C01,-1.2907816,-8.458522,2.2810876,10.997733,9.406074,Beat AML Consortium,Diagnosis,16-01191,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202884930143_R03C01,13.435507,-12.218542,0.40199712,-13.99811,-15.6884165,AAML1031,Diagnosis,PAXBSE,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202884930143_R04C01,-11.4696245,10.765749,21.202461,-3.2252717,-17.704836,AAML1031,Diagnosis,PAXBVX,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202884930143_R05C01,13.272865,-14.30478,-1.0410824,-14.573555,-12.1303,AAML1031,Diagnosis,PAXBXI,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202884930143_R06C01,14.38549,-12.144838,11.806948,15.164594,-15.134998,AAML1031,Diagnosis,PAXBZH,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with in-frame bZIP mutated CEBPA
202884930143_R07C01,13.356971,-14.222011,-1.0574147,-14.450229,-12.568237,AAML1031,Diagnosis,PAXCDU,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202884930163_R01C01,15.70027,-7.703632,-19.179083,-14.961522,21.400711,AAML1031,Diagnosis,PAWZZN,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202884930163_R02C01,12.605584,-14.847436,-0.26901233,-13.528877,-12.664065,AAML1031,Diagnosis,PAXAAA,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202884930163_R07C01,-11.85139,8.576912,21.718582,-1.923308,-17.703684,AAML1031,Diagnosis,PAXAFN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202884930163_R08C01,15.137385,-8.967007,-0.4935742,-17.1794,-14.559541,AAML1031,Diagnosis,PAXAKF,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202884930178_R01C01,13.99475,-12.740107,-0.71094984,-14.356082,-15.149283,AAML1031,Diagnosis,PAXBDM,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202884930178_R02C01,3.7665577,20.461271,-13.681585,-6.6801915,14.790022,AAML1031,Diagnosis,PAXBCW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202884930178_R03C01,-11.979867,10.242334,21.118912,-1.8289721,-17.850029,AAML1031,Diagnosis,PAXBEF,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202884930178_R04C01,13.132677,-14.178902,-0.96756476,-14.881964,-11.63318,AAML1031,Diagnosis,PAXBHX,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202884930178_R05C01,-12.140917,-5.320996,12.923803,11.497026,10.884483,AAML1031,Diagnosis,PAXBLJ,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202884930178_R07C01,-11.902853,10.78828,20.779858,-2.210087,-17.849726,AAML1031,Diagnosis,PAXBLW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202884930178_R08C01,-12.6616125,10.645115,20.282715,-3.147829,-18.820616,AAML1031,Diagnosis,PAXBLX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202884930197_R01C01,-12.665897,13.362682,18.07639,-7.300396,-19.443975,AAML1031,Diagnosis,PAXALR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202884930197_R02C01,13.258986,-13.839664,-1.0975987,-15.215742,-11.740329,AAML1031,Diagnosis,PAXANS,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202884930197_R03C01,-12.191295,11.988806,19.946037,-4.041295,-18.724459,AAML1031,Diagnosis,PAXARD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202884930197_R05C01,15.499053,-7.7043734,-19.212381,-15.027504,21.494701,AAML1031,Diagnosis,PAXAXY,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202884930197_R06C01,13.250352,-14.133283,-1.4592673,-14.860662,-12.627375,AAML1031,Diagnosis,PAXBAV,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202884930197_R07C01,-13.728985,-2.8731956,13.823296,11.722314,11.830331,AAML1031,Diagnosis,PAXBAZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270024_R01C01,-17.35676,-8.833863,-18.496174,15.791444,18.601444,AAML1031,Diagnosis,PAWYTW,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270024_R02C01,13.932217,-13.251745,-1.1288456,-14.747216,-13.612726,AAML1031,Diagnosis,PAWYVR,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202897270024_R03C01,4.6533093,18.40914,-14.199633,-7.0329,15.074201,AAML1031,Diagnosis,PAWYUC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270024_R04C01,1.5047714,22.358543,-13.185662,-7.1782823,13.7724695,AAML1031,Diagnosis,PAWZAW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270024_R05C01,-12.732835,11.313376,19.874142,-4.2595115,-19.13992,AAML1031,Diagnosis,PAWZAX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270024_R06C01,-15.622462,-11.190627,-17.110256,15.907837,19.4848,AAML1031,Diagnosis,PAWZAU,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270024_R07C01,-14.4315,-3.8050728,14.582661,11.615887,12.544372,AAML1031,Diagnosis,PAWYZR,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270024_R08C01,-16.254128,-10.765299,-16.476974,14.862031,17.981197,AAML1031,Diagnosis,PAWZHY,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270038_R01C01,13.706224,-10.498507,-0.6665937,-16.50708,-15.667294,AAML1031,Diagnosis,PAXFMH,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897270038_R07C01,13.817357,-13.728939,0.57372427,-11.759945,-16.856344,AAML1031,Diagnosis,PAXGES,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270038_R08C01,13.825272,-13.431976,-0.08326231,-12.607257,-17.015455,AAML1031,Diagnosis,PAXGGM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270043_R01C01,-18.065653,-10.13057,-17.606632,15.714167,19.506811,AAML1031,Diagnosis,PAWLAJ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270043_R03C01,14.723745,-11.192971,0.13319412,-14.25059,-16.238932,AAML1031,Diagnosis,PAWLER,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897270043_R04C01,16.324305,-7.622255,-19.381113,-14.333546,19.922054,AAML1031,Diagnosis,PAWLFB,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202897270043_R05C01,-12.85229,13.666828,19.425354,-5.486833,-19.55873,AAML1031,Diagnosis,PAWLEB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270043_R06C01,-11.813368,8.522037,21.802809,-1.9121916,-17.636974,AAML1031,Diagnosis,PAWLGJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270043_R07C01,-12.123083,-8.467214,20.506668,-12.243553,-16.765518,AAML1031,Diagnosis,PAWLHJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270043_R08C01,-17.363676,-11.264727,-17.184816,15.81279,19.27995,AAML1031,Diagnosis,PAWLII,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270045_R03C01,-12.540783,13.007614,17.19062,-8.460391,-19.26952,AAML1031,Diagnosis,PAWLRX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270045_R04C01,-15.307303,-3.6281555,15.210129,11.646905,13.05219,AAML1031,Diagnosis,PAWLTL,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270045_R06C01,-14.251398,-8.494171,-18.355944,15.923754,19.198616,AAML1031,Diagnosis,PAWLUE,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270045_R07C01,-4.9293528,-10.972257,7.133805,8.715347,10.312071,AAML1031,Diagnosis,PAWLTG,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202897270045_R08C01,14.468104,-11.967413,0.8523445,-12.327398,-18.301872,AAML1031,Diagnosis,PAWLYM,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897270052_R02C01,-11.529076,-11.838404,19.507196,-13.734457,-16.156837,AAML1031,Diagnosis,PAUHFI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270052_R03C01,1.1275945,20.279585,-13.0535555,-7.941108,13.981322,AAML1031,Diagnosis,PAUHXN,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270052_R05C01,-18.116922,-9.585315,-17.615353,15.52635,19.578318,AAML1031,Diagnosis,PAUJCF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270052_R06C01,-2.0679648,-9.946181,6.4966755,11.127396,10.213699,AAML1031,Diagnosis,PAUJMC,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202897270052_R07C01,13.391532,-14.62298,0.23277469,-11.886089,-15.5737,AAML1031,Diagnosis,PAUJNJ,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270052_R08C01,1.1661961,22.620213,-12.655632,-6.77917,14.234622,AAML1031,Diagnosis,PAUKDH,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270053_R01C01,-14.750291,-9.170208,-17.713139,15.551933,18.84581,AAML1031,Diagnosis,PAWKLB,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270053_R02C01,2.9955482,19.728914,-13.450341,-7.7685733,14.2849865,AAML1031,Diagnosis,PAWKLC,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270053_R03C01,14.033933,-10.343304,-0.7370768,-16.570131,-15.4258795,AAML1031,Diagnosis,PAWKMU,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202897270053_R04C01,10.545594,-26.564009,-13.5550165,4.411259,16.627094,AAML1031,Diagnosis,PAWKRF,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with other rare recurring translocations
202897270053_R05C01,14.13872,-11.038522,-1.047567,-16.073309,-15.532874,AAML1031,Diagnosis,PAWKPU,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270053_R06C01,-17.077883,-8.757244,-18.429802,15.662318,18.28839,AAML1031,Diagnosis,PAWKUR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270053_R07C01,-10.501752,12.556911,19.559006,-6.1039886,-19.233128,AAML1031,Diagnosis,PAWLAG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270053_R08C01,9.960469,-28.627687,-14.50752,4.4310412,17.008526,AAML1031,Diagnosis,PAWKYG,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202897270054_R01C01,12.955771,4.4541817,20.031075,-0.7004626,18.34927,AAML1031,Diagnosis,PAWPBT,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202897270054_R02C01,-13.419912,13.485408,19.825077,-4.690403,-19.551556,AAML1031,Diagnosis,PAWPET,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270054_R03C01,13.739565,-14.123846,-1.3287089,-14.540016,-12.682689,AAML1031,Diagnosis,PAWPGW,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270054_R04C01,-12.734404,10.07874,19.911585,-5.5114703,-18.652662,AAML1031,Diagnosis,PAWPKR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270054_R05C01,-12.989694,-4.134794,13.445252,11.605641,11.433697,AAML1031,Diagnosis,PAWPLE,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270054_R06C01,10.213061,-28.190813,-14.275795,4.349179,16.941418,AAML1031,Diagnosis,PAWPVR,Unknown,Discovery (train) Samples,GSE190931,Unknown,Otherwise-Normal Control
202897270054_R08C01,14.562032,-11.472955,-0.9848884,-16.647993,-11.086128,AAML1031,Diagnosis,PAWREX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270073_R02C01,-4.7856092,-11.707708,8.998605,9.812654,9.691521,AAML1031,Relapse,PAWHPL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202897270073_R03C01,-12.453239,-15.057574,23.23035,16.808533,-9.303545,AAML1031,Relapse,PAUTJD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270073_R04C01,-12.681355,-14.906244,23.304878,17.051756,-9.390058,AAML1031,Relapse,PAUPPD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270073_R05C01,-12.145673,-15.823918,25.092592,16.304142,-10.52071,AAML1031,Relapse,PAVDBT,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270073_R06C01,-12.654987,-14.989388,23.52661,17.002848,-9.536389,AAML1031,Relapse,PAVDHJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270073_R07C01,-16.472462,6.0132265,15.004702,11.657688,13.485863,AAML1031,Relapse,PAVCPM,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897270073_R08C01,-12.079616,-15.852383,25.02036,16.23654,-10.457537,AAML1031,Relapse,PAVGEV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897270075_R03C01,4.7087703,17.687256,-14.3584385,-7.6613827,14.783099,AAML1031,Diagnosis,PAXIJB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270075_R04C01,3.0453546,21.924572,-13.491767,-6.2180243,14.6368685,AAML1031,Diagnosis,PAXIKD,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270075_R05C01,3.5359294,20.480518,-13.635189,-6.376027,15.011708,AAML1031,Diagnosis,PAXIKL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270075_R06C01,-16.407068,-8.099123,-19.091461,15.983798,18.220175,AAML1031,Diagnosis,PAXIPJ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897270075_R07C01,1.9272505,23.08999,-13.29505,-6.28283,14.159758,AAML1031,Diagnosis,PAXISV,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897270075_R08C01,13.091474,-13.2318,-1.1783272,-16.154179,-11.217819,AAML1031,Diagnosis,PAXIWR,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370017_R01C01,15.828533,-11.662178,-1.415576,-15.33919,-12.958426,AAML1031,Diagnosis,PAXDBF,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370017_R02C01,-17.701273,-18.900259,0.22722878,-14.992678,-23.352001,AAML1031,Diagnosis,PAXCZX,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370017_R03C01,-14.988716,-8.73545,-18.086813,15.741584,19.185877,AAML1031,Diagnosis,PAXDDY,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370017_R04C01,-8.724693,-8.137638,12.293813,10.982475,11.316176,AAML1031,Diagnosis,PAXDEL,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370017_R05C01,14.010167,-10.617917,-0.686654,-16.426355,-14.954711,AAML1031,Diagnosis,PAXDEX,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370017_R06C01,-1.0206218,-11.365649,8.311677,10.389687,10.712511,AAML1031,Diagnosis,PAXDEG,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202897370017_R07C01,-17.758463,-2.0750976,-19.917599,-19.890514,4.9475994,AAML1031,Diagnosis,PAXDGH,Unknown,Discovery (train) Samples,GSE190931,Unknown,APL with t(15;17)(q24.1;q21.2)/PML::RARA
202897370017_R08C01,14.195162,-10.830501,-0.05224326,-14.728801,-17.420998,AAML1031,Diagnosis,PAXDHL,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370022_R01C01,-12.243818,11.621649,18.787931,-6.1158633,-18.647587,AAML1031,Diagnosis,PAXCPM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370022_R02C01,-4.0924387,-11.666134,9.283545,10.251183,9.831883,AAML1031,Diagnosis,PAXCNV,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202897370022_R03C01,-10.657783,12.788631,19.482315,-6.3120823,-19.540352,AAML1031,Diagnosis,PAXCVR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370022_R04C01,14.003384,-11.197607,-1.0705988,-16.71057,-13.539306,AAML1031,Diagnosis,PAXCVU,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202897370022_R05C01,-13.397085,-3.5628319,13.698975,11.652235,11.717805,AAML1031,Diagnosis,PAXCWZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370022_R06C01,14.572602,-10.618867,-0.598748,-15.898772,-15.202159,AAML1031,Diagnosis,PAXCWR,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202897370022_R08C01,-10.562064,12.843223,19.566977,-6.2776856,-19.409126,AAML1031,Diagnosis,PAXCYN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370025_R01C01,1.6547548,22.388887,-13.370213,-7.108294,13.729553,AAML1031,Diagnosis,PAWNPG,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370025_R02C01,1.4963962,21.102934,-13.077186,-7.3781924,14.133488,AAML1031,Diagnosis,PAWNSL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370025_R04C01,-0.7388133,-11.627564,9.154363,11.805277,10.361218,AAML1031,Diagnosis,PAWNXH,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202897370025_R05C01,-12.0731,-9.099594,20.437616,-12.525221,-16.66717,AAML1031,Diagnosis,PAWNYX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370025_R06C01,-11.881636,9.668243,21.611872,-1.6839771,-17.526537,AAML1031,Diagnosis,PAWNZJ,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370025_R08C01,-12.224111,10.613424,19.582415,-5.4796157,-18.706558,AAML1031,Diagnosis,PAWPDC,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370026_R01C01,-14.489334,-8.533362,-18.072731,15.677736,19.117617,AAML1031,Diagnosis,PAUKEZ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370026_R02C01,12.820796,6.7535214,21.465233,-1.1480584,21.890839,AAML1031,Diagnosis,PAUKTH,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370026_R04C01,0.82331103,21.393263,-12.780601,-7.5668135,13.981032,AAML1031,Diagnosis,PAULDS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370026_R05C01,5.328021,17.348303,-14.594353,-7.78598,14.749235,AAML1031,Diagnosis,PAULNJ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370026_R07C01,2.9360025,20.228647,-13.289148,-7.3861523,14.473491,AAML1031,Diagnosis,PAULRS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370027_R01C01,13.615359,-14.252281,0.35400346,-11.686977,-16.51318,AAML1031,Diagnosis,PAUNDC,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370027_R02C01,13.241158,-14.431895,-0.7704593,-14.095629,-12.604176,AAML1031,Diagnosis,PAUNBY,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370053_R01C01,-12.719945,-14.962235,23.60107,17.067587,-9.598851,AAML1031,Relapse,PAWCCR,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370053_R02C01,-12.310669,-15.493011,24.374731,16.54835,-10.0564785,AAML1031,Relapse,PAWHRR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370053_R03C01,-12.321543,-15.462063,24.294504,16.56762,-10.003659,AAML1031,Relapse,PAWECG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370053_R04C01,-12.113179,-15.780401,24.85802,16.287916,-10.352111,AAML1031,Relapse,PAWVCG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370053_R05C01,-12.061326,-15.872315,25.041441,16.214678,-10.468573,AAML1031,Relapse,PAWKGX,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370053_R06C01,-16.383015,5.9343786,14.934848,11.729703,13.462201,AAML1031,Relapse,PAXDDY,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370053_R07C01,-12.144443,-15.762902,24.878126,16.320904,-10.372241,AAML1031,Relapse,PAXIFA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370053_R08C01,-9.991953,-7.003103,12.304233,11.0939,11.236226,AAML1031,Relapse,PAXHPH,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370054_R01C01,-15.392014,0.083600685,14.591355,11.990764,12.660708,AAML1031,Relapse,PAVVKU,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202897370054_R02C01,-5.456536,-10.228991,9.593321,10.249641,10.595544,AAML1031,Relapse,PAVWVT,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370054_R04C01,-12.139385,-15.763436,24.866856,16.316118,-10.363307,AAML1031,Relapse,PAVMEH,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370054_R05C01,-13.078393,-14.674212,23.536278,17.4693,-9.626124,AAML1031,Relapse,PAVTRU,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370054_R06C01,12.842952,6.495235,21.24809,-0.95208824,21.467838,AAML1031,Relapse,PAVWRN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370059_R01C01,-17.254,-18.99707,0.7197844,-14.547265,-23.115902,AAML1031,Diagnosis,PAWXSX,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202897370059_R02C01,-0.22665833,-12.4022455,7.752342,10.2389965,10.801932,AAML1031,Diagnosis,PAWXSL,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202897370059_R04C01,-15.728048,-10.838884,-17.432463,16.096193,19.809698,AAML1031,Diagnosis,PAWXZJ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370059_R05C01,12.712291,-11.261911,-1.8320946,-18.247274,-13.162187,AAML1031,Diagnosis,PAWXWC,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202897370059_R07C01,-13.700656,13.774101,19.707802,-4.947783,-19.795332,AAML1031,Diagnosis,PAWYEK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370059_R08C01,-16.18282,-11.218193,-16.539892,15.168015,18.348587,AAML1031,Diagnosis,PAWYEM,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370074_R04C01,13.869398,-11.164817,-0.69017524,-15.464592,-16.61206,AAML1031,Diagnosis,PAWWFF,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370074_R05C01,0.8303392,-12.593007,8.626709,11.284297,11.199216,AAML1031,Diagnosis,PAWWID,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202897370074_R07C01,13.321901,5.0415163,19.66636,-1.8542751,18.59725,AAML1031,Diagnosis,PAWWJN,Unknown,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370074_R08C01,-12.72319,13.498962,19.6538,-4.6732926,-18.931635,AAML1031,Diagnosis,PAWWMJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370096_R01C01,-5.983552,-11.615325,5.8043976,6.5998416,10.523374,AAML1031,Relapse,PAVVAT,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202897370096_R03C01,-12.725743,-14.985047,23.693407,17.067007,-9.669272,AAML1031,Relapse,PAVUGM,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202897370096_R04C01,-9.446483,-7.5498104,12.444625,11.075729,11.303345,AAML1031,Relapse,PAVWNG,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370096_R05C01,-13.20322,-14.508852,23.296553,17.627491,-9.484894,AAML1031,Relapse,PAWIWJ,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370096_R06C01,-12.153351,-15.486971,23.945976,16.412846,-9.732877,AAML1031,Relapse,PAWDTX,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370096_R07C01,-12.997104,-14.679688,23.34543,17.396029,-9.477174,AAML1031,Relapse,PAVGKS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370096_R08C01,-11.929846,12.101882,17.878523,-7.922028,-19.232145,AAML1031,Relapse,PAWEYY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370100_R02C01,-15.9167385,-10.449194,-16.97847,15.603679,19.971457,AAML1031,Diagnosis,PAWNIK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370100_R03C01,-14.778289,-10.653572,-17.345198,16.002651,19.680235,AAML1031,Diagnosis,PAWNGC,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370100_R05C01,13.139756,-11.29247,-0.834811,-17.76057,-11.398321,AAML1031,Diagnosis,PAWNKT,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370100_R06C01,3.8164318,20.344172,-13.751011,-6.6784744,14.800117,AAML1031,Diagnosis,PAWNLU,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370100_R07C01,-14.492644,-1.7857857,14.240665,11.821574,12.255675,AAML1031,Diagnosis,PAWNMU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370100_R08C01,-12.155231,8.753331,21.502645,-1.4688148,-17.810537,AAML1031,Diagnosis,PAWNPU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370101_R01C01,-11.740546,8.451464,21.83043,-2.0552487,-17.61774,AAML1031,Diagnosis,PAWMAV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370101_R02C01,15.5088,-11.930288,12.141086,16.378878,-13.823544,AAML1031,Diagnosis,PAWMDY,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370101_R03C01,14.595568,-10.478561,0.20705336,-15.800917,-13.564501,AAML1031,Diagnosis,PAWMEZ,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202897370101_R04C01,14.181575,-9.600995,-0.49438342,-16.99079,-15.392634,AAML1031,Diagnosis,PAWMGH,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370101_R05C01,-13.0998955,-8.852089,-17.953766,15.902107,19.516293,AAML1031,Diagnosis,PAWMFH,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370101_R06C01,-11.035492,12.122879,18.831625,-7.0677075,-19.31253,AAML1031,Diagnosis,PAWMGT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370101_R07C01,-12.037627,10.663436,20.824018,-1.7982514,-18.078959,AAML1031,Diagnosis,PAWMHE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370101_R08C01,-13.567019,13.4897785,19.772217,-4.8235335,-19.75225,AAML1031,Diagnosis,PAWMII,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370102_R01C01,-11.829929,11.967757,18.36912,-7.3036385,-19.326698,AAML1031,Diagnosis,PAWZIG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370102_R02C01,-12.908686,-10.072245,-16.654123,15.328627,19.335173,AAML1031,Diagnosis,PAWZIX,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370102_R03C01,6.2898054,18.128008,-14.795314,-7.523046,14.6582575,AAML1031,Diagnosis,PAWZKW,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202897370102_R04C01,14.441539,-11.15542,0.27748796,-14.0221615,-17.173353,AAML1031,Diagnosis,PAWZNG,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370102_R05C01,12.68451,-14.5628,-0.44464618,-14.007481,-12.389694,AAML1031,Diagnosis,PAWZUF,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370102_R07C01,15.351282,-7.679717,-19.300262,-15.318131,21.884947,AAML1031,Diagnosis,PAWZWN,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202897370102_R08C01,15.110166,-9.157342,-0.4447262,-16.944414,-14.652452,AAML1031,Diagnosis,PAWZVT,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202897370106_R01C01,-15.317334,-0.24489315,14.582027,11.964348,12.612192,AAML1031,Diagnosis,PAUMCV,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202897370106_R03C01,15.320126,-11.953808,12.049112,16.17224,-12.593578,AAML1031,Diagnosis,PAUMGZ,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370106_R04C01,1.7968671,20.869768,-12.5984955,-7.507668,14.411245,AAML1031,Diagnosis,PAUMJB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370106_R05C01,13.645851,-14.050761,-0.52628154,-13.313625,-14.5704365,AAML1031,Diagnosis,PAUMMR,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370106_R06C01,-12.163051,-8.188619,20.568619,-12.119712,-16.810715,AAML1031,Diagnosis,PAUMTZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370106_R08C01,-11.511291,12.749401,18.499134,-7.382268,-19.64261,AAML1031,Diagnosis,PAUNBR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370107_R03C01,12.916263,-14.735,-0.40854666,-13.484794,-13.036178,AAML1031,Diagnosis,PAXCLE,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370107_R04C01,-11.654981,9.61351,21.60449,-1.8433043,-17.54974,AAML1031,Diagnosis,PAXCLX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370162_R02C01,15.4914665,-11.943563,12.096037,16.271769,-13.116087,AAML1031,Diagnosis,PAWRGZ,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202897370162_R03C01,15.273978,-7.753429,-19.1234,-14.741554,21.170403,AAML1031,Diagnosis,PAWRIY,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with in-frame bZIP mutated CEBPA
202897370162_R04C01,12.924288,-14.316568,-0.84126145,-14.581202,-12.095135,AAML1031,Diagnosis,PAWRKX,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202897370162_R06C01,1.6325054,23.197844,-13.2999325,-6.465218,13.951067,AAML1031,Diagnosis,PAWRPD,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202897370162_R07C01,-11.750035,9.263021,21.609674,-2.1493456,-17.626766,AAML1031,Diagnosis,PAWRPX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202897370162_R08C01,-13.158286,13.763537,18.873898,-6.303797,-19.887562,AAML1031,Diagnosis,PAWRSU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202900540129_R01C01,14.13204,4.3512793,18.50261,-6.5550237,16.528069,AAML1031,Diagnosis,PAXGZB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202900540129_R02C01,15.375253,-7.678639,-19.307428,-15.238213,21.733105,AAML1031,Diagnosis,PAXHCC,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202900540129_R03C01,-13.545172,-10.246036,-16.226757,14.98534,19.241722,AAML1031,Diagnosis,PAXHDA,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202900540129_R04C01,-13.279266,-3.7103524,13.679339,11.62364,11.751912,AAML1031,Diagnosis,PAXHGG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202900540129_R05C01,13.161095,4.457553,19.380676,-0.15608267,17.932808,AAML1031,Diagnosis,PAXHGR,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202900540129_R07C01,-11.8673935,10.972784,20.670645,-1.9570242,-17.998455,AAML1031,Diagnosis,PAXHTS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202900540129_R08C01,-12.271322,12.454283,19.378992,-5.0045977,-18.541708,AAML1031,Diagnosis,PAXHYG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570086_R01C01,12.654948,-11.190317,-1.9433365,-18.564821,-12.74229,AAML1031,Diagnosis,PAWYEP,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202905570086_R03C01,14.9672165,-11.989256,12.066855,16.06195,-15.187991,AAML1031,Diagnosis,PAWYKA,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202905570086_R05C01,-11.24449,11.297218,19.20572,-6.3392634,-19.313171,AAML1031,Diagnosis,PAWYGY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570086_R06C01,-9.0197115,-7.886045,12.320858,11.003612,11.32068,AAML1031,Diagnosis,PAWYNR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570086_R07C01,14.823164,-9.410497,-0.5865776,-16.828564,-15.272915,AAML1031,Diagnosis,PAWYNC,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202905570086_R08C01,13.039642,-14.324283,-0.8486203,-14.608209,-11.854934,AAML1031,Diagnosis,PAWYRT,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570087_R02C01,-11.971717,-9.895859,20.27437,-12.877318,-16.53555,AAML1031,Diagnosis,PAWWPA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570087_R03C01,-12.824707,13.508455,19.089052,-5.9189544,-19.474058,AAML1031,Diagnosis,PAWWLI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570087_R04C01,-4.870218,-11.05532,6.096848,7.317175,11.296299,AAML1031,Diagnosis,PAWWRG,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202905570087_R06C01,3.557029,18.663038,-13.970229,-7.679941,14.509827,AAML1031,Diagnosis,PAWWUN,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202905570087_R07C01,-11.681941,10.874541,21.120848,-4.031488,-17.766502,AAML1031,Diagnosis,PAWWWL,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570087_R08C01,-14.660064,-1.4807358,14.315766,11.85502,12.315629,AAML1031,Diagnosis,PAWWWM,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570093_R03C01,-12.430121,-15.068491,23.214516,16.783258,-9.277446,AAML1031,Relapse,PAWSJC,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570093_R04C01,-12.251459,12.499688,17.859013,-7.7512026,-19.293455,AAML1031,Relapse,PAXMLI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570093_R07C01,15.194418,-9.0095625,-0.30018273,-16.812933,-14.925858,AAML1031,Relapse,PAWLKP,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202905570093_R08C01,4.287302,20.172096,-13.9376,-7.134309,14.469983,AAML1031,Relapse,PAXIKL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202905570095_R01C01,-13.612897,-3.8990955,13.980338,11.600387,12.032305,AAML1031,Diagnosis,PAXGNZ,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570095_R02C01,12.982591,-12.752062,-1.4227927,-16.91983,-10.888412,AAML1031,Diagnosis,PAXGSJ,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570095_R03C01,0.533915,-12.644226,8.176212,11.081674,11.168605,AAML1031,Diagnosis,PAXGPF,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202905570095_R04C01,13.416462,-13.564409,0.0051505663,-13.579512,-14.081343,AAML1031,Diagnosis,PAXGTM,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
202905570095_R05C01,-15.32289,-3.5950832,15.218813,11.649247,13.066403,AAML1031,Diagnosis,PAXGVH,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570095_R06C01,-11.725973,-5.834029,12.928572,11.392794,11.102813,AAML1031,Diagnosis,PAXGVS,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570095_R07C01,10.114703,-28.390705,-14.377797,4.3762302,16.974031,AAML1031,Diagnosis,PAXGXR,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202905570095_R08C01,-16.345617,-11.069608,-17.330885,16.024302,19.68542,AAML1031,Diagnosis,PAXGYZ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905570131_R02C01,-3.7008953,11.451792,-17.626488,0.7569674,-21.104836,AAML1031,Diagnosis,PAVPXS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570131_R05C01,-12.7847595,-4.504929,13.409447,11.544061,11.491177,AAML1031,Diagnosis,PAVRAT,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202905570145_R04C01,12.207098,-13.434812,0.086919785,-14.8888855,-12.238491,AAML1031,Diagnosis,PAVRUZ,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202905570154_R07C01,13.331115,-14.491622,-0.19987041,-12.786619,-14.495787,AAML1031,Diagnosis,PAVHWZ,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570155_R02C01,-12.57685,-4.7208343,13.064165,11.596497,10.874895,AAML1031,Diagnosis,PAVANX,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570155_R03C01,-14.743972,-1.2762698,14.340518,11.871029,12.358128,AAML1031,Diagnosis,PAVAFA,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570155_R04C01,-14.707531,-3.8517442,14.803455,11.614181,12.728231,AAML1031,Diagnosis,PAVAVV,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905570155_R06C01,-12.046019,11.508991,18.920225,-5.8247943,-18.490114,AAML1031,Diagnosis,PAVAYH,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905570155_R07C01,-15.566565,-11.3978405,-17.055677,15.948306,19.488129,AAML1031,Diagnosis,PAVAYD,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905570155_R08C01,1.0271943,22.590162,-12.642262,-7.029657,14.051303,AAML1031,Diagnosis,PAVBAY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202905580026_R01C01,1.3776479,20.554726,-13.376285,-7.8764153,13.781814,AAML1031,Diagnosis,PAWRSI,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202905580026_R02C01,13.639304,-11.232145,-1.3590337,-17.509932,-12.086811,AAML1031,Diagnosis,PAWRSP,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202905580026_R03C01,-14.313625,-2.0114458,14.146663,11.799009,12.171598,AAML1031,Diagnosis,PAWRUK,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580026_R06C01,-14.677839,-1.4389322,14.31923,11.853867,12.33531,AAML1031,Diagnosis,PAWRYC,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580026_R08C01,-16.682034,-10.555308,-17.28478,15.904876,20.307919,AAML1031,Diagnosis,PAWSCV,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580041_R07C01,12.8989725,4.973955,20.543867,-0.34259623,19.274878,AAML1031,Diagnosis,PAVBNV,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202905580052_R03C01,-5.0666814,-9.905928,6.685603,9.027523,10.676545,AAML1031,Relapse,PAWZAU,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580052_R04C01,-12.169717,-15.657134,24.578638,16.374832,-10.169806,AAML1031,Relapse,PAXMIJ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580052_R05C01,-12.1171465,-15.203074,22.877625,16.468216,-8.981986,AAML1031,Relapse,PAXJGA,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580052_R06C01,-9.4925995,-7.2633176,11.647898,10.914105,11.103662,AAML1031,Relapse,PAXBAZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580052_R07C01,-15.220879,-10.60909,-15.483344,14.066299,17.778534,AAML1031,Relapse,PAXGDG,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580052_R08C01,-7.086089,-8.90764,9.579898,10.265476,10.65839,AAML1031,Relapse,PAXDHL,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580069_R01C01,-16.895365,-11.272633,-17.127197,16.032425,20.290794,AAML1031,Diagnosis,PAWSED,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580069_R02C01,4.4000773,17.765175,-14.253928,-7.6419277,14.793582,AAML1031,Diagnosis,PAWSHR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202905580069_R03C01,-15.0800085,-10.376653,-17.340935,15.984157,20.210482,AAML1031,Diagnosis,PAWSJZ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580069_R04C01,-13.427867,-8.57498,-18.155012,15.908984,19.420639,AAML1031,Diagnosis,PAWSJC,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580069_R05C01,-16.52088,-10.83099,-16.719181,15.125425,18.286749,AAML1031,Diagnosis,PAWSRG,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202905580069_R06C01,-12.679579,-4.339539,13.256433,11.581334,11.274263,AAML1031,Diagnosis,PAWSKR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580069_R07C01,13.989569,-11.43788,-0.12356443,-14.309136,-17.5168,AAML1031,Diagnosis,PAWSTK,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202905580069_R08C01,-10.597797,12.36374,19.750448,-5.6882963,-18.865517,AAML1031,Diagnosis,PAWSWU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580083_R05C01,-12.626012,12.77911,19.649843,-4.7450123,-19.789576,AAML1031,Diagnosis,PAVIYH,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580105_R03C01,-12.514935,13.391344,19.407606,-5.0481706,-18.955717,AAML1031,Diagnosis,PAXIAZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580105_R04C01,12.837268,6.4803467,21.311682,-1.1434962,21.46608,AAML1031,Diagnosis,PAXHZL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580105_R05C01,-11.149618,12.139298,19.960703,-4.024035,-18.116796,AAML1031,Diagnosis,PAXICE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580105_R06C01,13.370935,5.4684343,19.767347,-1.977609,19.111546,AAML1031,Diagnosis,PAXIDA,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202905580105_R07C01,0.84117615,20.658802,-13.381652,-8.074236,13.538128,AAML1031,Diagnosis,PAXIEG,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202905580105_R08C01,-12.148677,-8.254067,20.545826,-12.150155,-16.798645,AAML1031,Diagnosis,PAXIFA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580118_R06C01,-13.440027,-3.722534,13.816138,11.61682,11.896302,AAML1031,Diagnosis,PAUYKH,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580122_R03C01,-4.807994,-11.075815,9.5687275,10.426258,9.949841,AAML1031,Relapse,PAVAFA,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202905580122_R04C01,14.642166,-12.030922,11.833254,15.61006,-11.046124,AAML1031,Relapse,PAWRPX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202905580122_R05C01,15.258415,-7.7890253,-19.074772,-14.059447,20.068419,AAML1031,Relapse,PAWTYT,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580122_R06C01,-16.328058,6.784871,14.75386,12.010305,13.56297,AAML1031,Relapse,PAVSVU,Unknown,Discovery (train) Samples,GSE190931,Unknown,Otherwise-Normal Control
202905580122_R07C01,-13.756996,-4.152337,14.132134,11.575237,12.160461,AAML1031,Relapse,PAWAMM,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580122_R08C01,-14.802381,-1.1337467,14.355644,11.884108,12.374711,AAML1031,Relapse,PAWUNI,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202905580131_R01C01,15.267097,-9.592308,0.79247004,-14.7553215,-16.418377,AAML1031,Diagnosis,PAXETX,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202905580131_R02C01,-1.495045,-9.95405,4.37231,9.866586,10.394862,AAML1031,Diagnosis,PAXFAG,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202905580131_R03C01,-10.509065,12.492169,19.71412,-6.1523743,-19.304012,AAML1031,Diagnosis,PAXFBN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580131_R04C01,-15.33002,-3.5921257,15.221388,11.650183,13.066301,AAML1031,Diagnosis,PAXFEE,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580131_R05C01,14.966762,-7.7293043,-19.247578,-14.954306,21.395576,AAML1031,Diagnosis,PAXFEA,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202905580131_R07C01,13.351158,-14.6040535,0.37963316,-11.734847,-15.749347,AAML1031,Diagnosis,PAXFHW,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580140_R01C01,-11.830093,9.672978,21.534033,-1.7716228,-17.58568,AAML1031,Diagnosis,PAWTKY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580140_R02C01,-12.130491,-5.4461856,13.08593,11.437728,11.218439,AAML1031,Diagnosis,PAWTLZ,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202905580140_R03C01,15.321801,-11.59259,-1.1720785,-15.9846325,-11.521426,AAML1031,Diagnosis,PAWTNN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580140_R04C01,-11.051615,13.099944,19.13391,-6.703174,-19.639227,AAML1031,Diagnosis,PAWTPD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580140_R05C01,14.932604,-7.7274218,-19.24277,-15.196464,21.82797,AAML1031,Diagnosis,PAWTRR,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202905580140_R08C01,13.829863,-11.074242,-0.6955177,-16.48463,-13.8025,AAML1031,Diagnosis,PAWTTI,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202905580141_R07C01,-8.963622,-8.135267,12.939292,11.120376,11.488994,AAML1031,Diagnosis,PAVKAU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580149_R03C01,12.9044695,5.5166154,20.715956,-0.8004487,19.998512,AAML1031,Diagnosis,PAVZBA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580149_R05C01,13.069233,-14.850367,0.080321446,-12.323504,-14.583745,AAML1031,Diagnosis,PAVZBG,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580149_R06C01,4.690663,18.678673,-14.34022,-7.798953,14.333199,AAML1031,Diagnosis,PAVZCR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202905580149_R08C01,12.822214,6.742538,21.436085,-1.0802926,21.868498,AAML1031,Diagnosis,PAVZHF,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580150_R01C01,-12.688627,-4.4429345,13.269758,11.574856,11.26936,AAML1031,Diagnosis,PAVTFI,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202905580150_R07C01,11.170463,-26.580353,-13.418494,4.031527,16.697481,AAML1031,Diagnosis,PAVTXM,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202905580160_R05C01,-12.753561,-4.361648,13.157319,11.631317,10.973747,AAML1031,Diagnosis,PAVGBH,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580160_R07C01,-12.907985,-4.115965,13.3336,11.624246,11.265615,AAML1031,Diagnosis,PAVGEV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202905580161_R04C01,-13.21579,12.932375,20.049982,-4.214949,-19.162024,AAML1031,Diagnosis,PAVMES,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420001_R01C01,-14.343191,-2.400106,14.2426195,11.762394,12.243638,AAML1031,Diagnosis,PAXJAA,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420001_R02C01,-13.380384,-3.4620733,13.675824,11.665833,11.689668,AAML1031,Diagnosis,PAXJFS,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420001_R03C01,14.099859,-10.558131,-1.0328704,-16.777178,-14.786717,AAML1031,Diagnosis,PAXJFL,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420001_R04C01,-1.9078596,-9.075986,2.8349476,11.30661,8.760372,AAML1031,Diagnosis,PAXJGA,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202908420005_R02C01,-16.419624,6.1673923,14.681115,12.284432,13.5110445,AAML1031,Relapse,PAVLJH,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908420005_R03C01,-13.005903,-14.616071,23.150045,17.421473,-9.3403635,AAML1031,Relapse,PAVSFB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420005_R04C01,15.456947,-9.166114,1.5050187,-14.667667,-15.544,AAML1031,Relapse,PAVRWU,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420005_R05C01,-12.241555,-15.564788,24.442936,16.46601,-10.090361,AAML1031,Relapse,PAVGAM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420005_R06C01,-12.770347,-14.935956,23.638708,17.12001,-9.635837,AAML1031,Relapse,PAUXNM,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420005_R07C01,-8.467817,-7.9058995,10.724795,10.601043,11.012801,AAML1031,Relapse,PAUUZT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420005_R08C01,14.81707,-12.013045,11.891382,15.749305,-11.556319,AAML1031,Relapse,PAVLWV,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420013_R07C01,-9.30653,-7.665535,12.43466,11.06225,11.311688,AAML1031,Diagnosis,PAUYSN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420024_R02C01,-11.8434305,7.9512024,21.833765,-1.9525518,-17.740591,AAML1031,Diagnosis,PAWWWU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420024_R03C01,13.676287,-11.681152,-0.43497765,-14.81354,-16.72945,AAML1031,Diagnosis,PAWWYV,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202908420024_R04C01,2.3411615,20.712631,-13.040334,-7.817008,14.052325,AAML1031,Diagnosis,PAWWXU,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420024_R07C01,2.188715,22.154385,-12.393699,-5.645275,15.503629,AAML1031,Diagnosis,PAWWZL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420036_R08C01,-11.914493,12.334198,18.602158,-6.6455956,-18.80913,AAML1031,Diagnosis,PAULTY,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420037_R03C01,-12.579567,-14.927881,23.113852,16.956371,-9.238194,AAML1031,Relapse,PAXEPC,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420037_R04C01,-12.65617,-14.9271,23.314285,17.022566,-9.388384,AAML1031,Relapse,PAXDXW,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420037_R05C01,-12.821444,-14.732774,23.074522,17.224941,-9.251169,AAML1031,Relapse,PAWYZR,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908420037_R06C01,1.5499649,23.72883,-13.483081,-6.246122,13.811584,AAML1031,Relapse,PAWUUY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420037_R07C01,-16.496119,6.1833067,14.771144,12.16656,13.523667,AAML1031,Relapse,PAUPIY,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908420037_R08C01,-12.724794,-14.877209,23.316439,17.09776,-9.400973,AAML1031,Relapse,PAXLEE,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420039_R02C01,-11.414624,10.877698,20.954842,-2.8229373,-17.626612,AAML1031,Diagnosis,PAXGIX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420039_R04C01,-11.37974,11.475056,20.43551,-4.360112,-18.316326,AAML1031,Diagnosis,PAXGHE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420039_R05C01,15.20407,-9.677009,0.8083215,-14.789124,-16.146044,AAML1031,Diagnosis,PAXGKH,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420039_R06C01,-12.15982,8.551544,21.303493,-2.119226,-18.075745,AAML1031,Diagnosis,PAXGNI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420039_R07C01,-17.17509,-19.014227,0.80665433,-14.468339,-23.073849,AAML1031,Diagnosis,PAXGPE,Unknown,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420039_R08C01,-15.31546,-3.5667315,15.205113,11.652407,13.052293,AAML1031,Diagnosis,PAXGRE,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908420047_R02C01,-16.36124,-10.998446,-17.249493,16.017855,20.06526,AAML1031,Diagnosis,PAVLJH,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908420047_R06C01,-11.4176235,12.13112,19.154099,-5.690886,-18.596338,AAML1031,Diagnosis,PAVLWY,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420047_R07C01,15.228826,-11.951721,12.133765,16.285044,-15.082425,AAML1031,Diagnosis,PAVLWV,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420054_R03C01,-12.182918,-7.9954414,20.600927,-12.034494,-16.841202,AAML1031,Diagnosis,PAVGIX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420054_R08C01,12.8127775,6.851585,21.542242,-1.1801783,22.04601,AAML1031,Diagnosis,PAVGYA,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420069_R03C01,-11.879894,-15.170642,22.154354,16.273542,-8.452056,AAML1031,Diagnosis,PAVNUJ,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420069_R05C01,3.8764555,19.820286,-13.937497,-7.8944902,13.985025,AAML1031,Diagnosis,PAVNVF,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420120_R01C01,14.29251,-10.875355,-0.05298676,-14.734668,-17.07615,AAML1031,Diagnosis,PAWBAS,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202908420120_R02C01,15.3174305,-8.110707,-0.8956128,-18.793592,-12.754474,AAML1031,Diagnosis,PAWBDK,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420120_R08C01,12.601389,-14.450076,-0.5497218,-14.354846,-12.029031,AAML1031,Diagnosis,PAWBVL,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908420124_R01C01,14.946559,-7.7201343,-19.258955,-15.269344,21.927128,AAML1031,Diagnosis,PAXDMP,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202908420124_R03C01,-12.902238,-4.179976,13.293522,11.6324005,11.167004,AAML1031,Diagnosis,PAXDNI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420124_R04C01,-11.005748,12.1436205,20.09097,-4.2729325,-18.30878,AAML1031,Diagnosis,PAXDSN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420124_R05C01,-13.791599,-3.0509138,13.929373,11.697138,11.956693,AAML1031,Diagnosis,PAXDXW,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420124_R07C01,14.293862,-9.496259,-1.0973735,-18.692566,-11.750522,AAML1031,Diagnosis,PAXEES,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420124_R08C01,12.64268,-14.811759,-0.24964571,-13.495138,-12.78119,AAML1031,Diagnosis,PAXEFX,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908420142_R01C01,1.2031957,22.104538,-12.762228,-7.5931773,13.754832,AAML1031,Diagnosis,PAWSWR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420142_R02C01,-17.400528,-18.965094,0.5575641,-14.693973,-23.193516,AAML1031,Diagnosis,PAWSZL,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420142_R03C01,-1.1579711,-11.365654,9.943264,11.862731,10.384169,AAML1031,Diagnosis,PAWTBX,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202908420142_R04C01,1.1284816,22.251316,-12.822865,-7.3906555,13.812895,AAML1031,Diagnosis,PAWTEI,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420142_R05C01,-12.706074,10.755066,19.739382,-5.6766696,-18.835167,AAML1031,Diagnosis,PAWTEB,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420142_R06C01,-15.799925,-10.411476,-17.61155,16.12093,20.03127,AAML1031,Diagnosis,PAWTDZ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908420142_R07C01,-16.02541,-10.15504,-17.373642,15.844371,20.173588,AAML1031,Diagnosis,PAWTGF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908420142_R08C01,4.6150393,20.262543,-14.072895,-7.090533,14.431592,AAML1031,Diagnosis,PAWTJU,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908420145_R04C01,12.811739,6.7917433,21.50483,-1.1854202,21.962612,AAML1031,Diagnosis,PAWDTX,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420145_R05C01,13.623897,-13.698505,0.35191515,-12.074725,-16.995813,AAML1031,Diagnosis,PAWDVC,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420146_R04C01,13.561498,-14.2622,0.04784151,-12.235209,-15.773206,AAML1031,Diagnosis,PAVPLM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908420146_R05C01,15.468489,-11.926936,12.16113,16.414875,-14.359569,AAML1031,Diagnosis,PAVPMJ,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420146_R07C01,15.011649,-9.121837,-0.42746988,-17.023308,-14.696723,AAML1031,Diagnosis,PAVPIU,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202908420149_R02C01,-16.448124,-8.771494,-18.60051,15.948418,18.714584,AAML1031,Diagnosis,PAXEKE,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908420149_R04C01,14.741986,-10.925503,0.7791492,-13.420353,-17.680067,AAML1031,Diagnosis,PAXEPC,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908420149_R07C01,15.466623,-7.729561,-19.14793,-14.883744,21.350721,AAML1031,Diagnosis,PAXEWD,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202908420149_R08C01,1.9302777,-12.836256,9.5426855,11.459659,10.6422415,AAML1031,Diagnosis,PAXEWS,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908430004_R03C01,14.735421,-12.018372,11.8562975,15.682788,-11.006925,AAML1031,Diagnosis,PAVNGY,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202908430004_R05C01,12.643736,-12.802315,-0.3979088,-15.598184,-12.535098,AAML1031,Diagnosis,PAVNHD,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202908430007_R02C01,1.6613364,-13.491925,7.901329,11.713034,8.636149,AAML1031,Diagnosis,PAVDNF,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202908430007_R04C01,-0.59902906,-11.5812,9.754274,11.801716,10.581319,AAML1031,Diagnosis,PAVDVU,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202908430061_R01C01,-12.818157,13.432542,18.051521,-7.1966376,-19.361391,AAML1031,Diagnosis,PAVSJN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430061_R03C01,-12.239244,9.810129,21.043812,-1.4767915,-18.097548,AAML1031,Diagnosis,PAVSSE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430067_R01C01,-15.164405,-3.6059444,15.099164,11.645995,12.967903,AAML1031,Diagnosis,PAUZJJ,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908430067_R02C01,-12.453982,12.667206,19.525446,-4.6586323,-18.573467,AAML1031,Diagnosis,PAUZMH,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430067_R05C01,1.7285577,20.190447,-13.805228,-7.9358873,13.671071,AAML1031,Diagnosis,PAUZRT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908430067_R08C01,4.6131115,18.379278,-14.341547,-7.7047668,14.501508,AAML1031,Diagnosis,PAUZRX,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908430110_R04C01,-11.274594,-5.9401045,12.761863,11.30246,11.256501,AAML1031,Diagnosis,PAVHML,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430110_R05C01,-12.00364,-9.352201,20.315105,-12.6354,-16.615625,AAML1031,Diagnosis,PAVHNV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430110_R07C01,13.339948,-14.648861,0.06125082,-12.184207,-15.158988,AAML1031,Diagnosis,PAVHUF,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908430120_R03C01,15.042554,-9.980703,1.3768005,-14.406621,-15.124937,AAML1031,Diagnosis,PAUSFM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430137_R05C01,-11.146204,11.046454,21.00763,-3.8150733,-17.944084,AAML1031,Diagnosis,PAVALK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430137_R07C01,14.58077,-10.373359,-0.53985107,-16.33305,-14.425545,AAML1031,Diagnosis,PAVANE,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202908430150_R03C01,-10.704005,12.372832,19.926497,-5.535125,-18.864422,AAML1031,Diagnosis,PAVMPA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908430150_R05C01,5.595086,18.867487,-14.522263,-7.4435935,14.527874,AAML1031,Diagnosis,PAVMZL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908540028_R02C01,-2.917715,-11.813954,5.7328033,8.031992,10.785279,AAML1031,Diagnosis,PAWDBS,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
202908540028_R05C01,-14.436584,-10.743667,-17.142965,15.882644,19.575922,AAML1031,Diagnosis,PAWDBB,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908540028_R07C01,14.124707,-11.18135,0.004186696,-14.439281,-17.246246,AAML1031,Diagnosis,PAWDEG,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202908540028_R08C01,-12.385124,-4.8118424,13.079982,11.538811,11.083227,AAML1031,Diagnosis,PAWDHA,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202908540029_R03C01,-12.85866,-4.865025,13.605232,11.476542,11.776163,AAML1031,Diagnosis,PAWFEM,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908540029_R05C01,-11.646174,10.714426,20.937395,-1.9199598,-17.77388,AAML1031,Diagnosis,PAWFIZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540029_R06C01,-15.906868,-8.514163,-18.605967,15.879682,18.6353,AAML1031,Diagnosis,PAWFTV,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908540029_R07C01,13.91159,-11.759133,0.10528177,-14.346381,-15.902418,AAML1031,Diagnosis,PAWFVC,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540029_R08C01,5.9226255,18.449434,-14.654577,-7.4930344,14.603633,AAML1031,Diagnosis,PAWFZT,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908540030_R01C01,-11.940148,12.859725,18.526623,-6.981853,-19.139805,AAML1031,Relapse,PAWLEB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540030_R02C01,14.471596,-12.002278,-0.35047427,-14.047436,-16.31609,AAML1031,Relapse,PAWHFW,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202908540030_R04C01,6.1379237,17.76569,-14.7976465,-7.6445775,14.680758,AAML1031,Relapse,PAWHTL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908540030_R05C01,-12.783851,11.248907,21.070717,-3.3041625,-16.781307,AAML1031,Relapse,PAWPKR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540030_R07C01,3.6225746,12.34239,-10.895205,2.7796304,-25.62063,AAML1031,Relapse,PAWHKK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540030_R08C01,-11.827123,-10.627002,20.024895,-13.199929,-16.398184,AAML1031,Relapse,PAWHJI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540101_R02C01,14.337533,-7.783152,-19.278654,-13.842779,19.523703,AAML1031,Relapse,PAXISI,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202908540101_R03C01,14.498041,-11.60189,0.41706225,-13.3213215,-17.50699,AAML1031,Relapse,PAWKJC,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with mutated NPM1
202908540101_R04C01,-15.295391,-8.995777,-17.64644,15.402451,18.89919,AAML1031,Relapse,PAXMKT,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908540101_R05C01,-10.629815,12.501664,19.301662,-6.590414,-19.615604,AAML1031,Relapse,PAWTSD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540101_R06C01,-11.748227,11.811519,18.472967,-6.988135,-18.93222,AAML1031,Relapse,PAWYNR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540101_R07C01,14.84625,-10.922507,-0.95433426,-16.724356,-11.728156,AAML1031,Relapse,PAXJXC,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540101_R08C01,-8.955426,-8.029484,12.577762,11.052138,11.38512,AAML1031,Relapse,PAXICE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540225_R01C01,-7.687377,-8.098865,9.682403,10.450633,10.805494,AAML1031,Relapse,PAUVGD,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908540225_R03C01,-15.344351,-0.024592329,14.570193,11.983266,12.628867,AAML1031,Relapse,PAUVZD,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908540225_R04C01,-12.610539,13.212229,18.215864,-7.209744,-19.39305,AAML1031,Relapse,PAUNYL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540225_R05C01,-12.175452,-15.706072,24.761158,16.36518,-10.297413,AAML1031,Relapse,PAWANV,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540225_R07C01,-16.385239,5.6682634,14.754822,12.13113,13.445861,AAML1031,Relapse,PAVRUZ,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202908540225_R08C01,-12.277804,9.02465,20.9795,-2.62012,-18.371134,AAML1031,Relapse,PAVKJD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202908540238_R01C01,5.7332673,18.62232,-14.57339,-7.4329205,14.610656,AAML1031,Diagnosis,PAWEKL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202908540238_R02C01,-12.250936,-5.180351,13.02757,11.490251,11.066839,AAML1031,Diagnosis,PAWEKU,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202908540238_R06C01,-13.338655,-9.138239,-17.840624,15.914655,19.57131,AAML1031,Diagnosis,PAWERN,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202908540238_R08C01,13.304338,-11.611933,-1.2720755,-17.49811,-11.692528,AAML1031,Diagnosis,PAWEVC,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202915410028_R01C01,-0.8079184,-11.438957,9.740518,11.723751,10.504076,AAML1031,Diagnosis,PAWGAZ,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915410028_R05C01,-12.563762,-4.719247,13.031393,11.602204,10.821746,AAML1031,Diagnosis,PAWGFC,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202915410029_R05C01,12.621219,-13.808997,0.08528849,-14.101748,-12.92684,AAML1031,Diagnosis,PAWEEB,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202915410029_R06C01,-10.003136,-6.980822,12.340535,11.092836,11.273295,AAML1031,Diagnosis,PAWECG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410029_R07C01,-6.620578,-9.538303,11.333968,10.603715,11.2596035,AAML1031,Diagnosis,PAWEFF,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410029_R08C01,0.633938,-12.541515,7.7937465,10.6894045,10.788872,AAML1031,Diagnosis,PAWEFT,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
202915410038_R01C01,-4.4549823,-11.763819,9.431945,10.235691,9.670439,AAML1031,Relapse,PAWUWJ,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915410038_R02C01,4.3277526,17.62187,-14.252227,-7.738265,14.766046,AAML1031,Relapse,PAWSHR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410038_R03C01,3.382632,20.362814,-13.585474,-6.6920114,14.828616,AAML1031,Relapse,PAWWXU,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410038_R04C01,-11.940089,7.7521043,21.675749,-2.160962,-17.920925,AAML1031,Relapse,PAWMFY,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410038_R05C01,14.822519,4.691787,17.108551,-6.472316,15.535126,AAML1031,Relapse,PAWNPU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410038_R06C01,-14.439981,-8.578512,-18.020857,15.653402,19.096157,AAML1031,Relapse,PAWZUZ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915410038_R07C01,-14.997169,-9.08303,-17.565634,15.467705,19.241272,AAML1031,Relapse,PAWVGF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915410038_R08C01,14.304312,-13.111803,0.014414687,-12.546696,-16.913494,AAML1031,Relapse,PAXGGM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410049_R01C01,3.2377923,21.652046,-13.377757,-5.7870865,15.141142,AAML1031,Relapse,PAWCBZ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410049_R05C01,14.155935,4.1900964,17.918423,-6.0804324,16.589476,AAML1031,Relapse,PAWNHW,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915410049_R06C01,14.720404,-11.265729,0.89443284,-12.886743,-18.033237,AAML1031,Relapse,PAWLYM,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915410049_R07C01,-11.7944975,11.328129,19.130396,-5.480934,-18.281942,AAML1031,Relapse,PAWUAE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410049_R08C01,1.8696128,19.939777,-12.892115,-7.502253,14.59616,AAML1031,Relapse,PAWWEE,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410062_R01C01,14.242734,-12.060076,11.901512,15.5820465,-14.78793,AAML1031,Diagnosis,PAWHCT,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915410062_R02C01,14.188534,-11.465153,-0.4066983,-14.776888,-16.433031,AAML1031,Diagnosis,PAWHFW,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202915410062_R03C01,-11.966938,10.6584425,20.876665,-1.6672148,-17.959478,AAML1031,Diagnosis,PAWHFV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410121_R01C01,-12.366826,-15.259713,23.71231,16.668827,-9.610544,AAML1031,Relapse,PAXDSN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410121_R02C01,-12.3855295,-15.439277,24.382593,16.63041,-10.076427,AAML1031,Relapse,PAXLVV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410121_R05C01,-12.134554,-15.679914,24.564524,16.336996,-10.153969,AAML1031,Relapse,PAWHCT,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410121_R06C01,-6.7448173,-9.48263,11.409285,10.626728,11.251798,AAML1031,Relapse,PAUSFM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410121_R07C01,-12.116781,-15.773589,24.843327,16.293213,-10.342734,AAML1031,Relapse,PAXLDI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410122_R01C01,-0.62620467,-11.493552,9.807875,11.749313,10.541063,AAML1031,Relapse,PAVXEB,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915410122_R03C01,-12.070667,-15.84276,24.963469,16.231647,-10.417079,AAML1031,Relapse,PAXCKK,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410122_R04C01,-12.1360235,-15.783111,24.926476,16.307362,-10.403772,AAML1031,Relapse,PAWTWW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410122_R05C01,-12.081104,-15.851521,25.020578,16.23851,-10.458261,AAML1031,Relapse,PAXGHE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410122_R06C01,-12.056939,-15.834354,24.899502,16.221745,-10.369975,AAML1031,Relapse,PAXJAA,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410122_R07C01,-12.094306,-15.847472,25.040995,16.251152,-10.474948,AAML1031,Relapse,PAXMNR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410122_R08C01,-12.02256,-15.905692,25.055279,16.17035,-10.47144,AAML1031,Relapse,PAXLBH,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410123_R06C01,-10.063385,-6.9436283,12.31039,11.096598,11.234118,AAML1031,Relapse,PAUUKZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410123_R08C01,-13.098719,-14.632412,23.444695,17.502363,-9.584088,AAML1031,Relapse,PAULTY,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410140_R01C01,-5.5975738,-9.460704,8.546605,10.052821,10.775208,AAML1031,Relapse,PAXDEG,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915410140_R02C01,15.682105,-7.6982102,-19.290657,-13.898221,19.406733,AAML1031,Relapse,PAWZZN,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915410140_R03C01,4.4089756,18.673859,-14.0550995,-6.7209506,15.264493,AAML1031,Relapse,PAXIJB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410140_R04C01,12.828465,6.555699,21.432112,-1.23944,21.60254,AAML1031,Relapse,PAXJMY,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410140_R05C01,13.230794,5.4289103,19.572943,-1.0062124,19.125603,AAML1031,Relapse,PAWPVX,Unknown,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410140_R06C01,-14.815868,-8.771648,-17.795202,15.502793,19.035372,AAML1031,Relapse,PAWYEM,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915410140_R07C01,13.586508,-14.1081705,-0.43708187,-13.276558,-14.36894,AAML1031,Relapse,PAXLWH,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915410148_R01C01,-12.080615,-15.212956,22.807924,16.436321,-8.935661,AAML1031,Relapse,PAXAXY,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915410148_R02C01,-4.5345697,-12.076552,8.168472,9.06257,9.822078,AAML1031,Relapse,PAWZVT,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915410148_R03C01,-9.2436075,-7.65022,12.177864,10.993736,11.268497,AAML1031,Relapse,PAXGIX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410148_R04C01,-8.795677,-8.193532,12.649351,11.050057,11.418899,AAML1031,Relapse,PAWWCW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410148_R05C01,-4.4503736,-12.078457,9.181149,9.971827,9.507035,AAML1031,Relapse,PAXELP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202915410148_R06C01,-5.1872606,-11.100582,6.4399323,7.7898445,10.662925,AAML1031,Relapse,PAXKEZ,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915410148_R07C01,-13.829219,-2.588003,13.939632,11.733795,12.043849,AAML1031,Relapse,PAXJFS,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410148_R08C01,-12.502041,12.150385,20.527256,-3.2916431,-17.616793,AAML1031,Relapse,PAXCYN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410154_R01C01,1.6600617,20.978804,-12.833671,-7.6072683,14.155839,AAML1031,Diagnosis,PAWGPM,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410154_R02C01,4.3726263,18.831585,-14.186744,-7.42833,14.604791,AAML1031,Diagnosis,PAWGSX,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410154_R04C01,12.897382,6.204388,20.893608,-0.7077502,20.923023,AAML1031,Diagnosis,PAWGTG,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915410154_R06C01,1.3036076,22.52958,-13.006124,-7.2133937,13.762418,AAML1031,Diagnosis,PAWHAB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915410154_R07C01,-12.736393,-4.470147,13.21949,11.600414,11.108539,AAML1031,Diagnosis,PAWGYA,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915420065_R03C01,12.786257,-14.359331,-0.5163824,-14.346487,-11.963104,AAML1031,Diagnosis,PAUVGD,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915420094_R02C01,12.912896,6.1052203,20.746407,-0.5783728,20.739437,AAML1031,Relapse,PAVDZK,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420094_R03C01,-12.063496,-15.177763,22.632572,16.43584,-8.816335,AAML1031,Relapse,PAVPFR,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915420094_R06C01,-12.088408,-8.897309,20.455757,-12.434252,-16.69889,AAML1031,Relapse,PAVDYE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420094_R07C01,-11.880114,-10.382226,20.117594,-13.0927725,-16.445908,AAML1031,Relapse,PAVNUW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420094_R08C01,-6.5792894,-9.627579,11.294737,10.650401,11.107319,AAML1031,Relapse,PAVTFI,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915420117_R01C01,-16.107176,-10.215003,-16.85454,15.191779,19.01197,AAML1031,Relapse,PAVGJG,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915420117_R02C01,-11.990199,-10.048185,20.317545,-12.945812,-16.519503,AAML1031,Relapse,PAVKEX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420117_R03C01,-10.879125,12.720676,19.191658,-6.596821,-19.39785,AAML1031,Relapse,PAVLYV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420117_R04C01,-9.566007,-7.3238597,12.0720825,11.003147,11.216736,AAML1031,Relapse,PAVPKA,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915420117_R05C01,-11.884687,11.535178,4.2396646,-23.720062,10.888875,AAML1031,Relapse,PAUYRR,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915420117_R06C01,-0.7979911,-11.186404,4.459729,10.067629,9.403293,AAML1031,Relapse,PAVJRF,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915420117_R07C01,15.260457,-7.7469563,-19.209673,-13.967243,19.708439,AAML1031,Relapse,PAVHFP,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915420117_R08C01,-11.46286,12.009215,19.997284,-3.9922988,-18.349539,AAML1031,Relapse,PAVALK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420144_R03C01,-11.904149,-5.437538,12.989518,11.404374,11.26785,AAML1031,Diagnosis,PAVWNG,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915420144_R06C01,12.809329,6.5558214,21.304615,-0.7589117,21.612501,AAML1031,Diagnosis,PAVWRN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420156_R01C01,-12.179944,-8.032233,20.589207,-12.048158,-16.832436,AAML1031,Relapse,PAVRJP,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420156_R02C01,-0.9381568,-11.20087,9.626132,11.686863,10.528898,AAML1031,Relapse,PAUUPR,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915420156_R03C01,12.96536,6.2827315,21.045664,-1.6418117,20.95388,AAML1031,Relapse,PAVUBN,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420156_R04C01,13.957328,-13.275612,-1.1939076,-15.185448,-12.291738,AAML1031,Relapse,PAWAMB,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915420156_R05C01,15.206387,-9.362181,-0.9307747,-17.218735,-14.219665,AAML1031,Relapse,PAVJXG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915420156_R06C01,12.909849,6.2449036,20.967684,-0.95897007,20.975153,AAML1031,Relapse,PAUZVP,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915420156_R08C01,0.6045758,21.859402,-13.070122,-7.539139,13.652035,AAML1031,Relapse,PAWBSJ,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915420157_R02C01,-15.627407,-10.6889305,-15.674388,14.224566,17.834848,AAML1031,Relapse,PAVSAN,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915420157_R04C01,13.272242,5.5803127,19.121716,-0.5781811,19.144144,AAML1031,Relapse,PAVTDU,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202915420157_R05C01,-12.146969,11.280765,4.1026254,-23.300554,10.181799,AAML1031,Relapse,PAWCJK,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915420157_R06C01,14.451152,-11.359631,0.499947,-13.763161,-16.671053,AAML1031,Relapse,PAVTRM,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915420157_R07C01,1.8522997,19.250246,-13.292732,-7.806536,14.394782,AAML1031,Relapse,PAUZRT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915420157_R08C01,-10.703155,12.4631605,19.692432,-5.572528,-18.975012,AAML1031,Relapse,PAVKAU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915460079_R01C01,-14.659166,-8.638269,-17.997595,15.642978,19.11256,AAML1031,Relapse,PAWSRG,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915460079_R02C01,12.884755,6.542633,21.152712,-0.99401355,21.447681,AAML1031,Relapse,PAVZEC,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915460079_R03C01,13.140269,5.4175086,20.135727,-1.4340255,19.372967,AAML1031,Relapse,PAWPMA,Unknown,Discovery (train) Samples,GSE190931,Unknown,Otherwise-Normal Control
202915460079_R04C01,1.8499743,22.547014,-13.077542,-6.6390524,14.2012005,AAML1031,Relapse,PAWNPG,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915460079_R05C01,14.581303,-12.129009,11.842621,15.273076,-15.058797,AAML1031,Relapse,PAVTLN,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915460079_R06C01,-12.41185,-15.383152,24.255857,16.670502,-9.993643,AAML1031,Relapse,PAUMUZ,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915460079_R07C01,-12.273403,10.727259,20.517181,-2.1439974,-18.421007,AAML1031,Relapse,PAVWBW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915460079_R08C01,-12.7480545,-14.871558,23.356388,17.121569,-9.44098,AAML1031,Relapse,PAUXNH,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915470042_R04C01,-12.6676655,-4.4703994,13.061007,11.635569,10.821896,AAML1031,Diagnosis,PAVXCF,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915470059_R02C01,-12.144591,8.714291,21.278605,-2.0817685,-17.759766,AAML1031,Diagnosis,PAVVTF,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915470059_R05C01,15.235843,-11.946917,12.14548,16.317518,-15.206017,AAML1031,Diagnosis,PAVWBB,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915470059_R06C01,-11.334384,11.007715,20.734644,-3.9206772,-17.891539,AAML1031,Diagnosis,PAVWEA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915470060_R05C01,-15.233086,-0.41590232,14.550792,11.948109,12.578395,AAML1031,Diagnosis,PAVXSH,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202915590002_R01C01,-11.8653345,9.6122,21.695026,-1.488311,-17.476248,AAML1031,Diagnosis,PAVYVR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590002_R03C01,1.445612,21.216875,-13.406589,-7.6452904,13.708896,AAML1031,Diagnosis,PAWMKP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915590002_R04C01,12.799915,-11.26798,-1.7586755,-17.81502,-14.093436,AAML1031,Diagnosis,PAWMKF,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202915590002_R05C01,15.303882,-11.955032,12.116026,16.254017,-14.522023,AAML1031,Diagnosis,PAWMLK,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915590002_R06C01,-15.634896,0.23236795,14.732198,12.011264,12.750565,AAML1031,Diagnosis,PAWMLN,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202915590002_R08C01,-8.847486,-8.213701,12.851649,11.093031,11.471998,AAML1031,Diagnosis,PAWMFY,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590043_R01C01,4.4648786,17.91499,-14.285868,-7.738388,14.657549,AAML1031,Diagnosis,PAWUEX,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915590043_R02C01,14.047233,-9.962325,-0.7696542,-18.080389,-12.002188,AAML1031,Diagnosis,PAWUKE,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915590043_R03C01,-11.980826,-9.62025,20.281359,-12.754593,-16.573736,AAML1031,Diagnosis,PAWUMM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590043_R04C01,13.504768,-11.844775,-1.7376872,-17.48276,-11.216904,AAML1031,Diagnosis,PAWUNI,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202915590043_R06C01,12.896489,5.7788343,20.678095,-0.34442505,20.33604,AAML1031,Diagnosis,PAWUTL,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202915590043_R07C01,13.881243,-11.223389,-0.62659436,-15.087914,-17.402296,AAML1031,Diagnosis,PAWUUE,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915590043_R08C01,2.543924,18.83966,-13.573757,-7.919491,14.377186,AAML1031,Diagnosis,PAWUUY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915590070_R01C01,14.246061,-13.804028,-0.42929536,-12.414786,-16.5767,AAML1031,Diagnosis,PAWTWW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590070_R02C01,0.85972387,-12.847242,7.8476224,11.05896,10.923417,AAML1031,Diagnosis,PAWTYD,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202915590070_R03C01,-11.714591,11.421429,19.115856,-4.733555,-17.844362,AAML1031,Diagnosis,PAWUAE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590070_R04C01,12.99983,-13.444853,-1.2017872,-15.854948,-11.691566,AAML1031,Diagnosis,PAWTYT,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915590070_R05C01,-15.545636,-11.345966,-16.967537,15.8391485,19.39293,AAML1031,Diagnosis,PAWUBZ,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915590070_R06C01,12.981194,-13.635514,-0.98012674,-15.272777,-12.139292,AAML1031,Diagnosis,PAWUCF,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915590070_R07C01,-12.149406,12.707995,19.044521,-5.953687,-19.051756,AAML1031,Diagnosis,PAWUCG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590070_R08C01,4.066848,19.665352,-13.885626,-6.5150576,15.119635,AAML1031,Diagnosis,PAWUEW,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915590076_R01C01,12.852609,6.645513,21.353607,-1.1944319,21.673529,AAML1031,Diagnosis,PAWHIZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590076_R03C01,-11.656031,-11.059566,19.709646,-13.389966,-16.293007,AAML1031,Diagnosis,PAWHJI,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590076_R04C01,4.0598154,12.4089365,-10.866286,2.869721,-25.511536,AAML1031,Diagnosis,PAWHKK,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590076_R06C01,12.431181,-13.291668,-1.3239424,-17.118622,-9.866302,AAML1031,Diagnosis,PAWHPL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590076_R08C01,15.323619,-11.941311,12.149462,16.344198,-14.922663,AAML1031,Diagnosis,PAWHSM,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915590083_R02C01,6.278783,17.94462,-14.816916,-7.5885077,14.663036,AAML1031,Diagnosis,PAWHTL,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915590083_R03C01,2.8035142,22.106495,-13.314353,-5.969636,14.829246,AAML1031,Diagnosis,PAWHUX,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915590083_R04C01,13.588781,-14.164746,0.08256344,-12.155921,-16.156725,AAML1031,Diagnosis,PAWHZX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590083_R05C01,1.5581534,22.143587,-12.850748,-7.449098,13.837493,AAML1031,Diagnosis,PAWIAT,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915590083_R06C01,-11.57284,8.806325,21.881231,-2.1039271,-17.492805,AAML1031,Diagnosis,PAWICA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590083_R07C01,12.671922,-11.409088,-1.7680745,-18.343756,-12.336901,AAML1031,Diagnosis,PAWIDI,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202915590099_R01C01,13.560494,-13.636013,0.24215396,-12.360321,-16.717638,AAML1031,Diagnosis,PAWIUS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590099_R03C01,-13.221277,13.481115,19.53949,-5.2791667,-19.57983,AAML1031,Diagnosis,PAWIXW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590099_R04C01,13.46416,-11.3808155,-0.81843835,-15.748632,-16.233469,AAML1031,Diagnosis,PAWIZG,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202915590099_R05C01,0.84248203,-13.081846,8.201754,11.419134,10.491171,AAML1031,Diagnosis,PAWJDM,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915590099_R06C01,-13.029192,13.728083,18.234911,-7.086641,-19.70838,AAML1031,Diagnosis,PAWJGZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590099_R07C01,-11.709877,-5.315067,12.971533,11.398805,11.346492,AAML1031,Diagnosis,PAWJIM,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915590099_R08C01,-12.501128,-4.879614,12.909891,11.616305,10.588706,AAML1031,Diagnosis,PAWJKD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590131_R02C01,14.418906,-11.457811,-0.5519791,-15.069402,-15.468157,AAML1031,Relapse,PAUVEF,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590131_R04C01,14.143083,-7.8074503,-19.219858,-14.064554,20.021288,AAML1031,Relapse,PAVEYP,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915590131_R06C01,-11.846151,7.3676543,21.800798,-2.1613302,-17.878433,AAML1031,Relapse,PAUZTH,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915590131_R07C01,2.5884278,19.729477,-13.637889,-7.687666,14.1993265,AAML1031,Relapse,PAUYEV,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915590131_R08C01,13.368411,5.140136,19.82838,-2.47685,18.619925,AAML1031,Relapse,PAUPSX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202915600017_R02C01,14.272039,-12.199849,0.6766971,-12.469613,-18.06236,AAML1031,Diagnosis,PAWIIK,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600017_R03C01,-13.196106,-10.306991,-16.917599,15.639865,19.523306,AAML1031,Diagnosis,PAWIHN,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600017_R04C01,-0.34112197,-12.231615,7.3689823,11.08699,10.121428,AAML1031,Diagnosis,PAWILD,Unknown,Discovery (train) Samples,GSE190931,Unknown,MDS-related or secondary myeloid neoplasms
202915600017_R05C01,-15.384115,-10.94426,-17.209879,16.012522,19.931477,AAML1031,Diagnosis,PAWITY,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600017_R06C01,16.074842,-7.6610622,-19.333754,-13.929376,19.336578,AAML1031,Diagnosis,PAWIUT,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915600017_R07C01,-10.979633,12.352248,4.2053094,-24.585106,11.796725,AAML1031,Diagnosis,PAWIUZ,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600017_R08C01,-10.988997,12.404372,20.167294,-5.009706,-18.706425,AAML1031,Diagnosis,PAWIVB,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600023_R01C01,13.80018,-10.184774,-1.2131941,-18.65395,-11.067712,AAML1031,Diagnosis,PAWMKU,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600023_R02C01,13.785739,-13.952174,0.5854927,-11.519672,-16.958471,AAML1031,Diagnosis,PAWMNN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600023_R03C01,-18.072489,-11.187932,-17.041653,15.610828,19.271385,AAML1031,Diagnosis,PAWMPH,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600023_R04C01,14.181584,-9.6778755,-0.86400527,-18.306246,-12.05325,AAML1031,Diagnosis,PAWMRJ,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600023_R05C01,-11.075589,12.3393755,4.28746,-25.04782,12.097005,AAML1031,Diagnosis,PAWNAP,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600023_R06C01,13.854874,-12.863057,0.17726317,-12.726822,-17.543158,AAML1031,Diagnosis,PAWNBB,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915600023_R07C01,12.570483,-12.90026,-0.7233609,-16.29001,-11.239237,AAML1031,Diagnosis,PAWNFJ,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600038_R01C01,-6.1392407,-9.325155,8.2840805,9.704072,10.788054,AAML1031,Relapse,PAVALI,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600038_R02C01,14.722174,-7.7941713,-19.150528,-14.080999,20.071775,AAML1031,Relapse,PAUNSV,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915600038_R03C01,-15.50996,-9.974797,-16.096472,14.477201,18.639627,AAML1031,Relapse,PAURWH,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600038_R05C01,-11.754157,11.160869,18.894817,-6.4445324,-18.818724,AAML1031,Relapse,PAUVXT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600038_R06C01,-12.198281,-7.888027,20.621729,-11.987697,-16.860264,AAML1031,Relapse,PAUMTZ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600038_R07C01,-12.26975,-15.084513,22.849033,16.6411,-9.004034,AAML1031,Relapse,PAVBCV,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600038_R08C01,16.307564,-7.6751347,-19.223438,-14.127394,19.808277,AAML1031,Relapse,PAURUT,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915600043_R02C01,12.935288,5.8115573,20.502903,-0.64032286,20.264349,AAML1031,Relapse,PAUVAT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600043_R03C01,1.8080684,20.381907,-12.817502,-7.6571517,14.356395,AAML1031,Relapse,PAUVCB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600043_R06C01,16.94819,-7.5722156,-19.422165,-14.325719,19.751684,AAML1031,Relapse,PAUVMN,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915600043_R07C01,-12.263394,-15.62868,24.722195,16.465912,-10.287334,AAML1031,Relapse,PAVGDM,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600043_R08C01,14.090671,-12.313816,-0.20002495,-14.244458,-15.104113,AAML1031,Relapse,PAUSCS,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600053_R02C01,1.2787256,21.86203,-12.706836,-7.572368,13.895784,AAML1031,Diagnosis,PAWVUA,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600053_R03C01,-17.866098,-9.834324,-17.83378,15.758601,19.328451,AAML1031,Diagnosis,PAWVUX,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600071_R01C01,-12.182645,-8.016607,20.598879,-12.043621,-16.841337,AAML1031,Relapse,PAWNYX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600071_R02C01,2.0289137,19.711788,-13.095457,-7.4784527,14.600766,AAML1031,Relapse,PAWMKP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600071_R03C01,13.279219,3.7603385,18.762835,-0.101908855,16.554852,AAML1031,Relapse,PAWXIA,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915600071_R04C01,3.7258167,20.372679,-13.628116,-6.201863,15.205912,AAML1031,Relapse,PAWWZL,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600071_R05C01,13.193368,4.375453,19.389372,-0.4329374,17.741573,AAML1031,Relapse,PAWFRK,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with other rare recurring translocations
202915600071_R06C01,-12.191555,11.549768,20.42095,-3.664685,-17.391272,AAML1031,Relapse,PAWVGN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600071_R07C01,13.23747,4.8547964,19.566116,-0.8671672,18.407894,AAML1031,Relapse,PAWUTL,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600071_R08C01,-12.580803,-15.194037,24.038965,16.876942,-9.87878,AAML1031,Relapse,PAXETC,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600095_R01C01,12.733532,-11.906006,-1.6836222,-17.852415,-11.843662,AAML1031,Diagnosis,PAWJPN,Unknown,Discovery (train) Samples,GSE190931,Unknown,AML with mutated NPM1
202915600095_R02C01,0.87126964,-12.523541,8.10417,11.269714,11.545698,AAML1031,Diagnosis,PAWJVZ,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202915600095_R03C01,-5.6251636,-10.1805315,11.493088,10.657988,11.357633,AAML1031,Diagnosis,PAWKCU,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
202915600095_R07C01,13.692408,-11.669479,0.16396149,-14.603439,-15.616492,AAML1031,Diagnosis,PAWKJC,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE190931,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
202915600095_R08C01,3.3877873,21.284517,-13.556114,-6.2164044,14.869841,AAML1031,Diagnosis,PAWKIU,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600109_R01C01,16.71101,-7.586513,-19.410337,-14.469717,20.051586,AAML1031,Relapse,PAVCNG,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
202915600109_R02C01,4.4881744,17.934397,-14.246846,-7.550394,14.814695,AAML1031,Relapse,PAVDDA,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600109_R03C01,3.9508944,20.38504,-13.772229,-6.208881,15.138977,AAML1031,Relapse,PAURJZ,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600109_R04C01,-6.33612,-9.209189,8.739209,9.976125,10.716472,AAML1031,Relapse,PAUJCF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600109_R05C01,-10.996219,12.381307,4.394263,-25.037329,12.23608,AAML1031,Relapse,PAVLDU,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600109_R06C01,-12.955978,13.461499,18.126753,-7.1850514,-19.525938,AAML1031,Relapse,PAVDVV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600109_R07C01,-12.280784,-15.064893,22.812696,16.655918,-8.981566,AAML1031,Relapse,PAVHNV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600109_R08C01,-17.168737,-19.014269,0.8124925,-14.46535,-23.070652,AAML1031,Relapse,PAVBFN,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600118_R01C01,-4.3173647,-11.631806,9.508999,10.438942,9.718066,AAML1031,Diagnosis,PAWNYK,Unknown,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
202915600118_R02C01,-16.420916,6.03432,14.849888,11.9299755,13.486356,AAML1031,Diagnosis,PAWRUF,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915600118_R03C01,13.006664,4.9154363,19.992636,-0.23519984,18.900904,AAML1031,Diagnosis,PAWNHH,AML with other rare recurring translocations,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with other rare recurring translocations
202915600165_R02C01,-11.658479,10.610463,21.051073,-2.7339547,-17.817234,AAML1031,Diagnosis,PAWVCG,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600165_R03C01,-11.152831,12.301891,4.2377844,-25.121008,12.06561,AAML1031,Diagnosis,PAWVBV,AML with mutated NPM1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with mutated NPM1
202915600165_R04C01,-17.429632,-10.929329,-17.018772,15.683189,19.892565,AAML1031,Diagnosis,PAWVGF,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
202915600165_R05C01,-12.531274,12.640231,19.912449,-4.8028455,-18.67113,AAML1031,Diagnosis,PAWVGN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
202915600165_R06C01,3.7353523,20.343641,-13.717469,-6.5202622,14.928512,AAML1031,Diagnosis,PAWVLI,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
202915600165_R07C01,4.636047,18.044477,-14.360423,-7.797538,14.54471,AAML1031,Diagnosis,PAWVNP,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GSE190931,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
203027390010_R01C01,-7.1852555,-8.839219,9.821096,10.2862835,10.856611,Beat AML Consortium,Diagnosis,16-00524,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203027390010_R02C01,-3.9713037,-11.392814,5.876376,7.5403852,11.176379,Beat AML Consortium,Diagnosis,15-00650,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203027390010_R03C01,13.277663,-11.561442,-1.0571699,-17.331186,-12.108648,Beat AML Consortium,Diagnosis,17-00093,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203027390010_R04C01,13.990688,-11.122538,-0.22870404,-14.691737,-17.581022,Beat AML Consortium,Diagnosis,12-00211,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203027390010_R05C01,-12.068622,11.377806,4.0678515,-23.489628,10.350922,Beat AML Consortium,Diagnosis,13-00165,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203027390010_R06C01,2.0654774,-12.511348,7.994855,10.649289,9.258807,Beat AML Consortium,Diagnosis,13-00500,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203027390011_R01C01,13.011398,4.1911726,19.699005,-0.40536124,17.842157,Beat AML Consortium,Diagnosis,16-00525,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with other rare recurring translocations
203027390011_R02C01,10.129166,-28.331348,-14.350773,4.3771977,16.962685,Beat AML Consortium,Diagnosis,16-00699,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203027390011_R03C01,13.4636755,-12.024362,-1.328437,-17.30286,-10.477756,Beat AML Consortium,Diagnosis,16-00810,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203027390011_R04C01,-3.964548,-10.860966,6.3877163,8.950642,10.289035,Beat AML Consortium,Diagnosis,16-01049,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203027390011_R05C01,0.34322542,-12.513612,7.6555133,10.883491,10.819543,Beat AML Consortium,Diagnosis,16-00818,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
203027390011_R06C01,15.321905,-11.956257,12.052491,16.167845,-12.741913,Beat AML Consortium,Diagnosis,16-00867,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203027390011_R07C01,-11.701616,11.955325,3.8336818,-25.099054,11.425332,Beat AML Consortium,Diagnosis,15-00892,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203027390011_R08C01,-1.6029203,-8.945055,2.912171,11.259856,9.051452,Beat AML Consortium,Diagnosis,16-00880,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
203028200024_R01C01,15.810594,-11.889185,12.210658,16.621233,-13.488425,Beat AML Consortium,Diagnosis,16-00035,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200024_R02C01,15.467137,-11.938993,12.110664,16.309416,-13.388613,Beat AML Consortium,Diagnosis,16-00003,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200024_R03C01,-11.76827,11.674544,4.21917,-24.047226,11.088408,Beat AML Consortium,Diagnosis,16-00041,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200024_R04C01,14.577604,-12.054471,11.854547,15.554673,-12.549968,Beat AML Consortium,Diagnosis,16-00067,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203028200024_R05C01,-7.766869,-16.839344,-20.739538,-21.431528,14.780914,Beat AML Consortium,Diagnosis,16-00070,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
203028200024_R06C01,-1.6988127,-11.982279,8.263045,10.342901,10.884179,Beat AML Consortium,Diagnosis,16-00075,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200024_R07C01,-12.030109,11.649301,3.7988298,-24.674881,11.015225,Beat AML Consortium,Diagnosis,16-00026,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200024_R08C01,14.795408,-12.055458,11.949317,15.676222,-14.755841,Beat AML Consortium,Diagnosis,16-00102,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200041_R01C01,-4.302202,-9.467883,6.619091,9.854315,10.645561,Beat AML Consortium,Diagnosis,16-00145,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200041_R02C01,12.875346,-12.2874,-1.6539094,-17.906195,-9.919105,Beat AML Consortium,Diagnosis,16-00157,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200041_R03C01,14.22883,-10.753891,-0.4719108,-16.361528,-13.7330675,Beat AML Consortium,Diagnosis,16-00271,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200041_R04C01,-18.22559,-18.783937,-0.35457465,-15.517519,-23.630365,Beat AML Consortium,Diagnosis,16-00289,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200041_R05C01,15.522667,-11.929114,12.137146,16.380133,-13.602602,Beat AML Consortium,Diagnosis,16-00292,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200041_R06C01,-11.771588,11.880064,3.8552415,-24.981592,11.330067,Beat AML Consortium,Diagnosis,16-00303,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200041_R07C01,-12.222459,11.2928,4.1004195,-23.529018,10.729061,Beat AML Consortium,Diagnosis,16-00344,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200041_R08C01,-0.6457097,-11.0845585,5.0548205,10.203732,9.903254,Beat AML Consortium,Diagnosis,14-00240,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200053_R01C01,-7.634874,-17.001059,-20.801693,-21.341461,14.680664,Beat AML Consortium,Diagnosis,15-00470,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
203028200053_R02C01,-13.546658,-9.982012,-15.827822,14.385885,18.438953,Beat AML Consortium,Diagnosis,14-00193,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203028200053_R03C01,-12.839275,13.370428,18.157625,-7.172916,-19.482208,Beat AML Consortium,Diagnosis,14-00231,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
203028200053_R04C01,-11.610053,12.050507,3.8679616,-25.302822,11.644045,Beat AML Consortium,Diagnosis,15-00279,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200053_R05C01,-11.432145,12.125414,4.054208,-25.135529,11.771746,Beat AML Consortium,Diagnosis,14-00817,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203028200053_R06C01,-11.835773,11.823328,3.8383086,-24.91268,11.231817,Beat AML Consortium,Diagnosis,15-00872,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200053_R07C01,-7.135895,-17.524767,-21.121426,-20.912254,14.287363,Beat AML Consortium,Diagnosis,16-00120,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
203028200053_R08C01,-4.46683,-9.119622,6.7491026,10.189142,10.582873,Beat AML Consortium,Diagnosis,16-00701,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203028200074_R01C01,-17.955431,-18.845205,-0.052520502,-15.2459755,-23.486158,Beat AML Consortium,Diagnosis,15-00653,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203028200074_R02C01,15.527371,-11.929743,12.145408,16.386847,-13.866931,Beat AML Consortium,Diagnosis,17-00064,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200074_R04C01,-0.39094955,-8.593088,1.176999,9.90656,10.087158,Beat AML Consortium,Diagnosis,12-00066,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203028200074_R05C01,-18.141308,-9.650877,-17.728935,15.365439,18.338549,Beat AML Consortium,Diagnosis,13-00487,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203028200074_R06C01,-14.935199,-2.0439212,14.627567,11.794265,12.593906,Beat AML Consortium,Diagnosis,16-00466,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with other rare recurring translocations
203028200074_R07C01,15.493122,-7.7111144,-19.204609,-14.858276,21.212767,Beat AML Consortium,Diagnosis,16-01219,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
203028200074_R08C01,-0.5956323,-12.092831,6.8023314,10.277255,10.487754,Beat AML Consortium,Diagnosis,16-01102,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200086_R01C01,-11.9518585,13.120993,19.01833,-6.1458063,-19.32772,Beat AML Consortium,Diagnosis,13-00655,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
203028200086_R02C01,14.875939,-9.352021,-0.5238859,-16.859041,-15.090815,Beat AML Consortium,Diagnosis,13-00658,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200086_R03C01,-14.840085,-8.519812,-18.325283,15.844092,19.100422,Beat AML Consortium,Diagnosis,13-00497,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203028200086_R04C01,17.332022,-7.5409703,-19.396626,-14.839827,20.616688,Beat AML Consortium,Diagnosis,16-01093,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with in-frame bZIP mutated CEBPA
203028200086_R05C01,-0.42438564,-8.376923,1.0380708,10.132577,9.95282,Beat AML Consortium,Diagnosis,16-01216,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200086_R06C01,-6.3878107,-9.320591,9.382301,9.908551,11.127942,Beat AML Consortium,Diagnosis,15-00608,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200086_R07C01,0.4782346,-13.2762375,8.342869,11.448905,10.677196,Beat AML Consortium,Diagnosis,15-00614,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200086_R08C01,-4.4817405,-9.33634,6.89934,10.053992,10.589831,Beat AML Consortium,Diagnosis,12-00423,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203028200090_R01C01,1.475576,-13.357483,8.650234,11.512657,9.857541,Beat AML Consortium,Diagnosis,16-01237,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200090_R02C01,-18.116121,-18.809237,-0.23164044,-15.4075165,-23.571617,Beat AML Consortium,Diagnosis,17-00033,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200090_R03C01,0.28130016,-12.723155,7.718849,11.051681,10.450482,Beat AML Consortium,Diagnosis,15-00383,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
203028200090_R04C01,-11.552126,12.087952,3.9508018,-25.37013,11.740209,Beat AML Consortium,Diagnosis,10-00692,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200090_R05C01,-18.061848,-18.821379,-0.17038147,-15.35243,-23.542439,Beat AML Consortium,Diagnosis,09-00705,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200090_R06C01,-7.6759987,-16.878998,-20.85521,-21.293879,14.701146,Beat AML Consortium,Diagnosis,15-00742,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GSE159907,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
203028200090_R07C01,-17.62529,-11.316507,-16.68138,15.282466,18.703121,Beat AML Consortium,Diagnosis,16-01109,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203028200090_R08C01,-16.307556,-9.942527,-16.974165,15.198052,19.160778,Beat AML Consortium,Diagnosis,14-00423,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203028200092_R01C01,-18.172157,-18.79738,-0.29209742,-15.462988,-23.600716,Beat AML Consortium,Diagnosis,16-00109,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200092_R02C01,13.726916,-11.292205,-1.1895331,-17.531698,-11.334773,Beat AML Consortium,Diagnosis,16-00465,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with other rare recurring translocations
203028200092_R03C01,-1.5320429,-9.172587,3.0894275,10.986127,9.241785,Beat AML Consortium,Diagnosis,16-00273,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
203028200092_R04C01,14.101985,-12.965814,0.494709,-12.262667,-17.250988,Beat AML Consortium,Diagnosis,14-00477,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
203028200092_R05C01,15.372077,-7.7603273,-19.112099,-14.349675,20.491856,Beat AML Consortium,Diagnosis,15-00961,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with in-frame bZIP mutated CEBPA
203028200092_R06C01,13.999787,-11.701383,-0.83350617,-15.932168,-13.785979,Beat AML Consortium,Diagnosis,16-00540,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203028200092_R07C01,-1.4697942,-12.055969,7.902448,10.090654,10.875021,Beat AML Consortium,Diagnosis,16-00510,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
203028200092_R08C01,17.232098,-7.545412,-19.377535,-15.102672,21.112028,Beat AML Consortium,Diagnosis,16-00519,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
203028200095_R01C01,-1.2790031,-11.027416,6.9063506,10.921032,10.143025,Beat AML Consortium,Diagnosis,14-00832,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200095_R02C01,2.0483801,-12.605653,8.261176,10.820259,9.159539,Beat AML Consortium,Diagnosis,15-00075,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200095_R03C01,13.9068165,-11.216637,-0.9004689,-15.717054,-16.193153,Beat AML Consortium,Diagnosis,15-00123,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200095_R04C01,12.88566,-12.746113,-0.8981464,-16.724688,-10.639489,Beat AML Consortium,Diagnosis,15-00167,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200095_R05C01,13.211774,5.188385,19.89142,-1.3597299,18.959341,Beat AML Consortium,Diagnosis,15-00171,Unknown,Discovery (train) Samples,GSE159907,Unknown,Otherwise-Normal Control
203028200095_R06C01,0.23346254,-12.107045,7.128442,10.690812,10.669056,Beat AML Consortium,Diagnosis,15-00175,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200095_R07C01,14.959861,-10.56102,0.55640113,-13.993583,-17.205008,Beat AML Consortium,Diagnosis,15-00276,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203028200095_R08C01,-3.9974625,-10.207243,7.1184735,9.437055,11.0459585,Beat AML Consortium,Diagnosis,15-00300,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200121_R01C01,0.5845079,-13.140985,7.5146036,10.4195175,10.56718,Beat AML Consortium,Diagnosis,14-00329,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
203028200121_R02C01,-2.5377727,-10.713847,5.642439,9.5575485,10.256097,Beat AML Consortium,Diagnosis,14-00712,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203028200121_R03C01,-11.989488,-10.266724,20.323963,-13.045775,-16.49198,Beat AML Consortium,Diagnosis,14-00739,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
203028200121_R04C01,-12.191316,10.884688,19.794458,-5.5280766,-18.55121,Beat AML Consortium,Diagnosis,14-00781,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
203028200121_R05C01,-13.832941,-8.444638,-18.167562,15.801809,19.253927,Beat AML Consortium,Diagnosis,14-00359,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203028200121_R06C01,15.309568,-7.7139506,-19.211502,-15.089995,21.629593,Beat AML Consortium,Diagnosis,14-00787,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
203028200121_R07C01,-18.557358,-9.867143,-17.630064,15.362334,18.457283,Beat AML Consortium,Diagnosis,14-00798,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203028200121_R08C01,2.0179174,-12.892896,8.380747,10.872723,9.268666,Beat AML Consortium,Diagnosis,14-00901,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203286230121_R01C01,14.108953,-10.947675,-1.2581302,-16.045126,-16.529217,Beat AML Consortium,Diagnosis,AML33P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203286230121_R02C01,14.127538,-11.292007,-0.86807686,-14.884637,-18.00957,Beat AML Consortium,Relapse,AML33R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203286230121_R03C01,-16.022144,-8.906454,-18.474752,16.016676,19.090467,Beat AML Consortium,Diagnosis,AML32P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203286230121_R04C01,-12.743386,-8.310807,-18.360266,16.04322,19.519732,Beat AML Consortium,Relapse,AML32R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203286230121_R05C01,14.141931,-12.117605,11.772648,15.217051,-13.573298,Beat AML Consortium,Diagnosis,AML28P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with in-frame bZIP mutated CEBPA
203286230121_R06C01,-6.9932847,-8.788962,9.391456,10.189004,10.838749,Beat AML Consortium,Relapse,AML28R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203286230207_R01C01,14.636985,-10.415896,0.16947375,-14.689922,-17.228292,Beat AML Consortium,Diagnosis,AML31P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203286230207_R02C01,14.903778,-10.634462,0.7220381,-13.642964,-17.708305,Beat AML Consortium,Relapse,AML31R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203286230207_R03C01,1.7175964,-13.151564,8.17478,11.438059,9.19074,Beat AML Consortium,Diagnosis,AML29P,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203286230207_R04C01,1.8028885,-13.639545,8.303799,11.638007,9.709761,Beat AML Consortium,Relapse,AML29R,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203287590113_R01C01,-1.4829218,-9.271068,2.7467608,11.371795,8.694045,Beat AML Consortium,Diagnosis,AML43P,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203287590113_R02C01,-0.38149148,-8.400739,0.9755799,10.064212,9.98167,Beat AML Consortium,Diagnosis,AML37P,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203287590113_R03C01,-11.925737,11.723436,3.8600748,-24.728056,11.097517,Beat AML Consortium,Diagnosis,AML39P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203287590113_R04C01,-12.158788,11.231222,4.2274737,-23.0574,10.399691,Beat AML Consortium,Diagnosis,AML36P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203287590113_R05C01,14.532472,-12.064721,11.946572,15.631309,-15.605268,Beat AML Consortium,Diagnosis,AML41P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203287590113_R06C01,-5.5621095,-9.397095,7.7753787,9.576358,10.933639,Beat AML Consortium,Diagnosis,AML38P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203287590113_R07C01,-5.925597,-9.796731,9.773408,9.827648,11.375264,Beat AML Consortium,Diagnosis,AML34P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203675380157_R01C01,-18.015999,-18.831535,-0.12021551,-15.306803,-23.518667,Beat AML Consortium,Relapse,10-00792,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203675380157_R02C01,-12.065122,11.224195,4.4410324,-22.716114,10.590977,Beat AML Consortium,Relapse,10-00542,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203675380157_R03C01,-12.36862,11.19032,3.8555984,-23.522,10.02685,Beat AML Consortium,Relapse,15-00482,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203675380157_R04C01,14.420851,-12.273232,0.99302655,-11.9445095,-18.260069,Beat AML Consortium,Relapse,17-00350,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203675380157_R05C01,15.532047,-7.7070904,-19.28982,-13.91951,19.465767,Beat AML Consortium,Relapse,16-01097,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
203675380157_R06C01,-12.560722,12.930808,20.169338,-4.4164834,-19.022377,Beat AML Consortium,Relapse,16-00684,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
203675380157_R07C01,14.659618,-12.027813,11.834632,15.62035,-10.929957,Beat AML Consortium,Relapse,16-01094,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203675380157_R08C01,-12.252564,11.247421,3.8601098,-23.405037,9.859777,Beat AML Consortium,Relapse,16-01118,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203675380189_R01C01,-12.350969,11.159925,3.8946865,-23.315092,9.850358,Beat AML Consortium,Relapse,17-00963,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203693970001_R01C01,14.306124,-11.099512,-0.13886993,-14.52819,-17.261852,Beat AML Consortium,Diagnosis,10-00669,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203693970001_R02C01,14.596682,-11.753756,0.9510557,-12.367197,-18.275726,Beat AML Consortium,Relapse,14-00639,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203693970001_R03C01,-18.09084,-18.815016,-0.20153783,-15.380819,-23.55742,Beat AML Consortium,Diagnosis,10-00507,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203693970001_R04C01,-18.132488,-18.806086,-0.24831493,-15.423002,-23.580023,Beat AML Consortium,Relapse,11-00295,AML with mutated NPM1,Discovery (train) Samples,GSE159907,Acute myeloid leukemia (AML),AML with mutated NPM1
203693970001_R05C01,-12.510744,9.949973,20.085968,-5.2928925,-18.48279,Beat AML Consortium,Diagnosis,13-00353,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203693970001_R06C01,-11.794099,11.441816,18.594875,-7.1129985,-19.122059,Beat AML Consortium,Relapse,14-00015,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
203693970001_R07C01,-0.18696532,-12.667956,8.645117,11.148088,10.379326,Beat AML Consortium,Diagnosis,15-00778,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203693970001_R08C01,0.71154255,-13.40175,8.639317,11.5134735,10.553082,Beat AML Consortium,Relapse,16-01138,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE159907,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
203717920109_R06C01,-3.2353363,-11.0147,8.322911,10.018394,10.904366,Beat AML Consortium,Diagnosis,AML42P,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203717920109_R07C01,-0.6239024,-8.371712,1.3017371,10.387717,9.785528,Beat AML Consortium,Diagnosis,AML35P,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
203717920109_R08C01,14.825577,-12.011457,11.888456,15.751531,-11.388867,Beat AML Consortium,Diagnosis,AML40P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
203724130020_R01C01,-10.623222,-16.151281,-21.903517,7.257708,-21.78297,French GRAALL 2003–2005,Diagnosis,CD34_2,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203724130020_R02C01,-10.601271,-16.367537,-21.935612,7.328602,-21.807655,French GRAALL 2003–2005,Diagnosis,ISP_2,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203724130020_R03C01,-10.6377125,-16.011862,-21.882042,7.2122483,-21.766577,French GRAALL 2003–2005,Diagnosis,TCRn_2,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203724130020_R04C01,-10.616283,-16.221066,-21.913834,7.2806406,-21.790956,French GRAALL 2003–2005,Diagnosis,TCRp_2,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203724130020_R05C01,-10.604229,-16.338144,-21.931805,7.318845,-21.804379,French GRAALL 2003–2005,Diagnosis,SPo4_2,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
203724130020_R06C01,-10.609189,-16.290653,-21.924646,7.303306,-21.798872,French GRAALL 2003–2005,Diagnosis,SPo8_2,Unknown,Discovery (train) Samples,GSE147667,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
204339390018_R01C01,14.192722,-9.576098,-0.9569382,-18.601171,-11.665914,Beat AML Consortium,Diagnosis,OSU58P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390018_R02C01,-5.8760185,-11.593127,5.932474,6.8099065,10.471367,Beat AML Consortium,Diagnosis,OSU34P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
204339390018_R05C01,-16.256826,6.98492,14.2912655,12.83029,13.572069,Beat AML Consortium,Relapse,OSU34R,Unknown,Discovery (train) Samples,GSE159907,Unknown,Otherwise-Normal Control
204339390018_R07C01,-11.832512,11.8128195,3.9337127,-24.928968,11.309251,Beat AML Consortium,Diagnosis,OSU116P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390045_R01C01,14.346498,-12.158677,11.795609,15.10271,-15.399125,Beat AML Consortium,Relapse,OSU58R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390045_R03C01,-4.9103155,-9.018635,7.0414424,10.15876,10.564732,Beat AML Consortium,Diagnosis,OS54P,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
204339390045_R04C01,15.243135,-9.3870735,0.3276555,-15.873211,-14.919226,Beat AML Consortium,Diagnosis,OSU40P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390045_R06C01,14.446109,-12.183745,0.9720168,-12.015112,-18.318048,Beat AML Consortium,Diagnosis,OSU141P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390045_R08C01,-12.323677,11.17557,3.9048407,-23.305044,9.849764,Beat AML Consortium,Relapse,OSU33R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390070_R01C01,-11.7764225,11.65254,4.255151,-23.991173,11.057883,Beat AML Consortium,Diagnosis,OSU42P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390070_R02C01,-11.933262,11.453293,4.2439275,-23.453325,10.667231,Beat AML Consortium,Relapse,OSU42R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390070_R03C01,-4.6803045,-9.548593,7.0195966,9.71202,10.728694,Beat AML Consortium,Relapse,OSU54R,Unknown,Discovery (train) Samples,GSE159907,Unknown,MDS-related or secondary myeloid neoplasms
204339390070_R04C01,15.318251,-9.391859,0.46146068,-15.453498,-15.674244,Beat AML Consortium,Relapse,OSU40R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390070_R05C01,-11.957942,11.458535,4.199982,-23.545874,10.696694,Beat AML Consortium,Relapse,OSU116R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390070_R06C01,-12.324221,11.189519,3.8832333,-23.362583,9.901384,Beat AML Consortium,Diagnosis,OSU33P,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
204339390070_R07C01,14.497085,-12.064062,0.99542725,-12.083281,-18.296457,Beat AML Consortium,Relapse,OSU141R,Unknown,Discovery (train) Samples,GSE159907,Unknown,AML with mutated NPM1
213c0515-ede5-4e17-a168-58dfd9195ed0_noid,-16.203745,4.1105814,14.633775,12.338187,13.24799,TCGA AML,Diagnosis,TCGA-AB-2829,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
23d30668-6976-4a62-ab77-95e3d5fc80e3_noid,-10.732046,-15.078488,-21.73792,6.907604,-21.660658,TARGET ALL,Bone Marrow Normal,TARGET-00-SJNORM054698,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
2483113d-8f2a-4a3c-b394-b734019c9c41_noid,13.712978,-13.299233,0.39457086,-12.102096,-17.852615,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATISD,AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)/MECOM-rearrangement
24a7de70-efb6-4445-b24f-5233c9b34308_noid,12.099431,-25.962595,-12.961811,3.57348,16.663973,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040037,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
25028908-996b-48b7-9203-af75f375e342_noid,-16.267902,6.8549466,14.18364,13.066222,13.561702,AAML0531,Bone Marrow Normal,PASCFW,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
258907d8-57df-4256-9366-af6d6474af4f_noid,13.723209,3.9775355,19.883879,-7.439131,16.534117,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016344,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
25a9cff0-83ce-403d-97d5-f51b0376e2a4_noid,0.24196562,-12.789078,7.5956473,10.485734,10.045939,TCGA AML,Diagnosis,TCGA-AB-2970,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
266acba5-2930-4a0f-803b-a9564f713420_noid,-18.61507,-9.760107,-17.82211,15.460033,18.40625,TCGA AML,Diagnosis,TCGA-AB-2957,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
26dd43de-7399-4bcd-a61d-f6758c76dbe7_noid,13.697636,2.4048119,19.464346,-9.610358,16.2475,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASIIY,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
26f3cecd-5737-4d61-981f-0d0f189cc35a_noid,10.025536,7.907749,-24.27796,21.81495,-0.38707876,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPEZX,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,Otherwise-Normal Control
27f41789-7635-455d-828b-bcc7d779ab90_noid,-16.76016,6.1554613,14.418023,13.230082,13.605109,AAML0531,Bone Marrow Normal,PAPXRJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
28b1a91b-046e-4685-8f6f-2e8c22b304e7_noid,15.1025095,-9.305898,-0.94299686,-17.399218,-14.162473,TCGA AML,Diagnosis,TCGA-AB-2976,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
28b6470e-367b-431e-ba20-c2f6fbdd4d05_noid,-18.520493,-9.74932,-17.767149,15.413133,18.377493,TCGA AML,Diagnosis,TCGA-AB-2942,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
29acee9c-964a-47f3-b924-0cc971009f26_noid,14.687743,-12.06956,11.913134,15.576366,-14.520229,TCGA AML,Diagnosis,TCGA-AB-2977,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
29ef5b19-c9ea-4cd3-8cb7-5134ffe3671c_noid,13.57064,-13.276704,0.20554487,-12.329978,-18.060547,AAML0531,Bone Marrow Normal,PATISD,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
2a09228b-6833-4050-8255-3294cd16640b_noid,-3.7679076,9.458489,-18.45132,0.53405935,-21.392138,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PANWPI,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
2a416d7f-759b-4e71-8d12-5b094b52fa6a_noid,13.072496,5.28697,19.600786,-0.5670733,19.127657,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANYCG,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
2a942d5b-7831-4caa-98d2-2ae7e9cba21f_noid,-12.843596,13.506285,18.233088,-7.233545,-19.754332,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARASV,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
2ade2bf4-d84d-4633-bd30-9ed6d5359ff2_noid,15.054231,-11.979677,12.076478,16.109818,-14.883945,TCGA AML,Diagnosis,TCGA-AB-2984,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
2b631acf-8059-44fb-8c6d-673d4cfc0d2b_noid,-7.511787,-8.704388,10.113686,10.5543585,10.56087,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASHHH,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
2cbae9e6-5a16-4f7b-913c-678959cf5fe5_noid,12.828404,6.7273765,21.43174,-1.1244242,21.836964,TCGA AML,Diagnosis,TCGA-AB-2855,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
2cbdeb80-4b5e-480c-9b2a-a243cfe441b7_noid,14.942289,-9.941693,1.7213969,-14.069367,-15.478327,AAML0531,Bone Marrow Normal,PATKWH,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
2cc27311-b6f0-4957-840a-fc791638ae94_noid,-5.6600757,-11.480376,5.585964,6.4245334,10.981537,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASIEJ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
2d594f94-4f55-4cd0-a611-08ff33783973_noid,10.291579,-28.07419,-14.211635,4.320458,16.924795,AAML0531,Bone Marrow Normal,PASNKZ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
30143082-cb6a-42f3-a9bb-41a3f56dd826_noid,13.346495,5.4066,20.360788,-3.5732267,18.964655,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASNTZ,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,MDS-related or secondary myeloid neoplasms
30d5261d-63d7-4ce4-b6d0-88dcb9dad7be_noid,14.332586,-9.369841,-0.9827681,-18.739399,-11.6058445,TCGA AML,Diagnosis,TCGA-AB-2851,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
30f2c36e-9c8d-46e9-af25-3adbace7b1af_noid,15.437665,-7.9842696,-0.5687688,-18.48607,-13.013456,TCGA AML,Diagnosis,TCGA-AB-2932,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
310c7002-fa75-45bd-8693-56b559ce457b_noid,13.241333,2.5086818,19.45361,-10.372216,16.609138,TARGET ALL,Primary Blood Derived Cancer - Peripheral Blood,TARGET-10-PARXMV,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
315d46a6-744e-478d-ae52-8647e593ba46_noid,-16.631565,6.300824,14.580224,12.723733,13.583252,AAML0531,Bone Marrow Normal,PASIEJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
31f89b8b-881d-4ec0-9b79-143161f64519_noid,-4.2911716,-11.814474,9.038147,10.051599,9.670373,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARPDS,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
3271368c-e88b-407e-8fa9-3f100a7ed6eb_noid,-16.318663,4.7747674,14.606486,12.454377,13.344308,AAML0531,Bone Marrow Normal,PARPDS,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
328e0939-2e0d-4921-817b-ac016838796c_noid,-0.88744056,-11.788231,7.3623753,10.837372,10.313006,TCGA AML,Diagnosis,TCGA-AB-2904,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
339a37ef-3f36-4840-8e0a-af78e35f68ae_noid,-16.435991,5.172595,14.600565,12.567525,13.415753,AAML0531,Bone Marrow Normal,PASIEP,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
33e91a9f-d560-451d-9ead-768e197d83e9_noid,-4.3703117,-9.5907,6.912502,9.862426,10.696678,TCGA AML,Diagnosis,TCGA-AB-2908,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
3528f86c-bf50-471a-82e5-82d321d38591_noid,13.962528,0.18424153,19.408102,-11.630381,15.558625,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATCNI,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
356a9898-d5e9-4699-b910-da4282c11642_noid,1.1545967,21.151915,-12.221876,-8.062021,14.036144,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANLRE,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
372c6f90-e53a-4e93-834d-0ca7da03a284_noid,-15.934542,-8.655231,-18.39285,15.800861,18.812881,TCGA AML,Diagnosis,TCGA-AB-2846,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
37ee0d96-4454-4f40-9576-b2278d0f5bdc_noid,13.019505,4.7208734,19.973303,-0.8815891,18.594496,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARZIA,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
3873d7a8-cf42-470b-a576-460935531b29_noid,-0.8724328,11.521609,-14.445429,1.5730121,-23.987673,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PANKMB,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
38f9fc42-f5f0-4d04-b4de-b41c3cf6d1ee_noid,-8.359991,11.490158,-16.766235,-0.4695473,-23.408693,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040024,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
395ca965-96d6-4c64-85f1-fc07df1020f6_noid,16.971151,-7.5743904,-19.392508,-14.488806,20.073473,TCGA AML,Diagnosis,TCGA-AB-2845,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
39814399-c94d-49a4-9ce8-627829e1d6ee_noid,2.6477425,19.215052,-13.696202,-7.989905,14.133342,TCGA AML,Diagnosis,TCGA-AB-2950,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
39cc3d04-2d52-4aea-b4f0-8b2337af9db7_noid,1.6656054,21.033953,-12.58174,-7.7773657,14.147111,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PAMYAS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
3a32afee-f772-4406-a9f0-b3784337188b_noid,-2.6982784,-11.372754,8.181294,10.00372,10.822316,TCGA AML,Diagnosis,TCGA-AB-2860,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
3a64ee41-9554-4df2-a9e4-5c7b20be0cdb_noid,-11.720758,11.679191,4.300977,-23.937101,11.114228,TCGA AML,Diagnosis,TCGA-AB-2895,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
3b0a8d21-7c23-4ccd-b797-3e0f97672116_noid,-15.169991,-10.450486,-15.878976,14.349999,17.929054,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARSHM,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
3b753722-00c0-4da3-9b69-31592686d546_noid,-6.93769,12.265564,-19.255098,-0.21809995,-21.291117,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-SJBALL004182,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
3bb25021-6c26-4fcf-9556-a4a48e85c32d_noid,10.101187,-28.366669,-14.370636,4.3884096,16.967428,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASFJJ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
3bf879c1-5828-49cc-90ca-96549835f252_noid,-14.478578,-13.144462,2.1930048,24.943195,-12.692576,CCG2961,Bone Marrow Normal,PAEIKD,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
3c0d81a4-df38-471b-8d8c-7d78b3fd7f97_noid,-13.890776,-13.548355,2.1141183,26.60727,-13.540111,AAML0531,Bone Marrow Normal,PARUDL,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
3ccb9ee7-7729-4413-a68c-ae50b49e573f_noid,-13.665369,-13.6181,2.223988,26.961742,-13.695113,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PALGKX,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
3d35840e-8963-477f-a31e-b803f3e50c94_noid,-6.78426,12.157261,-19.146812,-0.17235784,-21.299488,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-SJALL040058,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
3d5f340a-8c2b-4c91-9685-8021cf3e4ad5_noid,-8.843743,-7.6523056,10.889478,10.7298,10.904074,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASVYA,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
3df7db37-2079-47e2-8ab8-c84601b3e1c0_noid,-10.952615,12.177829,19.059938,-6.766704,-19.596931,TCGA AML,Diagnosis,TCGA-AB-2894,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
3e0c96ac-22a6-4f96-9b1e-a981f7ea9fd2_noid,-1.7562392,-11.700435,7.662343,10.456069,9.988644,TCGA AML,Diagnosis,TCGA-AB-2983,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
3f07ee26-9032-4778-8efd-2c43c50bd30a_noid,-12.37562,10.595837,19.540562,-5.606635,-18.580742,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASMGW,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
3f447494-2d36-461a-8b4a-3aedb4f8a944_noid,-12.498678,13.921728,18.832361,-6.3435526,-19.608444,TCGA AML,Diagnosis,TCGA-AB-3005,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
3fb67ade-ade0-43c4-bce3-d85d586381c7_noid,-5.144121,-11.254815,7.3075733,8.473021,10.316268,CCG2961,Bone Marrow Normal,PAKTCX,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
4001134d-535f-4300-8a10-2407a09ca304_noid,3.9309003,12.136684,-11.591522,2.7539659,-24.821049,TARGET ALL,Primary Blood Derived Cancer - Peripheral Blood,TARGET-15-SJMPAL012424,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
40b7edbb-5470-4ffb-8f5a-8712072471d3_noid,13.039148,4.4002805,19.741365,-0.4925766,18.075274,TCGA AML,Diagnosis,TCGA-AB-2944,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
40c674cc-4672-4c65-bb00-c429b6e1ba8c_noid,-12.894155,-13.689863,2.8484147,27.644882,-13.903934,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASWAT,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
421d95b8-f2c7-414d-9179-7f571004b109_noid,12.018832,-26.027943,-13.007564,3.6137917,16.668663,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040037,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
426287c6-74fc-4a7f-8dc8-f0364b0750b3_noid,-10.671497,-15.675927,-21.830832,7.1025906,-21.727875,TARGET ALL,Bone Marrow Normal,TARGET-00-SJNORM016096,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
42af0434-afd9-4e7e-b69e-e07de75c43b3_noid,14.506244,-7.782327,-19.20175,-14.44532,20.651278,TCGA AML,Diagnosis,TCGA-AB-3000,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
43278141-b306-42a0-ba12-e7960d7b00bd_noid,-13.581864,-13.434687,2.5994475,26.401756,-13.342494,AAML0531,Blood Derived Normal,PASMHY,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
437e090a-aa04-4cf9-963d-babb5335f244_noid,-12.2581005,11.31078,3.7896845,-23.713808,10.08576,TCGA AML,Diagnosis,TCGA-AB-2945,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
43e896ef-15d9-42ca-9d90-87de40f4a466_noid,15.275023,-7.7413993,-19.117554,-15.167297,21.90938,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANCSC,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
44c10210-274c-4157-81bc-e543e1d616b8_noid,-6.9583664,-8.77328,9.248007,10.085692,10.918825,TCGA AML,Diagnosis,TCGA-AB-2830,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
44dfdcd7-3256-443e-b500-b111a24d4a6e_noid,-4.649094,11.108664,-17.40522,0.5190649,-21.344885,TARGET ALL,Primary Blood Derived Cancer - Peripheral Blood,TARGET-10-PANRIM,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
45b75b30-3060-489b-8bfd-163748741e1a_noid,-14.049168,-13.503333,2.0325432,26.369366,-13.4391165,AAML0531,Bone Marrow Normal,PARBTC,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
45df5067-42d3-417d-bb68-d2b0cf7d656e_noid,-8.848436,7.054226,-18.161823,-0.7405704,-20.88553,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046471,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
45f54495-9e1b-4912-83d0-cc8e278fdae3_noid,-4.5298276,-10.624588,6.838808,8.862606,10.614975,TCGA AML,Diagnosis,TCGA-AB-2915,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
4635d617-334d-41c0-91a2-97c0ed9f456c_noid,-1.8108157,-8.005366,2.5107424,11.267015,9.371462,TCGA AML,Diagnosis,TCGA-AB-2873,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
463c8889-8795-4623-9e2c-c073a0783097_noid,13.252216,-10.893598,-1.6156718,-17.409184,-15.145755,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PAMYJX,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
46aa62c6-59ab-424e-becb-4d45a126ad89_noid,-10.678205,-15.609719,-21.820845,7.081149,-21.720358,TARGET ALL,Bone Marrow Normal,TARGET-00-SJNORM016096,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
46bb9fca-6d17-4c35-a800-bf590c12edf1_noid,12.741052,6.079327,21.340694,-0.85837764,21.0934,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATKKJ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
46c9c6fa-b040-4c37-9083-92466815ccf4_noid,15.453815,-7.931417,-0.65872335,-18.615417,-12.961879,TCGA AML,Diagnosis,TCGA-AB-2963,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
4759e736-c761-4f4c-b278-b3e2e78f31b6_noid,11.302099,-26.687803,-13.431273,3.934641,16.734726,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARSET,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with other rare recurring translocations
476f82af-8b4a-4488-a506-ee22f176c83d_noid,12.1946125,1.8280429,20.376093,-10.795137,18.089497,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARTPW,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
47a58ed8-1556-40bc-8ba2-00bfd60d6424_noid,3.503284,13.812284,-12.06406,3.0506015,-25.720873,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012424,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
49307998-07f8-46ca-8524-8f98aedce5bb_noid,14.921099,-10.992172,-1.7443769,-16.409473,-14.951977,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAEERJ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
4a18cd75-2269-4815-bc96-dd929bf7af8c_noid,12.9068985,6.2609744,20.92499,-0.75051093,20.996534,TCGA AML,Diagnosis,TCGA-AB-2966,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
4a41429a-7e17-49a7-b6e6-edf466a8ec89_noid,3.8207822,13.906874,-12.762293,3.082253,-25.069675,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATXKD,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
4a767b07-8bc8-4677-b12b-03052a6a4acc_noid,5.47646,17.35616,-14.644441,-7.8207717,14.709035,TCGA AML,Diagnosis,TCGA-AB-2806,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
4aabe6db-45c8-440b-9c0d-1cc63e4b62d6_noid,14.236724,-12.107154,11.767932,15.251698,-12.840815,TCGA AML,Diagnosis,TCGA-AB-2959,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
4ac8bea8-b01e-4366-a0f1-fadf2373893f_noid,-6.938235,-9.304399,9.545788,10.476593,10.080964,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAEDKB,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
4adce0c4-47dd-4ab8-867c-a56f69733702_noid,-10.82883,11.917475,19.437496,-6.560664,-18.697884,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML016570,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
4aff5ce8-529f-4bb7-8349-32e0e2c91517_noid,13.827634,-14.164272,-1.3618853,-14.528959,-12.525508,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASFLG,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
4bfe2dbb-c8c1-4084-acd0-3a6949f9e422_noid,14.638827,-11.063356,-1.2032189,-16.765007,-12.420925,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML040268,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with other rare recurring translocations
4c5681e2-84b5-44a2-89ab-896ee6f74153_noid,15.630404,-8.880621,1.3166217,-14.869919,-15.95129,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARSAN,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with mutated NPM1
4c64d004-2365-4245-901e-20509f53a0b6_noid,-12.163765,10.8221035,20.634861,-2.0169964,-18.266716,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAEIKD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
4cf80a73-e497-4b57-99fb-86fb0047e4f4_noid,-7.5804944,-17.056421,-20.83897,-21.29305,14.637935,TCGA AML,Diagnosis,TCGA-AB-2862,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
4d0969fc-b45a-464d-9a6b-0922571f247c_noid,-15.19936,-3.616718,15.126874,11.646011,12.988006,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARCCH,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
4d2e635a-01aa-48ca-a8e6-ee7fd5523844_noid,-6.099825,-9.528778,8.60947,9.262096,11.385111,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANLLX,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
4d3fb608-c086-4289-b631-212975fbba93_noid,13.625771,2.3683338,19.450077,-9.724646,16.324203,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASJLN,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
4dabb721-bd21-4cc0-892c-7162c338e251_noid,-0.4633931,-8.647372,1.3333766,9.955628,10.056814,TCGA AML,Diagnosis,TCGA-AB-2916,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
4dffa194-758b-4f22-898e-4e0989bab86a_noid,-7.554508,-17.094223,-20.844929,-21.281113,14.618407,TCGA AML,Diagnosis,TCGA-AB-2823,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
4efed8c0-cb68-4428-ba0d-ea933a89c22a_noid,15.252468,-8.337814,-0.6612033,-18.428461,-12.773216,TCGA AML,Diagnosis,TCGA-AB-2818,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
4fcd6a6c-a106-436a-9aee-6ba5184fa072_noid,-7.356245,-17.305464,-20.971579,-21.11317,14.463282,TCGA AML,Diagnosis,TCGA-AB-2991,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
4fd6473b-a4a8-4498-9315-a1b3c1bfd207_noid,-11.724623,-6.337255,-33.756504,1.9436692,-9.871008,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPDAU,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
50131505-4263-4b17-8ab9-ba270adf4ef9_noid,13.36796,-14.426412,-0.26760697,-12.492319,-15.745202,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANLXM,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
50aefc8e-72c2-4b22-968d-e32e5e9ed7e8_noid,13.2655,2.3627958,19.51161,-10.349152,16.614075,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARXLS,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
51ffca21-43d7-4320-98cd-5542bf254aae_noid,-0.7847025,-12.489029,8.062898,10.461424,10.7822275,TCGA AML,Diagnosis,TCGA-AB-2952,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
52046788-2583-4380-8c55-1cb516d3c9a7_noid,-12.752987,13.778901,18.66741,-6.7391,-19.941893,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARBIU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
52bc4479-ebeb-4869-8f67-8fcf81c986db_noid,-14.0229645,-13.450812,2.1436849,26.210825,-13.3376045,AAML03P1,Bone Marrow Normal,PANSJB,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
53219646-cc41-41a2-a759-200868dfa23c_noid,14.615877,-10.595203,0.26696557,-14.520986,-16.999075,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANDIX,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
53ac998f-37d6-4b84-942e-90eed96d20f9_noid,2.2217538,22.666851,-13.2955675,-6.3887525,14.26376,TCGA AML,Diagnosis,TCGA-AB-2875,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
53cb28ac-c39c-49b1-91c1-e5badd4da30c_noid,-4.735311,-11.176297,5.9155555,7.117827,11.403101,TCGA AML,Diagnosis,TCGA-AB-2878,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
54710f2c-aefb-4f63-a9c8-5665d47e9c76_noid,14.368136,-12.15722,11.768546,15.073332,-14.531456,TCGA AML,Diagnosis,TCGA-AB-2874,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
547a2572-97d1-4496-9953-6a7a97d7eb75_noid,14.893058,-9.976165,1.5742873,-14.201709,-15.480379,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATKWH,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
549dec76-aa47-4bbd-932e-640118f20b55_noid,13.153753,-13.470607,-0.27999166,-13.056126,-17.311485,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASWLN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
55716057-e5a8-4ad0-8167-1c6fe4824bf1_noid,-14.7562,-8.604659,-17.665419,15.287992,18.786816,TCGA AML,Diagnosis,TCGA-AB-2888,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
561e02de-8c81-4331-a8f6-f7798de22f8c_noid,-8.920178,6.9286375,-18.138699,-0.76043296,-20.875843,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046471,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5653c0a9-3b3d-48d2-abfa-686c9525929c_noid,-12.146419,10.784118,20.659767,-1.8556893,-18.193285,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASIGA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
56dd504d-c22d-4f65-aa4e-da0f366aa739_noid,-13.081287,-8.620446,-18.09135,15.917849,19.482649,TCGA AML,Diagnosis,TCGA-AB-2914,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723654010_R01C01,-9.397037,7.1513095,-13.327962,-0.5813417,-24.544476,NOPHO ALL92-2000,Relapse,ALL_427r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R01C02,8.28437,8.927547,-22.102085,24.209604,-1.1097552,NOPHO ALL92-2000,Relapse,ALL_446r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,Otherwise-Normal Control
5723654010_R02C01,-8.825599,9.140533,-15.602562,-0.5431703,-23.511702,NOPHO ALL92-2000,Diagnosis,ALL_427,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723654010_R02C02,-11.523742,6.7981544,-17.094236,-1.3167939,-22.044893,NOPHO ALL92-2000,Diagnosis,ALL_446,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723654010_R03C01,-5.74775,10.438707,-12.948777,0.41700807,-25.336092,NOPHO ALL92-2000,Relapse,ALL_380r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R03C02,-5.433682,10.999276,-12.519828,0.46674675,-26.292158,NOPHO ALL92-2000,Relapse,ALL_419r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R04C01,-7.872769,10.428205,-13.813923,-0.17863092,-25.072456,NOPHO ALL92-2000,Diagnosis,ALL_380,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R04C02,-8.0216255,11.127547,-13.58747,-0.21609461,-25.672693,NOPHO ALL92-2000,Diagnosis,ALL_419,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R05C01,-4.4558606,10.850695,-10.717337,0.8726762,-27.024471,NOPHO ALL92-2000,Relapse,ALL_451r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R05C02,-7.1970105,10.6947,-13.102809,0.015280776,-25.758066,NOPHO ALL92-2000,Relapse,ALL_464r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R06C01,-7.0051794,9.789726,-11.219544,0.2271722,-26.332317,NOPHO ALL92-2000,Diagnosis,ALL_451,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654010_R06C02,-7.8491306,10.898807,-13.488329,-0.15410969,-25.522354,NOPHO ALL92-2000,Diagnosis,ALL_464,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654051_R02C01,-6.706197,10.623581,-12.876843,0.23163211,-25.203411,NOPHO ALL92-2000,Diagnosis,ALL_315,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654051_R02C02,-4.09654,10.555389,-17.684284,0.5794315,-21.538465,NOPHO ALL92-2000,Diagnosis,ALL_363,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654051_R04C01,12.045659,1.4019113,20.523567,-11.146668,18.253443,NOPHO ALL92-2000,Diagnosis,ALL_316,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654051_R04C02,-4.540299,10.978276,-13.641199,0.6630114,-25.022343,NOPHO ALL92-2000,Diagnosis,ALL_365,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654051_R06C01,-6.6387744,10.840468,-11.6318245,0.39017308,-25.699512,NOPHO ALL92-2000,Diagnosis,ALL_359,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723654051_R06C02,-6.473526,10.991394,-18.406153,-0.06902724,-21.49737,NOPHO ALL92-2000,Diagnosis,ALL_369,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723662004_R01C01,10.235037,8.770331,-22.721657,22.888844,-0.4794998,NOPHO ALL92-2000,Relapse,ALL_336r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,Otherwise-Normal Control
5723662004_R01C02,8.65865,7.9847174,-23.993092,22.38358,-0.6963316,NOPHO ALL92-2000,Relapse,ALL_444r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,Otherwise-Normal Control
5723662004_R02C01,6.7551227,9.549986,-21.255384,24.0432,-0.9341222,NOPHO ALL92-2000,Diagnosis,ALL_336,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5723662004_R02C02,5.8299117,9.613991,-20.775314,25.365822,-1.521327,NOPHO ALL92-2000,Diagnosis,ALL_444,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5723662004_R03C01,6.211726,12.643564,-11.011711,3.2806995,-24.691608,NOPHO ALL92-2000,Relapse,ALL_416r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662004_R03C02,1.283806,12.4021,-11.687843,2.3297977,-25.803492,NOPHO ALL92-2000,Relapse,ALL_368r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662004_R04C01,6.5956426,12.796306,-11.091737,3.376902,-24.573315,NOPHO ALL92-2000,Diagnosis,ALL_416,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662004_R04C02,-1.6257452,9.766999,-18.31074,1.0730808,-21.491724,NOPHO ALL92-2000,Diagnosis,ALL_368,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662004_R05C01,11.658667,1.5272077,20.786034,-11.078632,18.817595,NOPHO ALL92-2000,Relapse,ALL_358r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662004_R05C02,14.418796,-0.8198432,18.97537,-12.650602,14.8352995,NOPHO ALL92-2000,Relapse,ALL_374r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,APL with t(15;17)(q24.1;q21.2)/PML::RARA
5723662004_R06C01,13.687009,1.2242965,19.494934,-10.750349,16.07547,NOPHO ALL92-2000,Diagnosis,ALL_358,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662004_R06C02,14.909613,-2.3083158,18.769125,-14.022705,13.954641,NOPHO ALL92-2000,Diagnosis,ALL_374,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5723662005_R01C01,6.3436074,9.376577,-20.915176,26.06279,-1.8457562,NOPHO ALL92-2000,Diagnosis,ALL_124,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5723662005_R02C01,0.229951,12.077982,-11.6417265,2.0537927,-25.853771,NOPHO ALL92-2000,Relapse,ALL_119r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662005_R03C01,-1.2693021,11.650015,-11.638965,1.6712857,-25.863903,NOPHO ALL92-2000,Diagnosis,ALL_119,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662005_R04C01,-0.23745054,11.863968,-12.983814,1.8320646,-24.899519,NOPHO ALL92-2000,Relapse,ALL_128r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662005_R05C01,0.23639601,12.036834,-12.129033,2.0190306,-25.527487,NOPHO ALL92-2000,Relapse,ALL_128r2,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662005_R06C01,-4.6350436,-12.079233,9.467104,10.301758,9.176919,NOPHO ALL92-2000,Diagnosis,ALL_128,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with in-frame bZIP mutated CEBPA
5723662005_R06C02,-8.474071,8.66841,-16.935595,-0.5331474,-22.286713,NOPHO ALL92-2000,Diagnosis,ALL_172,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723662016_R02C01,11.632595,1.5651637,20.812595,-11.011435,18.86976,NOPHO ALL92-2000,Diagnosis,ALL_171,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662016_R02C02,-1.5770968,11.1145115,-18.211092,1.1862527,-21.169699,NOPHO ALL92-2000,Diagnosis,ALL_292,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662016_R04C01,-3.268692,11.080738,-13.128318,1.0530959,-24.968067,NOPHO ALL92-2000,Diagnosis,ALL_243,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662016_R04C02,9.763358,9.038627,-22.322008,22.9177,-0.42901838,NOPHO ALL92-2000,Diagnosis,ALL_309,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5723662016_R06C01,-6.406911,9.906942,-17.303421,-0.015133055,-22.118126,NOPHO ALL92-2000,Diagnosis,ALL_291,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723662016_R06C02,14.783432,-2.233622,19.681852,-13.258371,14.008869,NOPHO ALL92-2000,Diagnosis,ALL_310,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5723662024_R02C01,-18.234694,-2.0946276,-19.789225,-20.006699,5.132514,NOPHO ALL92-2000,Diagnosis,ALL_546,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5723662024_R02C02,-8.576158,8.92257,-16.886436,-0.54921067,-22.418163,NOPHO ALL92-2000,Diagnosis,ALL_563,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723662024_R04C01,8.851596,9.487148,-21.770727,22.589481,-0.20239772,NOPHO ALL92-2000,Diagnosis,ALL_550,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5723662024_R04C02,-5.892413,10.462236,-11.116797,0.48998722,-26.734636,NOPHO ALL92-2000,Diagnosis,ALL_553,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662024_R06C01,-7.547503,9.404238,-17.375004,-0.30332294,-21.937489,NOPHO ALL92-2000,Diagnosis,ALL_555,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723662024_R06C02,14.869928,-2.2153113,18.802748,-13.933568,14.022768,NOPHO ALL92-2000,Diagnosis,ALL_559,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5723662025_R02C01,12.203441,1.1910534,20.342167,-11.598492,17.904274,NOPHO ALL92-2000,Diagnosis,ALL_385,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662025_R02C02,8.377672,9.56317,-21.611443,22.759436,-0.28056195,NOPHO ALL92-2000,Diagnosis,ALL_458,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5723662025_R04C01,-0.42339396,11.570904,-16.252775,1.6063775,-22.475698,NOPHO ALL92-2000,Diagnosis,ALL_391,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662025_R04C02,-2.0760949,11.432187,-10.921247,1.510238,-26.400948,NOPHO ALL92-2000,Diagnosis,ALL_459,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662025_R06C01,6.701266,13.388871,-11.273343,3.5232413,-24.78364,NOPHO ALL92-2000,Diagnosis,ALL_402,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R01C02,-0.10583268,11.886967,-12.651558,1.8805838,-25.14563,NOPHO ALL92-2000,Relapse,ALL_27r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R02C02,0.2450434,12.008044,-12.273779,1.9984235,-25.414549,NOPHO ALL92-2000,Relapse,ALL_27r2,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R03C01,5.0663533,12.586824,-10.640163,3.090474,-25.41355,NOPHO ALL92-2000,Relapse,ALL_5r2,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R03C02,-1.3831205,12.030105,-15.047061,1.4690502,-23.12699,NOPHO ALL92-2000,Diagnosis,ALL_27,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R04C01,7.038855,13.42235,-11.019025,3.601195,-24.889263,NOPHO ALL92-2000,Diagnosis,ALL_5,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R04C02,-0.47936603,11.252145,-17.03409,1.5257884,-22.007187,NOPHO ALL92-2000,Relapse,ALL_39r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R05C01,3.4090233,13.849785,-12.021072,3.0475562,-25.827717,NOPHO ALL92-2000,Relapse,ALL_8r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R05C02,-2.938892,11.228136,-17.228544,0.92776746,-21.709875,NOPHO ALL92-2000,Diagnosis,ALL_39,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R06C01,3.8287768,14.329011,-12.380785,3.2141688,-25.696102,NOPHO ALL92-2000,Diagnosis,ALL_8,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662036_R06C02,9.178698,8.09882,-23.833498,22.372437,-0.60690755,NOPHO ALL92-2000,Relapse,ALL_124r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,Otherwise-Normal Control
5723662044_R02C01,-1.5563295,12.113835,-15.110803,1.4296864,-23.00976,NOPHO ALL92-2000,Diagnosis,ALL_481,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662044_R02C02,11.786688,1.5056603,20.728554,-10.984768,18.677208,NOPHO ALL92-2000,Diagnosis,ALL_502,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662044_R04C01,-8.245573,10.575721,-14.195336,-0.27737898,-24.774916,NOPHO ALL92-2000,Diagnosis,ALL_486,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662044_R04C02,-0.7436389,11.279107,-16.73181,1.4810624,-22.22537,NOPHO ALL92-2000,Diagnosis,ALL_537,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662044_R06C01,7.901102,9.737877,-21.299332,22.96253,-0.33740532,NOPHO ALL92-2000,Diagnosis,ALL_495,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5723662044_R06C02,-1.1428983,11.20489,-17.416508,1.3441163,-21.694199,NOPHO ALL92-2000,Diagnosis,ALL_542,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R01C01,5.230115,14.079025,-12.415857,3.3851233,-24.919485,NOPHO ALL92-2000,Relapse,ALL_205r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R01C02,11.515594,1.6482898,20.91414,-10.865868,19.074183,NOPHO ALL92-2000,Relapse,ALL_278r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R02C01,-17.43126,-2.0597663,-20.004143,-19.815344,4.8166223,NOPHO ALL92-2000,Diagnosis,ALL_205,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5723662046_R02C02,11.42917,1.7452925,20.946075,-10.828244,19.189686,NOPHO ALL92-2000,Diagnosis,ALL_278,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R03C01,-7.8892903,9.835994,-13.144604,-0.19763835,-25.718636,NOPHO ALL92-2000,Relapse,ALL_210r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R03C02,2.9843504,13.731404,-12.198516,2.9288545,-25.72165,NOPHO ALL92-2000,Relapse,ALL_257r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R04C01,-8.936128,8.945874,-15.677692,-0.5816131,-23.428928,NOPHO ALL92-2000,Diagnosis,ALL_210,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5723662046_R04C02,3.5584617,14.101619,-12.3856945,3.1099727,-25.623009,NOPHO ALL92-2000,Diagnosis,ALL_257,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R05C01,6.082739,12.956887,-11.486632,3.30976,-24.573412,NOPHO ALL92-2000,Relapse,ALL_244r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R05C02,1.0410569,12.248288,-11.938478,2.2321813,-25.580435,NOPHO ALL92-2000,Relapse,ALL_327r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R06C01,6.285939,13.095189,-11.733553,3.3633473,-24.382643,NOPHO ALL92-2000,Diagnosis,ALL_244,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662046_R06C02,-1.2456769,10.957452,-17.433212,1.2984786,-21.768063,NOPHO ALL92-2000,Diagnosis,ALL_327,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662052_R02C01,-5.2870436,11.250026,-12.288951,0.50312823,-26.66572,NOPHO ALL92-2000,Diagnosis,ALL_467,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662052_R02C02,-7.5854244,9.177999,-12.13474,-0.047678825,-26.0213,NOPHO ALL92-2000,Diagnosis,ALL_472,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662052_R04C01,14.803731,-2.1060557,19.011242,-13.692638,14.099545,NOPHO ALL92-2000,Diagnosis,ALL_466,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5723662052_R04C02,11.748517,1.4774607,20.714767,-11.162702,18.664955,NOPHO ALL92-2000,Diagnosis,ALL_484,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662052_R06C01,-5.5013385,10.709364,-17.586254,0.26923785,-21.36986,NOPHO ALL92-2000,Diagnosis,ALL_470,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5723662052_R06C02,6.4994493,13.230912,-11.052781,3.4641662,-24.946047,NOPHO ALL92-2000,Diagnosis,ALL_475,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
58132093-cdca-4301-9b6f-802b735ccabe_noid,-12.074251,-8.974761,20.432901,-12.468562,-16.684237,TCGA AML,Diagnosis,TCGA-AB-2985,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945001_R01C01,0.050933603,11.941071,-11.471956,1.9856229,-25.985619,NOPHO ALL92-2000,Diagnosis,ALL_225,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945001_R02C01,-6.5199323,11.310905,-12.997638,0.17014745,-26.18567,NOPHO ALL92-2000,Diagnosis,ALL_276,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945001_R02C02,-5.6162868,10.746621,-17.978544,0.19127122,-21.402258,NOPHO ALL92-2000,Diagnosis,ALL_290,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945001_R03C02,4.9507504,13.732417,-12.319401,3.2608485,-24.866299,NOPHO ALL92-2000,Diagnosis,ALL_295,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945001_R04C01,4.573628,10.561691,-19.310919,25.7156,-1.4222764,NOPHO ALL92-2000,Diagnosis,ALL_259,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945001_R04C02,7.9119086,9.828754,-21.051542,23.356276,-0.46017742,NOPHO ALL92-2000,Diagnosis,ALL_299,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945001_R05C02,14.882961,-2.2719004,18.903858,-13.891408,13.979804,NOPHO ALL92-2000,Diagnosis,ALL_334,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945001_R06C01,-2.3280401,9.451928,-18.523676,0.8727807,-21.396727,NOPHO ALL92-2000,Diagnosis,ALL_268,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945001_R06C02,6.1380343,12.857286,-11.004386,3.319158,-24.880116,NOPHO ALL92-2000,Diagnosis,ALL_302,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R01C01,-6.106189,10.175039,-10.953008,0.45296988,-26.704039,NOPHO ALL92-2000,Diagnosis,ALL_652,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R01C02,-9.07239,8.82359,-14.490304,-0.55049413,-24.283827,NOPHO ALL92-2000,Diagnosis,ALL_640,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R02C01,-5.639584,10.670886,-12.936381,0.40906197,-25.714571,NOPHO ALL92-2000,Diagnosis,ALL_659,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R02C02,-1.2473294,12.440723,-15.184893,1.5293082,-22.77841,NOPHO ALL92-2000,Diagnosis,ALL_539,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R03C01,5.8068743,13.032131,-11.835695,3.2675114,-24.476824,NOPHO ALL92-2000,Diagnosis,ALL_621,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R03C02,-3.5433853,9.209477,-18.63116,0.560907,-21.34034,NOPHO ALL92-2000,Diagnosis,ALL_432,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R04C02,-9.538231,7.852024,-14.496079,-0.6811069,-24.013868,NOPHO ALL92-2000,Diagnosis,ALL_591,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R05C01,8.480077,9.368699,-21.433945,24.311642,-0.97140616,NOPHO ALL92-2000,Diagnosis,ALL_618,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945004_R05C02,1.3769301,12.508635,-11.862184,2.3637927,-25.71056,NOPHO ALL92-2000,Diagnosis,ALL_566,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945004_R06C01,-7.2596226,9.190777,-17.692516,-0.25999266,-21.669556,NOPHO ALL92-2000,Diagnosis,ALL_620,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945007_R01C01,-0.78316027,11.705416,-15.415609,1.5697843,-23.06308,NOPHO ALL92-2000,Diagnosis,ALL_491,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945007_R01C02,-17.76225,-2.0750608,-19.91585,-19.894005,4.948578,NOPHO ALL92-2000,Diagnosis,ALL_556,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945007_R02C01,-3.253779,11.2679,-13.88636,0.99457395,-24.64114,NOPHO ALL92-2000,Diagnosis,ALL_536,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945007_R02C02,-6.9544435,9.416563,-17.946335,-0.1791731,-21.319313,NOPHO ALL92-2000,Diagnosis,ALL_572,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945007_R03C01,13.06111,4.839432,20.463388,-2.7525766,18.825972,NOPHO ALL92-2000,Diagnosis,ALL_570,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
5854945007_R04C01,5.281002,10.203976,-19.664145,26.269644,-1.7135143,NOPHO ALL92-2000,Diagnosis,ALL_540,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945007_R04C02,9.471515,8.232389,-23.70404,22.168911,-0.45075324,NOPHO ALL92-2000,Diagnosis,ALL_561,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945007_R05C01,-5.452865,-13.195595,-27.066078,-13.618099,-14.754136,NOPHO ALL92-2000,Diagnosis,ALL_577,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945007_R05C02,11.868849,1.3619165,20.58608,-11.430474,18.419483,NOPHO ALL92-2000,Diagnosis,ALL_597,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945007_R06C01,-8.914076,9.163012,-14.257336,-0.48888537,-24.512075,NOPHO ALL92-2000,Diagnosis,ALL_580,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945007_R06C02,-7.948983,9.948548,-13.336435,-0.16063368,-25.151382,NOPHO ALL92-2000,Diagnosis,ALL_600,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R01C01,-18.231237,-2.0952392,-19.790115,-20.005346,5.131787,NOPHO ALL92-2000,Diagnosis,ALL_392,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945009_R01C02,-4.343907,11.194588,-17.367468,0.60237414,-21.316229,NOPHO ALL92-2000,Diagnosis,ALL_387,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R02C01,7.67052,9.726504,-21.16388,23.48216,-0.5684536,NOPHO ALL92-2000,Diagnosis,ALL_431,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945009_R02C02,-0.60477155,11.808961,-12.685226,1.7666132,-25.090317,NOPHO ALL92-2000,Diagnosis,ALL_453,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R03C01,-18.228561,-2.0944636,-19.79104,-20.005611,5.130287,NOPHO ALL92-2000,Diagnosis,ALL_390,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945009_R03C02,11.529301,1.5838264,20.884123,-11.034625,18.998507,NOPHO ALL92-2000,Diagnosis,ALL_418,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R04C01,-3.316292,11.149545,-16.840147,0.85728115,-21.970266,NOPHO ALL92-2000,Diagnosis,ALL_433,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R04C02,6.12115,13.364138,-11.833858,3.3944278,-24.552652,NOPHO ALL92-2000,Diagnosis,ALL_528,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R05C01,-7.9564815,8.74653,-12.12978,-0.13700387,-25.860323,NOPHO ALL92-2000,Diagnosis,ALL_436,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R05C02,10.263109,8.694096,-23.041689,22.173212,-0.21786876,NOPHO ALL92-2000,Diagnosis,ALL_504,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945009_R06C01,-7.61894,9.221322,-12.253992,-0.052776307,-25.879654,NOPHO ALL92-2000,Diagnosis,ALL_437,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945009_R06C02,-0.24799319,11.635914,-16.286404,1.6521636,-22.433325,NOPHO ALL92-2000,Diagnosis,ALL_460,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945013_R01C01,-6.514269,10.059834,-17.804983,-0.038472675,-21.464115,NOPHO ALL92-2000,Diagnosis,ALL_245,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945013_R01C02,-3.5547962,11.034813,-10.612445,1.1921307,-26.39929,NOPHO ALL92-2000,Diagnosis,ALL_348,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945013_R02C02,-8.528128,9.788326,-16.173618,-0.4923895,-23.272703,NOPHO ALL92-2000,Diagnosis,ALL_349,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945013_R03C01,-7.775433,11.364059,-13.00451,-0.07811716,-25.851091,NOPHO ALL92-2000,Diagnosis,ALL_704,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945013_R03C02,-1.0394254,12.021914,-14.832881,1.562121,-23.319057,NOPHO ALL92-2000,Diagnosis,ALL_297,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945013_R04C02,14.864925,-2.3091874,19.160273,-13.725256,13.961226,NOPHO ALL92-2000,Diagnosis,ALL_335,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945013_R05C01,-7.8843193,9.326889,-16.999075,-0.379686,-22.391579,NOPHO ALL92-2000,Diagnosis,ALL_707,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945013_R05C02,-6.251776,9.350544,-17.838846,-0.032528706,-21.769775,NOPHO ALL92-2000,Diagnosis,ALL_303,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945013_R06C02,-6.8212485,12.307924,-19.213593,-0.18042292,-21.264006,NOPHO ALL92-2000,Diagnosis,ALL_319,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945014_R01C01,4.205485,14.3105955,-12.557658,3.2583194,-25.369677,NOPHO ALL92-2000,Diagnosis,ALL_686,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945014_R01C02,-7.7492843,9.135895,-12.628519,-0.12649149,-25.724693,NOPHO ALL92-2000,Diagnosis,ALL_637,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945014_R03C01,4.9183903,10.426911,-19.471472,25.830332,-1.486824,NOPHO ALL92-2000,Diagnosis,ALL_632,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945014_R03C02,10.580993,8.202466,-23.798685,22.018171,-0.31470823,NOPHO ALL92-2000,Diagnosis,ALL_695,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945014_R05C01,11.669017,1.4185947,20.765663,-11.270091,18.761478,NOPHO ALL92-2000,Diagnosis,ALL_633,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945014_R05C02,-6.53663,10.173981,-18.043741,-0.06961569,-21.457598,NOPHO ALL92-2000,Diagnosis,ALL_702,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945015_R01C01,8.099462,10.1063595,-20.512062,23.822645,-0.5317162,NOPHO ALL92-2000,Diagnosis,ALL_610,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945015_R01C02,9.614729,8.438691,-23.379778,22.265121,-0.40095165,NOPHO ALL92-2000,Diagnosis,ALL_615,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945015_R02C01,-3.8115149,11.580108,-17.488914,0.75126916,-21.093212,NOPHO ALL92-2000,Diagnosis,ALL_651,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945015_R02C02,11.728623,1.559011,20.756767,-10.975751,18.74353,NOPHO ALL92-2000,Diagnosis,ALL_648,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945015_R03C01,-9.125635,8.605593,-14.416843,-0.5655967,-24.292871,NOPHO ALL92-2000,Diagnosis,ALL_658,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945015_R03C02,-6.2652516,9.944849,-17.945911,0.014121501,-21.299427,NOPHO ALL92-2000,Diagnosis,ALL_667,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945015_R04C01,7.5322375,10.191269,-20.475897,23.532997,-0.43059704,NOPHO ALL92-2000,Diagnosis,ALL_646,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945015_R04C02,-17.59339,-2.0677607,-19.96138,-19.854136,4.882241,NOPHO ALL92-2000,Diagnosis,ALL_665,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945015_R05C01,3.8047788,14.124326,-12.375959,3.1577795,-25.550043,NOPHO ALL92-2000,Diagnosis,ALL_613,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945015_R05C02,12.626753,0.85980576,20.524942,-10.500556,17.771646,NOPHO ALL92-2000,Diagnosis,ALL_630,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945015_R06C01,14.788224,-2.223482,19.609262,-13.306551,14.013764,NOPHO ALL92-2000,Diagnosis,ALL_614,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945015_R06C02,-8.177928,10.998352,-13.686509,-0.26561317,-25.596203,NOPHO ALL92-2000,Diagnosis,ALL_668,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945018_R01C01,-7.7831335,11.355927,-13.353495,-0.14827435,-25.962019,NOPHO ALL92-2000,Diagnosis,ALL_360,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945018_R01C02,9.271363,10.598384,-19.244314,25.67901,-1.0097408,NOPHO ALL92-2000,Diagnosis,ALL_186,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945018_R02C01,0.100218646,11.441714,-16.440027,1.7111115,-22.451248,NOPHO ALL92-2000,Diagnosis,ALL_425,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945018_R02C02,-5.244301,10.338278,-13.264621,0.5067938,-25.122484,NOPHO ALL92-2000,Diagnosis,ALL_166,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945018_R03C01,8.582879,9.654491,-21.277607,23.44007,-0.5051656,NOPHO ALL92-2000,Diagnosis,ALL_448,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945018_R03C02,-0.22123376,11.496475,-15.885327,1.666354,-22.854553,NOPHO ALL92-2000,Diagnosis,ALL_199,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945018_R04C01,8.08212,10.156918,-20.274704,24.376987,-0.73825353,NOPHO ALL92-2000,Diagnosis,ALL_440,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945018_R04C02,13.142305,5.2105,20.50324,-3.0272584,19.149824,NOPHO ALL92-2000,Diagnosis,ALL_178,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
5854945018_R05C01,8.105663,9.99405,-20.401667,24.74341,-0.9448831,NOPHO ALL92-2000,Diagnosis,ALL_671,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945018_R05C02,-17.467888,-2.0617812,-19.99554,-19.824093,4.832211,NOPHO ALL92-2000,Diagnosis,ALL_176,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945018_R06C01,14.83396,-2.2559645,19.32461,-13.551532,13.988685,NOPHO ALL92-2000,Diagnosis,ALL_185,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945018_R06C02,-8.230566,9.815729,-16.180452,-0.4151027,-23.21109,NOPHO ALL92-2000,Diagnosis,ALL_197,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945023_R01C01,14.770399,-2.1856468,19.617172,-13.276066,14.04328,NOPHO ALL92-2000,Diagnosis,ALL_519,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5854945023_R01C02,-4.4081035,10.732567,-10.913543,0.9128843,-26.515621,NOPHO ALL92-2000,Diagnosis,ALL_476,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945023_R02C01,-9.621132,7.959321,-14.573387,-0.70157707,-23.99116,NOPHO ALL92-2000,Diagnosis,ALL_508,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945023_R02C02,-3.0430195,11.182414,-17.459478,0.88286424,-21.589434,NOPHO ALL92-2000,Diagnosis,ALL_505,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945023_R03C01,-5.56445,10.569802,-17.724745,0.23180716,-21.369377,NOPHO ALL92-2000,Diagnosis,ALL_518,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945023_R03C02,-6.502421,9.910641,-17.858212,-0.04425477,-21.408993,NOPHO ALL92-2000,Diagnosis,ALL_523,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5854945023_R04C01,6.2112813,10.417602,-19.4915,25.788935,-1.3666238,NOPHO ALL92-2000,Diagnosis,ALL_512,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945023_R04C02,-1.3279343,11.761782,-14.300282,1.4917849,-23.917372,NOPHO ALL92-2000,Diagnosis,ALL_489,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945023_R05C01,4.8458424,13.833119,-12.289981,3.2682545,-25.004433,NOPHO ALL92-2000,Diagnosis,ALL_468,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5854945023_R05C02,10.090716,8.866849,-22.37266,23.594828,-0.74076545,NOPHO ALL92-2000,Diagnosis,ALL_493,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5854945023_R06C02,-1.1647786,11.71411,-14.080836,1.536411,-24.151531,NOPHO ALL92-2000,Diagnosis,ALL_532,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501002_R01C01,-5.410511,-11.132593,5.422239,6.3267374,11.551177,NOPHO ALL92-2000,Diagnosis,ALL_33,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501002_R01C02,5.292677,9.973027,-19.926754,26.514383,-1.8943584,NOPHO ALL92-2000,Diagnosis,ALL_612,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501002_R02C01,11.10137,8.201543,-23.79546,22.045267,-0.286108,NOPHO ALL92-2000,Diagnosis,ALL_96,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501002_R03C01,-5.762965,11.410419,-12.451537,0.34711412,-26.887716,NOPHO ALL92-2000,Diagnosis,ALL_328,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501002_R03C02,-2.9644876,9.573028,-18.466965,0.7330067,-21.377588,NOPHO ALL92-2000,Diagnosis,ALL_619,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501002_R04C01,7.579147,9.052241,-21.930216,24.179142,-1.1060224,NOPHO ALL92-2000,Diagnosis,ALL_352,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501002_R05C01,-5.921778,10.975764,-12.039344,0.35519573,-26.840384,NOPHO ALL92-2000,Diagnosis,ALL_611,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501002_R05C02,13.360136,4.976855,20.21473,-3.952919,18.404133,NOPHO ALL92-2000,Diagnosis,ALL_624,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
5859501003_R01C01,-6.6632223,9.177525,-11.29414,0.24778256,-26.427511,NOPHO ALL92-2000,Diagnosis,ALL_657,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501003_R02C01,7.3271856,9.748395,-20.966877,24.044682,-0.8153464,NOPHO ALL92-2000,Diagnosis,ALL_645,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501003_R02C02,-5.581777,11.129891,-12.083003,0.4244343,-26.935678,NOPHO ALL92-2000,Diagnosis,ALL_626,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501003_R03C01,-6.9204946,11.956079,-18.941212,-0.19771583,-21.40753,NOPHO ALL92-2000,Diagnosis,ALL_622,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501003_R03C02,-17.46797,-2.061415,-19.995203,-19.824997,4.8322964,NOPHO ALL92-2000,Diagnosis,ALL_672,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5859501003_R04C01,12.493729,1.1241755,20.117414,-11.664852,17.477373,NOPHO ALL92-2000,Diagnosis,ALL_627,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501003_R04C02,-0.5646802,11.698997,-16.202715,1.5878966,-22.426847,NOPHO ALL92-2000,Diagnosis,ALL_629,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501003_R05C01,7.815155,9.909419,-21.002584,23.130545,-0.34831798,NOPHO ALL92-2000,Diagnosis,ALL_660,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501003_R05C02,-6.0990324,10.269135,-17.927467,0.065149665,-21.360088,NOPHO ALL92-2000,Diagnosis,ALL_631,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501003_R06C01,5.129777,13.784991,-12.299351,3.3046498,-24.854944,NOPHO ALL92-2000,Diagnosis,ALL_656,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501003_R06C02,-11.61259,-5.979958,-33.570232,1.8062019,-9.94514,NOPHO ALL92-2000,Diagnosis,ALL_634,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5859501005_R01C01,-4.703638,10.912538,-17.224766,0.50699574,-21.49179,NOPHO ALL92-2000,Diagnosis,ALL_549,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501005_R01C02,-9.422054,8.36699,-14.746164,-0.65728116,-23.983006,NOPHO ALL92-2000,Diagnosis,ALL_617,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5859501005_R02C01,-1.3372154,9.535358,-18.43654,1.1178395,-21.493708,NOPHO ALL92-2000,Diagnosis,ALL_554,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501005_R02C02,-11.360316,6.502718,-16.895142,-1.277274,-22.07293,NOPHO ALL92-2000,Diagnosis,ALL_395,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5859501005_R03C01,5.286477,13.45065,-12.030484,3.265306,-24.779013,NOPHO ALL92-2000,Diagnosis,ALL_557,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501005_R03C02,1.0505549,12.31545,-11.846299,2.25759,-25.694061,NOPHO ALL92-2000,Diagnosis,ALL_373,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501005_R04C01,-9.465743,8.208505,-14.495426,-0.6584368,-24.131453,NOPHO ALL92-2000,Diagnosis,ALL_654,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501005_R04C02,-1.4730092,11.813217,-15.605714,1.406451,-22.775082,NOPHO ALL92-2000,Diagnosis,ALL_421,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501005_R05C01,5.1110926,9.923285,-19.977974,26.5853,-1.9560013,NOPHO ALL92-2000,Diagnosis,ALL_608,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501005_R05C02,5.0077376,10.615182,-19.304342,25.468225,-1.266366,NOPHO ALL92-2000,Diagnosis,ALL_381,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501005_R06C01,-5.664154,10.399833,-10.590114,0.61340237,-26.802664,NOPHO ALL92-2000,Diagnosis,ALL_666,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501005_R06C02,6.005957,13.812057,-11.777196,3.4785695,-24.925568,NOPHO ALL92-2000,Diagnosis,ALL_435,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501006_R01C01,-1.7788696,11.500143,-11.033223,1.581624,-26.276098,NOPHO ALL92-2000,Diagnosis,ALL_641,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501006_R01C02,13.946656,0.15555944,19.334742,-11.759948,15.572065,NOPHO ALL92-2000,Diagnosis,ALL_643,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501006_R02C01,-5.4327216,-13.298876,-27.069643,-13.695964,-14.750094,NOPHO ALL92-2000,Diagnosis,ALL_675,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501006_R03C01,-5.4395175,-13.258667,-27.069447,-13.664128,-14.751211,NOPHO ALL92-2000,Diagnosis,ALL_663,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501006_R03C02,4.7498837,10.438512,-19.35422,26.1784,-1.6363453,NOPHO ALL92-2000,Diagnosis,ALL_636,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501006_R04C01,9.47469,8.952933,-22.383453,23.13554,-0.57154214,NOPHO ALL92-2000,Diagnosis,ALL_664,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501006_R04C02,14.919541,-2.3200922,18.68581,-14.103453,13.953691,NOPHO ALL92-2000,Diagnosis,ALL_649,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5859501006_R05C01,-8.175538,11.3719845,-13.389576,-0.234609,-25.881565,NOPHO ALL92-2000,Diagnosis,ALL_635,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501006_R05C02,-5.9711185,10.664288,-10.808718,0.5817681,-26.345911,NOPHO ALL92-2000,Diagnosis,ALL_724,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501006_R06C01,5.7105436,10.256555,-19.681955,25.941286,-1.5272452,NOPHO ALL92-2000,Diagnosis,ALL_676,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501006_R06C02,-3.180995,9.326026,-18.516539,0.6625082,-21.39891,NOPHO ALL92-2000,Diagnosis,ALL_740,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R01C01,-5.8903685,10.3218355,-17.700188,0.14452271,-21.380907,NOPHO ALL92-2000,Diagnosis,ALL_674,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R02C01,8.555347,9.387358,-21.7123,23.281727,-0.54214245,NOPHO ALL92-2000,Diagnosis,ALL_690rep1,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501007_R02C02,-0.9766391,11.724161,-14.008945,1.587855,-24.183167,NOPHO ALL92-2000,Diagnosis,ALL_669,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R03C01,-1.435817,10.114715,-18.35897,1.140063,-21.369822,NOPHO ALL92-2000,Diagnosis,ALL_4,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R03C02,-1.5390701,10.70876,-18.72299,1.136092,-20.949755,NOPHO ALL92-2000,Diagnosis,ALL_644,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R04C01,6.3677115,13.004174,-11.436638,3.371353,-24.534576,NOPHO ALL92-2000,Diagnosis,ALL_146,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R04C02,7.0184393,9.2950735,-21.503773,24.446518,-1.1694667,NOPHO ALL92-2000,Diagnosis,ALL_623,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501007_R05C01,-10.3454485,6.0846124,-14.4832945,-0.91087437,-23.514036,NOPHO ALL92-2000,Diagnosis,ALL_85,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R05C02,6.672452,9.331753,-21.293829,24.981073,-1.4001948,NOPHO ALL92-2000,Diagnosis,ALL_625,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501007_R06C01,-8.045372,8.528927,-13.00825,-0.21777245,-25.179815,NOPHO ALL92-2000,Diagnosis,ALL_49,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501007_R06C02,9.410848,8.93838,-22.686602,22.166128,-0.19017927,NOPHO ALL92-2000,Diagnosis,ALL_662,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501009_R01C01,14.81777,-1.9822052,18.444838,-14.041947,14.1841,NOPHO ALL92-2000,Diagnosis,ALL_736,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5859501009_R01C02,-4.7405963,10.735378,-10.602763,0.8831883,-26.522915,NOPHO ALL92-2000,Diagnosis,ALL_737,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501009_R02C01,4.710988,10.197952,-19.643152,26.380556,-1.808105,NOPHO ALL92-2000,Diagnosis,ALL_678,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501009_R02C02,-8.180148,9.778722,-13.283481,-0.2859012,-25.681547,NOPHO ALL92-2000,Diagnosis,ALL_721,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501009_R03C01,13.064049,5.3042746,20.436796,-2.5138671,19.382406,NOPHO ALL92-2000,Diagnosis,ALL_729,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
5859501009_R04C01,5.421254,9.855655,-20.159742,26.292896,-1.8376647,NOPHO ALL92-2000,Diagnosis,ALL_723,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501009_R04C02,14.798217,-1.9093617,18.32508,-14.087308,14.239329,NOPHO ALL92-2000,Diagnosis,ALL_728,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5859501009_R05C01,13.08552,5.7667584,20.806587,-2.7455707,20.020014,NOPHO ALL92-2000,Diagnosis,ALL_741,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501009_R06C01,-0.20503336,12.310702,-13.860863,1.8384736,-23.862196,NOPHO ALL92-2000,Diagnosis,ALL_679,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501009_R06C02,-5.43411,-13.291628,-27.06985,-13.690227,-14.750168,NOPHO ALL92-2000,Diagnosis,ALL_711,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501011_R01C01,14.716828,-2.1273253,19.922668,-12.993054,14.080572,NOPHO ALL92-2000,Diagnosis,ALL_638,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5859501011_R01C02,11.271421,8.254282,-23.623276,22.370707,-0.38626382,NOPHO ALL92-2000,Diagnosis,ALL_609,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501011_R02C01,-4.25863,11.09232,-12.315531,0.82155573,-25.960619,NOPHO ALL92-2000,Diagnosis,ALL_605,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501011_R02C02,14.735425,-2.1245549,19.797445,-13.081733,14.074111,NOPHO ALL92-2000,Diagnosis,ALL_607,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5859501011_R03C01,-3.6337023,10.2052555,-18.168217,0.6322637,-21.390694,NOPHO ALL92-2000,Diagnosis,ALL_606,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501011_R03C02,12.190106,1.1015873,20.287287,-11.905129,17.83198,NOPHO ALL92-2000,Diagnosis,ALL_647,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501011_R04C01,-7.935265,10.51794,-14.063796,-0.19543287,-24.836187,NOPHO ALL92-2000,Diagnosis,ALL_655,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501011_R04C02,-8.824749,8.455641,-13.939111,-0.46810135,-24.576185,NOPHO ALL92-2000,Diagnosis,ALL_650,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501011_R05C01,10.037809,8.412971,-23.46442,22.111702,-0.31561154,NOPHO ALL92-2000,Diagnosis,ALL_603,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501011_R05C02,9.452178,8.860855,-22.908941,21.791183,-0.0653501,NOPHO ALL92-2000,Diagnosis,ALL_616,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501011_R06C01,8.860484,9.352135,-22.145897,21.971432,-0.0031202098,NOPHO ALL92-2000,Diagnosis,ALL_602,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501011_R06C02,10.901829,8.070753,-24.022333,21.910053,-0.29558948,NOPHO ALL92-2000,Diagnosis,ALL_639,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501021_R01C01,12.059988,1.148701,20.377409,-11.874196,18.019827,NOPHO ALL92-2000,Diagnosis,ALL_441,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501021_R01C02,7.301155,9.251331,-21.586695,24.368992,-1.1312585,NOPHO ALL92-2000,Diagnosis,ALL_670,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501021_R02C01,9.573796,8.917613,-22.601341,22.56561,-0.3464712,NOPHO ALL92-2000,Diagnosis,ALL_364,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501021_R02C02,8.378745,9.893596,-21.109688,22.839785,-0.1908404,NOPHO ALL92-2000,Diagnosis,ALL_181,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501021_R03C01,-17.9675,-2.0831327,-19.860855,-19.94349,5.0281954,NOPHO ALL92-2000,Diagnosis,ALL_422,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5859501021_R04C02,-7.5646014,9.237543,-17.347372,-0.315689,-22.004002,NOPHO ALL92-2000,Diagnosis,ALL_207,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5859501021_R05C01,-15.675999,1.6436683,14.587704,12.092685,12.8624,NOPHO ALL92-2000,Diagnosis,ALL_397,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with other rare recurring translocations
5859501021_R05C02,-9.349818,7.3929133,-13.046299,-0.5585845,-24.903734,NOPHO ALL92-2000,Diagnosis,ALL_353,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501021_R06C01,-0.5683209,11.68828,-13.856631,1.6935066,-24.33542,NOPHO ALL92-2000,Diagnosis,ALL_372,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R01C01,-8.464756,10.982233,-14.048752,-0.37403733,-25.482414,NOPHO ALL92-2000,Diagnosis,ALL_300,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R01C02,-9.76515,7.477283,-14.06188,-0.7201845,-24.258417,NOPHO ALL92-2000,Diagnosis,ALL_367,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R02C01,-4.908142,10.667484,-10.92678,0.75435376,-26.791294,NOPHO ALL92-2000,Diagnosis,ALL_314,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R02C02,-1.9216101,11.450909,-11.706551,1.5129994,-25.74617,NOPHO ALL92-2000,Diagnosis,ALL_408,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R03C01,-7.5170937,10.855761,-12.47996,0.08572601,-25.453396,NOPHO ALL92-2000,Diagnosis,ALL_329,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R03C02,-8.239331,11.080017,-13.805242,-0.2646335,-25.377178,NOPHO ALL92-2000,Diagnosis,ALL_376,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R04C01,5.4200115,9.755622,-20.318993,26.236635,-1.85285,NOPHO ALL92-2000,Diagnosis,ALL_320,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501022_R04C02,9.303434,10.470974,-19.476767,25.519785,-0.9901845,NOPHO ALL92-2000,Diagnosis,ALL_362,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501022_R05C01,-5.0740156,10.591932,-13.680153,0.53443915,-24.819967,NOPHO ALL92-2000,Diagnosis,ALL_337,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R05C02,-8.314591,10.299863,-13.886139,-0.2862998,-24.968525,NOPHO ALL92-2000,Diagnosis,ALL_407,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501022_R06C01,-11.556725,-5.804596,-33.470608,1.7387724,-9.985645,NOPHO ALL92-2000,Diagnosis,ALL_429,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5859501022_R06C02,-6.0170836,10.071191,-17.737438,0.064810626,-21.764772,NOPHO ALL92-2000,Diagnosis,ALL_455,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501029_R01C01,-9.29303,8.026748,-13.967971,-0.58781075,-24.43423,NOPHO ALL92-2000,Diagnosis,ALL_347,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501029_R01C02,-8.059621,10.533158,-13.533992,-0.24287434,-25.604343,NOPHO ALL92-2000,Diagnosis,ALL_190,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501029_R02C01,13.219792,1.0508245,19.701721,-11.359479,16.5618,NOPHO ALL92-2000,Diagnosis,ALL_424,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
5859501029_R02C02,-9.342324,7.5266733,-13.097311,-0.5611541,-24.939472,NOPHO ALL92-2000,Diagnosis,ALL_231,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501029_R03C01,-1.9269499,10.5092535,-17.658852,1.0946981,-21.678617,NOPHO ALL92-2000,Diagnosis,ALL_442,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501029_R03C02,10.131355,9.296871,-21.632261,23.984512,-0.7371143,NOPHO ALL92-2000,Diagnosis,ALL_286,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501029_R04C02,5.3744216,10.067567,-19.787163,26.522839,-1.8569854,NOPHO ALL92-2000,Diagnosis,ALL_275,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501029_R05C01,8.713851,10.407217,-19.675758,25.1688,-0.91695786,NOPHO ALL92-2000,Diagnosis,ALL_23,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5859501029_R05C02,-5.7901473,10.085739,-11.270061,0.43642774,-26.976118,NOPHO ALL92-2000,Diagnosis,ALL_341,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5859501029_R06C01,-1.6964071,9.890588,-18.24996,1.0687863,-21.492094,NOPHO ALL92-2000,Diagnosis,ALL_37,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
59478874-ba40-45f3-a9a3-9c44288627cc_noid,-12.831178,-13.701151,2.8917904,27.71808,-13.931693,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASVYL,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
5958031006_R01C01,-11.645631,-6.0845857,-33.62437,1.846856,-9.9243355,NOPHO ALL92-2000,Diagnosis,ALL_87,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958031006_R01C02,-9.692224,7.3379073,-14.138175,-0.70690274,-24.121737,NOPHO ALL92-2000,Diagnosis,ALL_67,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031006_R02C01,-6.6415534,10.577734,-11.040291,0.3524737,-26.586182,NOPHO ALL92-2000,Diagnosis,ALL_97,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031006_R02C02,9.473514,10.434639,-19.53865,25.485132,-0.97607815,NOPHO ALL92-2000,Diagnosis,ALL_167,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031006_R03C01,12.004227,1.3479695,20.491262,-11.418056,18.227936,NOPHO ALL92-2000,Diagnosis,ALL_79,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031006_R03C02,-18.11959,-2.0895784,-19.820938,-19.979488,5.08731,NOPHO ALL92-2000,Diagnosis,ALL_192,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5958031006_R04C01,-9.523905,8.043484,-15.91066,-0.7507531,-23.022867,NOPHO ALL92-2000,Diagnosis,ALL_86,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958031006_R04C02,9.264569,8.232084,-23.724998,22.091455,-0.43627116,NOPHO ALL92-2000,Diagnosis,ALL_174,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031006_R05C01,-4.2283773,-12.073517,9.740755,10.48442,9.426701,NOPHO ALL92-2000,Diagnosis,ALL_75,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
5958031006_R05C02,3.938535,14.253627,-12.486937,3.205916,-25.501223,NOPHO ALL92-2000,Diagnosis,ALL_182,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031006_R06C01,-0.9652761,11.736075,-11.610927,1.7519742,-25.843447,NOPHO ALL92-2000,Diagnosis,ALL_77,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031006_R06C02,-10.005731,7.2782135,-14.588217,-0.81223637,-23.828104,NOPHO ALL92-2000,Diagnosis,ALL_193,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R01C01,9.219395,10.548789,-19.327013,25.642197,-1.0169595,NOPHO ALL92-2000,Diagnosis,ALL_346,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031027_R01C02,-6.368089,9.949645,-11.521487,0.294801,-26.664381,NOPHO ALL92-2000,Diagnosis,ALL_343,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R02C01,-4.126164,9.169252,-18.511032,0.4269863,-21.40284,NOPHO ALL92-2000,Diagnosis,ALL_313,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R02C02,9.352041,8.998226,-22.611809,22.127993,-0.15811457,NOPHO ALL92-2000,Diagnosis,ALL_322,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031027_R03C01,-3.857401,10.966252,-11.017035,0.99230313,-26.866154,NOPHO ALL92-2000,Diagnosis,ALL_344,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R03C02,9.357142,8.803414,-22.934736,21.97856,-0.16968587,NOPHO ALL92-2000,Diagnosis,ALL_361,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031027_R04C01,12.1230955,1.1429933,20.358152,-11.79349,17.958654,NOPHO ALL92-2000,Diagnosis,ALL_296,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R04C02,-3.725136,11.052459,-10.7666235,1.1256648,-26.426033,NOPHO ALL92-2000,Diagnosis,ALL_406,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R05C01,-5.4295087,-13.312371,-27.070288,-13.705638,-14.75001,NOPHO ALL92-2000,Diagnosis,ALL_356,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R05C02,-7.1076627,10.350892,-11.983929,0.21057507,-25.599396,NOPHO ALL92-2000,Diagnosis,ALL_321,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R06C01,-0.9120415,11.767724,-14.152672,1.6000727,-24.06053,NOPHO ALL92-2000,Diagnosis,ALL_317,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031027_R06C02,9.456276,8.432074,-23.508059,21.853104,-0.24985634,NOPHO ALL92-2000,Diagnosis,ALL_438,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031041_R01C01,-7.6450047,8.804848,-12.1971245,-0.06412953,-25.800919,NOPHO ALL92-2000,Diagnosis,ALL_235,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031041_R01C02,7.100956,13.535606,-10.998316,3.6387343,-24.955914,NOPHO ALL92-2000,Diagnosis,ALL_289,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031041_R02C01,-9.523328,7.4225864,-13.492342,-0.62280595,-24.579393,NOPHO ALL92-2000,Diagnosis,ALL_239,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031041_R02C02,-1.7821666,11.878092,-15.425767,1.3433337,-22.880735,NOPHO ALL92-2000,Diagnosis,ALL_213,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031041_R03C01,-6.1818247,10.427985,-10.657397,0.5228857,-26.497065,NOPHO ALL92-2000,Diagnosis,ALL_223,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031041_R03C02,9.273445,9.183878,-22.146297,22.803934,-0.36742932,NOPHO ALL92-2000,Diagnosis,ALL_269,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031041_R04C01,-9.110749,7.993464,-13.157135,-0.5086518,-25.087435,NOPHO ALL92-2000,Diagnosis,ALL_221,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958031041_R04C02,-9.938282,7.612459,-14.842236,-0.80330765,-23.7448,NOPHO ALL92-2000,Diagnosis,ALL_277,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958031041_R05C01,13.45296,0.58410543,19.738508,-11.353135,16.31056,NOPHO ALL92-2000,Diagnosis,ALL_211,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
5958031041_R05C02,14.589687,-1.4649168,18.926216,-13.2633295,14.506215,NOPHO ALL92-2000,Diagnosis,ALL_265,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5958031041_R06C01,5.3178425,9.898857,-20.093151,26.306257,-1.8371357,NOPHO ALL92-2000,Diagnosis,ALL_264,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958031041_R06C02,-10.478891,6.1599402,-16.559435,-1.0603077,-22.070444,NOPHO ALL92-2000,Diagnosis,ALL_279,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958091022_R01C02,5.4159465,10.217086,-20.02269,24.973242,-1.1762528,NOPHO ALL92-2000,Diagnosis,ALL_204,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958091022_R03C01,-8.327168,9.978022,-16.67461,-0.46250138,-22.899933,NOPHO ALL92-2000,Diagnosis,ALL_173,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958091022_R03C02,-5.182369,10.696699,-10.531498,0.8172522,-26.3014,NOPHO ALL92-2000,Diagnosis,ALL_206,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958091022_R05C01,-5.440723,-13.256821,-27.068827,-13.664182,-14.751372,NOPHO ALL92-2000,Diagnosis,ALL_202,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958091022_R05C02,8.749757,10.61169,-19.144348,25.962748,-1.1616315,NOPHO ALL92-2000,Diagnosis,ALL_258,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958154013_R01C01,-11.432787,-5.414362,-33.25417,1.5892286,-10.074516,NOPHO ALL92-2000,Diagnosis,ALL_465,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958154013_R01C02,-6.734779,11.636287,-13.204757,0.069448344,-26.475752,NOPHO ALL92-2000,Diagnosis,ALL_490,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154013_R02C01,-5.414035,-13.396119,-27.072145,-13.770398,-14.747052,NOPHO ALL92-2000,Diagnosis,ALL_469,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154013_R02C02,-1.5004932,9.739103,-18.492073,1.090649,-21.381626,NOPHO ALL92-2000,Diagnosis,ALL_485,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154013_R03C01,-5.0434933,10.594453,-18.068949,0.32409814,-21.295774,NOPHO ALL92-2000,Diagnosis,ALL_531,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154013_R03C02,4.6082597,10.751987,-19.136236,25.36954,-1.212339,NOPHO ALL92-2000,Diagnosis,ALL_487,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958154013_R04C01,-7.975709,11.034446,-14.206027,-0.22503205,-25.052765,NOPHO ALL92-2000,Diagnosis,ALL_474,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154013_R04C02,-11.023779,5.800176,-16.499115,-1.1979584,-22.077038,NOPHO ALL92-2000,Diagnosis,ALL_12,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958154013_R05C02,-10.402214,6.0348864,-14.61016,-0.9338128,-23.416924,NOPHO ALL92-2000,Diagnosis,ALL_13,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154013_R06C01,9.646177,10.688338,-19.059628,25.83595,-1.0093354,NOPHO ALL92-2000,Diagnosis,ALL_11,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958154013_R06C02,-6.1357136,10.5790615,-10.805102,0.5324253,-26.396376,NOPHO ALL92-2000,Diagnosis,ALL_2,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154022_R01C01,-2.6951144,11.272422,-10.791889,1.3694524,-26.461035,NOPHO ALL92-2000,Diagnosis,ALL_751,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154022_R01C02,-8.209204,9.608847,-16.451712,-0.42906806,-22.949005,NOPHO ALL92-2000,Diagnosis,ALL_730,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958154022_R02C01,-8.260485,10.627435,-14.977881,-0.3477201,-24.400137,NOPHO ALL92-2000,Diagnosis,ALL_682,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958154022_R02C02,-2.4424405,11.437474,-11.247841,1.3510194,-26.565008,NOPHO ALL92-2000,Diagnosis,ALL_726,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154022_R03C01,-11.608184,-5.966669,-33.560932,1.8010671,-9.949221,NOPHO ALL92-2000,Diagnosis,ALL_683,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958154022_R04C01,11.588171,1.6787068,20.858122,-10.829365,18.98137,NOPHO ALL92-2000,Diagnosis,ALL_744,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154022_R04C02,-2.8321862,10.999487,-18.130718,0.88187647,-21.20512,NOPHO ALL92-2000,Diagnosis,ALL_750,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5958154022_R05C01,8.525802,8.319805,-23.437506,22.63169,-0.68075925,NOPHO ALL92-2000,Diagnosis,ALL_684,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5958154022_R05C02,-11.401166,6.8817296,-16.96136,-1.2786115,-22.152725,NOPHO ALL92-2000,Diagnosis,ALL_731,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5958154022_R06C01,-5.3211126,-11.10809,4.9594007,5.925286,11.794822,NOPHO ALL92-2000,Diagnosis,ALL_685,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with other rare recurring translocations
5958154022_R06C02,-3.8964593,11.1797285,-16.356956,0.7552723,-22.237202,NOPHO ALL92-2000,Diagnosis,ALL_713,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801001_R01C01,-5.430375,-13.310612,-27.07033,-13.70492,-14.749343,NOPHO ALL92-2000,Diagnosis,ALL_496,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801001_R01C02,-11.226661,6.323215,-16.659075,-1.2383461,-22.16367,NOPHO ALL92-2000,Diagnosis,ALL_28,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975801001_R02C01,-5.7529893,10.168716,-11.227311,0.45877138,-26.960684,NOPHO ALL92-2000,Diagnosis,ALL_34,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801001_R02C02,-10.708488,4.6647525,-15.70107,-1.1121855,-22.168406,NOPHO ALL92-2000,Diagnosis,ALL_22,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975801001_R03C01,-8.295252,8.264651,-12.436747,-0.25639322,-25.587322,NOPHO ALL92-2000,Diagnosis,ALL_32,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801001_R03C02,11.6216,1.5483352,20.817509,-11.053194,18.868872,NOPHO ALL92-2000,Diagnosis,ALL_63,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801001_R04C01,9.990112,8.686823,-23.077028,22.087463,-0.20735948,NOPHO ALL92-2000,Diagnosis,ALL_89,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801001_R04C02,-10.200698,6.881725,-16.69417,-0.98141336,-22.161987,NOPHO ALL92-2000,Diagnosis,ALL_14,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975801001_R05C01,8.00865,8.962553,-22.114122,23.999113,-1.0324816,NOPHO ALL92-2000,Diagnosis,ALL_15,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801001_R05C02,8.345323,9.4846525,-21.50537,23.502113,-0.61188793,NOPHO ALL92-2000,Diagnosis,ALL_78,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801001_R06C01,-7.8050685,11.209178,-14.308557,-0.19438608,-25.081326,NOPHO ALL92-2000,Diagnosis,ALL_29,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801001_R06C02,7.1559224,13.479979,-10.938439,3.6385148,-24.948042,NOPHO ALL92-2000,Diagnosis,ALL_103,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801002_R01C01,-1.3720868,11.665465,-14.136534,1.4764105,-24.159334,NOPHO ALL92-2000,Diagnosis,ALL_735,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801002_R02C01,1.2553229,12.323039,-11.704274,2.3055477,-25.741392,NOPHO ALL92-2000,Diagnosis,ALL_680,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801002_R02C02,4.731559,10.45106,-19.378145,26.034233,-1.5753468,NOPHO ALL92-2000,Diagnosis,ALL_681,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801002_R03C01,9.671559,8.449659,-23.268951,22.595787,-0.52497864,NOPHO ALL92-2000,Diagnosis,ALL_725,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801002_R03C02,5.3739467,10.38493,-19.51108,25.896814,-1.4905312,NOPHO ALL92-2000,Diagnosis,ALL_712,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801002_R04C01,-5.8616724,10.154368,-13.672977,0.30819494,-24.976625,NOPHO ALL92-2000,Diagnosis,ALL_733,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801002_R04C02,-2.9641576,10.855256,-17.69583,0.8741413,-21.437302,NOPHO ALL92-2000,Diagnosis,ALL_738,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801002_R05C01,5.5801744,10.291289,-20.049004,24.516483,-0.95297736,NOPHO ALL92-2000,Diagnosis,ALL_734,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801002_R05C02,9.235829,9.074721,-22.18424,23.212353,-0.5759686,NOPHO ALL92-2000,Diagnosis,ALL_742,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801002_R06C01,9.232934,10.308349,-19.851974,25.05197,-0.86641985,NOPHO ALL92-2000,Diagnosis,ALL_722,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801002_R06C02,4.4816523,10.721527,-19.122047,25.57267,-1.3141354,NOPHO ALL92-2000,Diagnosis,ALL_739,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801006_R01C01,-3.3480253,11.101575,-12.213257,1.0969422,-25.6154,NOPHO ALL92-2000,Diagnosis,ALL_756,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801006_R01C02,10.962669,8.144136,-23.887938,22.009857,-0.30354714,NOPHO ALL92-2000,Diagnosis,ALL_759,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801006_R03C01,-4.5747204,9.119472,-18.462078,0.3201336,-21.413095,NOPHO ALL92-2000,Diagnosis,ALL_757,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801006_R03C02,8.407675,9.81022,-21.17627,23.024385,-0.2934963,NOPHO ALL92-2000,Diagnosis,ALL_760,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801006_R05C01,10.911256,8.305907,-23.590874,22.228336,-0.3349607,NOPHO ALL92-2000,Diagnosis,ALL_758,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801006_R05C02,-9.975076,7.381409,-16.97761,-0.92563605,-22.069283,NOPHO ALL92-2000,Diagnosis,ALL_761,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975801020_R02C02,8.745287,10.377935,-19.661152,25.360441,-1.003857,NOPHO ALL92-2000,Diagnosis,ALL_108,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801020_R04C01,-8.401147,8.090717,-13.353596,-0.32519153,-24.755255,NOPHO ALL92-2000,Diagnosis,ALL_105,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801020_R04C02,-10.50003,5.596377,-14.358692,-0.95233226,-23.451427,NOPHO ALL92-2000,Diagnosis,ALL_110,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801020_R06C01,4.5890803,10.743208,-19.176697,25.273949,-1.178537,NOPHO ALL92-2000,Diagnosis,ALL_106,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801020_R06C02,8.791601,9.766414,-21.111938,23.45937,-0.4554828,NOPHO ALL92-2000,Diagnosis,ALL_112,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801021_R01C01,-0.15997551,11.895893,-12.785891,1.8675133,-25.025667,NOPHO ALL92-2000,Diagnosis,ALL_324,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801021_R01C02,-8.330475,10.118598,-15.85553,-0.42157504,-23.59577,NOPHO ALL92-2000,Diagnosis,ALL_423,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975801021_R02C01,12.019006,1.1941111,20.423262,-11.780843,18.107304,NOPHO ALL92-2000,Diagnosis,ALL_378,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801021_R02C02,4.33591,10.860201,-19.039537,25.162891,-1.1152487,NOPHO ALL92-2000,Diagnosis,ALL_412,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801021_R03C01,10.863135,8.305816,-23.638977,22.061796,-0.2720433,NOPHO ALL92-2000,Diagnosis,ALL_439,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975801021_R03C02,-3.4402065,9.301919,-18.582233,0.5941603,-21.356298,NOPHO ALL92-2000,Diagnosis,ALL_401,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801021_R04C01,-7.7103877,9.14969,-17.35811,-0.35615677,-22.005484,NOPHO ALL92-2000,Diagnosis,ALL_445,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975801021_R04C02,-2.098328,11.134715,-18.461864,1.0480086,-20.969378,NOPHO ALL92-2000,Diagnosis,ALL_410,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801021_R05C01,3.343761,12.550477,-10.9310255,2.7727304,-25.806963,NOPHO ALL92-2000,Diagnosis,ALL_420,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801021_R05C02,-3.7263417,9.368701,-18.461533,0.5374587,-21.41046,NOPHO ALL92-2000,Diagnosis,ALL_403,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975801021_R06C01,-11.65325,-6.10855,-33.638866,1.8562182,-9.917846,NOPHO ALL92-2000,Diagnosis,ALL_411,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975801021_R06C02,6.67733,9.889757,-20.858477,23.726374,-0.6877134,NOPHO ALL92-2000,Diagnosis,ALL_430,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819002_R01C01,-7.1934223,10.199517,-13.047664,0.117500454,-24.796087,NOPHO ALL92-2000,Diagnosis,ALL_462,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819002_R01C02,-6.1254888,10.196021,-17.72883,0.06561073,-21.52762,NOPHO ALL92-2000,Diagnosis,ALL_753,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819002_R03C01,-8.685843,7.18979,-18.148914,-0.6959906,-20.902884,NOPHO ALL92-2000,Diagnosis,ALL_544,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819002_R03C02,-5.448085,10.55956,-10.593743,0.69427115,-26.634377,NOPHO ALL92-2000,Diagnosis,ALL_754,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819002_R05C01,-5.5598745,-11.267484,6.7245793,7.983654,10.165896,NOPHO ALL92-2000,Diagnosis,ALL_692,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with other rare recurring translocations
5975819002_R05C02,-10.780243,6.6231046,-16.648542,-1.1232085,-22.202429,NOPHO ALL92-2000,Diagnosis,ALL_755,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819003_R01C01,7.098709,13.693986,-11.107927,3.6697853,-24.972467,NOPHO ALL92-2000,Diagnosis,ALL_157,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819003_R01C02,-0.8150348,11.895174,-16.514198,1.5276544,-22.042934,NOPHO ALL92-2000,Diagnosis,ALL_116,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819003_R02C01,-2.3184047,11.356565,-10.946739,1.4537481,-26.339159,NOPHO ALL92-2000,Diagnosis,ALL_155,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819003_R02C02,10.155799,8.923046,-22.403568,23.207315,-0.55877316,NOPHO ALL92-2000,Diagnosis,ALL_143,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819003_R03C01,-10.460368,7.5485244,-15.847521,-0.9804006,-23.05809,NOPHO ALL92-2000,Diagnosis,ALL_237,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819003_R03C02,-12.509992,9.090126,19.693121,-5.1245255,-18.717243,NOPHO ALL92-2000,Diagnosis,ALL_80,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819003_R04C01,-17.630114,-2.0688303,-19.95131,-19.863503,4.896165,NOPHO ALL92-2000,Diagnosis,ALL_200,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819003_R04C02,4.349604,14.245006,-12.499134,3.2686737,-25.305193,NOPHO ALL92-2000,Diagnosis,ALL_58,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819003_R05C01,-5.4326854,-13.29839,-27.069702,-13.695526,-14.75003,NOPHO ALL92-2000,Diagnosis,ALL_241,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819003_R05C02,-1.1628144,11.683101,-11.65758,1.6901559,-25.892797,NOPHO ALL92-2000,Diagnosis,ALL_158,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819003_R06C01,5.1233,9.888097,-20.071022,26.437498,-1.9093307,NOPHO ALL92-2000,Diagnosis,ALL_115,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819011_R01C01,-5.9875865,11.371864,-12.757354,0.2953854,-26.496845,NOPHO ALL92-2000,Diagnosis,ALL_687,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819011_R01C02,-2.461315,11.2882805,-11.963653,1.372688,-25.501629,NOPHO ALL92-2000,Diagnosis,ALL_691,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819011_R02C01,12.071994,1.337261,20.469236,-11.340878,18.160664,NOPHO ALL92-2000,Diagnosis,ALL_694,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819011_R02C02,-8.251416,9.962701,-13.919337,-0.29373387,-24.948229,NOPHO ALL92-2000,Diagnosis,ALL_700,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819011_R03C01,14.887874,-2.142928,18.368921,-14.215846,14.071139,NOPHO ALL92-2000,Diagnosis,ALL_699,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819011_R03C02,-8.059434,8.961103,-12.596047,-0.21514152,-25.810785,NOPHO ALL92-2000,Diagnosis,ALL_689,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819011_R04C01,7.74504,9.483829,-21.287262,24.24357,-0.95882165,NOPHO ALL92-2000,Diagnosis,ALL_732,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819011_R04C02,7.604185,9.227638,-21.629747,24.340483,-1.1045221,NOPHO ALL92-2000,Diagnosis,ALL_715,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819011_R05C01,-7.75838,11.099489,-13.690761,-0.16163552,-25.593046,NOPHO ALL92-2000,Diagnosis,ALL_688,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819011_R05C02,12.345041,1.0281106,20.181921,-11.9413595,17.606495,NOPHO ALL92-2000,Diagnosis,ALL_743,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819011_R06C01,-7.4963894,10.205804,-16.364363,-0.25198248,-23.221289,NOPHO ALL92-2000,Diagnosis,ALL_714,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819011_R06C02,2.560292,13.218333,-11.863529,2.7470708,-25.789803,NOPHO ALL92-2000,Diagnosis,ALL_693,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819012_R01C01,-10.6437025,6.0287023,-15.457768,-1.0421607,-22.84625,NOPHO ALL92-2000,Diagnosis,ALL_139,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819012_R01C02,-3.1350427,11.169697,-10.779817,1.2518734,-26.545397,NOPHO ALL92-2000,Diagnosis,ALL_131,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819012_R02C01,4.854329,10.371113,-19.530416,25.90459,-1.5426482,NOPHO ALL92-2000,Diagnosis,ALL_159,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819012_R02C02,0.036154155,11.549387,-16.166822,1.7187272,-22.608002,NOPHO ALL92-2000,Diagnosis,ALL_160,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819012_R03C01,-10.592861,6.228929,-16.68946,-1.0958965,-22.031752,NOPHO ALL92-2000,Diagnosis,ALL_136,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819012_R03C02,-6.4813337,9.955126,-11.813773,0.17896748,-26.99753,NOPHO ALL92-2000,Diagnosis,ALL_111,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819012_R04C01,4.577084,10.521116,-19.363333,25.740534,-1.4439502,NOPHO ALL92-2000,Diagnosis,ALL_152,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819012_R04C02,11.603501,1.5831517,20.834887,-10.998184,18.912762,NOPHO ALL92-2000,Diagnosis,ALL_113,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819012_R06C01,-3.43858,11.297535,-12.030492,1.0292516,-26.265648,NOPHO ALL92-2000,Diagnosis,ALL_127,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R01C01,6.0038867,13.7375555,-11.971068,3.4556265,-24.73984,NOPHO ALL92-2000,Diagnosis,ALL_183,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R01C02,-9.809892,7.7514343,-14.731283,-0.7634455,-23.851793,NOPHO ALL92-2000,Diagnosis,ALL_98,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819020_R02C01,6.6717596,13.677488,-11.418259,3.5793607,-24.87991,NOPHO ALL92-2000,Diagnosis,ALL_164,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R02C02,-7.6070075,10.986998,-14.296039,-0.1466418,-24.989878,NOPHO ALL92-2000,Diagnosis,ALL_57,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R03C01,8.531096,9.317545,-21.772337,23.421211,-0.6263232,NOPHO ALL92-2000,Diagnosis,ALL_196,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819020_R03C02,3.960498,14.166913,-12.419384,3.1918736,-25.485254,NOPHO ALL92-2000,Diagnosis,ALL_52,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R04C01,8.158483,10.183472,-20.27971,24.23126,-0.6645087,NOPHO ALL92-2000,Diagnosis,ALL_82,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819020_R04C02,-6.1831746,11.140593,-13.38542,0.23682967,-25.739162,NOPHO ALL92-2000,Diagnosis,ALL_100,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R05C01,3.7856262,14.0544815,-12.337813,3.1392918,-25.538095,NOPHO ALL92-2000,Diagnosis,ALL_61,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R05C02,-6.8999863,11.24127,-13.070899,0.08146301,-26.06778,NOPHO ALL92-2000,Diagnosis,ALL_99,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819020_R06C01,-11.211598,6.3015957,-16.82961,-1.244937,-22.027872,NOPHO ALL92-2000,Diagnosis,ALL_91,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819020_R06C02,-17.05634,-2.0424259,-20.105728,-19.72671,4.6692443,NOPHO ALL92-2000,Diagnosis,ALL_62,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819032_R01C01,-1.5055612,11.570871,-11.254317,1.6328733,-26.133375,NOPHO ALL92-2000,Diagnosis,ALL_283,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819032_R01C02,-1.4819629,9.649053,-18.477297,1.0902537,-21.411335,NOPHO ALL92-2000,Diagnosis,ALL_246,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819032_R02C01,4.648876,10.499597,-19.288525,26.102453,-1.5931649,NOPHO ALL92-2000,Diagnosis,ALL_284,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819032_R02C02,11.56045,1.6731547,20.87358,-10.848638,19.014225,NOPHO ALL92-2000,Diagnosis,ALL_242,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819032_R03C01,1.3798797,12.478047,-11.7517395,2.3621922,-25.762306,NOPHO ALL92-2000,Diagnosis,ALL_351,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819032_R04C01,-11.654484,-6.115706,-33.63782,1.857995,-9.918605,NOPHO ALL92-2000,Diagnosis,ALL_426,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819032_R04C02,12.501532,0.9909118,20.302807,-11.2839,17.6293,NOPHO ALL92-2000,Diagnosis,ALL_461,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819032_R05C01,-6.8974695,11.029363,-13.208584,0.08178808,-25.809227,NOPHO ALL92-2000,Diagnosis,ALL_333,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819032_R05C02,14.758799,-1.8314903,18.420845,-13.953716,14.291572,NOPHO ALL92-2000,Diagnosis,ALL_417,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819032_R06C01,7.9988627,10.128061,-20.338957,24.302717,-0.72559935,NOPHO ALL92-2000,Diagnosis,ALL_261,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819032_R06C02,-11.5728445,-5.856489,-33.49771,1.7588682,-9.974731,NOPHO ALL92-2000,Diagnosis,ALL_506,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819033_R01C01,-3.1572726,11.144206,-17.381401,0.86592746,-21.55914,NOPHO ALL92-2000,Diagnosis,ALL_762,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819033_R01C02,-1.4357834,10.671568,-18.364088,1.1790804,-21.205036,NOPHO ALL92-2000,Diagnosis,ALL_379,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819033_R03C01,-5.335745,11.470892,-17.506306,0.39462528,-20.833002,NOPHO ALL92-2000,Diagnosis,ALL_763,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819033_R04C02,11.068784,8.041933,-24.04281,21.98712,-0.3248353,NOPHO ALL92-2000,Diagnosis,ALL_330,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819033_R05C01,-9.53368,7.4079156,-13.213761,-0.61543345,-24.827545,NOPHO ALL92-2000,Diagnosis,ALL_764,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819033_R05C02,-10.794898,6.032101,-15.939847,-1.1061051,-22.529064,NOPHO ALL92-2000,Diagnosis,ALL_227,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819033_R06C02,10.557251,8.07155,-24.047916,21.811811,-0.28158358,NOPHO ALL92-2000,Diagnosis,ALL_249,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819037_R01C01,6.566107,13.236436,-11.262436,3.466777,-24.753233,NOPHO ALL92-2000,Diagnosis,ALL_60,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819037_R01C02,-5.327881,10.926342,-11.759167,0.5124012,-27.01069,NOPHO ALL92-2000,Diagnosis,ALL_117,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819037_R02C01,-7.2403617,9.485514,-17.221355,-0.24028657,-22.30674,NOPHO ALL92-2000,Diagnosis,ALL_81,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819037_R02C02,7.4009986,9.301052,-21.486422,24.469849,-1.145871,NOPHO ALL92-2000,Diagnosis,ALL_84,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819037_R03C01,13.633015,0.4751358,19.51891,-11.575387,16.021961,NOPHO ALL92-2000,Diagnosis,ALL_56,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819037_R03C02,12.424847,1.4528584,20.171333,-11.301635,17.644321,NOPHO ALL92-2000,Diagnosis,ALL_142,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819037_R04C01,-11.773865,6.876003,-17.151438,-1.376124,-22.070093,NOPHO ALL92-2000,Diagnosis,ALL_137,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819037_R04C02,6.46315,9.895698,-20.761225,24.028793,-0.825309,NOPHO ALL92-2000,Diagnosis,ALL_104,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819037_R05C01,-17.698011,-2.071838,-19.933315,-19.879053,4.9226446,NOPHO ALL92-2000,Diagnosis,ALL_141,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819037_R05C02,-2.3417742,11.373046,-10.942278,1.4350845,-26.45102,NOPHO ALL92-2000,Diagnosis,ALL_125,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819037_R06C01,-5.430083,-13.313538,-27.069689,-13.706719,-14.749359,NOPHO ALL92-2000,Diagnosis,ALL_147,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819037_R06C02,4.853338,10.47472,-19.622128,25.078642,-1.1726326,NOPHO ALL92-2000,Diagnosis,ALL_150,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819040_R01C01,-5.252404,11.182642,-12.213824,0.52202356,-26.642324,NOPHO ALL92-2000,Diagnosis,ALL_696,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819040_R01C02,-18.132795,-2.091884,-19.816475,-19.981047,5.0944157,NOPHO ALL92-2000,Diagnosis,ALL_745,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819040_R02C01,4.653035,10.376374,-19.460892,26.119967,-1.6442341,NOPHO ALL92-2000,Diagnosis,ALL_697,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819040_R02C02,9.912519,8.918334,-22.406984,23.221073,-0.5850111,NOPHO ALL92-2000,Diagnosis,ALL_701,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819040_R03C01,9.313188,8.77912,-22.54987,23.420925,-0.76413274,NOPHO ALL92-2000,Diagnosis,ALL_698,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819040_R03C02,-6.219231,9.47493,-17.918932,-0.018802699,-21.62112,NOPHO ALL92-2000,Diagnosis,ALL_749,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819040_R04C01,-11.531187,6.668712,-17.099487,-1.3227826,-21.99741,NOPHO ALL92-2000,Diagnosis,ALL_716,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819040_R04C02,14.858741,-2.3192644,19.298443,-13.618183,13.947569,NOPHO ALL92-2000,Diagnosis,ALL_703,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819040_R05C01,-4.9999456,10.571833,-10.621426,0.7744394,-26.794909,NOPHO ALL92-2000,Diagnosis,ALL_752,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819040_R05C02,8.922547,7.9674034,-24.081785,22.160032,-0.5940298,NOPHO ALL92-2000,Diagnosis,ALL_706,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819040_R06C01,-1.047487,11.690615,-11.512639,1.7303969,-25.942642,NOPHO ALL92-2000,Diagnosis,ALL_746,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819040_R06C02,-1.6214576,10.00002,-18.236689,1.094322,-21.467932,NOPHO ALL92-2000,Diagnosis,ALL_747,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819043_R01C01,-11.370256,-5.2306676,-33.1457,1.5157584,-10.122387,NOPHO ALL92-2000,Diagnosis,ALL_236,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819043_R01C02,-4.613941,10.854355,-10.521669,0.91892815,-26.622313,NOPHO ALL92-2000,Diagnosis,ALL_247,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819043_R02C01,-8.528434,8.761881,-17.002815,-0.5386639,-22.211609,NOPHO ALL92-2000,Diagnosis,ALL_163,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819043_R02C02,-11.636676,-6.0575504,-33.608696,1.8362178,-9.92964,NOPHO ALL92-2000,Diagnosis,ALL_229,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819043_R03C01,-11.495245,-5.6115394,-33.365307,1.6636484,-10.02818,NOPHO ALL92-2000,Diagnosis,ALL_215,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819043_R03C02,11.73187,1.6052202,20.730715,-10.999777,18.722218,NOPHO ALL92-2000,Diagnosis,ALL_212,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819043_R04C01,-11.603983,-5.955668,-33.550697,1.7971699,-9.953478,NOPHO ALL92-2000,Diagnosis,ALL_248,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819043_R04C02,-5.493582,-12.9877405,-27.060009,-13.454403,-14.759187,NOPHO ALL92-2000,Diagnosis,ALL_226,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819043_R05C01,14.648011,-1.7811615,19.284466,-13.24185,14.323717,NOPHO ALL92-2000,Diagnosis,ALL_285,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819043_R05C02,13.56335,0.78711873,19.530088,-11.363478,16.12912,NOPHO ALL92-2000,Diagnosis,ALL_274,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819043_R06C01,-7.7478466,11.11025,-13.143553,-0.07689622,-25.614393,NOPHO ALL92-2000,Diagnosis,ALL_263,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819043_R06C02,13.317231,0.89711225,19.646658,-11.4422655,16.429813,NOPHO ALL92-2000,Diagnosis,ALL_230,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819055_R01C01,14.701984,-1.8363047,19.047098,-13.458079,14.277807,NOPHO ALL92-2000,Diagnosis,ALL_388,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819055_R01C02,14.774882,-1.8202908,18.245117,-14.082384,14.297383,NOPHO ALL92-2000,Diagnosis,ALL_509,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819055_R02C01,5.2718687,10.093364,-19.953781,25.823328,-1.5748087,NOPHO ALL92-2000,Diagnosis,ALL_525,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819055_R02C02,10.979436,8.152706,-23.868301,22.0344,-0.30873165,NOPHO ALL92-2000,Diagnosis,ALL_386,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819055_R03C01,-3.5536973,11.005441,-10.634531,1.1816796,-26.440132,NOPHO ALL92-2000,Diagnosis,ALL_389,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819055_R03C02,-2.367897,11.347668,-11.130864,1.4402188,-26.141685,NOPHO ALL92-2000,Diagnosis,ALL_471,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819055_R04C01,-6.8633966,12.244109,-19.189129,-0.1921583,-21.28573,NOPHO ALL92-2000,Diagnosis,ALL_409,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819055_R04C02,-10.724447,5.589523,-16.120876,-1.1129389,-22.220692,NOPHO ALL92-2000,Diagnosis,ALL_527,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819055_R05C01,-8.413463,10.761616,-15.099658,-0.39673194,-24.41658,NOPHO ALL92-2000,Diagnosis,ALL_454,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819055_R05C02,4.747517,10.28804,-19.60068,26.08088,-1.6511251,NOPHO ALL92-2000,Diagnosis,ALL_510,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819055_R06C01,-0.027216954,11.457392,-16.297241,1.6885321,-22.55359,NOPHO ALL92-2000,Diagnosis,ALL_529,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819056_R01C01,-11.609235,-5.970053,-33.562828,1.8025618,-9.948305,NOPHO ALL92-2000,Diagnosis,ALL_599,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819056_R01C02,-6.58452,12.156539,-18.975264,-0.10108942,-21.278938,NOPHO ALL92-2000,Diagnosis,ALL_595,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819056_R02C01,10.556155,8.280325,-23.732012,21.861263,-0.22433327,NOPHO ALL92-2000,Diagnosis,ALL_598,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819056_R02C02,13.872318,0.058009483,19.37959,-11.914521,15.646955,NOPHO ALL92-2000,Diagnosis,ALL_558,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819056_R03C01,-11.565065,-5.8304777,-33.48828,1.7488942,-9.977835,NOPHO ALL92-2000,Diagnosis,ALL_587,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819056_R03C02,13.636034,0.84180397,19.531616,-11.140469,16.097616,NOPHO ALL92-2000,Diagnosis,ALL_571,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819056_R04C01,4.471396,10.687491,-19.144464,25.66465,-1.3643061,NOPHO ALL92-2000,Diagnosis,ALL_584,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819056_R04C02,10.572934,8.316653,-23.5448,22.3237,-0.39530295,NOPHO ALL92-2000,Diagnosis,ALL_551,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819056_R05C01,5.193275,10.111092,-19.763899,26.392866,-1.8027949,NOPHO ALL92-2000,Diagnosis,ALL_575,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819056_R05C02,-10.827833,5.280853,-15.114277,-1.0850496,-22.856468,NOPHO ALL92-2000,Diagnosis,ALL_596,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819056_R06C01,9.473765,8.856022,-22.885426,21.894527,-0.10691439,NOPHO ALL92-2000,Diagnosis,ALL_567,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819056_R06C02,-8.365815,10.626466,-14.2166815,-0.348781,-25.11065,NOPHO ALL92-2000,Diagnosis,ALL_573,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819058_R01C01,-5.3341236,11.041821,-11.842345,0.48713458,-27.142578,NOPHO ALL92-2000,Diagnosis,ALL_267,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819058_R01C02,-4.1622105,11.12725,-11.401684,0.8978127,-26.65881,NOPHO ALL92-2000,Diagnosis,ALL_340,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819058_R02C01,12.919082,6.343303,21.301226,-2.2541027,21.16997,NOPHO ALL92-2000,Diagnosis,ALL_254,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819058_R02C02,-8.059271,9.226798,-13.082208,-0.23560151,-25.508434,NOPHO ALL92-2000,Diagnosis,ALL_273,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819058_R03C01,7.7267027,9.977914,-20.71811,23.757378,-0.5826286,NOPHO ALL92-2000,Diagnosis,ALL_251,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
5975819058_R03C02,-7.893507,7.6525526,-18.04259,-0.4976135,-21.305502,NOPHO ALL92-2000,Diagnosis,ALL_281,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5975819058_R04C02,-2.659222,11.082943,-17.491129,0.97282416,-21.545118,NOPHO ALL92-2000,Diagnosis,ALL_262,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819058_R05C01,-9.700506,7.2726007,-13.645087,-0.68388844,-24.485704,NOPHO ALL92-2000,Diagnosis,ALL_282,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5975819058_R06C01,-17.361893,-2.055787,-20.023195,-19.797432,4.78816,NOPHO ALL92-2000,Diagnosis,ALL_312,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
5975819058_R06C02,-10.873773,5.733063,-16.06644,-1.1400193,-22.337898,NOPHO ALL92-2000,Diagnosis,ALL_338,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
59c58d40-6d5b-4452-9134-196b1b16285a_noid,15.03304,-7.768905,-19.166906,-14.051643,19.95011,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASBBE,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
59da79a4-c5d5-44cf-bbb7-4e8182f01f77_noid,13.460477,4.8355527,19.235035,-2.04709,18.057241,TCGA AML,Diagnosis,TCGA-AB-2891,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5a124d37-6e8e-49a3-be3e-85ede3e96a3f_noid,13.60942,-14.345733,-1.2212434,-14.329847,-12.65955,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANZLR,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
5a35fd34-6b25-4188-9b38-5591c1e5bab2_noid,-3.8613667,-11.247995,7.2005773,8.682614,10.986013,TCGA AML,Diagnosis,TCGA-AB-2935,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
5a517bc3-c78b-4d12-9d2e-1797d21028c0_noid,14.063052,-11.419257,-1.2059332,-17.03765,-11.773163,AAML03P1,Bone Marrow Normal,PANZLR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with other rare recurring translocations
5aadc450-ee9d-484b-956b-460adce401c7_noid,13.640511,-11.248165,-0.7348162,-17.327505,-11.363763,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATKJB,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
5beb7000-42ed-41da-a78f-437992307c54_noid,-11.146363,12.32169,4.22894,-25.214104,12.1043625,TCGA AML,Diagnosis,TCGA-AB-2896,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
5c0482d3-d134-40f7-ba44-56d420b956cd_noid,-18.562065,-9.714889,-17.824371,15.435583,18.348658,TCGA AML,Diagnosis,TCGA-AB-2892,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5c5e2afd-4aad-45f4-8afe-336ad8a058b3_noid,15.565615,-11.920422,12.163335,16.444983,-13.885357,TCGA AML,Diagnosis,TCGA-AB-2919,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
5c9d6985-7ba3-47d9-b9ea-ca6c4f0a9b00_noid,13.683685,-7.8244133,-19.254416,-14.064777,20.03605,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARUCB,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
5cd917fe-ea6a-44ec-9ed5-b3a598c0c277_noid,13.286839,-10.940948,-1.6534693,-17.623474,-14.368086,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PAPXRJ,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
5cf29dcd-09bb-468c-9bea-b7a6d1e98370_noid,13.91069,4.164191,19.05608,-6.5139933,16.927807,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATALJ,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5d703122-91f2-4d0e-97ff-9cd3eef50fe7_noid,3.9915597,18.291325,-14.087061,-7.7462835,14.574948,TCGA AML,Diagnosis,TCGA-AB-2819,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
5d7447f6-422c-482f-b775-0a433ec41431_noid,-13.9534025,-13.553118,2.0465305,26.586855,-13.545046,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASJIM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
5de66c98-c735-4e3e-b1f2-5b4ef4518575_noid,-17.69869,-8.699766,-18.626804,15.930989,19.131584,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045735,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
5eeefc7f-cf6c-4cf1-a35a-56bbc767ba4f_noid,-11.722193,8.225596,21.885763,-2.0050442,-17.637579,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASVVS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5f1849e4-217c-40c0-bc09-38df9054af8e_noid,13.692795,4.545938,20.032873,-5.467168,16.614168,TARGET ALL,Recurrent Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016343,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),MDS-related or secondary myeloid neoplasms
5f95aba5-348b-49e1-9842-ca17f94f39a6_noid,-4.695287,-11.351261,5.472007,6.634511,11.509999,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARFXF,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
5fae599b-49ec-423b-9eb4-e10c4eedba07_noid,0.73392487,-11.425559,5.057047,10.133184,9.425661,TCGA AML,Diagnosis,TCGA-AB-2912,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
5fe66d60-bf60-4d84-b3e2-124bb8d6b6ee_noid,12.885889,6.1194463,21.052637,-1.1014744,20.865953,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASTZK,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R01C01,-2.6046412,11.107633,-17.409744,0.9904636,-21.625198,NOPHO ALL92-2000,Diagnosis,ALL_293,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R01C02,-4.234189,10.684247,-17.881489,0.5303701,-21.500462,NOPHO ALL92-2000,Diagnosis,ALL_7,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R02C01,14.935187,-2.37462,18.72403,-14.113712,13.91846,NOPHO ALL92-2000,Diagnosis,ALL_538,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486001_R02C02,-5.4393363,-13.264487,-27.069048,-13.669621,-14.751079,NOPHO ALL92-2000,Diagnosis,ALL_16,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R03C01,0.4289032,12.066567,-11.872555,2.0757265,-25.640411,NOPHO ALL92-2000,Diagnosis,ALL_357,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R03C02,14.726701,-2.07757,19.690641,-13.132361,14.109119,NOPHO ALL92-2000,Diagnosis,ALL_6,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486001_R04C01,6.835859,9.728288,-21.076769,23.7771,-0.75459653,NOPHO ALL92-2000,Diagnosis,ALL_548,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486001_R04C02,-7.832802,8.696643,-12.787044,-0.15597719,-25.41841,NOPHO ALL92-2000,Diagnosis,ALL_10,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R05C01,-8.378923,10.800555,-14.352734,-0.3421743,-24.953136,NOPHO ALL92-2000,Diagnosis,ALL_382,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R05C02,-8.566758,10.013328,-14.212424,-0.37702435,-24.702467,NOPHO ALL92-2000,Diagnosis,ALL_47,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R06C01,-3.1655998,11.157515,-10.819416,1.269405,-26.310688,NOPHO ALL92-2000,Diagnosis,ALL_499,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486001_R06C02,12.005892,1.2237419,20.459034,-11.66223,18.160992,NOPHO ALL92-2000,Diagnosis,ALL_30,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486002_R01C02,5.5082955,13.591058,-12.231306,3.326056,-24.62929,NOPHO ALL92-2000,Diagnosis,ALL_718,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486002_R02C02,-0.37039167,11.549188,-16.69467,1.5951797,-22.144838,NOPHO ALL92-2000,Diagnosis,ALL_708,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486002_R03C01,-6.2937894,11.0038185,-12.079138,0.29666427,-26.584192,NOPHO ALL92-2000,Diagnosis,ALL_370,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486002_R03C02,-2.2174273,9.496184,-18.513983,0.9027605,-21.39822,NOPHO ALL92-2000,Diagnosis,ALL_717,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486002_R04C01,5.2094502,10.159614,-19.676065,26.450546,-1.8080457,NOPHO ALL92-2000,Diagnosis,ALL_93,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486002_R04C02,7.822725,10.211412,-20.052269,24.868254,-0.9386515,NOPHO ALL92-2000,Diagnosis,ALL_709,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486002_R05C01,6.311473,9.848472,-20.642155,24.667889,-1.1128416,NOPHO ALL92-2000,Diagnosis,ALL_748,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486002_R05C02,14.188051,-0.46894535,19.285803,-12.229131,15.165917,NOPHO ALL92-2000,Diagnosis,ALL_710,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486002_R06C01,9.154894,8.7773285,-22.741438,22.774685,-0.5163084,NOPHO ALL92-2000,Diagnosis,ALL_705,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486002_R06C02,6.3667283,10.088673,-20.480225,24.036785,-0.76625854,NOPHO ALL92-2000,Diagnosis,ALL_720,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486007_R01C01,4.6661367,10.5190525,-19.377817,25.697012,-1.4214951,NOPHO ALL92-2000,Diagnosis,ALL_450,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486007_R01C02,-17.522688,-2.0638735,-19.980085,-19.837694,4.8538356,NOPHO ALL92-2000,Diagnosis,ALL_456,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486007_R02C01,13.035898,5.509128,20.772396,-2.668082,19.768282,NOPHO ALL92-2000,Diagnosis,ALL_457,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486007_R02C02,14.886219,-2.1945608,18.512701,-14.151231,14.045332,NOPHO ALL92-2000,Diagnosis,ALL_428,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486007_R03C01,5.102077,10.104582,-19.780859,26.364227,-1.8024254,NOPHO ALL92-2000,Diagnosis,ALL_434,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486007_R03C02,-9.054652,8.741825,-15.259185,-0.5890111,-23.671875,NOPHO ALL92-2000,Diagnosis,ALL_449,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005486007_R04C01,7.275251,9.948754,-20.768892,23.73546,-0.62086093,NOPHO ALL92-2000,Diagnosis,ALL_393,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486007_R04C02,-0.36740753,11.888864,-11.342639,1.9111385,-26.084457,NOPHO ALL92-2000,Diagnosis,ALL_413,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486007_R05C01,-8.235014,10.959298,-14.764509,-0.3315901,-24.716726,NOPHO ALL92-2000,Diagnosis,ALL_396,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005486007_R05C02,14.837886,-2.0262153,18.37314,-14.1358185,14.158777,NOPHO ALL92-2000,Diagnosis,ALL_414,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486007_R06C01,-18.316444,-2.0983076,-19.766636,-20.026834,5.16476,NOPHO ALL92-2000,Diagnosis,ALL_371,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486007_R06C02,14.890041,-2.3434472,19.047638,-13.838922,13.937704,NOPHO ALL92-2000,Diagnosis,ALL_507,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486008_R01C01,14.874848,-2.1409245,18.420673,-14.183937,14.083121,NOPHO ALL92-2000,Diagnosis,ALL_169,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486008_R01C02,-5.5831,10.652898,-10.497347,0.6975709,-26.524395,NOPHO ALL92-2000,Diagnosis,ALL_543,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486008_R02C01,6.8250175,13.2876,-11.113801,3.5295024,-24.80574,NOPHO ALL92-2000,Diagnosis,ALL_191,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486008_R02C02,4.846223,14.240022,-12.399321,3.3572443,-25.194508,NOPHO ALL92-2000,Diagnosis,ALL_568,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486008_R03C01,-5.4264307,-13.330676,-27.071482,-13.719913,-14.748291,NOPHO ALL92-2000,Diagnosis,ALL_180,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486008_R03C02,-6.1535993,10.205375,-10.689443,0.52248704,-26.414423,NOPHO ALL92-2000,Diagnosis,ALL_565,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486008_R04C01,6.1204767,9.87229,-20.743483,24.204288,-0.9333266,NOPHO ALL92-2000,Diagnosis,ALL_588,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486008_R04C02,7.97822,9.864314,-20.732145,24.262432,-0.80819446,NOPHO ALL92-2000,Diagnosis,ALL_581,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486008_R05C01,-7.5291724,10.30888,-16.063965,-0.23406637,-23.433674,NOPHO ALL92-2000,Diagnosis,ALL_564,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005486008_R05C02,14.841659,-2.057257,18.466795,-14.082352,14.135922,NOPHO ALL92-2000,Diagnosis,ALL_552,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486008_R06C01,9.143796,8.953079,-22.742756,21.895363,-0.09751392,NOPHO ALL92-2000,Diagnosis,ALL_589,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486008_R06C02,-11.616607,-5.9931235,-33.574566,1.8117975,-9.943636,NOPHO ALL92-2000,Diagnosis,ALL_560,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005486016_R01C01,14.919732,-2.397254,18.992514,-13.918443,13.896902,NOPHO ALL92-2000,Diagnosis,ALL_463,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486016_R01C02,6.771016,9.183015,-21.668922,24.42463,-1.2222401,NOPHO ALL92-2000,Diagnosis,ALL_488,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005486016_R02C02,-1.1216198,11.676892,-11.347329,1.7297802,-26.036095,NOPHO ALL92-2000,Diagnosis,ALL_478,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486016_R03C01,-0.084088564,11.515445,-16.20315,1.6839082,-22.587536,NOPHO ALL92-2000,Diagnosis,ALL_477,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486016_R03C02,14.805705,-2.2508824,19.545887,-13.375981,13.995136,NOPHO ALL92-2000,Diagnosis,ALL_530,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486016_R04C01,-4.5525527,10.825795,-10.62529,0.9165538,-26.615845,NOPHO ALL92-2000,Diagnosis,ALL_482,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486016_R04C02,-0.19921067,11.463185,-15.871009,1.6687471,-22.88428,NOPHO ALL92-2000,Diagnosis,ALL_514,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486016_R05C01,14.5004015,-1.5151572,19.991869,-12.452706,14.465194,NOPHO ALL92-2000,Diagnosis,ALL_483,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486016_R05C02,14.699856,-2.0290232,19.794746,-13.012842,14.138006,NOPHO ALL92-2000,Diagnosis,ALL_515,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005486016_R06C01,-0.96156543,11.831055,-14.243463,1.587656,-23.950172,NOPHO ALL92-2000,Diagnosis,ALL_513,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005486016_R06C02,-0.88421863,11.753619,-11.669533,1.7635224,-25.841959,NOPHO ALL92-2000,Diagnosis,ALL_517,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574002_R01C01,-17.716282,-2.0729804,-19.927874,-19.883705,4.9302454,NOPHO ALL92-2000,Diagnosis,ALL_415,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574002_R01C02,8.747407,9.294066,-21.911629,23.058739,-0.47111595,NOPHO ALL92-2000,Diagnosis,ALL_55,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574002_R02C01,-1.3550739,10.45616,-17.95324,1.2079104,-21.538399,NOPHO ALL92-2000,Diagnosis,ALL_156,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574002_R02C02,5.980637,9.938969,-20.314735,25.34102,-1.3784533,NOPHO ALL92-2000,Diagnosis,ALL_94,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574002_R03C01,-11.01806,6.5360765,-16.913515,-1.1964219,-22.009361,NOPHO ALL92-2000,Diagnosis,ALL_153,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574002_R03C02,-10.731014,5.9099317,-16.436146,-1.1227056,-22.113192,NOPHO ALL92-2000,Diagnosis,ALL_92,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574002_R04C01,9.311929,9.322159,-22.012274,22.57321,-0.22065556,NOPHO ALL92-2000,Diagnosis,ALL_122,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574002_R04C02,-11.472882,-5.5431075,-33.324234,1.6372992,-10.045957,NOPHO ALL92-2000,Diagnosis,ALL_50,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574002_R05C01,-18.078545,-2.087817,-19.829937,-19.970032,5.071336,NOPHO ALL92-2000,Diagnosis,ALL_140,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574002_R05C02,-1.5615493,10.870012,-18.299046,1.1676621,-21.178179,NOPHO ALL92-2000,Diagnosis,ALL_126,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574002_R06C01,8.971459,9.161134,-22.40723,22.019258,-0.08376937,NOPHO ALL92-2000,Diagnosis,ALL_149,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574002_R06C02,-4.855328,10.828561,-10.54045,0.89032274,-26.377033,NOPHO ALL92-2000,Diagnosis,ALL_68,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574003_R01C01,-9.92925,7.333623,-14.928906,-0.81195736,-23.589369,NOPHO ALL92-2000,Diagnosis,ALL_69,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574003_R01C02,-7.25309,10.85019,-13.070418,0.05653608,-25.445452,NOPHO ALL92-2000,Diagnosis,ALL_118,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574003_R02C01,-11.42467,6.7126694,-16.88417,-1.2854484,-22.158804,NOPHO ALL92-2000,Diagnosis,ALL_101,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574003_R02C02,7.561064,9.68209,-21.210768,23.543736,-0.6190019,NOPHO ALL92-2000,Diagnosis,ALL_135,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574003_R03C01,4.38939,10.715546,-19.08532,25.729145,-1.3873167,NOPHO ALL92-2000,Diagnosis,ALL_132,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574003_R03C02,-7.5831285,9.08697,-12.471903,-0.07979008,-25.828485,NOPHO ALL92-2000,Diagnosis,ALL_43,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574003_R04C01,11.761581,2.2683702,20.785078,-9.832601,19.021671,NOPHO ALL92-2000,Diagnosis,ALL_102,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574003_R04C02,-1.9819479,11.459557,-11.856617,1.4809933,-25.696815,NOPHO ALL92-2000,Diagnosis,ALL_1,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574003_R05C01,-9.9689,7.3818645,-14.728757,-0.8083687,-23.750374,NOPHO ALL92-2000,Diagnosis,ALL_138,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574003_R05C02,-0.80457056,12.146068,-15.387873,1.6034714,-22.804466,NOPHO ALL92-2000,Diagnosis,ALL_399,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574003_R06C01,6.87062,9.564673,-21.343472,23.671307,-0.7693853,NOPHO ALL92-2000,Diagnosis,ALL_578,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574003_R06C02,14.800148,-1.9921675,18.60052,-13.934036,14.182399,NOPHO ALL92-2000,Diagnosis,ALL_66,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574005_R01C01,9.249749,8.702418,-23.1167,21.857187,-0.16722572,NOPHO ALL92-2000,Diagnosis,ALL_208,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574005_R01C02,-3.1444535,11.310645,-11.348635,1.1334007,-26.806568,NOPHO ALL92-2000,Diagnosis,ALL_201,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574005_R02C01,-10.576024,6.7188535,-16.137442,-1.0455061,-22.579046,NOPHO ALL92-2000,Diagnosis,ALL_219,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574005_R02C02,12.950676,1.4781787,19.825413,-11.098978,16.958975,NOPHO ALL92-2000,Diagnosis,ALL_233,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574005_R03C01,-10.822416,6.0504966,-16.323402,-1.1330259,-22.257545,NOPHO ALL92-2000,Diagnosis,ALL_216,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574005_R03C02,-7.343601,9.559363,-13.008548,-0.051137187,-25.607563,NOPHO ALL92-2000,Diagnosis,ALL_214,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574005_R04C01,-7.6434574,11.209297,-13.405956,-0.08136,-25.567673,NOPHO ALL92-2000,Diagnosis,ALL_224,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574005_R04C02,4.8476324,10.32858,-19.505238,26.204182,-1.6780661,NOPHO ALL92-2000,Diagnosis,ALL_188,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574005_R05C01,8.879963,8.938948,-22.392212,23.168379,-0.6367697,NOPHO ALL92-2000,Diagnosis,ALL_177,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574005_R05C02,-17.864622,-2.0794957,-19.888512,-19.918665,4.988384,NOPHO ALL92-2000,Diagnosis,ALL_218,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574005_R06C01,14.861429,-2.07573,18.352594,-14.183787,14.1224,NOPHO ALL92-2000,Diagnosis,ALL_217,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574005_R06C02,-1.2621598,11.34966,-17.015787,1.3493884,-21.91236,NOPHO ALL92-2000,Diagnosis,ALL_232,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574006_R01C01,-1.2692989,12.089091,-15.145694,1.4978591,-23.015537,NOPHO ALL92-2000,Diagnosis,ALL_547,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574006_R01C02,-8.330217,9.225326,-16.96515,-0.4864084,-22.40755,NOPHO ALL92-2000,Diagnosis,ALL_194,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574006_R02C01,-17.598972,-2.067644,-19.959082,-19.856112,4.8841233,NOPHO ALL92-2000,Diagnosis,ALL_569,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574006_R02C02,1.518358,12.408531,-11.646103,2.3743312,-25.745121,NOPHO ALL92-2000,Diagnosis,ALL_175,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574006_R03C01,3.8218937,14.172016,-12.425686,3.169734,-25.540003,NOPHO ALL92-2000,Diagnosis,ALL_592,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574006_R03C02,8.209331,10.187903,-20.238174,24.346996,-0.70456445,NOPHO ALL92-2000,Diagnosis,ALL_198,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574006_R04C01,9.503632,8.4154005,-23.50397,21.949278,-0.29161888,NOPHO ALL92-2000,Diagnosis,ALL_574,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574006_R04C02,-7.077744,9.196105,-17.944666,-0.22238833,-21.364822,NOPHO ALL92-2000,Diagnosis,ALL_168,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574006_R05C01,-7.6898236,9.03068,-12.317533,-0.06577882,-25.69258,NOPHO ALL92-2000,Diagnosis,ALL_545,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574006_R05C02,-2.094197,11.4148,-10.985939,1.510224,-26.285147,NOPHO ALL92-2000,Diagnosis,ALL_195,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574006_R06C01,-11.545947,-5.773366,-33.447495,1.7264932,-9.995419,NOPHO ALL92-2000,Diagnosis,ALL_234,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574006_R06C02,-8.12256,9.196191,-17.036053,-0.43675333,-22.289944,NOPHO ALL92-2000,Diagnosis,ALL_187,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574007_R01C01,11.688947,1.790388,20.793825,-10.700269,18.856255,NOPHO ALL92-2000,Diagnosis,ALL_719,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R01C02,-11.36823,6.889978,-17.057537,-1.2755586,-22.07756,NOPHO ALL92-2000,Diagnosis,ALL_673,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574007_R02C01,-6.9470634,11.016391,-12.982952,0.11539275,-25.722723,NOPHO ALL92-2000,Diagnosis,ALL_70,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R02C02,-2.3195617,10.937563,-17.483265,1.041774,-21.638542,NOPHO ALL92-2000,Diagnosis,ALL_677,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R03C01,-1.745995,11.099002,-18.590343,1.1217444,-20.918104,NOPHO ALL92-2000,Diagnosis,ALL_661,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R03C02,6.096446,9.831485,-20.686806,24.597149,-1.1086222,NOPHO ALL92-2000,Diagnosis,ALL_727,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574007_R04C01,-2.979538,11.401265,-16.631933,0.96584845,-22.04665,NOPHO ALL92-2000,Diagnosis,ALL_628,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R04C02,9.834728,8.637345,-23.160778,22.035917,-0.21715315,NOPHO ALL92-2000,Diagnosis,ALL_301,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574007_R05C01,-1.240895,12.23188,-15.219925,1.5124415,-22.87063,NOPHO ALL92-2000,Diagnosis,ALL_642,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R05C02,-5.9464273,10.553166,-11.375495,0.4119875,-26.966227,NOPHO ALL92-2000,Diagnosis,ALL_332,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R06C01,-1.2571462,11.636963,-11.316365,1.6975026,-26.018517,NOPHO ALL92-2000,Diagnosis,ALL_653,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574007_R06C02,8.983944,10.41239,-19.563051,25.51825,-1.0356662,NOPHO ALL92-2000,Diagnosis,ALL_326,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574008_R01C01,4.0465136,13.999285,-12.404296,3.1662998,-25.34585,NOPHO ALL92-2000,Diagnosis,ALL_130,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574008_R01C02,-8.080913,8.818193,-12.866009,-0.21948367,-25.424139,NOPHO ALL92-2000,Diagnosis,ALL_355,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574008_R02C01,-1.179511,12.185641,-14.923821,1.5376616,-23.13332,NOPHO ALL92-2000,Diagnosis,ALL_24,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574008_R02C02,-0.87636405,11.490309,-15.289091,1.5396166,-23.275087,NOPHO ALL92-2000,Diagnosis,ALL_383,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574008_R03C01,14.242772,-0.099908486,19.165081,-11.81918,15.174528,NOPHO ALL92-2000,Diagnosis,ALL_20,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574008_R03C02,7.606954,10.10205,-20.673,23.301699,-0.36281222,NOPHO ALL92-2000,Diagnosis,ALL_498,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574008_R04C01,-5.4340296,-13.292283,-27.069786,-13.690944,-14.750096,NOPHO ALL92-2000,Diagnosis,ALL_17,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574008_R04C02,10.034428,8.731074,-23.057438,21.93751,-0.12723078,NOPHO ALL92-2000,Diagnosis,ALL_541,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574008_R05C01,14.535888,-1.5998422,19.68454,-12.792904,14.44763,NOPHO ALL92-2000,Diagnosis,ALL_38,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574008_R05C02,-4.4021063,11.020929,-11.700344,0.85314995,-26.169111,NOPHO ALL92-2000,Diagnosis,ALL_524,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574008_R06C01,14.943888,-2.5047982,19.11559,-13.902126,13.826502,NOPHO ALL92-2000,Diagnosis,ALL_404,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574008_R06C02,-11.555892,-5.8025208,-33.468964,1.7379425,-9.986583,NOPHO ALL92-2000,Diagnosis,ALL_148,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574017_R01C01,-17.794312,-2.0760417,-19.907244,-19.902304,4.960518,NOPHO ALL92-2000,Diagnosis,ALL_366,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574017_R01C02,10.258987,8.821841,-22.53763,23.25151,-0.6064698,NOPHO ALL92-2000,Diagnosis,ALL_18,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574017_R02C01,-2.791079,11.222565,-11.041652,1.3450584,-26.16416,NOPHO ALL92-2000,Diagnosis,ALL_252,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574017_R02C02,-6.187861,9.828901,-11.264208,0.3383434,-26.907757,NOPHO ALL92-2000,Diagnosis,ALL_31,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574017_R03C01,10.099353,8.431479,-23.219856,22.859722,-0.60549057,NOPHO ALL92-2000,Diagnosis,ALL_305,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574017_R04C01,-5.9549594,10.07965,-13.109257,0.33593825,-25.229462,NOPHO ALL92-2000,Diagnosis,ALL_520,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574017_R04C02,-7.4055862,8.486077,-17.752163,-0.33489618,-21.709883,NOPHO ALL92-2000,Diagnosis,ALL_51,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574017_R05C01,-8.079691,9.8,-13.046908,-0.25686762,-25.930748,NOPHO ALL92-2000,Diagnosis,ALL_405,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574017_R05C02,11.636547,1.5757242,20.813929,-10.998749,18.864792,NOPHO ALL92-2000,Diagnosis,ALL_72,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574017_R06C01,-0.3711958,11.334029,-16.909197,1.5653492,-22.074484,NOPHO ALL92-2000,Diagnosis,ALL_521,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574017_R06C02,-9.468044,8.355315,-14.58938,-0.6589059,-24.08844,NOPHO ALL92-2000,Diagnosis,ALL_256,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574018_R01C01,5.098453,10.377645,-19.471476,26.07246,-1.5863115,NOPHO ALL92-2000,Diagnosis,ALL_582,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574018_R01C02,5.4107213,10.047548,-19.873838,26.323698,-1.7811441,NOPHO ALL92-2000,Diagnosis,ALL_400,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574018_R02C01,-5.429457,-13.314429,-27.070095,-13.707091,-14.7495775,NOPHO ALL92-2000,Diagnosis,ALL_594,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574018_R02C02,10.909006,8.425015,-23.348207,22.465693,-0.38687018,NOPHO ALL92-2000,Diagnosis,ALL_511,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574018_R03C01,-6.8625326,9.251017,-11.706319,0.16056061,-26.272905,NOPHO ALL92-2000,Diagnosis,ALL_447,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574018_R03C02,-18.552664,-2.1066291,-19.703876,-20.081678,5.2558365,NOPHO ALL92-2000,Diagnosis,ALL_473,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574018_R04C01,-2.0612502,11.056007,-17.78636,1.0918657,-21.440779,NOPHO ALL92-2000,Diagnosis,ALL_452,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574018_R04C02,4.394552,10.639127,-19.1666,25.832743,-1.4547851,NOPHO ALL92-2000,Diagnosis,ALL_583,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574018_R05C01,8.196371,9.835882,-20.73461,24.389072,-0.85161805,NOPHO ALL92-2000,Diagnosis,ALL_394,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574018_R05C02,-5.4400983,-13.260745,-27.068947,-13.666785,-14.751102,NOPHO ALL92-2000,Diagnosis,ALL_593,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574018_R06C02,9.689621,8.157701,-23.928585,21.769203,-0.30029705,NOPHO ALL92-2000,Diagnosis,ALL_586,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574021_R01C01,1.3257475,12.3969755,-11.710143,2.3338978,-25.755312,NOPHO ALL92-2000,Diagnosis,ALL_494,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R01C02,-1.6060864,12.164714,-15.092714,1.4235731,-22.986652,NOPHO ALL92-2000,Diagnosis,ALL_480,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R02C01,-1.5715349,11.5437355,-11.434626,1.619346,-25.909496,NOPHO ALL92-2000,Diagnosis,ALL_492,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R02C02,-1.3914206,9.697927,-18.29964,1.1236793,-21.547516,NOPHO ALL92-2000,Diagnosis,ALL_497,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R03C01,14.463242,-1.1307113,18.760891,-13.171954,14.754487,NOPHO ALL92-2000,Diagnosis,ALL_522,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574021_R03C02,-2.85365,11.248344,-11.04746,1.3213608,-26.236952,NOPHO ALL92-2000,Diagnosis,ALL_479,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R04C01,-5.4345646,-13.289471,-27.069437,-13.68836,-14.750219,NOPHO ALL92-2000,Diagnosis,ALL_534,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R04C02,-2.958405,11.227252,-10.77704,1.307129,-26.468882,NOPHO ALL92-2000,Diagnosis,ALL_535,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R05C01,-2.6170075,11.351555,-11.016332,1.3378808,-26.608032,NOPHO ALL92-2000,Diagnosis,ALL_503,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R05C02,12.898828,6.4092393,21.316881,-2.0727317,21.299107,NOPHO ALL92-2000,Diagnosis,ALL_533,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R06C01,13.930609,0.2447096,19.391066,-11.596099,15.616942,NOPHO ALL92-2000,Diagnosis,ALL_516,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574021_R06C02,9.466652,8.926779,-22.628086,22.427263,-0.2957628,NOPHO ALL92-2000,Diagnosis,ALL_585,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574026_R01C01,9.809252,8.453572,-23.349224,22.30138,-0.39478657,NOPHO ALL92-2000,Diagnosis,ALL_222,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574026_R01C02,-0.42011565,12.538369,-15.94261,1.7066025,-22.16143,NOPHO ALL92-2000,Diagnosis,ALL_307,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574026_R02C01,-17.65567,-2.0702653,-19.944492,-19.868967,4.906577,NOPHO ALL92-2000,Diagnosis,ALL_579,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574026_R02C02,-0.72540003,11.501504,-16.914848,1.4961241,-21.95089,NOPHO ALL92-2000,Diagnosis,ALL_342,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574026_R03C01,14.825494,-1.9669806,18.2218,-14.215385,14.208717,NOPHO ALL92-2000,Diagnosis,ALL_253,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574026_R03C02,-1.6271061,10.633185,-17.94723,1.1557794,-21.483881,NOPHO ALL92-2000,Diagnosis,ALL_304,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574026_R04C01,12.147938,1.1753827,20.322834,-11.811004,17.910822,NOPHO ALL92-2000,Diagnosis,ALL_375,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574026_R05C01,-11.748039,-6.410879,-33.798878,1.9731667,-9.856491,NOPHO ALL92-2000,Diagnosis,ALL_306,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574026_R06C01,-0.2951083,11.683084,-15.905543,1.6625454,-22.715563,NOPHO ALL92-2000,Diagnosis,ALL_325,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574029_R01C01,-11.665389,6.8657055,-17.203667,-1.352832,-22.007673,NOPHO ALL92-2000,Diagnosis,ALL_287,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6005574029_R01C02,14.270315,-0.22979371,19.194632,-11.917588,15.113412,NOPHO ALL92-2000,Diagnosis,ALL_179,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574029_R02C01,13.434734,0.6503555,19.594276,-11.579643,16.265114,NOPHO ALL92-2000,Diagnosis,ALL_165,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574029_R02C02,-2.0458255,11.437287,-11.188653,1.5171745,-26.083332,NOPHO ALL92-2000,Diagnosis,ALL_323,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574029_R03C02,14.649421,-1.8688217,19.789577,-12.883177,14.234083,NOPHO ALL92-2000,Diagnosis,ALL_331,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6005574029_R04C01,11.899569,1.2496895,20.497858,-11.769098,18.277105,NOPHO ALL92-2000,Diagnosis,ALL_311,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574029_R04C02,9.223357,8.384198,-23.587955,21.806898,-0.26767436,NOPHO ALL92-2000,Diagnosis,ALL_250,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574029_R05C01,9.755535,9.164648,-21.898842,23.734686,-0.7132494,NOPHO ALL92-2000,Diagnosis,ALL_294,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574029_R05C02,7.763048,10.469555,-19.535873,25.355944,-1.0473825,NOPHO ALL92-2000,Diagnosis,ALL_270,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6005574029_R06C01,-6.381869,10.742258,-10.691477,0.5191846,-26.259827,NOPHO ALL92-2000,Diagnosis,ALL_162,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6005574029_R06C02,14.878583,-2.2808895,18.94228,-13.8741045,13.979618,NOPHO ALL92-2000,Diagnosis,ALL_161,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
603e172b-cae4-4a8f-87e9-96a46b66abd5_noid,12.048408,-25.993048,-12.985917,3.6001554,16.664812,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040037,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
6042308096_R01C01,-10.996037,4.789901,-15.640059,-1.1728044,-22.317358,NOPHO ALL92-2000,Diagnosis,ALL_144,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6042308096_R02C01,-10.616463,5.916774,-16.18387,-1.0811986,-22.284872,NOPHO ALL92-2000,Diagnosis,ALL_53,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6042308096_R03C01,8.957112,10.416185,-19.59427,25.401386,-0.99055296,NOPHO ALL92-2000,Diagnosis,ALL_271,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6042308096_R05C01,-10.952034,5.7414904,-16.300182,-1.1713266,-22.182055,NOPHO ALL92-2000,Diagnosis,ALL_240,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6042308096_R06C01,14.924891,-2.342135,18.726044,-14.086318,13.937017,NOPHO ALL92-2000,Diagnosis,ALL_266,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
61382fc0-e829-43cb-ab20-b8952e94f17c_noid,-15.040795,-0.7441566,14.468838,11.917806,12.497782,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARXMP,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
6173c8f6-3781-4fcc-b018-c832c44af830_noid,-4.9670744,-11.275277,5.678368,6.8046227,11.326629,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANGDN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
61ca4f02-4806-4ce9-bd1f-fd7230a96ad7_noid,9.34301,8.880487,-22.873745,21.807617,-0.07341672,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PANYXC,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,Otherwise-Normal Control
61eb50d7-50dd-46a9-ba82-c60593c0d79d_noid,-13.879295,-13.486695,2.2251678,26.407652,-13.420388,CCG2961,Bone Marrow Normal,PAKERZ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
620cae70-43bb-4f51-af79-5ce543533ae6_noid,-15.417058,-0.029062465,14.621611,11.983795,12.656631,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAKERZ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
62aff18c-9be8-4187-9358-a207cbcb7831_noid,13.7169485,5.123877,20.034817,-5.2208896,17.625822,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016447,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),MDS-related or secondary myeloid neoplasms
62f6e14f-8adf-4918-853b-fb0758744a54_noid,-1.4749807,-7.979654,2.165522,11.187966,9.419341,TCGA AML,Diagnosis,TCGA-AB-2928,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
62fb1b33-3a14-411a-9fe7-1a9a36641cd2_noid,13.378408,-11.462533,-1.9048595,-18.256058,-10.739433,TCGA AML,Diagnosis,TCGA-AB-3006,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
634eceab-3b42-4157-8e0b-4133a247abba_noid,-14.493703,-13.552718,1.519984,26.28759,-13.50014,AAML0531,Bone Marrow Normal,PASTUH,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
6376a0c2-f700-47bf-b8a2-034967b8af58_noid,-14.455196,-13.57534,1.5233909,26.382019,-13.547453,AAML0531,Bone Marrow Normal,PARBIU,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
6437d973-2072-41b1-a716-8d6990784156_noid,-6.596605,-9.159498,8.652209,9.446538,11.186788,TARGET ALL,Primary Blood Derived Cancer - Peripheral Blood,TARGET-10-SJBALL014594,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
64d4bd0b-28c1-463a-b6f3-42e811c9b784_noid,14.082318,-12.1184845,11.744245,15.181541,-12.878233,TCGA AML,Diagnosis,TCGA-AB-2805,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
660276fd-1658-45e7-989e-7f52245f9b54_noid,13.7977705,-14.148654,-1.3185287,-14.400384,-12.907238,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASPLU,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
662be7ec-980c-46ed-b3b5-859a17a9acb2_noid,-14.787963,-1.364697,14.389675,11.860494,12.401507,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASJTM,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
66693b79-d541-4299-823b-0e513968228f_noid,-14.007619,-3.0985332,14.131313,11.685596,12.164444,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PATKBK,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
6689c386-42b6-4d7a-8c22-72f7a5a19617_noid,13.858268,-11.246479,1.2583684,-13.80073,-15.871505,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATHIU,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
66b0cfc3-8732-4daa-9dfd-1ec4927b143d_noid,-16.32938,4.837017,14.615193,12.443771,13.354832,TCGA AML,Diagnosis,TCGA-AB-2980,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
66fe9b8e-ddc6-42a5-a3c7-8dbac60e666f_noid,-7.8894773,11.027297,-16.967403,-0.36445007,-23.053432,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPIGH,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
67232ac4-8b00-4614-a3d8-a6de9897d3fd_noid,14.7853565,4.8688397,17.593922,-6.6476617,15.479061,TCGA AML,Diagnosis,TCGA-AB-3001,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
67c7c5ef-83fe-4bd9-8a63-e098a7f527f0_noid,0.59233683,-13.138195,8.477606,11.51876,10.816642,TCGA AML,Diagnosis,TCGA-AB-2920,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
68480b12-1097-4ece-a2ea-bdd04ecb1806_noid,-15.996864,3.0297694,14.616589,12.2536745,13.086376,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASCGR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
68eb320d-e4c2-42be-9ba7-58073359b75f_noid,-12.24359,-7.5852,20.697504,-11.849771,-16.915627,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASZLJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689077_R01C01,-11.548407,-5.777627,-33.454357,1.7292602,-9.992772,NOPHO ALL92-2000,Diagnosis,ALL_154,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689077_R01C02,-10.230626,6.8176904,-14.752139,-0.8835242,-23.574873,NOPHO ALL92-2000,Diagnosis,ALL_65,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689077_R02C01,-9.885796,6.435866,-13.602203,-0.7353719,-24.192944,NOPHO ALL92-2000,Diagnosis,ALL_83,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689077_R02C02,11.752834,1.4546885,20.711246,-11.193334,18.652723,NOPHO ALL92-2000,Diagnosis,ALL_42,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689077_R03C01,-9.724113,6.7749667,-13.770209,-0.6981846,-24.153156,NOPHO ALL92-2000,Diagnosis,ALL_133,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689077_R03C02,9.225583,10.638562,-19.12997,25.86285,-1.0726838,NOPHO ALL92-2000,Diagnosis,ALL_25,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689077_R04C01,8.868502,10.436014,-19.664585,25.061666,-0.8507562,NOPHO ALL92-2000,Diagnosis,ALL_73,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689077_R04C02,-10.578273,5.9083505,-15.13268,-1.0095936,-23.030325,NOPHO ALL92-2000,Diagnosis,ALL_114,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689077_R05C01,-10.787503,6.171926,-16.375097,-1.1242206,-22.254993,NOPHO ALL92-2000,Diagnosis,ALL_129,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689077_R05C02,13.917386,0.20836392,19.34298,-11.729984,15.618543,NOPHO ALL92-2000,Diagnosis,ALL_145,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689077_R06C01,7.5716867,8.928863,-21.957825,24.698029,-1.3619758,NOPHO ALL92-2000,Diagnosis,ALL_109,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689077_R06C02,-8.174917,10.838585,-13.9071245,-0.2562665,-25.199528,NOPHO ALL92-2000,Diagnosis,ALL_54,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689147_R01C01,10.714664,8.384889,-23.53087,22.038446,-0.24361046,NOPHO ALL92-2000,Diagnosis,ALL_19,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689147_R01C02,-6.623392,9.208385,-17.924181,-0.124738775,-21.584618,NOPHO ALL92-2000,Diagnosis,ALL_601,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689147_R02C01,-5.9106116,10.156107,-13.183701,0.39077145,-24.824871,NOPHO ALL92-2000,Diagnosis,ALL_35,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689147_R02C02,-11.655466,-6.115973,-33.643345,1.8594604,-9.916365,NOPHO ALL92-2000,Diagnosis,ALL_562,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689147_R03C01,-10.207099,6.7400293,-16.047144,-0.95349437,-22.604874,NOPHO ALL92-2000,Diagnosis,ALL_36,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689147_R04C01,7.3001957,10.42158,-19.385324,26.110138,-1.4067614,NOPHO ALL92-2000,Diagnosis,ALL_40,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689147_R04C02,-6.639404,10.632723,-12.64978,0.31313494,-24.962582,NOPHO ALL92-2000,Diagnosis,ALL_576,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689147_R05C02,6.045334,9.914999,-20.141338,26.05363,-1.6688783,NOPHO ALL92-2000,Diagnosis,ALL_590,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689147_R06C01,-9.049153,7.5746846,-12.532059,-0.45132032,-25.310556,NOPHO ALL92-2000,Diagnosis,ALL_41,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689147_R06C02,-9.237891,7.5375724,-12.879691,-0.5135172,-25.023643,NOPHO ALL92-2000,Diagnosis,ALL_59,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689155_R01C01,-9.491884,6.650761,-13.004605,-0.5937307,-24.605394,NOPHO ALL92-2000,Diagnosis,ALL_443,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689155_R01C02,8.635183,9.527953,-21.78085,22.353228,-0.108955264,NOPHO ALL92-2000,Diagnosis,ALL_354,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689155_R02C01,9.326402,10.627153,-19.116814,25.958014,-1.1076356,NOPHO ALL92-2000,Diagnosis,ALL_228,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689155_R02C02,5.384684,9.892234,-20.091156,26.34563,-1.8489488,NOPHO ALL92-2000,Diagnosis,ALL_384,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929689155_R03C01,-9.019009,7.307714,-12.786495,-0.45238426,-24.937849,NOPHO ALL92-2000,Diagnosis,ALL_272,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689155_R03C02,-0.7216059,12.6709795,-15.809453,1.6507788,-22.16354,NOPHO ALL92-2000,Diagnosis,ALL_74,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689155_R04C01,-9.127067,7.362357,-12.814822,-0.48093206,-24.95966,NOPHO ALL92-2000,Diagnosis,ALL_288,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689155_R04C02,-5.835073,11.360139,-12.637728,0.33303505,-26.620722,NOPHO ALL92-2000,Diagnosis,ALL_45,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689155_R05C01,-11.638187,-6.061614,-33.61367,1.8378149,-9.927405,NOPHO ALL92-2000,Diagnosis,ALL_339,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929689155_R05C02,-4.2410126,-12.127413,9.628361,10.475828,9.318736,NOPHO ALL92-2000,Diagnosis,ALL_44,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),MDS-related or secondary myeloid neoplasms
6929689155_R06C01,-3.2791636,9.2843275,-18.600636,0.6302721,-21.359303,NOPHO ALL92-2000,Diagnosis,ALL_298,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929689155_R06C02,-9.369723,7.468671,-13.144082,-0.57013077,-24.874407,NOPHO ALL92-2000,Diagnosis,ALL_3,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726073_R02C02,-17.563921,-2.0656059,-19.968868,-19.847551,4.8695803,NOPHO ALL92-2000,Diagnosis,ALL_501,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6929726073_R04C01,-6.8348365,12.155231,-19.145538,-0.18464993,-21.298182,NOPHO ALL92-2000,Diagnosis,ALL_604,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726073_R04C02,-2.3615603,11.35162,-10.92154,1.4313473,-26.45687,NOPHO ALL92-2000,Diagnosis,ALL_170,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726073_R05C02,-5.664856,10.586185,-17.651241,0.2203442,-21.325676,NOPHO ALL92-2000,Diagnosis,ALL_107,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726073_R06C02,14.0247345,0.27176625,19.28872,-11.54429,15.507229,NOPHO ALL92-2000,Diagnosis,ALL_189,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726081_R01C01,5.446603,12.723551,-10.559448,3.1897871,-25.416481,NOPHO ALL92-2000,Relapse,ALL_5r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726081_R02C02,-11.630427,-6.036467,-33.5985,1.8283008,-9.933698,NOPHO ALL92-2000,Diagnosis,ALL_255,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929726081_R03C01,10.53802,7.950558,-24.194597,21.906385,-0.36657438,NOPHO ALL92-2000,Relapse,ALL_109r2,Unknown,Discovery (train) Samples,GSE49031,Unknown,Otherwise-Normal Control
6929726081_R04C01,8.73746,10.431666,-19.418772,25.909723,-1.206258,NOPHO ALL92-2000,Relapse,ALL_109r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,Otherwise-Normal Control
6929726081_R04C02,-0.1814295,11.584674,-16.576853,1.6495003,-22.233982,NOPHO ALL92-2000,Diagnosis,ALL_308,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726081_R05C01,9.482414,8.525133,-23.237373,22.312672,-0.39892283,NOPHO ALL92-2000,Relapse,ALL_198r1,Unknown,Discovery (train) Samples,GSE49031,Unknown,Otherwise-Normal Control
6929726081_R06C01,5.899654,12.726546,-11.1542845,3.239597,-24.753172,NOPHO ALL92-2000,Relapse,ALL_244r2,Unknown,Discovery (train) Samples,GSE49031,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726081_R06C02,-10.784426,7.3753204,-17.125881,-1.1270161,-22.08491,NOPHO ALL92-2000,Diagnosis,ALL_398,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929726092_R01C01,-1.6596657,11.851853,-14.616087,1.4033465,-23.603941,NOPHO ALL92-2000,Diagnosis,ALL_151,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726092_R01C02,-1.5580728,11.87367,-14.850707,1.4288415,-23.329544,NOPHO ALL92-2000,Diagnosis,ALL_318,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726092_R02C01,-5.812588,10.099887,-10.879,0.5095057,-26.852743,NOPHO ALL92-2000,Diagnosis,ALL_48,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726092_R02C02,4.476962,10.753423,-19.060337,25.624008,-1.3249648,NOPHO ALL92-2000,Diagnosis,ALL_500,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929726092_R03C01,-9.562158,6.6899095,-13.0462265,-0.6147985,-24.616844,NOPHO ALL92-2000,Diagnosis,ALL_46,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726092_R04C01,-0.8116357,12.850011,-15.604054,1.6503515,-22.21079,NOPHO ALL92-2000,Diagnosis,ALL_95,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726092_R05C01,-11.276583,6.8622847,-16.988445,-1.2515308,-22.105562,NOPHO ALL92-2000,Diagnosis,ALL_21,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929726092_R06C01,-17.450167,-2.0608375,-19.999706,-19.820265,4.8250694,NOPHO ALL92-2000,Diagnosis,ALL_350,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
6929726118_R01C01,-9.25764,8.722843,-15.051764,-0.62739533,-23.845741,NOPHO ALL92-2000,Diagnosis,ALL_64,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929726118_R01C02,13.740306,0.7110701,19.482372,-11.258363,15.915283,NOPHO ALL92-2000,Diagnosis,ALL_184,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726118_R02C01,-5.432921,-13.297625,-27.069971,-13.694706,-14.749886,NOPHO ALL92-2000,Diagnosis,ALL_280,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726118_R02C02,-11.686907,6.638847,-17.044971,-1.3573686,-22.056437,NOPHO ALL92-2000,Diagnosis,ALL_220,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929726118_R03C01,6.154129,10.009126,-20.586208,24.069595,-0.82568604,NOPHO ALL92-2000,Diagnosis,ALL_88,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6929726118_R03C02,-1.6387781,12.089799,-15.454692,1.3946711,-22.732256,NOPHO ALL92-2000,Diagnosis,ALL_260,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726118_R04C01,12.550252,1.1074395,20.091785,-11.637923,17.410313,NOPHO ALL92-2000,Diagnosis,ALL_134,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929726118_R05C01,-10.163331,6.9879103,-14.87825,-0.87243646,-23.540735,NOPHO ALL92-2000,Diagnosis,ALL_123,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929726118_R05C02,-10.7194395,5.283588,-14.993529,-1.0525928,-22.918564,NOPHO ALL92-2000,Diagnosis,ALL_377,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6929726118_R06C02,13.373999,1.559338,19.599846,-10.744789,16.469126,NOPHO ALL92-2000,Diagnosis,ALL_345,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6929742081_R01C01,-0.8542673,-9.814795,3.388575,10.627211,9.55338,CETLAM SMD-09 (MDS-tAML),Diagnosis,48R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929742081_R01C02,14.8697,-11.998901,11.8715725,15.776752,-10.476887,CETLAM SMD-09 (MDS-tAML),Diagnosis,4R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),AML with mutated NPM1
6929742081_R02C01,-5.0596747,-10.464436,10.847716,10.465311,11.237492,CETLAM SMD-09 (MDS-tAML),Diagnosis,134R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929742081_R02C02,-2.45009,-11.787597,8.0122,10.13086,10.231615,CETLAM SMD-09 (MDS-tAML),Diagnosis,106R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929742081_R03C02,-3.2282238,-11.640735,6.361715,8.294423,10.881661,CETLAM SMD-09 (MDS-tAML),Diagnosis,146R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929742081_R04C01,-15.283373,-13.485532,0.8667325,25.626043,-13.302346,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),7CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
6929742081_R04C02,14.418983,-10.045884,-1.08509,-16.94978,-15.24265,CETLAM SMD-09 (MDS-tAML),Diagnosis,119R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929742081_R05C01,-0.101037495,-12.451807,7.2551184,11.340217,9.916383,CETLAM SMD-09 (MDS-tAML),Diagnosis,59R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929742081_R05C02,-0.59216243,-10.18529,3.8809817,10.78861,9.533796,CETLAM SMD-09 (MDS-tAML),Diagnosis,137R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929742081_R06C01,-2.9637296,-11.374545,7.109614,9.578485,10.292515,CETLAM SMD-09 (MDS-tAML),Diagnosis,144R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R01C02,0.0076831565,-12.93276,7.8191724,11.127889,10.167537,CETLAM SMD-09 (MDS-tAML),Diagnosis,138R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R02C01,-3.1307688,-11.526261,6.238597,8.507053,10.718142,CETLAM SMD-09 (MDS-tAML),Diagnosis,145R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R02C02,0.61770326,-13.016265,7.3986983,11.338211,9.588707,CETLAM SMD-09 (MDS-tAML),Diagnosis,31R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R03C01,-0.6639236,-10.1268,3.7329123,10.698181,9.565547,CETLAM SMD-09 (MDS-tAML),Diagnosis,141R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R04C01,-4.0125675,-12.116076,8.907012,10.021091,9.536058,CETLAM SMD-09 (MDS-tAML),Diagnosis,154R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R04C02,-0.6584415,-10.820849,4.6824527,10.476836,9.763164,CETLAM SMD-09 (MDS-tAML),Diagnosis,51R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R05C01,1.029088,-13.471588,8.265667,10.756207,9.840353,CETLAM SMD-09 (MDS-tAML),Diagnosis,133R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R05C02,12.890996,4.7217546,20.59906,-1.6374326,18.903479,CETLAM SMD-09 (MDS-tAML),Diagnosis,156R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6929806071_R06C01,1.1883546,-14.070654,8.231279,11.8686695,10.039123,CETLAM SMD-09 (MDS-tAML),Diagnosis,109R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
6940715d-4781-4e1f-9fc3-7913b90a516c_noid,14.998624,-9.682525,-1.1619328,-17.21275,-14.404833,TCGA AML,Diagnosis,TCGA-AB-2993,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
6969568050_R01C01,6.756011,9.602133,-21.128063,24.211185,-0.9823688,NOPHO ALL92-2000,Diagnosis,ALL_9,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6969568050_R01C02,-3.7176535,11.326671,-13.097599,0.8956599,-25.524597,NOPHO ALL92-2000,Diagnosis,ALL_76,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6969568050_R02C01,6.6865225,10.101,-20.447304,24.083183,-0.7542193,NOPHO ALL92-2000,Diagnosis,ALL_90,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6969568050_R02C02,-6.8248267,12.047832,-19.070885,-0.17701134,-21.294594,NOPHO ALL92-2000,Diagnosis,ALL_209,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6969568050_R03C01,8.237355,10.362417,-19.820057,24.908806,-0.86664385,NOPHO ALL92-2000,Diagnosis,ALL_71,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6969568050_R03C02,8.768083,10.494538,-19.43035,25.568808,-1.0430661,NOPHO ALL92-2000,Diagnosis,ALL_238,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
6969568050_R04C02,-11.466773,-5.522337,-33.29747,1.6296041,-10.055471,NOPHO ALL92-2000,Diagnosis,ALL_120,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6969568050_R05C01,-2.5850923,11.231367,-12.720517,1.2989341,-24.90422,NOPHO ALL92-2000,Diagnosis,ALL_203,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6969568050_R05C02,1.7046547,12.571586,-11.817735,2.439743,-25.675852,NOPHO ALL92-2000,Diagnosis,ALL_526,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
6969568050_R06C01,-11.000383,5.79563,-15.967496,-1.1613075,-22.456238,NOPHO ALL92-2000,Diagnosis,ALL_121,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6969568050_R06C02,8.760791,10.484135,-19.403982,25.70716,-1.1034396,NOPHO ALL92-2000,Diagnosis,ALL_26,Unknown,Discovery (train) Samples,GSE49031,Acute lymphoblastic leukemia (ALL),Otherwise-Normal Control
69f54b39-9f48-4780-896f-80426fb4d847_noid,13.691452,4.7035604,19.903072,-5.560003,17.243605,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATGWP,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,MDS-related or secondary myeloid neoplasms
6a3f18cd-81d9-4ae8-9561-ee7153ef4e7a_noid,-5.2804823,-10.215709,10.485968,10.28189,11.341591,TCGA AML,Diagnosis,TCGA-AB-2907,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
6aad5144-2211-4192-be0c-8e3c534b0ab2_noid,12.899397,-14.94254,0.591962,-11.726132,-14.982301,AAML0531,Bone Marrow Normal,PATJMY,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with other rare recurring translocations
6ac7069b-3aed-46a4-9c2f-c766274a92b0_noid,1.2814146,-12.691827,8.063902,10.574348,9.82037,TCGA AML,Diagnosis,TCGA-AB-2899,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
6b24f64a-bbf0-4d5a-ab09-ca037226934b_noid,-13.039652,-13.721571,2.6595147,27.66421,-13.953038,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASCRZ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
6b347dfe-1074-4c99-a3f9-89665e018936_noid,-5.311936,-11.176798,5.889235,6.991492,11.09276,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASIEJ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
6c138b7b-c106-4207-b611-902edb06545e_noid,-15.8688755,2.2848222,14.62553,12.151478,12.97238,TCGA AML,Diagnosis,TCGA-AB-2827,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
6c52a417-981b-42cb-91fe-d3c8566781c3_noid,-7.53133,-8.405933,9.482018,10.168789,10.900922,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANYNR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6ce96de1-7e35-434f-97bf-fa08f1219f9d_noid,-16.491182,6.6418753,14.306082,13.098829,13.591446,AAML0531,Bone Marrow Normal,PASJTM,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
6d1204e8-acb7-4bc2-9b9a-32a100c7975f_noid,-16.636583,6.4703813,14.411002,13.067762,13.607158,AAML03P1,Bone Marrow Normal,PANLIR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
6d50e1e5-6152-423b-9d56-7a21c36458a7_noid,11.762047,-26.200787,-13.132886,3.7369516,16.679358,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012420,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
6dfb3e19-420c-44be-8780-5f7e908be458_noid,-13.181276,-13.694919,2.566172,27.49321,-13.887917,AAML03P1,Bone Marrow Normal,PANTWV,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
6e7047af-70c6-4f3d-94da-d14df9a72479_noid,-16.055714,-10.470781,-17.440384,15.856165,19.412683,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAEFGR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
6eb99777-6ae7-4bcb-966e-c413bc0adc52_noid,9.671805,8.436222,-23.486267,21.90416,-0.2528712,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPAJU,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,Otherwise-Normal Control
6f48983b-424c-4945-9dff-d1e79cf3f868_noid,13.1398535,-14.821301,0.23804404,-12.023435,-15.018364,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATJMY,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
6fd074f3-61f8-4e37-b0aa-0c8c20a58a54_noid,-14.653071,-13.406723,1.604311,25.714897,-13.198656,CCG2961,Blood Derived Normal,PAKSMZ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
70033833-1b2e-4c65-ad4e-8f8b9569033d_noid,-13.474602,-13.540736,2.5327404,26.81437,-13.559702,AAML03P1,Bone Marrow Normal,PANLLX,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
704c1631-5714-4bbb-80ca-02454f0ed726_noid,10.671539,-27.23181,-13.789608,4.226877,16.78347,AAML0531,Bone Marrow Normal,PASYWA,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
7099f682-c591-46a8-b7ed-815685e2d536_noid,11.313941,-26.5727,-13.382332,3.9477952,16.710815,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASJYI,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with other rare recurring translocations
70e1f047-4560-4225-be8b-801524aa5f33_noid,3.0299428,12.15839,-11.01952,2.6260521,-25.61248,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PASLSD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
70f4a0f1-3115-4ea6-9da2-e9cc076f9582_noid,13.792962,3.2527573,19.119442,-9.072175,16.193176,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASZEW,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
710c36ec-f26c-492d-9c66-f907e396e9c2_noid,11.8258095,-26.18288,-13.111783,3.7028427,16.68221,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045737,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with other rare recurring translocations
7149219a-801f-4bad-b80a-4dfc5ec996ec_noid,1.2967039,22.629288,-12.463582,-6.620176,14.470784,TCGA AML,Diagnosis,TCGA-AB-2937,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
71bb2bb2-2a3b-4898-893c-914496281bfd_noid,14.306086,-11.079185,0.11665761,-14.424891,-16.927217,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASGMZ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
71cb8b0a-ee44-4179-b0eb-cd57f35e2c49_noid,-16.264515,6.7457542,14.151626,13.139016,13.549692,AAML0531,Bone Marrow Normal,PARFIW,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
7212f9f5-e6a6-41d6-add2-89e5b4048667_noid,-10.709102,-15.305749,-21.773304,6.981727,-21.685608,TARGET ALL,Bone Marrow Normal,TARGET-00-SJNORM016096,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
7310440003_R01C01,-0.45314842,-12.21784,7.491311,11.346184,9.874086,CETLAM SMD-09 (MDS-tAML),Diagnosis,80R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440003_R01C02,-1.1543078,-9.987308,3.3596215,10.010776,9.782952,CETLAM SMD-09 (MDS-tAML),Diagnosis,111R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440003_R02C01,-1.9172491,-11.52566,6.2222376,9.832693,10.1560545,CETLAM SMD-09 (MDS-tAML),Diagnosis,135R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440003_R02C02,13.762838,-12.979059,0.31885192,-12.50166,-17.67914,CETLAM SMD-09 (MDS-tAML),Diagnosis,129R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),AML with other rare recurring translocations
7310440003_R03C01,-5.756915,-10.132767,11.195509,10.5681925,11.218839,CETLAM SMD-09 (MDS-tAML),Diagnosis,84R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440003_R04C01,-2.8759384,-11.785869,6.036216,8.189341,10.880993,CETLAM SMD-09 (MDS-tAML),Diagnosis,127R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440003_R04C02,-6.3728094,-9.397177,9.146421,10.124257,10.589799,CETLAM SMD-09 (MDS-tAML),Diagnosis,115R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440003_R05C01,15.316414,-9.471119,1.0344818,-14.748959,-16.011112,CETLAM SMD-09 (MDS-tAML),Diagnosis,23R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),AML with mutated NPM1
7310440003_R05C02,-0.43995273,-12.140684,8.724403,11.658404,10.137272,CETLAM SMD-09 (MDS-tAML),Diagnosis,148R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440003_R06C01,14.168954,-12.139222,11.777439,15.143758,-14.501903,CETLAM SMD-09 (MDS-tAML),Diagnosis,130R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440007_R01C02,-0.28155515,-10.76018,4.597398,10.420982,9.720304,CETLAM SMD-09 (MDS-tAML),Diagnosis,132R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440007_R02C01,-15.368764,-13.52102,0.7286968,25.69498,-13.364964,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),3CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
7310440007_R02C02,-1.9335458,-12.001559,6.794268,9.499284,10.18013,CETLAM SMD-09 (MDS-tAML),Diagnosis,155R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440007_R03C02,-5.720042,-10.660037,7.106614,8.533275,10.291211,CETLAM SMD-09 (MDS-tAML),Diagnosis,95R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440007_R04C01,-2.4634047,-11.825767,7.8467617,10.164495,9.928146,CETLAM SMD-09 (MDS-tAML),Diagnosis,142R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440007_R04C02,1.0745596,-14.196845,7.985954,9.869714,9.99833,CETLAM SMD-09 (MDS-tAML),Diagnosis,131R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440007_R05C01,-0.20820457,-10.853631,4.65973,10.955745,9.553999,CETLAM SMD-09 (MDS-tAML),Diagnosis,136R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7310440007_R06C02,13.915398,-12.211308,11.656633,14.730999,-14.412125,CETLAM SMD-09 (MDS-tAML),Diagnosis,153R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
7321d638-5cbc-4794-9269-6ea3119a6309_noid,-2.9523942,-11.161662,8.348035,10.159547,10.782035,TCGA AML,Diagnosis,TCGA-AB-2868,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
73e4c9d9-3576-4b4e-9b64-7d659bcaa308_noid,11.900849,-26.115053,-13.067905,3.6686351,16.675364,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL042793,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
7430ffc4-585b-420a-aae4-9886a10170d8_noid,-5.4882765,11.358828,-12.5236435,0.40658873,-26.814035,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPDCR,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
75001ca0-1f98-4c35-be99-596960ab50c3_noid,15.428291,-7.725943,-19.176208,-14.773545,21.12135,TCGA AML,Diagnosis,TCGA-AB-2921,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
750f5331-f444-4a6a-a3e4-3388b97e46ff_noid,-0.22185765,-12.277373,7.807031,11.410622,10.278927,TCGA AML,Diagnosis,TCGA-AB-2820,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
75e5f62a-101f-4598-b4a2-396bad415242_noid,-14.906696,-1.0843613,14.424648,11.886439,12.44756,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PASJGZ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
76ae675f-987f-4ddd-b1df-41a3df346348_noid,-8.893901,-7.8518863,11.674965,10.929915,11.022518,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARBTC,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
78245229-1337-4a08-b3ed-4c18001ab612_noid,14.690043,-12.023333,11.840011,15.643658,-10.856843,TCGA AML,Diagnosis,TCGA-AB-2867,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
782b8cbb-8a4a-4c26-981f-a1321fd4f781_noid,-16.559233,6.358597,14.422663,12.962899,13.575474,AAML03P1,Bone Marrow Normal,PANLXM,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
7881dfc1-23a9-4424-b20d-3316491caad9_noid,-14.458393,-13.257078,2.031839,25.327492,-12.9174595,AAML03P1,Bone Marrow Normal,PANDER,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
788315f0-696c-44a6-9adf-35f939397ff3_noid,-7.5567713,-17.09008,-20.844488,-21.28162,14.620242,TCGA AML,Diagnosis,TCGA-AB-2998,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
78c040a1-8b2f-4e67-9e7a-0aa9d3922479_noid,-15.098012,-0.6381041,14.487329,11.927787,12.514931,TCGA AML,Diagnosis,TCGA-AB-2938,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
7a7f51d4-4113-4953-895d-310881fef4b1_noid,-12.455775,10.639787,19.708155,-5.843377,-18.849098,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANGTF,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
7b290fb4-0e25-4530-b44e-37e42c362229_noid,-10.869489,12.780345,19.184486,-6.718714,-19.34093,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045736,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
7b6b463e-a833-4dc0-b742-edb4bb042a6c_noid,13.695942,-13.939747,0.259338,-12.01098,-16.571344,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANLXM,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
7b830c0b-c7a5-4332-a54b-2c90a7711662_noid,-15.002683,-0.8357074,14.45485,11.908336,12.483153,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PAPBEJ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
7ba43757-3080-418e-955e-9393ceb08c4d_noid,13.205933,5.7052174,20.600294,-2.943239,19.643341,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016108,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
7c0fc18e-59dc-4c12-92a2-ff9c77d7952d_noid,-7.601916,-17.042429,-20.816319,-21.320065,14.655704,TCGA AML,Diagnosis,TCGA-AB-2840,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
7c468845-1c77-4982-b395-c2fdf34011d0_noid,-2.4229853,-10.713695,5.257069,9.322715,10.3334255,TCGA AML,Diagnosis,TCGA-AB-2917,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
7cafd6b6-476e-4ec9-9612-83442aacbbfc_noid,-14.1532135,-13.285383,2.285189,25.589632,-12.998591,AAML0531,Bone Marrow Normal,PARNNT,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
7cb9cfd2-4ee8-4017-a7e4-b7827fc56e9b_noid,3.8704112,14.170882,-12.48715,3.17392,-25.471073,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PANYHW,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
7cf2b414-76b2-4d59-ac8c-8ab55d351047_noid,-13.819671,-13.351619,2.5020084,25.996101,-13.159944,AAML0531,Blood Derived Normal,PASCGR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
7d06e211-5036-4594-b765-631b2ab7c91c_noid,13.1576395,-14.324109,-0.0671946,-12.214955,-16.721176,AAML0531,Recurrent Blood Derived Cancer - Peripheral Blood,PASGCE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
7d9853ae-9a78-45cc-9dd1-4ce117f7e99f_noid,-12.079383,-15.155,22.600426,16.457561,-8.801072,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANCSC,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
7e75e21e-65db-43b5-a361-86dfa4f96d28_noid,10.065086,-28.440855,-14.4087715,4.397962,16.979694,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARHRS,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
7ef46a82-9197-4b55-83b7-8d1c6e41ffb2_noid,13.523793,5.2471757,20.180622,-4.3866715,18.36206,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012417,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),MDS-related or secondary myeloid neoplasms
7f328a10-3362-4b14-984d-af740edc87a1_noid,14.724848,-11.314585,-1.4813108,-16.4869,-13.36174,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARVUA,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
7f91dcee-8d96-4f4b-b896-a756dd891abe_noid,-6.1328664,-10.655164,10.072508,10.853342,9.2285185,AAML0531,Bone Marrow Normal,PARNZW,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
7fa5f965-8498-46c3-948e-814cf9c35173_noid,-2.5633426,-11.450861,8.032102,10.148285,10.430124,TCGA AML,Diagnosis,TCGA-AB-2882,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
807a0549-e900-4f77-985f-93ad7244d4ac_noid,-5.2999883,-11.349769,5.5877204,6.4967737,11.31557,AAML0531,Bone Marrow Normal,PASHMK,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with other rare recurring translocations
81812630-3ba1-4f2a-b896-4d2f519d8637_noid,-17.400303,-8.953473,-18.573708,15.935912,18.76566,AAML03P1,Primary Blood Derived Cancer - Peripheral Blood,PANYNR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8359018041_R01C01,0.48840636,-13.442168,8.314803,10.505081,10.267299,CETLAM SMD-09 (MDS-tAML),Diagnosis,102R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018041_R01C02,14.284783,-12.066918,11.886685,15.542225,-14.519514,CETLAM SMD-09 (MDS-tAML),Diagnosis,40R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018041_R02C02,0.7165593,-13.652425,7.8826895,11.592455,9.812821,CETLAM SMD-09 (MDS-tAML),Diagnosis,139R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018041_R04C02,14.415089,4.430465,17.944326,-7.3797684,15.72497,CETLAM SMD-09 (MDS-tAML),Diagnosis,125R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8359018041_R05C01,1.3242562,-13.784764,8.351824,11.63742,9.87452,CETLAM SMD-09 (MDS-tAML),Diagnosis,93R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018041_R06C01,6.027569,18.843811,-14.619762,-7.3612967,14.590494,CETLAM SMD-09 (MDS-tAML),Diagnosis,78R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8359018041_R06C02,0.43595377,-13.450478,7.68953,10.997926,9.246824,CETLAM SMD-09 (MDS-tAML),Diagnosis,86R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R01C01,-0.2560329,-10.726131,4.476905,10.791337,9.575651,CETLAM SMD-09 (MDS-tAML),Diagnosis,11R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R01C02,14.343232,-12.073507,11.954973,15.603583,-16.561321,CETLAM SMD-09 (MDS-tAML),Diagnosis,149R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R02C01,-15.420237,-13.476928,0.74799836,25.521965,-13.274323,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),9CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
8359018048_R02C02,-0.10760548,-12.86417,7.1582127,11.412829,9.595082,CETLAM SMD-09 (MDS-tAML),Diagnosis,7R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R03C01,-15.400873,-13.509176,0.714902,25.639252,-13.339443,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),8CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
8359018048_R03C02,-0.61364675,-10.646967,4.4089727,10.489934,9.692044,CETLAM SMD-09 (MDS-tAML),Diagnosis,17R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R04C01,0.5135511,-13.248741,7.6033936,11.491926,9.468978,CETLAM SMD-09 (MDS-tAML),Diagnosis,158R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R04C02,-0.51463354,-11.912273,6.001646,10.14834,10.020434,CETLAM SMD-09 (MDS-tAML),Diagnosis,100R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R05C02,-4.430878,-11.43232,5.855605,7.2114997,11.189061,CETLAM SMD-09 (MDS-tAML),Diagnosis,152R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R06C01,15.642811,-9.406132,-1.1571813,-17.031271,-14.396211,CETLAM SMD-09 (MDS-tAML),Diagnosis,29R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018048_R06C02,1.3125573,-13.9312105,7.905497,11.893716,9.919831,CETLAM SMD-09 (MDS-tAML),Diagnosis,64R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018062_R01C01,-5.285379,-10.350961,11.260563,10.609654,11.307413,CETLAM SMD-09 (MDS-tAML),Diagnosis,26R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018062_R05C02,0.116443396,-13.075386,8.034839,11.580334,9.738985,CETLAM SMD-09 (MDS-tAML),Diagnosis,13R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018166_R01C02,-0.4982581,-10.268384,3.851106,10.689691,9.560477,CETLAM SMD-09 (MDS-tAML),Diagnosis,147R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018166_R03C02,13.218734,4.7560053,19.72339,-1.3507947,18.369112,CETLAM SMD-09 (MDS-tAML),Diagnosis,150R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359018166_R06C01,-0.36467126,-12.607408,8.012508,11.465253,9.716041,CETLAM SMD-09 (MDS-tAML),Diagnosis,15R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359026002_R01C02,-4.9955463,-11.134188,9.756054,10.357799,9.989814,CETLAM SMD-09 (MDS-tAML),Diagnosis,42R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8359026002_R05C01,-15.311644,-13.486449,0.8373826,25.614006,-13.3026705,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),10CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
8359026002_R06C01,0.7533756,-13.279611,7.3620734,11.621142,10.115699,CETLAM SMD-09 (MDS-tAML),Diagnosis,54R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8363800211_R02C02,-2.3274634,-12.302037,8.64424,10.548274,9.796065,CETLAM SMD-09 (MDS-tAML),Diagnosis,151R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8363800211_R05C02,-15.537668,-13.494533,0.6075395,25.514671,-13.299421,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),6CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
8363800211_R06C02,-15.402526,-13.494986,0.73719186,25.591114,-13.311196,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),1CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
8363800249_R01C01,-15.382833,-13.468683,0.7979562,25.515223,-13.260878,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),2CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
8363800249_R03C01,-0.56461596,-10.360567,4.045494,10.634739,9.616535,CETLAM SMD-09 (MDS-tAML),Diagnosis,157R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8363800249_R04C02,-15.2504015,-13.508942,0.86283755,25.721178,-13.350611,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),5CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
8363800249_R05C02,-15.329496,-13.489637,0.81694293,25.61369,-13.306594,CETLAM SMD-09 (MDS-tAML),Control (Healthy Donor),4CTR,Otherwise-Normal Control,Discovery (train) Samples,GSE152710,Otherwise-Normal (Control),Otherwise-Normal Control
83a2831f-4014-4077-a834-47f4dfbe8356_noid,-0.1324029,11.963778,-11.446797,1.9695249,-26.011246,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046470,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
83a91fbf-a19b-4a1a-9e58-d3526eb7e099_noid,-3.3369346,-11.373974,6.0799046,8.221191,10.969126,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANDIX,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
83b6b856-e339-4096-a56d-ae128893714d_noid,14.813369,-12.096247,11.878012,15.444519,-14.337714,TCGA AML,Diagnosis,TCGA-AB-2826,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
83ebfdd3-d5a6-4936-942b-ecb8cbead26e_noid,-6.241479,-11.258158,6.6071,7.5998473,10.073495,CCG2961,Bone Marrow Normal,PADYIR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
84652ba7-d522-44f4-8937-df407f71754d_noid,15.617228,-7.716975,-19.168814,-14.761012,21.080484,TCGA AML,Diagnosis,TCGA-AB-2880,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
847f7fb7-abfc-4ec3-bc7b-ec41f6e69071_noid,-18.160072,-10.465941,-17.158213,15.37883,19.07237,TCGA AML,Diagnosis,TCGA-AB-2870,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
86f6424c-db59-4f85-97c6-3bc0bc031cdd_noid,14.009512,-13.537985,-0.65157485,-13.370416,-15.583224,TCGA AML,Diagnosis,TCGA-AB-2946,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
87772053-09f9-4470-b1a1-2f4344e040f7_noid,-16.578762,6.5952716,14.463585,12.862923,13.603368,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PATDHA,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
8795194035_R06C02,14.582471,-10.92287,0.24867696,-15.063713,-14.462254,CETLAM SMD-09 (MDS-tAML),Diagnosis,122R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8795194164_R02C02,1.8834884,-13.183342,8.467748,10.842145,9.401336,CETLAM SMD-09 (MDS-tAML),Diagnosis,143R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
8795194164_R03C01,-0.3182169,-8.531759,0.98993325,9.88675,10.080502,CETLAM SMD-09 (MDS-tAML),Diagnosis,68R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
87cb8a96-0958-4b77-8105-d3c3b6500a99_noid,-18.617922,-9.480879,-18.03792,15.506478,18.315619,TCGA AML,Diagnosis,TCGA-AB-2889,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
87dc2a8d-4a74-45fb-8916-95b6012f1114_noid,-12.565747,12.976045,17.808233,-7.686694,-19.373901,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045734,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
87eb5137-a58d-4d2f-ab04-862fd40bd876_noid,0.3467198,-12.85421,8.450849,11.404819,10.653153,TCGA AML,Diagnosis,TCGA-AB-2885,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
880d7fed-0413-4957-83c2-0faa67e5a940_noid,-6.023662,-9.715097,8.801641,9.331606,11.307132,TCGA AML,Diagnosis,TCGA-AB-2871,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
88921a44-5d17-4d5f-989d-97d887728563_noid,-13.788277,-13.605023,2.121714,26.85289,-13.660846,AAML0531,Bone Marrow Normal,PASGMZ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
890de14a-9da0-4364-9c37-5771fd1561d3_noid,13.659905,-14.01743,-0.86185586,-13.904144,-13.706742,TCGA AML,Diagnosis,TCGA-AB-2930,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8911635e-c941-4e29-80b5-0846bf3eb426_noid,13.29342,-10.981002,-1.5841508,-17.380676,-14.817138,AAML03P1,Bone Marrow Normal,PAMYJX,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
899b86dd-24c4-4ad4-a7f8-2e1ddc96949d_noid,-6.2017207,-10.526851,10.822803,11.127883,9.510711,AAML0531,Bone Marrow Normal,PASYEJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
8a0514d5-3e2c-4c1a-9d98-3317741b4988_noid,-18.446291,-9.58544,-17.899347,15.452432,18.334555,TCGA AML,Diagnosis,TCGA-AB-2881,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8a62d8f3-d14a-4389-bc6e-4dd28dd5a2be_noid,-7.6751842,-16.979692,-20.753075,-21.400318,14.716293,TCGA AML,Diagnosis,TCGA-AB-2841,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
8aad9584-eed3-4298-aab6-3a2f289e8d4b_noid,12.881234,6.287592,20.965298,-0.61190593,21.077806,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARYVW,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8ce55818-0e51-4bcc-8f25-a105c9f92c72_noid,-12.582702,10.909175,19.794092,-5.702222,-18.779396,TCGA AML,Diagnosis,TCGA-AB-2883,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8d15f2d0-0d21-4484-8262-1e8c8eb52012_noid,3.1206834,12.104953,-10.687604,2.655032,-25.84557,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARWXU,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8d6905a9-37ad-4de7-baab-6b0b8f480f31_noid,1.4233278,22.183294,-12.126394,-6.2462125,15.112573,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATDHA,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8d6c4a62-a088-4c32-8e5f-6ed8f01e5af6_noid,16.328005,-7.7098055,-19.081957,-14.322837,20.35792,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANLIR,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
8e45456e-3610-47ba-9ddf-fc8bd0b1375e_noid,-12.465312,9.810579,19.64305,-5.2137814,-18.615685,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAECCE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8f18abae-49a8-4f86-8192-ff21037039c1_noid,-7.217794,-8.613147,9.400967,10.314666,10.678553,AAML0531,Recurrent Blood Derived Cancer - Peripheral Blood,PAPVZK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8f642f4d-fdce-4bf3-8990-aabe84e9abbb_noid,-15.989705,7.1597605,13.950353,13.190575,13.530901,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARNIA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8fe01522-a4a0-43ee-adcb-99f9d79ca0e4_noid,12.796584,6.3242755,21.397985,-1.1936016,21.337133,AAML0531,Bone Marrow Normal,PATKKJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
909648ab-9ad8-48d1-beed-a7bf1467da68_noid,-10.708916,-15.3075485,-21.774893,6.98205,-21.685383,TARGET ALL,Bone Marrow Normal,TARGET-00-SJNORM016096,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
90d6d47a-a44b-43ab-bc9c-0fb89fc8f7eb_noid,-14.659338,-13.4871,1.4673048,25.977152,-13.356615,AAML0531,Bone Marrow Normal,PASGCE,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
91bee2ec-72ae-4723-9130-6cd7c1f8a338_noid,14.599705,-9.510524,-0.46253622,-17.402658,-13.374259,TCGA AML,Diagnosis,TCGA-AB-2836,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
920110ab-36c0-4fe3-8f05-464486522edf_noid,13.450898,-14.135067,-1.1040092,-14.651066,-12.244095,AAML0531,Bone Marrow Normal,PASFLG,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with other rare recurring translocations
92dba4ba-c00d-4a50-add9-12485325d408_noid,13.165722,-14.265616,-0.9676179,-14.671903,-11.997817,TCGA AML,Diagnosis,TCGA-AB-2918,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
9304aa83-9d86-4821-99d0-6a2126ab8177_noid,13.594846,-14.224842,-0.07407055,-12.461206,-15.455753,TCGA AML,Diagnosis,TCGA-AB-2834,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
93ace1f7-ec35-42c8-b1a2-4d18c7ea2dfc_noid,-2.4307392,10.319062,-18.01292,0.93838584,-21.492985,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATDKH,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9407210111_R01C01,-5.025991,-11.189295,10.157854,10.731064,9.721902,CETLAM SMD-09 (MDS-tAML),Diagnosis,72R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9407210111_R02C01,-0.90220606,-9.645653,3.200096,10.705105,9.486034,CETLAM SMD-09 (MDS-tAML),Diagnosis,20R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9407210111_R06C02,0.9704778,-13.845987,8.086038,10.199377,10.042679,CETLAM SMD-09 (MDS-tAML),Diagnosis,88R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9407210127_R02C02,-0.98388153,-10.977008,5.2595353,10.204431,10.161971,CETLAM SMD-09 (MDS-tAML),Diagnosis,75R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9407210127_R05C01,-0.5377385,-12.132532,6.4624767,10.544361,10.006817,CETLAM SMD-09 (MDS-tAML),Diagnosis,37R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9407210127_R06C02,-1.1625667,-12.05013,6.6771173,10.4534235,10.015159,CETLAM SMD-09 (MDS-tAML),Diagnosis,34R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
94a5d305-5d56-4a9f-8d4a-8ea6dd4c897d_noid,13.837677,-13.894542,-1.1012217,-14.164312,-13.663215,TCGA AML,Diagnosis,TCGA-AB-2856,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
94e7ea12-54a5-4819-90df-47f693e7234f_noid,-11.326233,-5.0836086,-33.060085,1.4647838,-10.156351,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARMGY,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9545de37-b089-4246-a8c4-d2c6736be40b_noid,-7.6555305,-17.018393,-20.747692,-21.401693,14.703376,TCGA AML,Diagnosis,TCGA-AB-2803,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
9584b6d5-cdf7-43c6-a1d6-0371c5c4ce53_noid,-7.7650313,-8.489133,10.016289,10.346962,10.80962,AAML0531,Bone Marrow Normal,PARPPY,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
958f7d1b-e3b2-4c16-beb7-7d3378a462bf_noid,-2.2113395,-10.35647,7.4671574,11.241811,10.119554,AAML0531,Recurrent Blood Derived Cancer - Peripheral Blood,PARUBT,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
96236b05-dbe4-4c84-8d1f-3ee2572946da_noid,-16.404802,5.832227,14.467553,12.739144,13.480202,AAML0531,Bone Marrow Normal,PARXMP,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
963a625f-e99c-40b3-8657-1297ce2017b4_noid,-7.3215837,-17.333797,-21.000813,-21.075193,14.434909,TCGA AML,Diagnosis,TCGA-AB-3012,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
9652b27f-d949-4af7-8c23-e5b918d2ddf5_noid,-16.579443,-10.926798,-17.382421,16.12351,20.246529,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARDMG,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9691df8a-e05a-47e8-b0d4-d7aa412f6cb1_noid,-19.176752,-8.912713,-18.372437,15.473703,18.157566,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML007113,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
96d96113-cb8f-4b83-83ee-696506861927_noid,-12.85764,-10.037164,-16.526993,15.204021,19.252787,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARCEC,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
970bf65f-b72f-4744-a44a-426ae5d70f9f_noid,-0.7775198,-11.8575325,7.54666,10.360168,10.304391,TCGA AML,Diagnosis,TCGA-AB-2847,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
97666602-f0d9-44e6-a72c-eb5bdf1e25fe_noid,-1.1583239,-8.968454,2.765286,11.019331,9.349402,TCGA AML,Diagnosis,TCGA-AB-2975,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
9781b00e-0d37-4fd6-bb58-85cf78b432b6_noid,-14.177232,-13.248177,2.3278723,25.448011,-12.91983,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARNIA,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
9804b677-d11f-4d72-ba67-b7f14f633773_noid,-7.2193656,12.208065,-18.832777,-0.27097577,-21.683409,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046467,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
984d6f47-d781-4e69-a343-732f6ff8e533_noid,-17.653841,-9.507912,-18.213243,15.860011,18.865252,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARIMT,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
98be5fff-b5c5-4147-98b8-47c898769f1a_noid,-16.833303,6.419864,14.451461,13.2311735,13.651393,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARCUK,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
9904796134_R02C02,-1.2081732,-9.45833,2.7258599,10.337528,9.531161,CETLAM SMD-09 (MDS-tAML),Diagnosis,1R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9904796134_R03C01,-2.0104756,-11.915168,6.7342916,9.601794,10.20306,CETLAM SMD-09 (MDS-tAML),Diagnosis,62R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9904796134_R05C02,14.705885,-12.0224495,11.845666,15.655238,-10.931876,CETLAM SMD-09 (MDS-tAML),Diagnosis,104R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9904796134_R06C01,-1.0053858,-9.997761,3.6896205,10.463936,9.640569,CETLAM SMD-09 (MDS-tAML),Diagnosis,9R,MDS-related or secondary myeloid neoplasms,Discovery (train) Samples,GSE152710,Myelodysplastic syndrome (MDS or MDS-like),MDS-related or secondary myeloid neoplasms
9931b91e-e69b-4438-a2fb-ca6ae86b8484_noid,15.418081,-11.950688,12.115141,16.272703,-14.063608,TCGA AML,Diagnosis,TCGA-AB-2990,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
9a2e50c7-6fbb-4f4e-9dfa-b5bca08e3527_noid,-9.290557,-7.513132,11.809215,10.943576,11.12689,AAML0531,Bone Marrow Normal,PARCCH,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with other rare recurring translocations
9a918964-7005-46df-ada7-868b8d61fd3e_noid,-4.8049026,-10.778761,6.563698,7.8493605,11.351631,TCGA AML,Diagnosis,TCGA-AB-2854,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9b1dd872-7a8f-4bef-bd8d-9eafe93bd3db_noid,12.7734165,-12.5095625,-1.5986618,-17.677853,-10.113941,TCGA AML,Diagnosis,TCGA-AB-2816,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
9b49b171-aa58-405c-a564-d47e7da5805d_noid,-11.8722725,11.653474,4.061833,-24.24356,11.016399,TCGA AML,Diagnosis,TCGA-AB-2947,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
9b6c037f-4b9a-4b8f-883d-1eef375353e0_noid,-11.679151,11.066556,20.560926,-4.5594807,-18.003317,TCGA AML,Diagnosis,TCGA-AB-2893,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9b7a68ea-666b-469d-bad1-1150b18031b0_noid,-13.535103,-13.650908,2.2922146,27.147974,-13.772431,AAML0531,Bone Marrow Normal,PARUBT,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
9c789545-e685-4eb9-8d4e-24ad7b5a232d_noid,-5.6360774,-11.446568,5.4925585,6.314627,11.098638,TCGA AML,Diagnosis,TCGA-AB-2824,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
9c7f7ad0-7826-404e-be67-1df5cbeef3ba_noid,-13.102516,-13.659995,2.7015848,27.420559,-13.825221,AAML03P1,Bone Marrow Normal,PANLRE,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
9c950137-bdcb-40c3-86c8-5d3213f9bad9_noid,-1.3481299,-9.966091,4.184963,10.322943,9.911783,TCGA AML,Diagnosis,TCGA-AB-2949,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
9ce9fc2f-9350-4bff-bdbe-8069867f51a2_noid,-8.455097,11.707449,-16.862553,-0.50102717,-23.464579,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040024,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9db72165-d248-47c3-aa15-c6336af0ecab_noid,11.885482,-26.143095,-13.082703,3.6736012,16.679726,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL042793,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
9e52d011-95f0-445f-91f0-1976cf53256f_noid,-1.1457253,-10.241714,4.1286592,10.201311,9.870678,TCGA AML,Diagnosis,TCGA-AB-2933,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
9eae71f4-127b-4cad-9ff5-d7eb36364c0b_noid,15.6681,-8.952029,2.0140524,-14.240671,-15.637939,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAKIWK,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
9eaf1cc3-6b08-43b6-b1ad-7c7aea0b66a2_noid,-5.918465,-11.671045,7.190405,8.275692,9.479304,CCG2961,Bone Marrow Normal,PADZCG,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
9ee8b7e1-a79c-404b-939b-6a920f922f92_noid,-14.416012,-10.062762,-16.260508,14.692799,18.490814,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAEFGR,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9f4ca0c5-1e8a-4d2c-9164-c0b6d8a77e95_noid,-13.949774,-13.477209,2.175412,26.3362,-13.394907,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASJGZ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
9fc4d130-a956-449e-a653-81fd47864137_noid,-6.7379923,12.375528,-19.329556,-0.16755696,-21.224216,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012422,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
a08c6a6c-ea04-4af7-b6d6-519ccbf79ce2_noid,13.024179,-12.890176,-1.1615189,-16.538712,-11.007341,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PAMXZY,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
a0f03e0c-cc30-4a5e-8ab9-faa13916ffc8_noid,-6.5892115,-9.723985,9.852789,10.547294,10.059771,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAEDKB,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
a17907fa-327a-4127-b804-94f322f85147_noid,4.276156,13.973523,-12.443357,3.1942928,-25.192478,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPIGX,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
a19169b4-294c-437f-957f-fbf6f6a30bbc_noid,-9.78557,-17.108805,10.5965185,-20.773987,14.098187,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATRGV,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with mutated NPM1
a26e47d7-e603-42d6-8fbb-13f776e2bdb2_noid,-10.641882,13.075018,19.424463,-6.527902,-19.6674,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAEIKD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
a2c4f981-1d32-476c-a9cb-23db2981c391_noid,-12.993657,12.119638,19.88778,-5.207557,-19.056643,TCGA AML,Diagnosis,TCGA-AB-2910,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
a367972c-f344-4050-805e-f594b097aec5_noid,12.816279,6.6687694,21.46245,-1.1947111,21.782608,TCGA AML,Diagnosis,TCGA-AB-3009,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
a37341ac-83cc-4205-a185-3d2c8a3dbfc6_noid,-7.607941,-17.03082,-20.81788,-21.319393,14.659627,TCGA AML,Diagnosis,TCGA-AB-2906,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
a3ad9c2b-e745-4242-99bc-c73c9674a780_noid,14.17806,5.36248,19.838362,-6.589057,16.118584,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASWFN,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
a3d9018b-b3c1-4620-83ec-93a5823b76b2_noid,-1.8350275,-10.643901,6.718257,10.819533,10.207024,TCGA AML,Diagnosis,TCGA-AB-2813,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
a3ea8a6f-a925-4914-b805-385f04d1d807_noid,14.550503,-12.054187,11.836364,15.5317135,-12.1195345,TCGA AML,Diagnosis,TCGA-AB-2821,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
a41b1adc-8d77-4cea-9381-952246d0dc73_noid,11.576351,-26.343912,-13.231858,3.826278,16.68993,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012427,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
a5d5621d-6334-40a8-bee2-184bc04f5e86_noid,-16.415548,6.766212,14.269282,13.068688,13.586243,AAML0531,Bone Marrow Normal,PARUCB,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
a6d7aeb2-ad0d-47bb-911a-ead586467ef8_noid,-5.505301,-10.3057375,11.4128475,10.668675,11.243139,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASWPD,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
a6e48c94-b406-4fa0-89de-c0ef83a866b6_noid,-13.771896,-13.625923,2.1042745,26.931612,-13.7029295,AAML0531,Bone Marrow Normal,PASDXR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
a72afbc3-2e60-46e2-b8ee-eb59ced71ed2_noid,-7.1889677,-10.803043,6.2460303,7.1399107,10.147328,TCGA AML,Diagnosis,TCGA-AB-2804,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
a7a1ab26-6e27-48f6-8166-e31181036bc9_noid,-13.174753,-13.728638,2.515624,27.61112,-13.955504,AAML0531,Bone Marrow Normal,PARTAL,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
a7e0f5d9-8d0a-49e6-b1cf-f445a8f8393e_noid,-12.034235,11.594074,4.040484,-24.719585,10.965249,TCGA AML,Diagnosis,TCGA-AB-2811,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
a859251c-03b5-4e6f-b7b2-5528f441bafd_noid,-8.284618,11.369697,-16.857643,-0.45580462,-23.274939,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040024,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
a90451f1-1222-46e1-8b9b-004f45e97690_noid,-9.667172,-7.2084618,12.020991,11.027666,11.15478,AAML0531,Bone Marrow Normal,PATJHJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with other rare recurring translocations
a9241c94-1bf7-48b4-ac1d-07564fdc809a_noid,15.231596,-9.366863,0.504452,-15.347674,-16.13082,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANLLX,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
a940a72a-56ee-4986-b8ec-fab37f00f433_noid,-7.637685,-16.990494,-20.806711,-21.336414,14.682042,TCGA AML,Diagnosis,TCGA-AB-2897,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
a9de89d6-3f28-4952-8046-8d05c96eabc9_noid,-6.8677216,12.172948,-19.103731,-0.18958744,-21.331228,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-SJBALL004182,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
aa03f716-9ab0-4ddf-b47f-339827ae6f5f_noid,-12.078327,11.321373,4.145014,-23.229881,10.318909,TCGA AML,Diagnosis,TCGA-AB-2869,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
aa1c2f79-ab1a-4145-aedb-03e02a2aa1d2_noid,4.1277604,12.448386,-10.85874,2.8938892,-25.53608,AAML0531,Recurrent Blood Derived Cancer - Peripheral Blood,PATJHJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
aa73cd77-fcee-4f62-83b8-bec83177aaee_noid,-14.688106,-13.206102,1.8786739,25.037725,-12.803938,AAML0531,Bone Marrow Normal,PASIGA,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
ab24d5d6-3df4-4f52-87cb-3d59047563ec_noid,3.6307108,14.130271,-12.333148,3.1325777,-25.663252,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012425,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
abd84dc0-8989-44cb-aea6-4a5e7fdbbb2d_noid,10.117592,-28.378428,-14.372004,4.376668,16.971537,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASNKZ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
ac0c9469-55bc-4749-92f5-3e25cd74ae03_noid,-13.914823,-13.613792,1.9848965,26.81055,-13.667234,AAML0531,Bone Marrow Normal,PARXYR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
ac46b04b-a02f-4049-8231-f20e868ab971_noid,-0.26579165,11.91369,-11.434878,1.9301007,-26.034773,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046470,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
ac5a6e8a-fc9f-400f-87de-7def9d2373d0_noid,-11.670018,-10.244255,19.706032,-13.022198,-16.403774,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045742,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
add9e84f-1927-4dea-af2c-009d6401345e_noid,-12.206612,11.2590685,3.8061154,-23.252848,9.7241,TCGA AML,Diagnosis,TCGA-AB-2988,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
ae638120-a9ee-4bba-9cbd-32c8f4eab591_noid,-14.902993,-2.9517677,14.7749605,11.707094,12.703822,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASVYA,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
ae8fb349-01b0-4242-8040-b27306ecab98_noid,-6.859095,12.312016,-19.327696,-0.20040034,-21.2247,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-SJBALL004182,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
aeb680b4-7775-449d-9064-6eab0bed0054_noid,3.5112429,18.7902,-13.903905,-8.005135,14.251957,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASHBI,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
aeddddda-7bc9-494f-8bc6-48b49d1ed505_noid,15.3115225,-8.2019205,-0.47923347,-18.284615,-13.025914,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARLSL,AML with mutated NPM1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with mutated NPM1
aee8c674-00c2-42cb-a68b-c2c6f76acb9f_noid,3.8112457,20.80907,-13.838852,-6.1069627,15.008854,AAML0531,Recurrent Blood Derived Cancer - Peripheral Blood,PARPPY,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
af2bdc16-bee8-4fc6-8adf-5cf586eac2d3_noid,-16.346493,5.067232,14.680741,12.313095,13.381573,TCGA AML,Diagnosis,TCGA-AB-2995,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,APL with t(15;17)(q24.1;q21.2)/PML::RARA
af7ff6e8-d005-4567-aeac-2877b4b3da38_noid,-15.055596,-3.595322,15.014839,11.6446905,12.901312,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASTTW,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
af8ca3f2-b003-4b80-b268-7f99d5f91515_noid,17.606829,-7.828104,-18.431929,-14.06017,20.706245,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045739,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with other rare recurring translocations
af91ddab-3888-4911-b6d7-3b2fa746bbd9_noid,13.852073,-7.815538,-19.247358,-14.092013,20.069763,TCGA AML,Diagnosis,TCGA-AB-3008,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
af9f053b-eb56-48a0-b6b7-a53007891721_noid,-7.5879207,-17.061798,-20.819628,-21.311993,14.645465,TCGA AML,Diagnosis,TCGA-AB-2997,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
afab714f-7d31-4062-b753-e863c6181c73_noid,-7.465711,-17.181078,-20.90859,-21.198515,14.548218,TCGA AML,Diagnosis,TCGA-AB-2872,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
afbb6597-cb54-4901-9e52-415159027d19_noid,-9.613087,-17.516325,10.625082,-20.899239,14.146455,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATKVD,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with mutated NPM1
afdf5306-6655-4b2c-a2ee-2db9fac63a24_noid,-12.79553,-9.273932,-17.43832,15.668266,19.434713,TCGA AML,Diagnosis,TCGA-AB-2909,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
afe59751-bb68-4c6e-b77f-c3c2137fe97a_noid,-17.395721,-18.967,0.56325096,-14.688541,-23.190657,TCGA AML,Diagnosis,TCGA-AB-2848,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
b10866e5-841f-4cc2-8edd-1bd89d99650e_noid,-16.449165,-8.819894,-18.443514,15.885588,18.915909,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PASMHY,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
b177e6ca-2743-47f2-aeb8-9363cd0cd4a3_noid,-6.079769,-11.696899,5.6069107,6.2863283,10.604626,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASHMK,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
b19cc421-5722-4ef7-8735-e2c4e7780857_noid,14.232531,-0.3508629,19.222492,-12.084509,15.131958,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASRCV,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,APL with t(15;17)(q24.1;q21.2)/PML::RARA
b1f3629b-50be-4c98-9034-57d595002ac2_noid,13.275487,5.555838,20.474455,-3.2141163,19.31598,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATBGC,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
b21c611d-1a6e-4968-8930-cb394b2b4e9d_noid,-15.025683,-0.9758813,14.500508,11.894213,12.526415,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAKERZ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
b2503d59-89d8-425c-a791-9cd6f8a29d66_noid,-14.063218,-13.631837,1.8122051,26.786907,-13.68975,AAML0531,Bone Marrow Normal,PASPLU,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
b2667850-1833-4f9a-af89-3441596905bc_noid,13.416163,-14.440961,0.2779968,-11.7767515,-16.26933,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012418,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
b2b3b96a-54ec-458c-b901-10626c6dc565_noid,-14.19873,-2.4806695,14.141354,11.752814,12.160586,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASJIM,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
b3002854-532d-456e-b0ae-b835becbfcc8_noid,-6.792771,-8.953249,9.063897,9.734924,11.178794,AAML0531,Bone Marrow Normal,PARSAN,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
b37e10a9-1710-44ca-b6d6-3e210ece43c3_noid,-14.1583395,-13.29421,2.2652862,25.616558,-13.016458,AAML0531,Bone Marrow Normal,PASAUT,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
b4194df8-5036-47b7-b891-a8c5275a3cd5_noid,15.384172,-9.451923,0.93326765,-14.656895,-16.496897,TCGA AML,Diagnosis,TCGA-AB-2812,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
b44074ad-d819-4990-9c35-32e4efb83f49_noid,-1.6039116,-10.235819,4.830106,9.730999,10.486601,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANYCG,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
b4a9a95f-516d-436e-a14b-3221102c4b67_noid,-5.4858336,-9.75578,7.8839607,9.145692,11.211836,TCGA AML,Diagnosis,TCGA-AB-2890,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
b4d1b88c-d55c-46e5-b211-33c5f2d39230_noid,15.25667,-8.252871,-0.46249005,-18.291714,-12.927538,TCGA AML,Diagnosis,TCGA-AB-2924,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
b4fc3dba-2d04-46ad-8bed-c6cf752f8b66_noid,15.170177,-8.470444,-0.48755163,-18.256124,-12.64032,TCGA AML,Diagnosis,TCGA-AB-2835,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
b54bc046-87d2-431b-82b4-ad8694521851_noid,-13.122968,-13.697254,2.615457,27.5386,-13.898926,AAML0531,Bone Marrow Normal,PASHHH,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
b57ee3da-cda3-432f-8ff0-9f8d2b29d5a1_noid,-9.679652,6.415841,-17.224672,-0.9051425,-21.538458,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045738,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
b6876c65-969b-4e74-82d2-9af83def97e0_noid,-16.456049,5.4765224,14.552152,12.656162,13.452663,AAML0531,Bone Marrow Normal,PATKJB,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
b6b43e6c-61d0-4ba8-b2a8-4a773a507b6a_noid,-7.5987654,-17.056757,-20.806717,-21.329771,14.655334,TCGA AML,Diagnosis,TCGA-AB-2999,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
b6bfd510-f308-4cf6-923c-81abf7c4d7bc_noid,14.62038,-9.097685,-0.8611087,-18.520105,-12.15692,TCGA AML,Diagnosis,TCGA-AB-2837,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
b74a6238-98a8-49a5-89b0-dde952618f25_noid,-14.164831,-13.225824,2.3696315,25.385128,-12.879916,CCG2961,Blood Derived Normal,PAEDKB,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
b77909eb-0b88-4e6e-9498-3be83550da4b_noid,13.487038,-14.401938,0.26741546,-11.938541,-15.803597,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012418,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
b7cc1c4d-d567-40c5-8133-e4744e0482e1_noid,14.049056,-12.660841,0.5519975,-12.300012,-17.99945,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASWLN,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
b8116f99-c662-4fdb-8048-73a2a887d323_noid,-14.0424,-13.397652,2.2085779,26.025465,-13.232668,AAML0531,Bone Marrow Normal,PASZLJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
b931e9e4-9f3c-4d71-878b-03243f087adf_noid,13.489566,-13.734156,-0.44434044,-12.863269,-16.954601,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASTUH,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
b93e195d-9c75-4be1-baed-252ebd0163d6_noid,4.5578237,12.664519,-11.161539,3.0038512,-25.2639,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATJHJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
ba186cdf-263b-41c3-922f-7bd5907025f9_noid,-16.496933,5.3997936,14.606353,12.603096,13.453764,AAML0531,Bone Marrow Normal,PASLSD,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
ba2b4334-376a-4f87-b386-c5f7c3aa73ac_noid,14.7925205,-12.014481,11.87274,15.718979,-11.125651,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARBTV,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
bb20d71e-3af9-463d-914a-e896ae3e527c_noid,1.0793092,21.5367,-12.179809,-7.846899,14.075796,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANNHB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
bc9332de-050f-4def-aa78-f52d6f3fb23e_noid,-0.09126029,-12.716951,7.814136,10.883186,10.698221,TCGA AML,Diagnosis,TCGA-AB-2838,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
bca2acf1-c728-48ef-9a0a-5fab2f73fe2c_noid,-2.3323717,-9.9895525,4.9869704,9.629814,10.526127,TCGA AML,Diagnosis,TCGA-AB-2927,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
bcb56fa6-1b29-4c06-833a-d05e5ad3d430_noid,-0.57487607,11.830545,-11.494317,1.8434448,-26.01805,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046470,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
bd15966b-29a1-471d-afa4-d3869c66ca65_noid,-1.27203,-8.527541,2.399049,10.952668,9.464733,TCGA AML,Diagnosis,TCGA-AB-2978,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
be2741cd-4941-4470-b41c-60f5ac2ba3a1_noid,-3.7752662,-11.07805,6.1935554,8.154605,11.115256,TCGA AML,Diagnosis,TCGA-AB-2843,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
be2af872-a30c-4f7b-9234-a3bb5a38000d_noid,14.023704,-11.343615,-0.66216815,-14.836592,-17.619038,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAEFGT,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
be2eb7ac-dcc5-481f-8a37-e137f18b62d2_noid,-3.0621567,9.626129,-18.417221,0.71616894,-21.39068,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPGPJ,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
be7a3f62-2d41-4c88-a287-e9da4f76a3f8_noid,14.517999,-10.600739,-1.2450695,-16.797804,-14.31538,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARUWX,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,Otherwise-Normal Control
bec046eb-2562-4ff4-a088-b6cf49edba02_noid,14.695434,-12.028852,11.85974,15.651793,-11.533772,TCGA AML,Diagnosis,TCGA-AB-2822,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
beea0c59-aa4b-468f-bd3a-45009f31a4b1_noid,-16.311153,6.539362,14.231259,13.046209,13.53762,AAML0531,Bone Marrow Normal,PARSHM,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
bf9284e4-c9f7-45bb-84b5-ba4ef1d0a75a_noid,13.081317,4.4215155,19.787003,-1.0141119,18.083578,AAML0531,Bone Marrow Normal,PARZIA,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
bfef4e4e-bff7-4381-bb29-787261610d6c_noid,14.622969,-9.879587,-1.01388,-17.04247,-14.782376,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PADZCG,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
c00ed630-244f-4036-a6d3-d726412394aa_noid,-14.205315,-13.3902855,2.0654128,25.905523,-13.20306,AAML0531,Bone Marrow Normal,PARYVW,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c037ac65-1921-4e88-9851-fa612fd4b2df_noid,-11.172259,12.304499,4.252378,-25.254496,12.130091,TCGA AML,Diagnosis,TCGA-AB-2825,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
c0a8e7cb-10bc-496c-aa64-6c5783f32102_noid,-13.297915,-8.807732,-17.959656,15.86528,19.467274,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PATIAK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
c0ac2349-0b7e-44e0-ad37-2d15f31876c6_noid,-15.9865885,7.4870806,13.817655,13.429313,13.568921,AAML0531,Bone Marrow Normal,PASJGZ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c0c71422-ddb2-48a7-b995-04a9e37114c0_noid,-11.765495,11.568268,4.3752337,-23.500944,10.947724,TCGA AML,Diagnosis,TCGA-AB-2931,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
c1074820-f5cb-4451-aa26-67758e4327a2_noid,14.622457,-11.153462,-1.4535695,-16.458569,-14.129039,AAML0531,Bone Marrow Normal,PARVUA,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c130fb6b-b240-4f01-bf74-31da13aec022_noid,14.403609,-10.854995,-1.5163617,-16.968937,-13.969327,CCG2961,Primary Blood Derived Cancer - Peripheral Blood,PAEERJ,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
c177f348-8f49-4ba4-a565-f232efc666ae_noid,1.1284302,-12.827826,9.139761,11.291968,9.613204,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATHBG,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,MDS-related or secondary myeloid neoplasms
c20e0518-abd3-4f8e-8c03-55b55e040693_noid,-5.3293657,-11.309415,5.505177,6.4270935,11.359212,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARNNT,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
c2352e46-4c5c-40bc-b6ab-78a5af86b89a_noid,-11.636495,11.955229,3.9922912,-24.9711,11.485722,TCGA AML,Diagnosis,TCGA-AB-2965,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
c23ed80c-a623-42ff-abee-5a77315ca28c_noid,13.511318,2.7306936,19.287247,-10.051688,16.301796,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATGBY,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
c2e140f3-f174-49e5-af4d-db64e2f5880e_noid,-14.216403,-13.306773,2.1898699,25.624287,-13.03538,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAKVGI,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
c36c6942-15f3-43a1-8c30-e1af68b2cead_noid,13.462094,-13.891215,-0.5954887,-14.185705,-13.013578,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL043771,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
c3716c61-91bc-4236-a3e2-5c9713559bb6_noid,3.19863,19.893093,-13.575806,-7.737679,14.201754,TCGA AML,Diagnosis,TCGA-AB-2886,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
c37f4828-23b5-4100-85c2-0003ad6a1227_noid,-7.6405873,-17.008701,-20.784044,-21.361864,14.687623,TCGA AML,Diagnosis,TCGA-AB-2982,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
c39342b3-d5ec-42b3-adb9-10ad39c6523c_noid,11.262235,-26.702196,-13.446257,3.9574974,16.733334,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-PARWPU,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
c446fc35-b605-4fa8-b570-c57e54289ef7_noid,14.251836,-7.849612,-19.0347,-13.717288,19.661846,TCGA AML,Diagnosis,TCGA-AB-2939,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
c48d03ad-675c-41f7-b442-1e759ea96214_noid,-13.125079,13.910429,18.671745,-6.7380595,-20.121485,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARBIU,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
c4cf00f2-7a03-4bfd-895c-690c17bda3af_noid,-7.327625,-8.56488,9.59251,10.190283,10.95509,AAML0531,Blood Derived Normal,PARDMG,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
c56f0235-0629-40bc-8625-2918fc8a1e05_noid,12.938655,-15.358091,0.15034476,-11.81578,-14.636344,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PAMYMA,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
c598a454-f971-4921-8568-827bdc83b563_noid,3.1366644,12.210817,-10.98168,2.6595743,-25.640585,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASLSD,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
c59eda9a-9d14-43d8-ab49-5e64f3832e94_noid,-11.796933,11.016453,19.137815,-6.125863,-18.930658,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PASCGR,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
c5afeaf2-b555-4b3e-857b-8decf95c893a_noid,-12.710131,-13.611208,3.1454093,27.499691,-13.769393,AAML03P1,Bone Marrow Normal,PAPBEJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c649701d-37d6-4f05-acf5-0301f2453ef2_noid,-16.257206,-11.296032,-16.790976,15.610364,19.296429,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATIAK,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
c6857d76-d855-462d-9447-a01af629f85b_noid,-12.600188,-13.758763,3.01839,28.04801,-14.06741,AAML0531,Bone Marrow Normal,PASBBE,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c69a92eb-2821-4110-b73a-3f1bc9abc6f5_noid,-13.276484,14.056759,19.16444,-5.9297295,-20.018286,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML003322,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
c6e04e4e-7e8e-40e7-99de-91f435e37c59_noid,-16.547117,6.154957,14.4455805,12.916776,13.549599,AAML03P1,Bone Marrow Normal,PANNHB,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c7765e2d-5dad-480e-a239-3f32c6e8af86_noid,5.450649,9.87758,-20.447582,25.189482,-1.3860996,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPEWV,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,Otherwise-Normal Control
c827d976-6147-42e2-829d-3384cc7a17a4_noid,-13.597358,-13.55572,2.387788,26.796892,-13.57978,AAML03P1,Bone Marrow Normal,PANYCG,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c82c30f6-045e-432c-a561-215f1ce5f81a_noid,4.616491,13.153008,-11.84794,3.087627,-24.969133,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012419,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
c8412d29-d2c6-47eb-b112-0ba1c8dd1549_noid,15.223411,-7.761879,-19.097343,-14.745059,21.22124,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASIEP,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
c86ad6b2-a0da-4c8d-9f37-ceda17e035fd_noid,-12.882644,-13.706646,2.8313959,27.71011,-13.939031,AAML03P1,Bone Marrow Normal,PAMYAS,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c87dddb2-3052-4876-9e35-d7aff994b7d5_noid,-14.600454,-13.535614,1.4420061,26.170734,-13.457648,AAML03P1,Bone Marrow Normal,PANYNR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c8a59d70-1442-49e6-bd31-e2c57e02080b_noid,-13.157772,-13.649434,2.6597862,27.359026,-13.801766,AAML0531,Bone Marrow Normal,PASWLN,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c951cb48-98bf-4515-b46e-2fc43cb0ffc0_noid,-13.157189,-13.551801,2.8172817,27.03793,-13.610534,CCG2961,Bone Marrow Normal,PAEFGR,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c98db3e6-f69c-4ea6-ba45-ae8245a67317_noid,-12.765115,-13.666779,3.008451,27.64697,-13.871423,CCG2961,Bone Marrow Normal,PAEFGT,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
c9a12f69-e527-4d7f-b0d1-2d1cc933b65f_noid,-3.8903532,9.403118,-18.525822,0.49539864,-21.378767,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARAMR,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
c9f84d81-427c-4cda-8c8a-932ba5b5e996_noid,14.720466,-12.020816,11.846814,15.661647,-10.899448,TCGA AML,Diagnosis,TCGA-AB-2887,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
ca008c90-57c7-49f2-bdef-85f0eb4ca630_noid,-15.985788,7.4082737,13.877172,13.316068,13.558969,AAML0531,Bone Marrow Normal,PARNIA,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
cb40b676-9fdc-4aae-8427-a10fc281e0cb_noid,2.1538506,-12.245336,7.920746,10.818658,9.338633,TCGA AML,Diagnosis,TCGA-AB-2807,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
cbec8c88-7a28-4d16-ae9c-76f54253769d_noid,-5.6231585,10.911033,-17.993011,0.20526344,-21.279984,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPGMC,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
cc1ba7ae-1c88-4df5-be03-16d0530524be_noid,-12.061789,12.331485,18.247187,-6.7236342,-18.660765,TCGA AML,Diagnosis,TCGA-AB-2987,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
cc2bcca5-c0c1-4446-8cfe-1c825b07b171_noid,14.813177,-11.053416,0.8614214,-13.084171,-17.97021,TCGA AML,Diagnosis,TCGA-AB-2839,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
cc88dba5-bf3a-421e-9dba-e945973990bf_noid,13.204843,5.6970506,20.611609,-2.9583063,19.650673,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASFLK,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
cc8da526-7843-43c3-a134-b630115d6571_noid,10.188258,-28.245485,-14.302813,4.3552976,16.950445,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PABLDZ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
cd6c5f0e-dd0d-49f6-badb-75ba3f74e006_noid,-13.221876,-13.625062,2.6372616,27.241816,-13.748564,AAML0531,Bone Marrow Normal,PASHBI,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
cdb2dcb5-b6dc-4a70-a0ea-d898f4289f1a_noid,-7.2543,-17.41872,-21.030752,-21.031895,14.384373,TCGA AML,Diagnosis,TCGA-AB-3007,APL with t(15;17)(q24.1;q21.2)/PML::RARA,Discovery (train) Samples,GDC_TCGA-AML,Acute promyelocytic leukemia (APL),APL with t(15;17)(q24.1;q21.2)/PML::RARA
cdc8cd91-ad42-4460-97e2-b1b1b50c0ec0_noid,14.464573,-12.050815,11.780279,15.470881,-10.797847,TCGA AML,Diagnosis,TCGA-AB-2992,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
ce773f80-a5b5-4cf9-9701-b693af82c8f8_noid,-12.520237,9.57063,19.675993,-5.160139,-18.644032,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PAECCE,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
cec18048-4866-49d5-899d-aa45921344c3_noid,13.917427,3.9913461,19.069426,-7.1606364,16.697433,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASJJR,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
cf5203dd-c54f-4a2e-98c5-bd7a250b4f82_noid,15.359015,-11.953875,12.119046,16.264458,-14.410642,TCGA AML,Diagnosis,TCGA-AB-2900,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
cfd39f41-5f8c-40a8-860e-b7a21c9a4b89_noid,13.545782,4.9090815,20.059742,-4.858046,17.966084,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016447,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),MDS-related or secondary myeloid neoplasms
cfd9205a-c9f8-493c-9938-4415a46fa6af_noid,-14.03829,-13.38625,2.2323074,25.987665,-13.210182,AAML0531,Bone Marrow Normal,PASWPD,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
d075a42b-bde2-4025-9296-8ac242354402_noid,13.114825,5.1033416,19.643507,-0.6089089,18.874277,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANTNA,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
d0b1bcde-7ac2-4bfa-bf7f-8a58e0cc764c_noid,-15.934649,2.7815688,14.618871,12.1764765,13.0295105,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046472,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
d1b053be-31bd-42b0-89cf-53dbcf6dc0ce_noid,1.114201,22.467907,-12.061397,-6.5771804,14.765222,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANDER,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
d24dd69b-5e32-4dca-97c7-12d8863dafdc_noid,-11.741745,7.9948735,21.867529,-2.078231,-17.693663,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASVVS,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
d2cdcd2b-31b8-4020-894a-9a6cf1ac9c52_noid,-8.841227,-8.088886,12.355939,11.023516,11.273774,AAML0531,Bone Marrow Normal,PASTTW,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
d36fca25-8cfb-4aaf-bb30-1058cfcbd6e8_noid,-14.02981,-13.231379,2.491029,25.481377,-12.901533,AAML0531,Bone Marrow Normal,PASVVS,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
d3ab7cce-8763-44e1-a4f1-6bfe13b4eb4f_noid,-16.756384,6.428986,14.4946995,13.043374,13.632442,AAML0531,Bone Marrow Normal,PARLSL,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
d567f462-f127-48c5-8829-9c380eab88f3_noid,14.663466,-12.02734,11.827141,15.614455,-10.667902,AAML0531,Bone Marrow Normal,PARBTV,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),MDS-related or secondary myeloid neoplasms
d576aaa5-7741-40d9-a06d-2c72428af9ba_noid,-7.13921,-8.7332735,9.517897,10.116529,10.979708,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARIMT,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
d5820fdb-5e78-4ebe-8555-09936a1f6328_noid,-18.498287,-9.492444,-17.973948,15.460663,18.27817,TCGA AML,Diagnosis,TCGA-AB-2815,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
d587c5c1-5e9a-4eea-8963-babdabb70f2d_noid,-13.448661,-13.512586,2.6028266,26.73829,-13.507252,AAML0531,Bone Marrow Normal,PASRTP,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
d58d02dd-a855-4af4-93f5-8ea1f1837b0f_noid,13.277798,-11.080664,-1.6227665,-18.10025,-12.31921,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PAPXRJ,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
d5ae5865-c405-4a32-afe1-26c0a37c3efd_noid,0.58350974,22.146898,-12.496051,-6.955703,14.301676,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML045741,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
d7399c31-0041-42aa-9d76-6040395562bc_noid,14.800731,-10.91587,-1.5673193,-16.427685,-14.801022,CCG2961,Bone Marrow Normal,PAEERJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
d73e78e9-c331-4d49-9ffd-5f73d74dcae2_noid,14.885119,-9.581764,-0.61963606,-16.721275,-15.020147,CCG2961,Recurrent Blood Derived Cancer - Bone Marrow,PADZCG,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
d7ae5d69-b7b2-4c39-bda0-f9640d0a2041_noid,15.457414,-11.941011,12.128143,16.322506,-13.990614,TCGA AML,Diagnosis,TCGA-AB-2810,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
d7e14462-cdf4-41f2-96a8-a8dd6d180b6c_noid,-18.159113,-18.792145,-0.29718968,-15.461301,-23.601603,TCGA AML,Diagnosis,TCGA-AB-2971,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
d7ff2323-c258-44a5-904b-f3cf4325e617_noid,15.215167,-11.961326,12.114508,16.226248,-14.920938,CCG2961,Primary Blood Derived Cancer - Peripheral Blood,PAKSMZ,AML with mutated NPM1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with mutated NPM1
d866f66f-b7a4-431f-aea0-4ca600550c7c_noid,12.707192,-12.380318,-1.8610803,-18.181992,-9.562695,TCGA AML,Diagnosis,TCGA-AB-2802,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
d88199cf-d317-402c-aca8-3a9cf3bfa986_noid,4.9986324,9.7389555,-20.411903,25.989616,-1.8011585,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPAWY,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,Otherwise-Normal Control
d8a056e0-32bb-4675-9572-3dbb4c4eb6d0_noid,13.690998,-10.6841135,-1.139832,-17.592966,-12.876866,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PARVAI,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
d95061e2-8ffa-4f01-a1cb-1155fd6ddeea_noid,-11.928683,12.202009,17.840069,-8.041033,-19.34913,TCGA AML,Diagnosis,TCGA-AB-2861,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
d99a1988-883e-4136-89ca-670b5939a792_noid,-4.4840536,-10.77373,6.319473,7.7845397,11.511056,TCGA AML,Diagnosis,TCGA-AB-2857,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
db38e3d4-c71f-493c-b38d-13a66dcdcd7a_noid,10.078333,-28.423817,-14.399058,4.3928857,16.97735,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASFHK,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with mutated NPM1
dbf6383b-fa4b-417d-ba75-cbb727bc8146_noid,13.46466,4.3270826,18.859001,-1.2232518,17.069593,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASWPD,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
dc90b95f-c63a-4f49-aab1-4c2723914b31_noid,3.7539794,12.050487,-11.365808,2.7147923,-25.009222,TARGET ALL,Primary Blood Derived Cancer - Peripheral Blood,TARGET-15-SJMPAL012424,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
dc9882f1-982e-4e63-95d3-950636fe7baf_noid,-17.682522,-18.90543,0.24827,-14.97287,-23.341919,TCGA AML,Diagnosis,TCGA-AB-2879,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
dc98fa8b-8a94-4c5d-87c4-05a017786c02_noid,-17.995829,-18.836334,-0.09721428,-15.286385,-23.50742,TCGA AML,Diagnosis,TCGA-AB-2903,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
dcb15851-48aa-42f6-8a1a-e2a65be88abb_noid,13.507232,5.0851507,20.0666,-4.551882,18.330618,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATFWF,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,MDS-related or secondary myeloid neoplasms
dcea483a-5103-491c-ab29-f006ca309f0a_noid,12.911849,6.2685513,20.892471,-0.7260129,20.986546,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PARYVW,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
dd0359ee-8048-41ce-a506-037e7ecd063e_noid,-12.960919,-13.655766,2.8397934,27.492662,-13.831139,AAML0531,Bone Marrow Normal,PARNAW,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
dd118a4d-e4de-4c87-bc60-c22fee5ae529_noid,-12.827113,13.778757,18.59998,-6.185646,-19.135666,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-20-SJAML003320,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
de132664-f80e-46d5-aa61-f0cebfc4afad_noid,14.32303,-11.775018,-0.41939816,-14.712939,-15.408997,TCGA AML,Diagnosis,TCGA-AB-2844,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
df7e3244-2fba-4408-a990-888246966b53_noid,-10.111389,6.4084945,-17.0369,-0.99426574,-21.732927,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL016342,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
df82f109-363c-4140-9d38-6779f8c60c88_noid,-11.611964,11.911252,4.0625963,-24.662193,11.357771,TCGA AML,Diagnosis,TCGA-AB-2974,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
e036c3cb-a36b-4626-9c94-eb79067a129d_noid,13.340074,-14.383251,-0.967892,-14.330142,-12.354928,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASDXR,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
e163d036-2541-4cb2-965f-f41fa67477ce_noid,-7.409558,-8.657365,9.968337,10.301899,10.943149,AAML0531,Bone Marrow Normal,PARCEC,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
e19576cf-746e-4c41-8523-7510782b412b_noid,-16.672623,-8.409602,-18.79981,15.896527,18.456942,TCGA AML,Diagnosis,TCGA-AB-2828,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
e1d7ec15-3bb1-4eba-a423-e05134c2e17f_noid,13.739818,4.3660593,19.998938,-6.605791,16.59535,TARGET ALL,Recurrent Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL003414,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
e1daa186-616c-4144-9f8e-79d5843c9488_noid,-1.3778262,-8.213181,2.237875,11.088281,9.433842,TCGA AML,Diagnosis,TCGA-AB-2898,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
e211af66-862b-413f-baff-bd9179f96a89_noid,3.5850313,18.794382,-13.871224,-7.605337,14.574526,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PAMYAS,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
e217cdd3-2cd4-434f-ac89-9d682b92b5a7_noid,11.976049,-26.039894,-13.020762,3.635128,16.667421,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL040037,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
e36c114f-1102-47b6-a346-0cb2e6f5e583_noid,0.2711786,-12.656185,8.374644,11.198524,10.6901655,TCGA AML,Diagnosis,TCGA-AB-2929,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
e3915304-852a-4f4f-977b-34ff7d14c2b4_noid,3.1673558,12.039376,-10.431428,2.6658769,-26.016766,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PARWXU,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
e3b8ff87-7dd7-470f-9aee-f17f346ede27_noid,14.680208,-12.02855,11.855789,15.6488285,-11.472091,TCGA AML,Diagnosis,TCGA-AB-2936,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
e459592c-2e40-4c7e-a503-eb7175f7db6a_noid,-2.2763596,-11.242943,8.094158,10.542492,10.56756,TCGA AML,Diagnosis,TCGA-AB-2943,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
e4c68553-85f2-439f-9996-0971380be29e_noid,-5.9870505,-10.574125,10.488211,11.059452,9.465884,CCG2961,Primary Blood Derived Cancer - Peripheral Blood,PADYIR,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
e59424f2-a3ca-46c1-aeb9-193a5cd5f4aa_noid,-3.964946,-9.777042,6.992725,10.025752,10.636355,TCGA AML,Diagnosis,TCGA-AB-2996,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
e7228204-40c0-4780-8707-d822e32f479b_noid,-8.929466,6.869127,-18.188145,-0.7676683,-20.816963,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046471,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
e734da42-a984-4ac2-adae-eeaffef47b4b_noid,16.759525,-7.6117644,-19.33729,-14.174222,19.648983,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANLIR,AML with in-frame bZIP mutated CEBPA,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
e81aa9f2-d2cd-4db6-9247-ad705e8845f5_noid,-8.763329,-8.262181,12.759492,11.068025,11.447923,AAML0531,Blood Derived Normal,PATAIJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
e8389e5d-0067-4fb5-b1b4-9bdd09feafe0_noid,-11.415367,12.137198,3.8280756,-24.875305,11.457416,TCGA AML,Diagnosis,TCGA-AB-2969,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
e844b417-c4ad-41db-b361-e93e3c88d3f3_noid,-12.020248,12.161645,17.87109,-7.7108355,-19.043118,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PATAIJ,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
e8885df6-f636-4950-9abd-80ac94f55791_noid,14.191684,-12.126902,11.804957,15.225412,-14.734528,TCGA AML,Diagnosis,TCGA-AB-2926,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with in-frame bZIP mutated CEBPA
e90dcc10-17fa-48dc-a709-8a3396ca3238_noid,14.883077,-8.688593,-0.79830456,-18.654861,-12.205186,TCGA AML,Diagnosis,TCGA-AB-3011,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
e9e2d4a5-d590-4897-8a8c-e251bf2e3011_noid,12.074752,-25.959694,-12.96571,3.5872638,16.661152,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012420,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
ea72d9e7-2703-4404-9ea2-550b51eb5aef_noid,13.413071,2.6590023,19.532253,-9.727312,16.565886,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARUEU,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
ea832f1b-e9db-4ae8-b40f-139d827b94f7_noid,13.527506,-11.999503,1.272496,-13.671759,-14.56942,AAML0531,Bone Marrow Normal,PASVJS,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
eb3059f2-d248-4365-8107-f780acca403c_noid,-12.866249,-13.663035,2.9161494,27.575457,-13.855403,AAML0531,Bone Marrow Normal,PASJIM,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
eb936406-f60c-45bb-89f8-5b9e5ea664c4_noid,14.610449,-12.046699,11.8507395,15.577112,-12.085459,TCGA AML,Diagnosis,TCGA-AB-2863,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
eb983f69-b2b4-4152-b98a-1743899a794f_noid,11.170472,-26.879898,-13.538128,3.9815767,16.761993,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012421,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with other rare recurring translocations
ec8b3b8b-3e67-40f4-a722-8bf6544c5651_noid,-4.290556,-9.438594,6.588058,9.961445,10.501084,TCGA AML,Diagnosis,TCGA-AB-2948,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
ecb1b0ed-65b1-4a02-af60-efad202004d0_noid,14.899811,-10.421338,0.6147829,-14.05497,-17.376797,TCGA AML,Diagnosis,TCGA-AB-2989,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
ed2e4bab-c279-49fa-84f1-30f91e4a020e_noid,-16.381226,6.900253,14.200181,13.15941,13.595073,CCG2961,Bone Marrow Normal,PAKIWK,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
efb8e585-64cc-4413-a2f4-1bdfab2d54b4_noid,-10.73217,-15.075614,-21.735474,6.906709,-21.660688,TARGET ALL,Bone Marrow Normal,TARGET-00-SJNORM054698,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Otherwise-Normal (Control),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
eff06a45-4e14-477b-9428-3b5b314cec33_noid,13.234029,1.4145325,19.575558,-11.224994,16.521618,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASRMM,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f13c12b7-185a-4c96-86b6-5b0b0e701f97_noid,-4.1731253,-11.109337,6.008722,7.6227922,11.32964,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAKIWK,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,MDS-related or secondary myeloid neoplasms
f1d43a24-fef3-41fe-8681-fecbd82dae4b_noid,-16.497845,5.646943,14.50721,12.783161,13.483496,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PANNHB,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),Otherwise-Normal Control
f200c34f-9910-43b6-890e-6fcb9a701895_noid,14.659239,-9.698628,-0.6012984,-16.90645,-14.594329,TCGA AML,Diagnosis,TCGA-AB-2986,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
f240e230-16d4-4505-8907-3d90bd37d796_noid,14.556291,-12.169469,11.795188,15.072964,-15.32372,TCGA AML,Diagnosis,TCGA-AB-2866,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
f30fb61d-b08c-4e74-aa50-3a3f0fee6b03_noid,13.758404,-11.244696,-0.9921637,-15.374084,-17.708334,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASRTP,AML with mutated NPM1,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with mutated NPM1
f32cabaf-8878-4c7a-8754-2dcc13e764e6_noid,-15.257658,9.033628,15.463716,9.671988,13.650604,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL046466,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
f3c62e33-2e54-41c7-a1b1-354314300ec5_noid,3.64187,14.053254,-12.325554,3.1156347,-25.607847,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-15-SJMPAL012425,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Mixed phenotype acute leukemia (MPAL),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f478ac66-7b25-474c-8662-abd004065f8a_noid,-12.129295,10.955708,19.910553,-5.1366167,-18.463844,TCGA AML,Diagnosis,TCGA-AB-2956,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f4812d4e-b276-47be-8389-0437b1632882_noid,-1.3271865,-10.155228,4.516829,9.978118,10.311394,TCGA AML,Diagnosis,TCGA-AB-2922,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
f4a5505a-f819-434b-8f84-498ce19823cb_noid,-13.608396,-13.619487,2.2739391,27.002,-13.704089,AAML03P1,Bone Marrow Normal,PANCSC,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
f52bc0fa-610e-4a46-b0a2-0ad76d6c7fac_noid,13.054731,4.0221977,19.4916,-0.27308002,17.502523,TCGA AML,Diagnosis,TCGA-AB-2814,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with other rare recurring translocations
f543268b-8e6c-4029-8ab7-368e8a00db46_noid,-0.9640383,-8.220805,1.7127815,10.769566,9.615533,TCGA AML,Diagnosis,TCGA-AB-2934,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
f5b2c1f0-ee80-4061-b39b-6004c8471404_noid,12.508104,1.1175145,20.545124,-10.417294,17.930204,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PATGYH,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f613eedb-011d-44fc-b0f7-1e0509f65678_noid,-9.357301,-17.764187,10.654002,-20.849083,14.134203,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASHUP,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with mutated NPM1
f691c731-90b6-412b-bc48-0ab610e5b7c9_noid,-14.471176,-13.486707,1.6499949,26.07933,-13.372056,AAML0531,Bone Marrow Normal,PASRLS,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
f71dfba8-0b5b-46a2-8f5d-82e01e1c69aa_noid,10.369936,-27.872889,-14.112068,4.3054442,16.88972,AAML0531,Bone Marrow Normal,PASFJJ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
f7439a0c-764d-410d-a79e-d323ba2aa10a_noid,-14.591224,-1.673045,14.296325,11.831134,12.313697,AAML0531,Primary Blood Derived Cancer - Bone Marrow,PASCFW,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
f79329e9-697f-4df2-b650-488f6a28e0db_noid,13.689184,3.7220993,19.692482,-7.942092,16.607391,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARPYJ,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f805d82d-045c-4e85-b1ba-66ff786999cf_noid,-2.2461665,9.908833,-17.801619,0.9621346,-21.812319,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PANJRD,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f81837ec-784c-45d3-9ce2-3cdf1f219980_noid,14.086237,-11.664523,-0.39264974,-14.246695,-17.61701,TCGA AML,Diagnosis,TCGA-AB-2913,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f8281fca-1b6d-458b-988b-7b010cade942_noid,13.4339075,2.5458589,19.679485,-9.484424,16.637903,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PASHNK,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
f86fd4aa-433d-4585-b81d-5ca2a12027e7_noid,-0.46304289,-8.706708,1.4342426,9.96581,10.06293,TCGA AML,Diagnosis,TCGA-AB-2833,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
f87b8d81-f642-43b3-bb7f-50635896a9bf_noid,-16.430664,5.212132,14.606087,12.544458,13.417669,AAML03P1,Bone Marrow Normal,PANDIX,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
f911064b-111c-4c94-af71-f1dcd325e841_noid,12.821897,-12.416203,-1.6242423,-17.83602,-9.77644,TCGA AML,Diagnosis,TCGA-AB-2884,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
f9cd9d51-b69a-4518-b5b7-99338a323c64_noid,-14.825319,-1.2048336,14.3877125,11.87656,12.403547,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAKVGI,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
fa2ae001-0436-419d-938c-0862fb985a34_noid,13.256799,-11.580039,-1.0316343,-15.573364,-17.191895,AAML03P1,Recurrent Blood Derived Cancer - Bone Marrow,PAMYJX,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
fa7baeb9-a9d9-4cde-b326-edee1ff33ca7_noid,13.277751,1.9667746,19.561602,-10.623979,16.569256,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PARTBP,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
fa8aede5-e42d-49dc-bf65-7a3da34d8dd4_noid,14.37426,-11.050463,0.21960083,-14.223323,-17.148928,CCG2961,Primary Blood Derived Cancer - Bone Marrow,PAKTCX,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with mutated NPM1
faa32946-e27f-42a3-8b9d-782f7d2a77c9_noid,13.858354,-11.941271,0.01264414,-13.802745,-17.4293,AAML03P1,Primary Blood Derived Cancer - Bone Marrow,PANSJB,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
fafc11c5-1e98-4fe0-a029-29ba5a1e3100_noid,-16.863758,6.0126047,14.571131,13.05156,13.611914,AAML0531,Bone Marrow Normal,PASCRZ,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
fbddb667-018c-4e17-9858-96c273b6d5e2_noid,10.240486,-28.160221,-14.257025,4.3375826,16.937809,AAML0531,Bone Marrow Normal,PARHRS,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
fcdaabff-e76c-48dc-9acd-dc36beb0f4ac_noid,13.8674135,-14.068999,-1.36623,-14.446691,-13.001511,AAML0531,Recurrent Blood Derived Cancer - Bone Marrow,PASPLU,AML with other rare recurring translocations,Discovery (train) Samples,GDC_TARGET-AML,Acute myeloid leukemia (AML),AML with other rare recurring translocations
fcfa89d8-f11e-4264-be00-e112c4c619f5_noid,13.091174,5.08239,19.575617,-0.2599221,18.85645,AAML0531,Primary Blood Derived Cancer - Peripheral Blood,PASCRZ,Unknown,Discovery (train) Samples,GDC_TARGET-AML,Unknown,AML with other rare recurring translocations
fd0d7fba-01de-4035-b3fa-41a84a4c562d_noid,-2.5153265,9.837127,-18.289572,0.86882854,-21.435081,TARGET ALL,Primary Blood Derived Cancer - Bone Marrow,TARGET-10-PAPHGD,Unknown,Discovery (train) Samples,GDC_TARGET-ALL,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
fd4e4be4-3306-4037-b4e9-7886283243ed_noid,13.255684,5.1862497,19.966438,-1.9624764,18.902077,AAML0531,Bone Marrow Normal,PASTZK,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
fe185655-3aa5-4c5c-9dfd-630e0ee71710_noid,-11.661216,13.486123,18.866564,-6.7877493,-19.845997,TCGA AML,Diagnosis,TCGA-AB-2832,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Discovery (train) Samples,GDC_TCGA-AML,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
ff7f7d14-5fb7-44bc-b67a-d07610873330_noid,-5.839739,-9.873024,8.698593,8.985325,11.653097,TCGA AML,Diagnosis,TCGA-AB-2831,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,AML with mutated NPM1
ff87c237-583a-4aa1-880c-7d77d00ba0a6_noid,-3.2886794,-11.198377,7.2912645,9.627376,10.2037,TCGA AML,Diagnosis,TCGA-AB-2964,Unknown,Discovery (train) Samples,GDC_TCGA-AML,Unknown,MDS-related or secondary myeloid neoplasms
ffeac099-79b4-4fbf-a283-275d31baf531_noid,-16.651571,6.6778784,14.3845005,13.113633,13.632799,AAML0531,Bone Marrow Normal,PARFXF,Otherwise-Normal Control,Discovery (train) Samples,GDC_TARGET-AML,Otherwise-Normal (Control),Otherwise-Normal Control
8221916056_R01C01,13.008729,-11.074321,-1.6492358,-17.905739,-13.667738,AML02,Diagnosis,AML02_11,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
8221916056_R01C02,-11.420347,11.521381,20.299639,-4.056964,-18.092272,AML02,Diagnosis,AML02_19,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221916056_R02C01,13.422521,-14.358597,-0.034372866,-12.408961,-15.433642,AML02,Diagnosis,AML02_12,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8221916056_R02C02,-18.35968,-9.523077,-17.953066,15.529472,18.564962,AML02,Diagnosis,AML02_20,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221916056_R03C02,-11.7383,9.460316,21.599903,-2.1161566,-17.582054,AML02,Diagnosis,AML02_21,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221916056_R04C01,1.3426808,-13.063672,8.811961,11.386971,10.175929,AML02,Diagnosis,AML02_14,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
8221916056_R04C02,-18.36371,-9.703702,-17.789854,15.465495,18.557495,AML02,Diagnosis,AML02_22,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221916056_R05C01,-11.687521,12.95371,19.449286,-5.7176447,-19.100212,AML02,Diagnosis,AML02_16,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221916056_R06C01,1.2182057,21.72427,-12.6236515,-7.4246964,14.096108,AML02,Diagnosis,AML02_17,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8221932112_R01C01,12.99203,-12.800995,-0.77122825,-16.146719,-11.681686,AML02,Diagnosis,AML02_26,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8221932112_R01C02,2.2739182,19.837025,-13.373086,-7.6024923,14.338356,AML02,Diagnosis,AML02_15,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8221932112_R02C01,4.3649487,18.122025,-14.221881,-7.705914,14.632056,AML02,Diagnosis,AML02_27,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8221932112_R02C02,14.204871,-9.953247,-0.9356753,-17.984932,-12.340671,AML02,Diagnosis,AML02_34,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8221932112_R03C01,-12.029424,11.498993,19.064438,-5.9291935,-18.653044,AML02,Diagnosis,AML02_29,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221932112_R03C02,-17.716589,-9.341547,-18.14229,15.709122,18.77177,AML02,Diagnosis,AML02_35,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221932112_R04C01,14.325063,-10.878489,-0.7151224,-15.986568,-14.99343,AML02,Diagnosis,AML02_30,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8221932112_R04C02,-10.996779,12.617641,19.43736,-5.997102,-19.099869,AML02,Diagnosis,AML02_36,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221932112_R05C01,-5.4183836,-11.33173,5.635415,6.5757804,11.180802,AML02,Diagnosis,AML02_31,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8221932112_R05C02,-14.355882,-3.936148,14.550998,11.600959,12.519623,AML02,Diagnosis,AML02_37,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8221932112_R06C02,1.613093,20.80587,-12.970391,-7.2655945,14.394192,AML02,Diagnosis,AML02_38,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8221932113_R01C02,13.672873,-14.0603485,-1.1436173,-14.375537,-12.986265,AML02,Diagnosis,AML02_45,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8221932113_R02C01,-10.744682,6.304462,-16.471401,-1.1144147,-22.221193,AML02,Diagnosis,AML02_40,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221932113_R03C01,-14.535145,-3.8484626,14.670496,11.612405,12.617148,AML02,Diagnosis,AML02_41,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8221932113_R04C01,-17.935375,-10.301426,-17.314674,15.330709,18.48515,AML02,Diagnosis,AML02_42,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221932113_R04C02,13.292232,-13.066768,-1.1213092,-15.939258,-11.80685,AML02,Diagnosis,AML02_51,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8221932113_R05C01,-10.6461,6.228344,-16.493944,-1.0953326,-22.161327,AML02,Diagnosis,AML02_43,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221932113_R05C02,0.7429113,-11.414743,5.050014,10.116983,9.439872,AML02,Diagnosis,AML02_52,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
8221932113_R06C01,13.647644,-11.564389,-1.2233717,-17.080906,-12.313134,AML02,Diagnosis,AML02_44,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8221932113_R06C02,-11.591369,11.363521,20.443207,-2.9208348,-17.974337,AML02,Diagnosis,AML02_53,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221932114_R01C02,-17.739946,-10.670367,-17.396038,15.691577,19.120443,AML02,Diagnosis,AML02_61,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221932114_R02C01,-12.096406,12.107786,19.574858,-5.2556257,-18.96449,AML02,Diagnosis,AML02_56,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221932114_R02C02,14.553426,-9.679699,-0.5481081,-17.160479,-13.931016,AML02,Diagnosis,AML02_62,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8221932114_R03C01,1.6466007,21.500954,-13.066245,-7.0380697,14.265227,AML02,Diagnosis,AML02_57,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8221932114_R03C02,-11.72056,12.333902,19.610796,-4.8517194,-18.446413,AML02,Diagnosis,AML02_64,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221932114_R04C01,13.637303,-10.759949,-1.3565853,-17.878311,-12.582043,AML02,Diagnosis,AML02_58,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
8221932114_R05C01,-11.497582,12.174201,20.204126,-4.641777,-18.427906,AML02,Diagnosis,AML02_59,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8221932114_R06C02,15.03481,-9.001096,-0.2647703,-17.275646,-13.7892885,AML02,Diagnosis,AML02_68,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8221932153_R01C01,-16.953545,-11.2291765,-17.015587,15.692292,19.260706,AML02,Diagnosis,AML02_01,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8221932153_R03C02,15.017702,-8.85881,-0.4117302,-17.61195,-13.602255,AML02,Diagnosis,AML02_102,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8221932153_R05C02,13.198805,-14.321722,-0.86314744,-14.23971,-12.680998,AML02,Diagnosis,AML02_116,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8343981012_R01C02,17.053299,-7.588668,-19.298883,-14.787501,20.717644,AML02,Diagnosis,AML02_132,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
8343981012_R02C02,13.35035,-12.564652,-1.2519315,-16.388716,-12.189293,AML02,Diagnosis,AML02_107,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8343981012_R03C02,-17.68038,-11.030334,-17.145958,15.728768,19.555254,AML02,Diagnosis,AML02_158,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8343981012_R06C01,15.606974,-7.7055206,-19.189535,-14.999248,21.464218,AML02,Diagnosis,AML02_166,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
8784225049_R01C01,13.120078,5.654962,20.447948,-1.9889457,19.717987,AML02,Diagnosis,AML02_69,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784225049_R01C02,-10.751817,-6.372447,12.674752,11.237824,11.282706,AML02,Diagnosis,AML02_75,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8784225049_R02C01,-11.008068,-6.14826,12.744305,11.275489,11.282892,AML02,Diagnosis,AML02_70,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8784225049_R02C02,-11.667158,9.298296,21.65849,-2.1336248,-17.578907,AML02,Diagnosis,AML02_77,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784225049_R03C02,-12.08028,-5.438878,12.8373375,11.515873,10.667729,AML02,Diagnosis,AML02_78,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8784225049_R04C01,-18.123545,-10.005253,-17.5345,15.380235,18.490265,AML02,Diagnosis,AML02_72,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784225049_R04C02,3.503795,19.49249,-13.787642,-7.376069,14.532646,AML02,Diagnosis,AML02_79,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784225049_R05C01,16.078812,-7.643398,-19.284046,-15.091142,21.408186,AML02,Diagnosis,AML02_73,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
8784225049_R05C02,-1.9415721,-9.07633,2.79162,11.312281,8.77842,AML02,Diagnosis,AML02_80,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),MDS-related or secondary myeloid neoplasms
8784225050_R01C01,1.5282553,21.012016,-13.165492,-7.6140285,13.942586,AML02,Diagnosis,AML02_84,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784225050_R01C02,-11.901233,-5.331518,12.92192,11.45029,11.075903,AML02,Diagnosis,AML02_90,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8784225050_R02C02,17.228605,-7.595517,-19.24554,-14.760074,20.725246,AML02,Diagnosis,AML02_91,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
8784225050_R03C01,-5.809489,-11.553542,5.6515245,6.4533978,10.788501,AML02,Diagnosis,AML02_86,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
8784225050_R03C02,-11.566745,12.06944,20.071867,-3.9713821,-18.296494,AML02,Diagnosis,AML02_92,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784225050_R04C01,-14.741131,-3.770252,14.810684,11.6235695,12.7310705,AML02,Diagnosis,AML02_87,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8784225050_R04C02,-13.682333,-3.3365211,13.926701,11.658216,11.988358,AML02,Diagnosis,AML02_93,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8784225050_R05C01,-14.77167,-3.6634295,14.813249,11.634897,12.733071,AML02,Diagnosis,AML02_88,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8784225050_R05C02,-11.130156,-6.0447493,12.781232,11.2941,11.282989,AML02,Diagnosis,AML02_94,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
8784225050_R06C01,16.736996,-7.627013,-19.255838,-14.564049,20.446377,AML02,Diagnosis,AML02_89,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
8784225081_R01C01,-11.450736,12.026494,4.1854844,-24.746412,11.608671,AML02,Diagnosis,AML02_98,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784225081_R02C01,-0.31368575,-12.979282,7.52611,9.860516,10.1188345,AML02,Diagnosis,AML02_101,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
8784225081_R02C02,1.2059261,-13.156836,8.502763,11.271617,9.989991,AML02,Diagnosis,AML02_111,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
8784225081_R03C01,14.876711,-8.990208,-0.5742704,-17.901546,-13.059848,AML02,Diagnosis,AML02_102,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784225081_R04C01,-11.104943,12.118659,19.574293,-5.7937365,-19.017338,AML02,Diagnosis,AML02_104,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784225081_R04C02,-11.664546,9.007339,21.696177,-2.202453,-17.619598,AML02,Diagnosis,AML02_115,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784225081_R05C01,-14.337583,-2.094836,14.181857,11.790379,12.201822,AML02,Diagnosis,AML02_105,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784225081_R06C01,16.437561,-7.638083,-19.244267,-14.980705,21.216112,AML02,Diagnosis,AML02_109,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
8784233006_R01C01,-14.202595,-13.263088,2.2660472,25.492466,-12.952698,AML02,Diagnosis,AML02_121,Unknown,Validation (test) Samples,St Jude Children's,Unknown,Otherwise-Normal Control
8784233006_R01C02,-11.933224,13.162276,18.998358,-6.2471757,-19.321793,AML02,Diagnosis,AML02_129,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233006_R03C02,-11.94555,-10.011613,20.228891,-12.922966,-16.513231,AML02,Diagnosis,AML02_131,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233006_R04C01,3.5354826,20.714931,-13.6302185,-6.6395016,14.731635,AML02,Diagnosis,AML02_125,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784233006_R05C01,14.03987,-10.408196,-1.0204368,-17.780565,-12.224914,AML02,Diagnosis,AML02_127,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784233006_R06C01,-16.118746,-10.702058,-17.255201,15.914508,20.002542,AML02,Diagnosis,AML02_128,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233049_R01C01,-17.387606,-9.133116,-18.287676,15.7730055,18.770433,AML02,Diagnosis,AML02_135,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233049_R01C02,-17.953096,-9.650046,-17.869722,15.636039,18.9857,AML02,Diagnosis,AML02_136,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233049_R02C01,1.2284534,21.915907,-12.888108,-7.3604827,13.933872,AML02,Diagnosis,AML02_146,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784233049_R02C02,14.720329,-9.232012,-0.6769915,-17.939623,-12.829948,AML02,Diagnosis,AML02_180,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784233049_R03C01,-15.88471,-9.430293,-17.674662,15.626599,19.282776,AML02,Diagnosis,AML02_159,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233049_R03C02,14.494958,-10.798034,0.06082897,-14.865829,-16.105803,AML02,Diagnosis,AML02_191,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784233049_R04C01,-11.785767,12.287233,19.491749,-4.922105,-18.439358,AML02,Diagnosis,AML02_190,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233049_R04C02,-11.8671665,8.219092,21.692095,-2.1599157,-17.786976,AML02,Diagnosis,AML02_199,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233049_R05C01,-10.578085,6.3961587,-16.404995,-1.0670344,-22.278341,AML02,Diagnosis,AML02_198,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233049_R05C02,1.2041483,21.519426,-12.894869,-7.4512568,13.999279,AML02,Diagnosis,AML02_208,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784233049_R06C01,1.2978289,21.755814,-12.771011,-7.1476893,14.222091,AML02,Diagnosis,AML02_216,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784233049_R06C02,-0.3556017,-12.367403,7.915523,11.208402,10.128415,AML02,Diagnosis,AML02_165,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
8784233110_R01C01,-12.070185,13.190739,19.354765,-5.7171407,-19.264637,AML02,Diagnosis,AML02_167,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233110_R01C02,14.304541,-10.514324,-0.97485775,-16.86364,-14.100533,AML02,Diagnosis,AML02_193,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784233110_R02C01,-18.2891,-9.813162,-17.76134,15.533259,18.774353,AML02,Diagnosis,AML02_192,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233110_R02C02,12.84428,-11.5475235,-1.6135628,-17.924723,-12.464971,AML02,Diagnosis,AML02_201,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
8784233110_R03C01,13.109135,5.6140447,20.564919,-2.224762,19.716963,AML02,Diagnosis,AML02_200,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233110_R03C02,-12.127298,-8.418517,20.520681,-12.230386,-16.773304,AML02,Diagnosis,AML02_140,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233110_R04C01,-12.058577,-8.639684,20.343826,-12.313564,-16.733713,AML02,Diagnosis,AML02_139,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233110_R04C02,1.0623542,21.928127,-12.739536,-7.325848,14.015497,AML02,Diagnosis,AML02_153,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784233110_R05C01,-12.816827,12.6408615,20.08676,-4.3901186,-18.852545,AML02,Diagnosis,AML02_169,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233110_R05C02,14.18412,-10.01394,-1.0621718,-18.034374,-12.346993,AML02,Diagnosis,AML02_212,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with mutated NPM1
8784233110_R06C01,-11.352178,12.440524,19.86876,-4.748999,-18.567284,AML02,Diagnosis,AML02_182,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233110_R06C02,-12.071939,13.237868,19.4097,-5.5603943,-19.278057,AML02,Diagnosis,AML02_142,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233111_R01C01,-17.824593,-11.1143675,-17.025774,15.59397,19.28895,AML02,Diagnosis,AML02_174,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233111_R01C02,13.480627,-13.873804,-1.1169903,-14.89726,-12.233608,AML02,Diagnosis,AML02_196,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
8784233111_R02C01,3.1442204,20.180899,-13.510639,-6.8354154,14.803476,AML02,Diagnosis,AML02_186,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784233111_R02C02,14.532991,-10.2608185,-0.20156878,-15.498069,-16.447193,AML02,Diagnosis,AML02_204,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784233111_R03C01,-12.474793,13.386922,19.315601,-5.22481,-19.021053,AML02,Diagnosis,AML02_195,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
8784233111_R03C02,1.528425,20.693163,-13.084532,-7.6458764,14.079064,AML02,Diagnosis,AML02_214,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
8784233111_R04C01,14.891303,-9.598337,-0.03465051,-15.954407,-15.771837,AML02,Diagnosis,AML02_203,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
8784233111_R04C02,-0.7130058,-11.02303,4.5487494,10.263856,9.591728,AML02,Diagnosis,AML02_157,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
8784233111_R05C01,-17.87278,-9.962896,-17.692793,15.664117,19.187965,AML02,Diagnosis,AML02_156,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
8784233111_R05C02,13.019792,-11.140961,-1.6325067,-18.131021,-12.692737,AML02,Diagnosis,AML02_177,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
8784233111_R06C01,-12.987901,13.619628,19.548868,-5.2369895,-19.549904,AML02,Diagnosis,AML02_187,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082021_R01C02,-14.27674,-2.2202713,14.165554,11.775549,12.200672,AML02,Diagnosis,AML02_113,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082021_R02C01,-12.069354,13.072542,19.415335,-5.123454,-18.81737,AML02,Diagnosis,AML02_03,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082021_R02C02,-10.618423,-6.500998,12.606276,11.210277,11.269468,AML02,Diagnosis,AML02_126,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
9379082021_R03C01,-11.418562,12.061283,20.066143,-3.7702587,-17.974625,AML02,Diagnosis,AML02_33,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082021_R03C02,-18.01417,-9.780549,-17.77403,15.609524,19.010239,AML02,Diagnosis,AML02_138,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9379082021_R04C01,-11.965319,-9.9429455,20.26499,-12.897554,-16.527412,AML02,Diagnosis,AML02_82,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082021_R04C02,-18.059284,-10.716243,-17.256516,15.582284,19.169312,AML02,Diagnosis,AML02_141,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9379082021_R05C01,-11.599834,10.619371,21.052923,-2.5193896,-17.721037,AML02,Diagnosis,AML02_96,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082021_R05C02,12.783958,-11.547861,-1.6596824,-17.970621,-12.5592,AML02,Diagnosis,AML02_143,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
9379082021_R06C01,-5.559865,-11.421398,5.690369,6.615814,10.98749,AML02,Diagnosis,AML02_99,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9379082021_R06C02,2.388178,19.995937,-13.290064,-7.49067,14.421617,AML02,Diagnosis,AML02_145,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9379082097_R01C02,0.17776051,-13.185246,8.008001,10.705629,9.695449,AML02,Diagnosis,AML02_162,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
9379082097_R02C01,-12.758128,12.993199,19.883263,-4.678349,-18.964983,AML02,Diagnosis,AML02_149,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082097_R02C02,14.145082,-10.2423935,-1.0353379,-17.996178,-11.785464,AML02,Diagnosis,AML02_160,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with mutated NPM1
9379082097_R03C01,-11.461974,11.18973,20.644089,-3.6411357,-17.935184,AML02,Diagnosis,AML02_150,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082097_R03C02,14.955604,-9.120236,-0.28307417,-17.013735,-14.476238,AML02,Diagnosis,AML02_168,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
9379082097_R04C01,2.403171,20.137745,-13.206861,-7.6047187,14.332471,AML02,Diagnosis,AML02_152,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9379082097_R04C02,16.514725,-7.6643972,-19.171738,-14.766341,20.952858,AML02,Diagnosis,AML02_171,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
9379082097_R05C02,2.182892,19.88727,-13.336247,-7.694946,14.26146,AML02,Diagnosis,AML02_173,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9379082097_R06C01,-12.256747,12.810944,18.324383,-6.9945908,-19.16751,AML02,Diagnosis,AML02_155,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082105_R01C01,16.227139,-7.6726427,-19.190886,-14.823194,21.065033,AML02,Diagnosis,AML02_176,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
9379082105_R01C02,13.056147,5.7624984,20.638763,-1.8991342,20.027294,AML02,Diagnosis,AML02_194,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082105_R02C01,-12.891726,13.628396,19.511395,-5.211651,-19.529884,AML02,Diagnosis,AML02_178,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082105_R02C02,13.465594,-13.031097,-1.1405333,-15.768066,-12.13279,AML02,Diagnosis,AML02_206,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9379082105_R03C01,10.351783,-28.014856,-14.177207,4.295248,16.914001,AML02,Diagnosis,AML02_181,Unknown,Validation (test) Samples,St Jude Children's,Unknown,Otherwise-Normal Control
9379082105_R03C02,1.1454213,22.023596,-12.828253,-7.3065658,13.9564,AML02,Diagnosis,AML02_211,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9379082105_R04C01,11.767321,-26.23866,-13.148139,3.7287576,16.688549,AML02,Diagnosis,AML02_183,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9379082105_R04C02,-17.11986,-9.975692,-17.200615,15.319323,19.112392,AML02,Diagnosis,AML02_213,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9379082105_R05C01,13.348371,-13.573981,-1.0695568,-15.303647,-12.011695,AML02,Diagnosis,AML02_185,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9379082105_R05C02,-10.733787,12.722926,19.597002,-6.0174875,-19.238781,AML02,Diagnosis,AML02_215,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9379082105_R06C01,-11.718587,12.709724,19.680403,-4.6859975,-18.576283,AML02,Diagnosis,AML02_188,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9420867136_R01C02,13.598209,-14.1742735,0.41118717,-11.73506,-16.480072,AML02,Diagnosis,AML02_04,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9420867136_R02C02,-11.8243065,12.417481,18.300385,-7.3247304,-19.246561,AML02,Diagnosis,AML02_05,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9420867136_R03C02,-17.304285,-18.985489,0.66449183,-14.598102,-23.14232,AML02,Diagnosis,AML02_09,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
9420867136_R04C02,-11.958831,-5.481752,13.028293,11.419718,11.226789,AML02,Diagnosis,AML02_60,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9420867136_R05C02,-0.8509371,-11.640349,7.1771445,11.125971,10.015576,AML02,Diagnosis,AML02_67,Unknown,Validation (test) Samples,St Jude Children's,Unknown,MDS-related or secondary myeloid neoplasms
9420867136_R06C01,-14.535167,-3.8502088,14.670505,11.612413,12.6171875,AML02,Diagnosis,AML02_02,AML with other rare recurring translocations,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
9420867136_R06C02,12.897716,6.414254,21.22004,-1.3933277,21.273565,AML02,Diagnosis,AML02_74,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9420867155_R01C01,1.8122306,20.4569,-13.197355,-7.6678157,14.116099,AML02,Diagnosis,AML02_83,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9420867155_R01C02,-11.75628,11.768573,3.9931161,-24.443733,11.127952,AML02,Diagnosis,AML02_122,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
9420867155_R02C01,-11.527941,11.953784,4.0258837,-24.507788,11.277512,AML02,Diagnosis,AML02_97,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
9420867155_R02C02,-18.225206,-10.207338,-17.513983,15.534161,18.953182,AML02,Diagnosis,AML02_123,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9420867155_R03C01,1.1640655,21.770487,-12.757909,-7.3883324,14.026742,AML02,Diagnosis,AML02_103,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9420867155_R03C02,-11.227843,11.910186,20.06893,-4.7446213,-18.414732,AML02,Diagnosis,AML02_130,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9420867155_R04C01,-11.480451,12.575747,19.66139,-5.0598693,-18.694828,AML02,Diagnosis,AML02_110,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9420867155_R05C01,-11.4970665,11.973795,4.1763315,-24.663673,11.540055,AML02,Diagnosis,AML02_114,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
9420867155_R06C01,-11.193667,12.848973,19.624653,-5.598877,-19.073984,AML02,Diagnosis,AML02_120,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020001_R01C02,16.505156,-7.631698,-19.255087,-14.935044,21.11974,AML08,Diagnosis,AML08_SP_24,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
9426020001_R02C01,-12.138602,-8.374089,20.529573,-12.202743,-16.779005,AML08,Diagnosis,AML08_SP_23,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020001_R02C02,11.439928,-26.57205,-13.354507,3.8797233,16.724535,AML08,Diagnosis,AML08_SP_31,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9426020001_R03C01,-12.501738,13.100872,19.435131,-5.070803,-18.797884,AML08,Diagnosis,AML08_SP_30,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020001_R03C02,-0.47450042,11.628048,-15.95841,1.6187593,-22.685032,AML08,Diagnosis,AML08_SP_37,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020001_R04C01,-11.791041,8.570461,21.756239,-2.0965521,-17.651731,AML08,Diagnosis,AML08_SP_36,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020001_R04C02,3.5505655,20.433985,-13.6277485,-6.703405,14.7893915,AML08,Diagnosis,AML08_SP_42,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426020001_R05C01,-12.700902,13.555819,19.313011,-5.398724,-19.285591,AML08,Diagnosis,AML08_SP_41,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020001_R05C02,-11.85558,-10.554227,20.06634,-13.161988,-16.415747,AML08,Diagnosis,AML08_SP_49,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020001_R06C01,-13.854393,-8.5752945,-18.132465,15.834079,19.307013,AML08,Diagnosis,AML08_SP_237,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9426020001_R06C02,17.161327,-7.5778832,-19.304895,-14.897099,20.881409,AML08,Diagnosis,AML08_SP_54,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with in-frame bZIP mutated CEBPA
9426020002_R01C01,-10.331335,7.046459,-16.628014,-1.0043907,-22.284164,AML08,Diagnosis,AML08_SP_25,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9426020002_R01C02,-12.051284,-9.032203,20.391447,-12.493944,-16.6705,AML08,Diagnosis,AML08_SP_106,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020002_R03C01,17.240587,-7.573984,-19.30877,-14.86665,20.8128,AML08,Diagnosis,AML08_SP_11,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with in-frame bZIP mutated CEBPA
9426020002_R03C02,-12.006293,12.649725,19.15569,-5.8474755,-18.990417,AML08,Diagnosis,AML08_SP_80,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020002_R04C01,13.367546,-11.002485,-1.4351506,-17.971184,-12.360017,AML08,Diagnosis,AML08_SP_26,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(6;9)(p23;q34.1)/DEK::NUP214
9426020002_R04C02,-11.263721,12.55672,19.26697,-6.296585,-19.140415,AML08,Diagnosis,AML08_SP_18,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426020002_R05C01,-15.073261,-3.5976753,15.02931,11.645099,12.910655,AML08,Diagnosis,AML08_SP_107,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9426020002_R05C02,-5.1981225,-11.245256,5.7916756,6.832688,11.235176,AML08,Diagnosis,AML08_SP_22,Unknown,Validation (test) Samples,St Jude Children's,Unknown,Otherwise-Normal Control
9426020002_R06C01,2.979825,20.291098,-13.604593,-7.3188653,14.334181,AML08,Diagnosis,AML08_SP_230,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426020002_R06C02,-11.900824,-10.852875,20.17591,-13.303182,-16.389551,AML08,Diagnosis,AML08_SP_33,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426021041_R01C01,-5.4127903,-11.350516,5.824784,6.814406,11.000597,AML08,Diagnosis,AML08_SP_39,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with other rare recurring translocations
9426021041_R01C02,-18.07781,-9.496055,-17.996712,15.596056,18.65708,AML08,Diagnosis,AML08_SP_28,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9426021041_R02C01,-11.203451,11.812457,20.138039,-4.4826794,-18.229868,AML08,Diagnosis,AML08_SP_44,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426021041_R02C02,1.1661685,22.09297,-12.714345,-7.1572537,14.120598,AML08,Diagnosis,AML08_SP_46,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426021041_R03C01,-11.987736,11.113221,19.518076,-5.8998246,-18.843174,AML08,Diagnosis,AML08_SP_58,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426021041_R04C01,-18.07629,-9.9823265,-17.612083,15.577101,19.12518,AML08,Diagnosis,AML08_SP_12,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9426021041_R04C02,-11.759671,12.092766,19.893116,-4.5319533,-18.373188,AML08,Diagnosis,AML08_SP_51,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426021041_R05C01,3.8332765,19.137432,-13.886175,-7.1936703,14.777177,AML08,Diagnosis,AML08_SP_217,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426021041_R05C02,13.759434,-13.563489,-1.0803964,-14.676401,-13.194667,AML08,Diagnosis,AML08_SP_20,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with other rare recurring translocations
9426021041_R06C01,-12.3529825,10.149424,20.7064,-3.031546,-18.224945,AML08,Diagnosis,AML08_SP_19,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426021041_R06C02,1.4522842,22.441517,-12.944707,-6.7249947,14.225542,AML08,Diagnosis,AML08_SP_29,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426021149_R01C01,-12.778236,13.408336,19.593397,-5.14105,-19.365086,AML08,Diagnosis,AML08_SP_34,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426021149_R01C02,1.1320751,22.34177,-12.725369,-7.0347075,14.0994215,AML08,Diagnosis,AML08_SP_6,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426021149_R02C02,14.1890745,-10.11007,-0.8410705,-17.566992,-12.961734,AML08,Diagnosis,AML08_SP_35,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
9426021149_R03C01,-17.593622,-9.923568,-17.700409,15.702201,19.302032,AML08,Diagnosis,AML08_SP_216,AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)/CBFB::MYH11
9426021149_R03C02,13.412078,-10.81932,-1.3900313,-17.94868,-12.771581,AML08,Diagnosis,AML08_SP_8,AML with t(6;9)(p23;q34.1)/DEK::NUP214,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(6;9)(p23;q34.1)/DEK::NUP214
9426021149_R04C01,-12.519629,10.018703,19.824512,-4.7329974,-18.703844,AML08,Diagnosis,AML08_SP_120,AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(9;11)(p22;q23.3)/KMT2A-rearrangement
9426021149_R04C02,1.0615712,22.337622,-12.730034,-7.005747,14.116555,AML08,Diagnosis,AML08_SP_48,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426021149_R05C01,1.1798369,21.893232,-12.804467,-7.2878785,14.02551,AML08,Diagnosis,AML08_SP_240,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
9426021149_R05C02,13.360536,-11.380533,-1.1735437,-17.606,-11.733229,AML08,Diagnosis,AML08_SP_53,Unknown,Validation (test) Samples,St Jude Children's,Unknown,AML with mutated NPM1
9426021149_R06C01,1.7287806,21.093979,-13.08553,-7.1150546,14.353212,AML08,Diagnosis,AML08_SP_21,AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1,Validation (test) Samples,St Jude Children's,Acute myeloid leukemia (AML),AML with t(8;21)(q22;q22.1)/RUNX1::RUNX1T1
